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Abstract 
 
Inorganic transition metal complexes have been under extensive investigation for many 
years in supramolecular assemblies due to their favourable photophysical and redox 
properties including; absorbance and emission in the visible region of the spectrum, 
large stokes shifts, long lifetimes, intense luminescence, good photostability and useful 
photosensitising properties for photodynamic therapy.  Their properties make them 
potentially very valuable biological probes but to date relatively little application of 
transition metals in this area have been made.  This thesis focuses on a range of novel 
ruthenium and iridium luminophores, their bioconjugates and nanoparticle conjugates 
which were prepared for applications in cell imaging.  A key aim of this thesis was the 
synthesis, characterisation and identification of novel bioconjugates suitable for 
applications in cellular imaging.  Some preliminary studies of their application in cell 
imaging are also presented.   
 
 
Chapter 1 outlines how metal complexes have been used previously in cellular imaging 
and how conjugation of these transition metal complexes to biomolecules has lead to 
more targeted and improved applications in medical diagnostics, photodynamic therapy, 
cellular imaging and pharmaceutical drug delivery.  Chapters 3 & 4 detail the synthesis 
and photophysical characterisation of a series of Raman and oxygen sensitive, water 
soluble and water insoluble ruthenium (II) and novel iridium (III) polypyridyl 
complexes suitable for biomolecule coupling.  Following conjugation of these 
luminophores to gold nanoparticles in Chapter 3 and cell penetrating peptides in 
Chapter 5, the dye-conjugates were shown to transport efficiently across the cellular 
membrane of mammalian SP2 and CHO cells and locate throughout the cell’s 
organelles.  Whereas, using confocal fluorescence microscopy, the parent complexes 
were shown not to internalise within the cellular structures.  The inherent properties of 
the dyes, such as Raman and lifetime sensitivity, may then be used to determine pH and 
oxygen levels inside the cell.  This could provide critical information for the early 
detection of certain diseases, as abnormal pH and oxygen levels are indicative of 
cancerous tumours.  Furthermore, the generation of singlet oxygen following light 
absorption by the luminophores is known to cause additional cell apoptosis.   
 
Finally, Chapter 6 describes attempts to functionalise the nucleobase guanine with a 
fluorescent fluorescein molecule through a short and rigid linker.  A range of synthetic 
techniques such as Suzuki coupling, Sonogashira coupling, click chemistry and 
Buchwald-Hartwig coupling were used in an effort to achieve this.  Using DNA as a 
scaffold for the first time, the modified nucleoside may be incorporated into the 
sequence of DNA which may be surface immobilised.  Thus, providing an efficient light 
harvesting supramolecular assembly for the conversion of solar energy into electrical 
potential.  
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Chapter 1: Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“The journey of a thousand miles begins with one step” – Lao Tsu. 
 2 
1.0 Introduction to Molecular Photophysics 
 
When a molecule absorbs a photon of light energy it is excited to higher 
vibration energy state.  There are many ways in which the molecule may lose its excess 
energy in returning back to it’s original ground state energy level, as illustrated by the 
Jablonski diagram in Figure 1.1.   
 
 
 
Figure 1.1: Jablonski diagram illustrating the radiative and non-radiative processes 
involved in the absorption and resultant relaxation of a molecule following excitation 
by a photon of light energy.[1] 
 
 
Non-radiative deactivation processes include vibrational relaxation whereby an 
excited electron returns to the ground energy state without the emission of a photon 
through energy transfer to the environment caused by collisions.  Internal conversion 
(IC) is a non-radiative isoenergetic process that involves the transfer of an electron 
between states of the same multiplicity.  Intersystem crossing (ISC) is also an 
isoenergetic non-radiative deactivation process involving the transfer of an electron 
 3 
between an excited singlet (S) and exited triplet (T) state since the vibrational energy 
levels within the singlet and triplet states overlap.  The singlet and triplet states are 
electronic isomers of each other; their differences are due to the electronic spin 
configurations of each state.  ISC is also enhanced with the presence of heavy and 
paramagnetic atoms such as ruthenium and iridium.  
 
The molecule may also lose its excess energy through radiative processes known 
as luminescence, which may be further subdivided into fluorescence and 
phosphorescence.  Fluorescence is a radiative deactivation process between states of the 
same multiplicity in a molecule (for example: S1  S0) and is the emission process for 
many organic fluorophores.  Phosphorescence, on the other hand, is a radiative 
deactivation process between states of different multiplicity (for example: T1  S0) and 
is common for many transition metal complexes.  The spin forbidden nature of this 
transition explains why excited state lifetimes are generally much greater for metal 
complexes than that seen for organic fluorophores.  
 
Another mode of deactivation for an excited state molecule is non-radiative 
molecular quenching and may be described as (i) dynamic quenching; which is a 
process of collisional deactivation of the excited state molecule as a result of diffusion-
based interactions within the system or (ii) static quenching; which is the interaction of 
the luminophore with the quencher molecule to form a non-emissive complex and 
inhibits excited state formation of the chromophore in the first place.  
 
 
 
 
 
 
 
 
 
 
 
 
 4 
1.0.1 Luminescent Quantum Yields (φf) and Lifetimes (τ) 
Both luminescent quantum yields and luminescent lifetimes are two important 
quantitative assessments of a chromophore’s emission efficiency.  Determining the 
lifetime of a molecule is important as it gives insight into how long a chromophore 
remains in an excited energy state and therefore, the time it has to interact with its 
surrounding environment.  The lifetime of a chromophore may be effected by many 
factors including the presence of heavy atoms and the solvents used.   
A molecule’s quantum yield (φf) is a fractional quantity of the number of emitted 
photons relative to the number of photons absorbed as shown in Equation 1.1. 
φf = # photons emitted / # photons absorbed……….(Eq 1.1) 
Luminescent quantum yields may approach but never achieve unity as the rate of non-
radiative decay decreases but there will always be some energy lost as a result of Stokes 
losses.  The luminescent quantum yield is a key parameter in calculating quenching rate 
constants, energy transfer rates and radiative / non-radiative decay rate constants.[2]  
Together with experimentally determined emission lifetimes (τ) the quantum yield may 
be used to estimate unimolecular rate constants for radiationless processes such as 
internal conversion and intersystem crossing within the system.   
In a given system all of the unimolecular phototransitions expected to occur in a 
molecule include the absorption of light energy (Iabs) followed by some or all of; 
internal conversion (IC), intersystem crossing (ISC), fluorescence (F) or 
phosphorescence (P).  Steady-state approximation for the concentration of the first 
excited singlet energy state [S1] assumes that the rate of absorption of light is equal to 
the combined rates of deactivation of S1.  
 
Iabs = (kIC + kISC + kf) [S1]……….(Eq 1.2) 
 
As most of the complexes in this thesis deal with phosphorescence and therefore 
emission from the triplet state [T1], steady-state approximations also assume that the 
rate of formation of triplet states is equal to their rates of deactivation, giving Equation 
1.3. 
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kISC [S1] = (kISC + kP) [T1]……….(Eq 1.3) 
 
Therefore, under steady-state conditions for phosphorescent complexes, the 
quantum yield of key processes may be described as the ratio of the decay rates to the 
total deactivation rates of that state.  The quantum yields for the transitions may then be 
expressed as. 
 
ɸIC = kIC / (kF + kISC + kIC)……….(Eq 1.4) 
ɸISC = kISC / (kF + kISC + kIC)……….(Eq 1.5) 
ɸP = ɸISC x kIC / (kP + kISC)……….(Eq 1.6) 
 The quantum yield may also be related to the lifetime (τ) of the chromophore.  
The singlet (τS) and triplet lifetimes (τT) are equal to the inverse of the sum of all the 
rates that deactivate their respective energy levels and may be written as seen in 
Equations 1.7 and 1.8 respectively. 
 
τS = 1 / (kF + kISC + kIC)……….(Eq 1.7) 
τT = 1 / (kP + kISC)……….(Eq 1.8) 
 
Therefore, the expression of key quantum yield states may be defined as follows: 
 
ɸIC = (kIC)(τS)……….(Eq 1.9) 
ɸISC = (kISC)(τS)……….(Eq 1.10) 
ɸP = (ɸISC)(kP)(τT)……….(Eq 1.11) 
 
 Hence, the measured values of τS does not provide information on the pure 
radiative lifetime of fluorescence from the singlet energy state.  However, 
phosphorescent lifetimes provide a direct insight into the lifetime of the excited triplet 
energy state (τT) as shown in Equation 1.11.[2]  An increase in temperature usually 
causes a decrease in both the quantum yield and lifetime of a molecule as non-radiative 
decay processes such as vibrations, rotations and collisions become more likely.  
Frequently, for ruthenium polypyridyl complexes, the population of the geometrically 
distorted 3MC states are thermally induced leading to decomposition of the complex.[3, 
4]
 
 6 
1.1 Charge Transfer Transitions in Metal Complexes   
 
 Most transition metal polypyridyl complexes display very intense absorption 
bands in the visible and near UV regions of the electromagnetic spectrum.  Absorbance 
bands are usually assigned to electronic transitions which can be regarded as metal 
centred (MC) transitions, ligand centred (LC) transitions or charge transfer (CT) as 
illustrated in Figure 1.2.  In general, in a metal complexes’ ground energy state the σL 
and πL ligand orbitals are full.  The metal’s d orbitals are partially filled depending on 
the oxidation state of the metal. Other anti-bonding σ*L and π*L ligand orbitals are 
usually empty.   
 
Once light energy is absorbed the population of these orbitals change.  Metal-
centred (MC) transitions (or d-d transitions) are low in energy and their absorbance 
often corresponds to the wavelength of visible light as seen for many brightly coloured 
ruthenium (II) metal complexes.  This involves a rearrangement of the metal d-electrons 
from the t2g to eg sets.  Interligand charge transfer (ILCT) transitions are of much higher 
energy and generally occur when chromophoric ligands are coordinated to the metal 
centre.  MLCT is particularly common since it involves promotion of an electron from 
the highest occupied molecular orbital (HOMO) to the lowest unoccupied molecular 
orbital (LUMO).[5]  All of these excited energy states may have singlet or triplet 
multiplicity although spin-orbit coupling causes singlet-triplet mixing in MC and 
MLCT excited energy states.[6] 
 
Figure 1.2: Energy level diagram for octahedral metal complexes showing the possible 
electronic transitions. 
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Many of the photophysical and redox characteristics of [Ru(bpy)3]2+ have been 
detailed extensively in the literature[3, 4, 6-8] and it may be used as a prototype to explain 
similar processes occurring in other ruthenium (II) polypyridyl complexes discussed in 
Chapter 3.  Figure 1.3 shows the typical absorbance and emission profile for the 
[Ru(bpy)3]2+ complex in acetonitrile solution. 
 
 
 
Figure 1.3: Absorbance and normalised emission spectra (excited at 451 nm, slit 
widths: 5 nm – normalised to 1 arbitrary unit) of 20 x 10-6 M [Ru(bpy)3]2+ in 
acetonitrile solution. 
 
 
The UV-vis spectrum of [Ru(bpy)3]2+ is dominated by a spin allowed MLCT 
transition from the ruthenium (dπ orbital) to a bipyridyl ligand (π*) orbital at 451 nm 
with a further MLCT transition at a higher energy at 241 nm.  The strong absorbance at 
286 nm is attributed to LC (π-π*) electronic transitions within the bipyridyl ligands 
orbitals.[4] 
 
The emission spectrum of [Ru(bpy)3]2+ has a maximum emission at 611 nm 
when excited into the MLCT band at 451 nm.  It has a phosphorescent lifetime of 470 
ns in degassed acetonitrile and 954 ns in degassed aqueous solution.  It has a quantum 
yield of 0.0642 in aerated acetonitrile at room temperature.[9]  For most ruthenium (II) 
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polypyridyl complexes, the lowest excited energy state is a 3MLCT state which 
undergoes relatively slow radiationless transitions and thus a relatively long emission 
lifetime.[3]  The intersystem crossing from singlet to triplet state has been shown to be 
close to unity.[4]  Transient absorption spectroscopy has been used to calculate that it 
takes approximately 100 fs for the formation of the excited triplet state following 
absorption of a photon of light in acetonitrile solution.[7, 8]  This does not necessarily 
indicate the true intersystem crossing rate as it also contains the overall evolution of the 
singlet excited state to the thermalised triplet excited state but presumably contains the 
intersystem crossing rate within the results.  
 
 
UV-vis light absorption by iridium (III) complexes is mostly ligand centred (LC) 
and therefore light energy is absorbed at shorter wavelengths when compared to 
ruthenium (II) complexes and they also tend not to be as brightly coloured.  A typical 
example of an iridium (III) absorbance and emission profile is shown in Figure 1.4. 
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Figure 1.4: Absorbance and normalised emission spectra (excited at 381 nm, slit 
widths: 5 nm - normalised to 1 arbitrary unit)) of 20 x 10-6M [Ir(dfpp)2(picCOOH)]+ in 
acetonitrile solution. 
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 The UV-vis spectrum of [Ir(dfpp)2(picCOOH)]+ is dominated by LC 
difluorophenyl pyridine π-π* electronic transitions giving maximum absorbance peaks 
at 245 nm and 283 nm.  This is consistent with reports of other iridium (III) complexes 
containing difluorophenyl pyridine, bipyridyl or terpyridine ligands.[10, 11]  The shoulder 
at 324 nm may be assigned to the intraligand π-π* transition of the [picCOOH] ancillary 
ligand.  There is evidence of a smaller peak extending down into longer wavelengths at 
381 nm which is attributed to MLCT from the iridium dπ to [dfpp] π* orbital.   
 
 
[Ir(dfpp)2(picCOOH)]+ has a maximum emission at 521 nm when excited into 
the MLCT band at 381 nm and a quantum yield of 0.103 in aerated acetonitrile at room 
temperature.  The emission decay follows biexponential kinetics with a lifetime of 195 
+/- 3 ns in aerated acetonitrile and 241 +/- 5 ns in degassed acetonitrile with the second 
lifetime component of around 1 ns in duration.  However, its emission lifetime in 
degassed methanol is as long as 842 +/- 9 ns.   
 
 
The optical transitions of ruthenium and iridium polypyridyl complexes may be 
tuned with the addition of certain electron withdrawing or donating ligands and 
therefore, one may control the nature of the lowest excited state energy.[3]  In general, a 
broadening of absorption bands at lower energy levels suggests that the new ancillary 
ligand charge-transfer state will be the lowest triplet excited energy state.[7]  To shift the 
t2g - π* band to longer wavelengths of the spectrum one may add electron withdrawing 
groups to the cyclometalating ligands of ruthenium and iridium complexes in an effort 
to lower their π* energy level.  Another technique is to introduce an electron donating 
ligand to stabilise the positive hole at the metal centre following MLCT.  Replacement 
of bipyridyl (bpy) ligands with a stronger π-acceptor ligand, such as biquinoline (biq), 
results in a shift in absorbance to longer wavelengths because of a decrease in the 
ligand’s π* (LUMO) energy level upon coordination.  Metal d-orbitals may then also 
overlap with ligand π* orbitals and thus back-bonding occurs creating a strong chemical 
bond.  
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For a metal-ligand complex to be luminescent the crystal field strength must be 
strong enough to raise the metal d-orbitals to a higher energy level than that of the 
3MLCT or 3LC states and hence, prevent a route for radiationless decay back to the 
ground state.  In octahedral metal-ligand complexes LC and MLCT excited states are 
not usually strongly displaced compared to the ground state geometry and thus, when 
LC or MLCT states are the lowest excited states, the complex does not undergo fast 
radiationless decay to the ground state and luminescence can usually be observed.[3]  
The features in ruthenium (II) and iridium (III) absorbance and emission profiles may 
be explained by the spin-orbit coupling of the d6 metal centres, leading to large stokes 
shifts.  Spin-orbit coupling involves mixing of both the singlet and triplet excited energy 
states of the molecule.  However, the lowest lying energy state responsible for emission 
remains largely triplet in nature.  The efficiency of intersystem crossing following light 
absorption is known to be close to unity for ruthenium (II) and iridium (III) polypyridyl 
complexes.[12, 13] 
 
 
Bipyridine ligands are good σ-donor ligands as the lone pair of electrons on the 
nitrogen is able to form a σ-bond with the unoccupied orbital of the metal ion centre.  
This leads to smaller ligand field strength and as a result the 3MC states are closer in 
energy to the 3MLCT states allowing thermal access.  Consequently, these compounds 
tend to be photolabile.[14]  The photostability of iridium is generally greater than that of 
ruthenium due to the larger ligand field splitting in iridium complexes resulting in a 
thermally inaccessible 3MC excited energy state.[15] 
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1.1.1 Ruthenium (II) and Iridium (III) Polypyridyl Complexes as Biological Probes:
  
One of the key objectives of this thesis was the synthesis and identification of 
suitable transition metal probes for potential conjugation to cell penetrating 
biomolecules for applications in cellular imaging.  With this in mind a series of 
ruthenium (II) and iridium (III) metal complexes were prepared and fully characterised.  
Transition metal complexes have been under intensive investigation for many years as 
sensors due to their favourable photophysical and redox properties including; 
absorbance and emission in the visible region of the electromagnetic spectrum, large 
stokes shifts, long-lived intense luminescence, good photostability and useful singlet 
oxygen photosensitising properties.[16]  These properties make them potentially very 
valuable as biological probes but this has not been explored until the last 5 years.   
 
Their long lived emission is of particular interest, allowing for discrimination 
from the shorter-lived background fluorescence present in many biological samples.  
Their large Stokes shifts also reduce the possibility of concentration quenching or self-
absorption of the complex and in addition, their red shifted emission is removed from 
regions of the spectrum where autofluorescence of biological samples often occurs in 
FLIM and confocal microscopy measurements.  Autofluorescence from biological 
samples interfere with luminescence even in the red region. Therefore, a key aim is to 
try and move to the NIR region > 700 nm in analysis of biological samples.[17, 18]  
However, time gating experiments may also remove the shorter lived autofluorescence 
components present in biological samples.   
 
The majority of luminophores previously used for diagnostic purposes are 
organic typically with short-lived fluorescent lifetimes (<10 ns) and limited somewhat 
by their environmental sensitivity.  As a result they are not very well suited to examine 
oxygen concentration or environmental sensitivity in biological samples.  Furthermore, 
longer-lived biological processes on a microsecond timescale such as membrane 
diffusion, protein rotation and protein folding may be studied using luminescence 
anisotropy results from the inorganic transition metal probes.  The emission maxima of 
many ruthenium (II) complexes are in the region of 600 nm to 700 nm and thus, 
correspond to low absorption of biological samples.  Another advantage is that they 
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tend not to exhibit dimer formation or have associated photobleaching problems as is 
common for some organic based molecular probes.[19]  
 
 Iridium (III), like ruthenium (II), is a d6 transition metal atom and as such 
displays many optical characteristics similar to ruthenium (II) complexes.  However, 
many iridium complexes have shown greater emission, quantum yields and longer 
lifetimes.  The stronger spin-orbit coupling of iridium complexes results in greater 
mixing singlet and triplet excited energy states, allowing for efficient intersystem 
crossing and largely removing the spin-forbidden nature of a phosphorescent 
transition.[20, 21]  Furthermore, modification of ancillary ligands yields tunable emission 
from blue to red as illustrated in results published by Zhao et al.[22, 23] in Figure 1.6.  
Such tunable photophysical characteristics are generally not seen to the same extent for 
ruthenium (II) metal complexes.  It has been well demonstrated that the photophysical 
properties, in particular emission wavelength of iridium (III) complexes, is determined 
by the ligand structure.  The emission of iridium (III) complexes 1-5 (Figure 1.5) is 
significantly red-shifted with extension of the conjugated length of the ancillary ligand.   
 
 
 
 
Figure 1.5: Chemical structures of iridium (III) complexes synthesised by Zhao et al.[23] 
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Figure 1.6: Normalised emission spectra of iridium (III) complexes 1-5 (illustrated in 
Figure 1.5) synthesised by Zhao et al.[23] in dichloromethane at room temperature. 
 
 
The addition of ancillary ligands with environmentally sensitive functional 
groups, such as ionisable protons, can offer additional pH sensitivity to a metal complex 
which may be reproduced in their optical properties or photophysics.  Recently, there 
has been considerable interest in the binding ability of pH sensitive ruthenium (II) 
polypyridyl complexes to DNA given their potential therapeutic effects.[24, 25]    Bai et 
al.[25] reported how the pH sensitive [Ru(bpy)2(picCOOH)]2+ complex showed 
successful intercalation with double stranded calf-thymus DNA.  This was indicated by 
an increase in the emission intensity and quantum yield of the molecular probe upon the 
addition of increasing amounts of DNA to a solution containing the metal complex.  
Intramolecular hydrogen bonding between luminophore and DNA offers protection to 
the probe from the surrounding aqueous environment as the dye intercalates within the 
DNA.  This family of ruthenium (II) complexes could potentially be modified to exhibit 
pH-dependent DNA damage and therefore, display preferential selectivity towards 
cancerous cells. 
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1.1.2 Ruthenium (II) and Iridium (III) Complexes with pH Sensitive Ancillary 
Ligands 
 
It is noted that there has been very limited study into metal complexes with 
multidentate protonatable/deprotonatable groups and their potential interactions with 
DNA.[26]  2-(4-Carboxylphenyl)imidazo[4,5-f][1,10]phenanthroline) [(picCOOH)], 
illustrated in Figure 1.7, is coordination to both ruthenium (II) and iridium (III) metal 
centres in this thesis.  The ligand has two ionisable protons located on the imidazole 
ring giving rise to well defined acid-base characteristics and a terminal carboxyl 
functionality that allows for the efficient conjugation to biomolecules such as 
polypeptides.  The substitution of the carboxyl functionality with either nitro or amino 
substituent has also been achieved and their photophysical comparison forms detailed 
analysis in Chapter 3. 
 
 
Figure 1.7: Ionisable sites on 2-(4-carboxylphenyl)imidazo[4,5-f][1,10]phenanthroline) 
[(picCOOH)] ligand. 
 
 
One of the reasons our group is so interested in the [pic(COOH)] ligand is that 
remarkably, when coordinated to a metal centre the resulting luminophores displayed 
longer lifetimes (> 600 ns) and increased emission intensities (more than twice) in 
aqueous media, lending to the arguments for their use as molecular probes for biological 
media.  Pellegrin et al.[27, 28] details the extensive photophysical characterisation of the 
ruthenium (II) polypyridyl complex, [Ru(bpy)2(picCOOH)]2+, containing this pH 
sensitive ancillary ligand.   
 
 
N
N N
H
N
COOH
Ionisable sites 
 15 
Its subsequent conjugation to biomolecules such as polypeptides[19, 29] has shown 
how the acid-base characteristics of the ligand may be exploited to glean information on 
intracellular environments for example.  Neugebauer et al.[19] reported how conjugation 
of this pH sensitive probe to a cell penetrating peptide allowed for the passive diffusion 
of the probe across a cell membrane (Figure 1.8).  Once inside the cell membrane, the 
pH of the cytoplasm had a direct effect on both the lifetime and relative Raman peak 
intensities of the ruthenium (II) multimodal probe.  As a result, by using the same 
molecular probe, one could efficiently determine both pH (by using the relative Raman 
peak intensities) and oxygen concentrations (by using the lifetime of the dye) within the 
cell.  This could potentially provide critical information in the identification of 
cancerous tumours as they are known to express abnormal pH and oxygen levels.[30-32]   
 
 
 
 
Figure 1.8: Flow diagram illustrating the cellular uptake and determination of 
intercellular pH (using Raman spectroscopy) and oxygen levels (using lifetimes) using 
the same pH sensitive [Ru(bpy)2(picCOOH)]2+ multimodal probe.[33] 
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Interestingly, the uncoordinated nitro funtionalised pH sensitive ligand 2-(4-
nitrophenyl)imidazo[4,5-f][1,10]phenanthroline) [(picNO2)] displayed preferential 
selectivity towards certain anions allowing for their fast and easy colorimetric 
determination by the naked eye.[34]  The ligand exhibited a red shift in its absorbance 
spectrum of up to 89 nm when bound to anions in the order of AcO- > H2PO4- > F- when 
performed in DMSO.  Furthermore, the emission of the ligand is completely quenched 
upon the addition of fluoride (F-) to the solution as shown in Figure 1.9.  This lends to 
arguments for its potential use as an efficient fluoride sensor as high fluoride 
concentrations are known to be toxic and can cause fluorosis.[35] 
 
 
 
Figure 1.9: Quenching of emission of the [(picNO2)] ligand upon addition of F- anion.  
Sample was excited at 387 nm in DMSO.[34] 
 
 
1H-NMR studies indicated that the mechanism of interaction between sensor and 
anions (such as AcO-, H2PO4- or F-) is one of deprotonation, by forming a hydrogen 
bond with the H1’ proton.  Whereas, Cl-, Br- and I- anions formed a hydrogen bond with 
the NH, Hc’ and H1’ protons as illustrated in Figure 1.10 below.  
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Figure 1.10: Proposed colorimetric anion binding mechanism to the [(picNO2)] 
ligand.[34] 
 
 
The [Ru(bpy)2(picNO2)]2+ metal complex also demonstrated anion binding 
affinity, which displayed similar results to that seen for the free [(picNO2)] ligand. [24, 34]  
Shi et al.[24] reported of the synthesis of ortho-, meta- and para-nitro substituted 
[Ru(bpy)2(picNO2)]2+ complexes with the intention of examining their comparative 
DNA intercalating abilities in a procedure very similar to that of Bai et al.[25]  Of 
particular interest is the discovery that the location of the nitro substituent has a 
dramatic effect on the emission intensity of the pH sensitive complex.  Ortho-
subsitiuted and para-substituted complexes failed to display any luminescence, whereas, 
the meta-functionalised nitro group showed a bright emission profile.  This has 
implications for the compounds synthesised in this thesis and is discussed in detail in 
Chapter 3.   
 
The synthesis of the amino functionalised ligand 2-(4-aminophenyl) 
imidazo[4,5-f][1,10]phenanthroline) [(picNH2)] and coordination to a ruthenium metal 
centre has also been reported.[36, 37]  They highlighted the complexes ability to (i) 
intercalate into the DNA base pairs and upon irradiation possibly photocleave the 
plasmid pBR 322 DNA, (ii) display anti-tumor activity against transfected cells and (iii) 
exhibit good antioxidant activity against hydroxyl radicals that may induce DNA 
damage in humans.  Once again, these results were determined through a series of 
absorbance, luminescence, viscosity and cell viability studies. 
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Iridium (III) complexes containing derivatives of the protonable ligand have also 
previously been reported.  Zhao et al.[22] synthesised and characterised a series of 
iridium (III) complexes (Figure 1.11) that were used to study the influences of protons 
and anions on the photophysical properties of the complexes.   
 
 
Figure 1.11: Series of cationic iridium (III) complexes 1-3 containing different pH 
sensitive phenanthroline derivatives.[22] 
 
 
Similar to the research conducted by Chen et al.,[34] the addition of anions and 
protons to the complexes’ solution had a significant effect on their photophysical 
properties.  Following the addition of CF3COOH, all three iridium (III) complexes show 
a significant change in emission from yellow to red.  The addition of anions, such as F-, 
CH3COO- or H2PO4-, caused variations in both the absorbance and emission profiles of 
the complex and was characterised by a quenching of emission intensity along with a 
colour change from greenish-yellow to brown as shown in Figure 1.12.  However, the 
iridium complex 1 showed the largest binding affinity towards the fluoride anion and is 
suggested that it too may act as a potential phosphorescent chemosensor for fluoride 
anions. 
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Figure 1.12: Colour (top) and emission (bottom) changes for iridium (III) complex 1 
(Figure 1.11) in the presence of 2 equivalences of F- and CF3COOH in acetonitrile 
solutions.[22]  
 
 
There are many examples outlined in this introduction where derivatives of the 
pH sensitive phenanthroline ligand have been reported to be useful in a wide range of 
areas from the colorimetric identification of specific ions to the determination of 
intracellular pH and oxygen levels.  This thesis provides detailed studies on a series of 
ruthenium (II) and iridium (III) complexes containing the phenanthroline ligand.  Due to 
its favourable chemical properties and ease of functionalised synthesis, this ancillary 
bridging ligand was also utilised as an efficient way to luminescently label other 
molecules.  Examples of which are discussed in Chapter 3 and Chapter 5 in the 
luminescent labelling of gold nanoparticles and cell penetrating peptides, respectively.   
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1.2 Introduction to Photoactive Supramolecular Chemistry 
 
Supramolecular chemistry derives its inspiration from many of the structural 
aspects of biology.  A key objective is to construct well-organized assemblies from 
smaller molecular subunits that are held together by intermolecular non-covalent 
bonding interactions such as hydrogen bonding, van der Waals forces, metal 
coordination and electrostatic bonding.  Supramolecular chemistry is described as 
‘chemistry beyond the molecule’ and is not only concerned with the individual 
components but more importantly the organisation, orientation and interaction of these 
subunits with one another.[5, 38-40]  Jean-Marie Lehn is considered to be one of the 
earliest innovators in the field of supramolecular chemistry.  He was awarded the Nobel 
Prise for his work in chemistry in 1987, along with Donald Cram and Charles Pedersen, 
for “their development and use of molecules with structure-specific interactions of high 
selectivity”.   
Subsequent research in the area of supramolecular chemistry has led to the 
development of brand new classes of materials that are capable of light or electronically 
stimulated chemistry and long-range electronic communications.[41]  Photochemically 
active supramolecular assemblies have potential applications that are widespread, from 
new photonic devices, such as solar energy conversion[42-44], to the understanding of 
drug-acceptor interactions[45, 46] and the study of biological processes including protein-
protein interactions.[5] 
In its most simplistic form, a photoactive supramolecular system may be 
described as A-L-B.  A and B consist of two molecular components, at least one of 
which is photoactive, and L is a linker or bridge that allows efficient communication 
between the two components.  Following photoexcitation, the excited assembly of A*-
L-B may lose its energy through a number of photochemical and photophysical 
processes as illustrated in Figure 1.13. 
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Figure 1.13: Photochemical and photophysical processes through which the 
photoexcited A*-L-B dyad may lose its excess energy.[41] 
 
This concept of a photoactive supramolecular A-L-B dyad is carried throughout 
the work presented in this thesis.  The photoactive components (A) consist mainly of 
inorganic, ruthenium (II) and iridium (III) polypyridyl complexes, or organic 
fluorophores such as fluorescein.  The bridging units (L) take the shape of polyethylene 
glycol linkers, hexanoic acid linkers, functionalised pH sensitive phenanthroline ligands 
or simple carbon-carbon bonds and they are conjugated to substrates, in which the 
second component (B) are nanoparticles, polypeptides or nucleoside units. 
 
The resultant A-L-B assemblies often exhibit an increase in their photophysical 
characteristics and their applications are above that of the sole parent photoactive 
subunit.  All of which occurs without destroying the individual character of the subunit; 
a true characteristic of a supramolecular assembly.[41]   
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Supramolecular assemblies are often described as a ‘bottom-up’ approach in the 
manufacturing of functional electronic devices i.e. using atoms and molecules to build 
much larger structures.  They frequently use redox centres and chromophores as 
building blocks to create assemblies on solid surfaces.  A surface allows for potentially 
controllable lateral interactions between the subunits and collectively increases the 
strength of the intermolecular communication within the assembly.  It also provides a 2-
D organisation for the supramolecular adsorbate.  Furthermore, the surface itself may 
become a part of the assembly to drive certain electronic processes.[41]  Most 
importantly the surface provides a route to addressability through measurement or 
control of current and potential.   
 
The impact of a metal surface on a luminophore may be explained under the 
following headings: 
 
(i) Intermolecular interactions between surface bound molecules: the nature of the 
linker used to attach the luminophore to a surface provides topographical control of the 
surface bound molecules, affecting intermolecular communication between them.  This 
often leads to more rigid, sheltered environments and therefore increased protection 
from oxygen, causing a decrease in the rate of non-radiative deactivation.[47]  
Conversely close packing of dyes may cause an increase in the self-quenching of the 
luminophore. 
 
(ii) Energy transfer from the luminophore to metal surfaces: this is considered to be one 
of the major deactivation pathways for metal surface bound molecules and is highly 
dependent on (a) a size, shape and orientation of the molecules dipole with respect to 
the substrate’s axis, (b) the distance between molecule and substrate and (c) the spectral 
overlap between the emission of the luminophore and the absorption of the substrate to 
which it is conjugated.[47] 
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(iii) Electron transfer between the luminophore and surface: the binding of a 
luminophore to a metal conductor may result in quenching of excited states if an 
electron/hole transfer occurs to the conduction/valance band of the conducting substrate.  
 
(iv) Plasmonic enhancement of emission: the binding of a luminophore to a plasmonic / 
coinage metal substrate may also lead to enhanced emission intensity.  The plasmonic 
field interacts with the absorption or emission of the dye.  The magnitude of the 
enhancement is dependent on the type of substrate and the distance between 
luminophore and substrate.  A balance of quenching, resulting from energy transfer to 
the substrate versus plasmonic enhancement from the metal substrate, must be struck.  
This distance dependence relationship is believed to be most enhanced at a distance of 
around 10 nm from luminophore to substrate.[48, 49]  The process of metal enhanced 
luminescence is explained in more detail in section  below.  
 
1.2.1 Examples of Photoactive Supramolecular Assemblies 
 
The separation of charge within a donor-acceptor assembly is one of the key 
processes exploited in photoactive supramolecular systems.  Plant photosynthesis is an 
example of charge separation in an energy producing biological process.[11]  Absorption 
of a photon of light by chlorophyll produces a transmembrane potential gradient 
allowing for the flow of electrons.  Consequently, the production of protons ultimately 
provides the chemical energy necessary for adenosine triphosphate (ATP) synthesis.  In 
semiconductors, surfaces undergo light induced charge separation leading to an 
electron-hole pair that results in a potential difference that is widely exploited in many 
photovoltaic devices.[7, 8] 
 
Due to their photosensitising properties ruthenium and iridium transition metal 
complexes have been the subject of intensive research for many years in an effort to 
mimic the charge transfer process, with a view to improving existing technologies 
across a wide range of areas from solar energy conversion to material science to medical 
diagnostics.[7]  There are many examples throughout the literature where ruthenium[50-
56]
 and iridium[11, 57, 58] {{}}metal complexes have been used as subunits in 
supramolecular assemblies.   
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A recent example was reported by Sykora et al.,[44] who demonstrated a light 
induced charge separated process by mimicking antenna-electron transfer in 
photosynthesis using a supramolecular assembly based on derivatised polystyrene 
(Figure 1.14).  This mimics both the light-harvesting and energy conversion steps of 
photosynthesis in a laboratory environment.  Irradiation of the assembly by visible light 
leads to the excitation of the bound chromophore unit, a ruthenium (II) polypyridyl 
complex, which acts as an antenna fragment within the polymer.  Following absorption 
of a photon and thermal equilibration, an excited state is formed, which can rapidly 
transfer energy to its neighbour leading to energy migration along the polymer chain 
until it reaches the reaction centre.  The ruthenium reaction centre is both a metal to 
ligand charge transfer (MLCT) chromophore and a quencher complex with an electron 
transfer donor [phenothiazine (PTZ)] and acceptor [methylviologen (MV2+)] 
coordinated to the metal bound ligands.  This resulted in a redox separated state with 
transiently stored oxidative (PTZ+) and reductive (MV-) redox equivalence.  
Subsequently this undergoes a back electron transfer returning the original ground state 
complex at a rate of 6.3 x 106 s-1 (t = 160 ns), providing a primitive model for the 
photosynthetic conversion of light energy to chemical energy.  A similar rationale was 
proposed for the work in Chapter 6, using DNA for the first time as the scaffold for the 
model photoantenna system.  
 
 
 
Figure 1.14: Diagram illustrating a supramolecular photoantenna assembly providing 
a primitive model for the photosynthetic conversion of light energy to chemical energy 
based on a polystyrene backbone.[44]  
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 A recently published example by Robson et al.,[59] involving a ruthenium 
supramolecular assembly, details a series of nine bis-tridentate ruthenium (II) 
complexes each containing one cyclometalating ligand with terminal triphenylamine 
substituent shown in Figure 1.15.[59]  The aim was to establish if a correlation existed 
between different electron donating/withdrawing substituents with the physiochemical 
properties of the dual chromophoric scaffold.  This may potentially serve as a guide for 
designing future light-harvesting assemblies.  They showed how they can systematically 
tune the redox potentials of both the ruthenium and triphenylamine units.  This was in 
contrast with the slight changes observed in their equivalent optical transitions by 
simply changing the substituents.  This systematic control over the redox potentials is 
made possible because the ground state oxidation potentials of each unit may be altered 
over a wide range of potentials by altering the type of substituents on the coordinated 
ligands.  As a result, the HOMO may be directed to either the ruthenium metal centre or 
the triphenylamine unit.  For example, the oxidation potential may be localised on the 
triphenylamine unit when electron donating groups are placed at position R1 and an 
electron withdrawing groups at R2, as seen for complex 6.  The ability to control the 
redox properties, as the absorbance wavelength remains unaltered, makes it possible to 
induce an electronic cascade and increase the thermodynamic driving force for the 
reaction between the electrolyte and photoxidised dye in any potential solar cells.  
Whilst still maintaining a good overlap with the solar spectrum.   
 
 
Figure 1.15: Chemical structures of the nine supramolecular bis-tridentate ruthenium 
(II) assemblies synthesised by Robson et al.[59] 
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 Pellegrin et al.[27] described the synthesis of a self assembled supramolecular 
dyad system consisting of a ruthenium (II) polypyridyl complex and an anthraquinone-
2-carboxylic acid subunit as shown in Figure 1.16. 
 
 
 
Figure 1.16: Schematic diagram of a self assembled supramolecular dyad system 
consisting of a ruthenium (II) polypyridyl complex and an anthraquinone-2-carboxylic 
acid subunit.[27] 
 
 
Oxidative quenching of the excited state of the complex by anthraquinone-2-
carboxylic acid was investigated for both complexes in aqueous and non-aqueous 
media.  By measuring the redox potential, luminescence intensity and lifetimes of the 
complexes, the energetics and dynamics of the photoinduced electron transfer between 
ruthenium donor and acceptor was examined.  In polar media, this was found to be a 
dynamic process suggesting that the quenching rate was controlled by bimolecular 
collisions.  The quenching rate constant (kq) was calculated to be approximately equal to 
6.7 x 109 M-1 s-1 in water for the carboxyl terminated self assembled dyad.  In contrast 
the in aprotic solvent, dichloromethane, quenching occurred through a static quenching 
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mechanism as determined by a Stern-Volmer plot.  This indicated that the association 
between the luminophore and quencher was most likely through hydrogen bonding 
between the carboxylic acid moieties of the ruthenium complex and the anthraquinone 
carboxylic derivative.  The rate of electron transfer between the subunits was estimated 
to be 4.7 x 107 s-1 using lifetime measurements.   
 
In contrast, for the analogous complex in which the carboxylate was methyl 
protected, a mixture of static and dynamic quenching behaviour in aprotic solvent was 
observed by Stern-Volmer plots.  This had a bimolecular quenching rate constant of 7.0 
x 108 M-1 s-1.  The statically quenched ruthenium component is thought to arise from H-
bonding interactions between the carboxyl of anthraquinone quencher and the nitrogen 
on the imidazole ancillary ligand.  H-bonding, prevalent in biological systems, is known 
to facilitate electron transfer[27] and this is an interesting example of solvent induced 
switching between two electron transfer pathways, one unimolecular, most likely driven 
by H-bonding and one bimolecular. 
 
 Flamigni et al.[11] reported on the use of an iridium terpyridine, [Ir(tpy)2]3+, 
subunit in porphyrin arrays for the conversion of light energy.  Initially ruthenium and 
osmium terpyridine units were employed as photosensitisers in triads containing organic 
donors and acceptors.  However, the relatively low excited state energy of these 
complexes provided an energy sink, seriously competing with the charge separation 
process through recombination of the ground state energy.[11]  [Ir(tpy)2]3+, by 
comparison, exhibited higher excited state energy levels favouring charge separation, 
longer excited state lifetimes and stronger absorption/emission profiles.  The iridium 
complex was used in arrays containing electron accepting gold porphyrins (PAu) and 
electron donating base-free porphyrins (PH2).  Modification of the base-free porphyrin 
with zinc (PZn) allowed alteration of the photoreactivity and led to very efficient charge 
separation with a lifetime on the order of a microsecond.   
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Figure 1.17: Energy level diagram and photoinduced processes in supramolecular 
assemblies PH2 – I r - PAu in acetonitrile and PZn – Ir - PAu in toluene.[11] 
 
A charge separated state of PH2+ -Ir- PAu- that stored energy of about 1.5 eV 
was estimated.  The resultant lifetime of 3.5 ns was disappointingly short due 
recombination of the charge separated state to a close lying triplet energy state localised 
on the base-free porphyrin moiety (Figure 1.17(a)).  Modification to include a zinc 
porphyrin subunit lead to a lower energy oxidation potential and a higher triplet excited 
state energy of the PZn-Ir-PAu supramolecular assembly (Figure 1.17(b)).  Using 
transient absorption spectroscopy, it was found that recombination of the triad to its 
ground state occurred from the charge separated intermediate state while displaying a 
remarkably longer lifetime of 450 ns in toluene.  This charge separated state could store 
energy of about 1.3 eV and was formed with 100% efficiency.  Considering its lifetime 
and stability in air, this is one of the most successful examples of charge separation 
based on a transition metal complex.   
 Lehn et al.[60] also described remarkable charge separated efficiencies in the 
synthesis of a supramolecular assembly containing multichromophoric cyclodextrins 
(Figure 1.18) for the conversion of light energy via the antenna effect.  Energy transfer 
from the napthoyl antenna chromophores to the encased merocyanine dye was shown to 
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occur with 100% efficiency by FRET and thus mimic important features of 
photosynthetic units.  The mechanism of homo energy transfer (between naphthoate 
chromophores) and hetero energy transfer (between naphthoate chromophores and the 
merocyanine dye) was attributed to Coulombic interactions rather than short-range 
interactions.  
 
 
Figure 1.18: Schematic illustration of the supramolecular assembly between the 
hepthanapthoate β-cyclodextrin (CD-NA) and the merocyanine (DCM-OH) 
fluorophore.[60] 
 
 Pellegrin et al.[28] described the synthesis of a novel photoactive ruthenium (II) 
polypyridyl complex coordinated to an adamantyl pendent that formed a self-assembled 
supramolecular structure with β-cyclodextrins (Figure 1.19).  The self-assembly was 
driven by the hydrophobic host-guest interaction between the adamantyl and the 
cyclodextrin.  This association was found to be pH dependent with an association 
constant of 8.8 x 103 M-1 in neutral media and 2.24 x 104 M-1 in basic media.  Results 
suggested that photoinduced electron transfer between the luminophore and methyl 
viologen (MV) terminus was strongly and reversibly controlled by pH.  At pH above 
8.5, an efficient electron transfer occurred, resulting in the oxidation of the ruthenium 
 30 
centre in the charge separated state and the formation of the MV+· radical, which was 
identified by transient absorbance studies and steady state photolysis.  It is thought that 
the increased electron transfer rate under basic pH conditions was facilitated more 
efficiently through the anionic imidazole ligand, via what is effectively a hole transfer 
between donor and acceptor.   
Conversely, assembly of the modified ruthenium luminophore with an 
unfunctionalised cyclodextrin exhibited no significant pH dependence of formation and 
therefore, the charge interactions between the methyl viologen and cationic ruthenium 
complex is thought to drive the pH dependence of the self-assembly process.  Such 
switchable electron transfer is desirable in molecular electronics, where these materials 
may behave as logic gates.[28] 
 
 
Figure 1.19: Schematic diagram illustrating the self-assembled supramolecular 
structure between a modified photoactive ruthenium (II) polypyridyl complex and β-
cyclodextrin. [28] 
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1.2.2 Photoactive Self-Assembled Monolayers (SAMs) and Metal Enhanced 
Fluorescence 
 
 Self assembled monolayers (SAMs) offer a very easy way of controlling the 
chemical composition and physical structure of a substrate surface.  This control has far 
reaching implications for many aspects of surface chemistry including; nano-scale 
photonic devices, wetting, solar energy conversion, catalysis and chemical sensing.[41, 61, 
62]
  Furthermore, the introduction of photoactive SAMs is one of the most versatile ways 
of generating photoactive molecular devices as the surface provides a means of 
addressability to the SAM.  As a result, light may be exploited to initiate photochemical 
events that may subsequently be detected by electrochemical methods or may result in 
the generation of photocurrents.[41]  
 
 Immobilisation of molecular dyads onto semiconductor surfaces leads to new 
electron transfer pathways as the solid support becomes an active contributor to the 
interfacial supramolecular triad.[41]  Argazzi et al.[63] elegantly highlighted this 
phenomenon in a report describing the surface immobilisation of a ruthenium-
phenthiazine (PTZ) dyad (similar to the sensitiser used previously in mimicking model 
photoantenna assembly based on a polystyrene backbone) onto TiO2 as illustrated in 
Figure 1.20.   
 
Figure 1.20: Schematic diagram illustrating the ruthenium-phenthiazine (PTZ) dyad 
immobilised onto a TiO2 surface and the possible electron transfer pathways.[63] 
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 The charge-separated state of TiO2- - Ru(II) – PTZ+ was achieved by electron 
injection from the ruthenium unit to the TiO2 substrate followed by electron transfer 
from the phenothiazine (PTZ) unit to the oxidised ruthenium metal centre.[3]  The 
charge separated species decays to the ground state with a rate of 3.6 x 103 s-1 (lifetime 
of 300 ns).  This is three orders of magnitude longer lived than the unsupported dyad in 
solution.  This sensitiser has also been shown to efficiently convert light energy into 
electrical energy in regenerative solar cells using an NaI/I2 electrolyte.[63] 
 
Metal substrates especially gold and silver, are often used to enhance the 
photophysical characteristics of an attached luminophore[47, 64-67] and has already been 
discussed in Section 1.2.  Metal-luminophore interactions can result in increased 
quantum yields but may also display a consequent decrease in the lifetime of a given 
chromophore; owing to an enhanced local electric field and an increase in the intrinsic 
system decay rate.[49, 68]  The type and length of the bridging unit in the A-L-B assembly 
is critical to the electronic communication between the metal and photoactive 
components.  Linker length should be sufficiently long to facilitate maximum emission 
enhancement of the luminophore preventing efficient quenching by the metal substrate.  
Unless energy transfer to the metal is desirable.[69, 70]  
 
  Malicka et al.[48] have highlighted this distance dependent relationship in a study 
using layers of protein to separate fluorescently labelled DNA oligomers from silver 
island films (SIFs) by fluorescent means.  The process involved adsorption of a layer of 
biotinylated bovine serum albumin (BSA) followed by deposition of further layer of 
avidin.  The treatment may be repeated many times adding a thickness of about 9 nm for 
each BSA-avidin layer as illustrated in Figure 1.21.  The fluorescently functionalised 
DNA oligomers were then deposited onto the separate layers of BSA-avidin and the 
resulting emission intensity was measured as a function of the distance from the SIFs. 
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Figure 1.21: Schematic diagram illustrating the SIFs with layers of biotinylated BSA, 
avidin and functionalised DNA oligomers to determine the distance dependent 
relationship between a metal substrate and luminophore.[48] 
 
Figure 1.22 below shows the emission intensity of the Cy3- and Cy5- labelled 
DNA oligomers at various distances from the SIFs.  Results showed that the greatest 
luminescence enhancement is when one layer of BSA-avidin is present and hence, a 
distance of about 9 nm from metal substrate to luminophore.  Any greater and the 
luminescence is significantly reduced for both of the fluorescently labelled DNA 
oligomers.  However, using a BSA-avidin bilayer does not give a high degree of control 
over the distance from metal substrate to luminophore as there is no option to determine 
the metal enhanced emission at distances other than 9, 18, 27 nm etc.  These results are 
confirmed in experiments performed in Chapter 3, where a ruthenium (II) complex at a 
distance of 13.2 nm (in linear conformation) from the metal nanoparticle exhibited 
greater emission intensity than that of the same dye located at a distance of only 3.3 nm 
from the substrate.  
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Figure 1.22: Distance dependence on emission intensities of the Cy3-(left) and Cy5-
(right) labelled DNA oligomers form SIFs.[48] 
 
Using core-shell silver colloids coated with silica gel of varying thickness Aslan 
et al.[49] also described this phenomenon of luminescent enhancement as a result of a 
nearby silver metal substrate.  Europium and rhodamine dyes were doped inside the 
silica pores and an Alexa 647 fluorophore was covalently attached to the silica shell 
itself.  The diameter of the silver nanoparticle was 130 +/- 10 nm for all preparations 
with silica coatings ranging from 2-35 +/- 1 nm in thickness.  The silica gel surrounding 
the silver metal core provides (a) robustness, chemical inertness and the versatility 
needed for conjugation of molecules to the silver colloid, (b) protection of the metal 
core from ions present in solution and (c) allows for the optimum distance for metal 
enhanced fluorescence which was determined to be at a silica shell thickness of around 
10 nm.   
 
The significance of the silver core to the enhanced luminescence of the dyes is 
demonstrated in Figure 1.23 below.  Here, the emission intensities of the attached 
luminophores are compared directly with one another using a shell-core with and 
without the metal nanoparticle.  The europium and rhodamine doped nanoparticles 
displayed an enhanced emission intensity that was 8 and 20 times, respectively, that of 
the controlled substrate containing no silver core.  Whereas, the confocal fluorescence 
image (Figure 1.23) of the covalently linked Alexa 647 dye showed an approximate 10 
fold increase in emission intensity with the silver nanocore nearby.   
 35 
 
 
Figure 1.23: (top) Emission intensity of europium and rhodamine doped nanoparticles 
with and without core silver nanoparticles.  All maximum enhancement values were 
recorded using the optimised silica shell thickness of 11 +/- 1 nm. (bottom) Confocal 
fluorescence microscopy images showing difference in luminescent intensity of an Alexa 
647 linked supramolecular assembly in the presence and absence of the silver 
nanocore.
[49]
 
 
By comparison, Thomas et al.[47, 71] used gold nanoparticles to enhance the 
fluorescence of 1-aminomethylpyrene by means of inducing electron transfer from the 
photoactive moiety directly to the metal substrate.  1-Aminomethylpyrene is an organic 
molecule that is weakly luminescent when dissolved in an organic solvent.  This is due 
to intramolecular quenching of the excited energy state by electron transfer from the 
lone pair of electrons on the nitrogen atom to the aromatic pyrene rings.  However, 
when bound to AuNPs the quantum yield and emission intensity of 1-
aminomethylpyrene dramatically increases as binding of the amine group to the gold 
substrate suppresses the intramolecular electron transfer of the nitrogen lone pairs to the 
pyrene moiety.   
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Figure 1.24: Schematic diagram illustrating the binding of 1-aminomethylpyrene to 
gold nanoparticles, and resultant increase in fluorescence following attachment to the 
metal substrate.[71] 
Studies have indicated that densely packed chromophores on metal nanoparticles 
dramatically suppressed quenching of the excited energy state of bound molecules.[65, 72]  
Stellacci et al.[65] reported the first supramolecular assembly consisting completely of a 
self-assembled layer of chromophores on silver nanoparticles (Figure 1.25).  It is 
claimed that this allows for the close packing of about 2500 chromophores on a single 
silver nanoparticle surface with a diameter of less then 10 nm.  The resulting two-
photon excited fluorescent nanobeacons were ultra-bright, exhibited higher quantum 
yield efficiencies and displayed a decrease in sensitivity to photobleaching compared to 
the individual unbound chromophores.  Perhaps another interesting experiment would 
have been to examine the enhanced photophysics of the dye as a function of the alkane 
chain linker length to determine if these results were due to their proximity to the 
nanoparticle or the local environments in which the chromophore is located upon 
conjugation. 
 
Figure 1.25: Chemical structure of 11-{4-methoxy-2,5-bis[(E)-2-(4-
nitrophenyl)ethenyl]phenoxy}-1-undecanethiol (left) and schematic representation of 
closely packed silver nanoparticle (right).[65] 
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Chapter 3 discusses attempts to utilise SAMs in creating a nanoconjugate system 
suitable for multimodal cellular imaging.  The length of the bridging linkers were varied 
in an effort enhance the luminescence and Raman signal of an adsorbed ruthenium 
luminophore.  The resultant nanoconjugate displaying the superior results was then 
exploited for the purposes of cellular imaging of mammalian cells.  Additionally, in the 
attempts to create a model photoantenna in Chapter 6, it was proposed to use SAMs to 
control the lateral spacing between adjacent oligonucleotide sequences and therefore, 
have a direct impact on the communication between chromophores within the 
supramolecular assembly.   
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1.3 Metal Complexes used for Cellular Uptake/Imaging 
 
Until approximately 5 years ago, very few research groups had reported the use 
of phosphorescent heavy metal complexes in bioimaging.[23]    However, due to their 
favourable optical and redox properties, metal complexes have been examined very 
recently as possible candidates for real-time live cell imaging, most particularly; zinc 
(II)[45], rhenium (I) [73], platinium (II)[74] and rhodium (III).[75]   
 
In order for a luminophore to be a suitable candidate for cellular imaging it must 
be photostable, have a high quantum yield, reasonably non-toxic, cell permeable, have 
visible to NIR emission and depending on the application, show a preference for 
localisation within a certain organelle of the cell.  Of the non ruthenium and iridium 
complexes, an interesting paper published by Kowol et al.[45] described the synthesis of 
the first zinc (II) complex containing Triapine.  Triapine, or 3-aminopyridine-2-
carboxaldehyde thiosemicarbazones (Figure 1.26), is one of the most promising 
antitumor chemotherapeutic compounds to have entered into phase I and phase II 
clinical trials.  It has been shown to inhibit the enzyme ribonucleotide reductase which 
is essential for cell propagation.  Coordination of the Triapine unit to a zinc (II) metal 
centre increased antineoplastic activity and displayed more selective affinity for the 
nucleoli within the nucleus of human colon carcinoma cells as shown in Figure 1.27.  
Co-staining studies with nucleolar protein fibrillarin and the zinc (II) complex showed 
preferential selectivity towards the nucleoli of these cells, as illustrated in Figure 1.27 
image H below.  
 
 
Figure 1.26: Structures of Triapine unit and zinc (II) Triapine complex.[45] 
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Figure 1.27: Live cell images of human colon carcinoma cells incubated with 0.25 mM 
Triapine (A, C, E, G) in PBS and 0.25 mM in 0.5% DMSO/PBS zinc (II) Triapine 
complex (B, D, F, H) representing their bright field images, luminescence images, false 
colour images and co-staining images from top to bottom respectively.[45]   
 
 
In another study reported by Bieda et al.[75], the cytotoxicity of a series of 
rhodium (III) complexes (Figure 1.28) towards colon and breast cancer cell lines was 
determined.  Compounds 4, 6, 8 and 9, containing polypyridyl ligands with increasing 
numbers of phenyl ring attached, demonstrated an increase in the antiproliferative 
potency with increasing surface area and hydrophobicity.  It was claimed that 
compound 9, containing the dppz ligand, is even more potent than cisplatin.  Cisplatin is 
the chemotherapeutic drug used most to treat many cancers but has many undesirable 
side effects, high toxicity and problems with drug resistance in primary and metastatic 
cancers.[76]  As a result, research has intensified into transition metal complexes because 
of their favourable properties suited to anti-cancer drug design for photodynamic 
therapy. 
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Figure 1.28: Series of rhodium (III) complexes synthesised by Bieda et al for cellular 
imaging.[75] 
 
 
Much of the relatively limited research surrounding ruthenium (II) complexes 
for live cellular imaging involved compounds containing the dipyridophenazine (dppz) 
cyclometalating ligand.  These particular complexes have been shown to act like a 
‘molecular light switch’.  They are brightly luminescent when intercalated with DNA or 
protected from aqueous environments and virtually non-emissive when in aqueous 
solutions.[77]  Svensson et al.[77, 78] reported the synthesis of a series of 
[Ru(phen)2(dppz)]2+ derivatives, where the dppz ligand was altered with alkyl chains of 
different lengths (Figure 1.29).   
 
 
 
 
Figure 1.29: Series of ruthenium (II) derivatives containing the dppz ligand  synthesised 
by Svensson et al. for cellular imaging.[77] 
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They reported how slight modifications to the lipophilicity of the dye to the dppz 
ligand resulted in large variations in its distribution throughout the membrane, its DNA 
binding ability and its cellular uptake in CHO cells.  Figure 1.30 shows the distribution 
of the assorted dyes throughout the cell structure using confocal fluorescence 
microscopy.  A decrease in the alkyl chain length resulted in a higher emission intensity 
in the nucleus compared to the cytoplasm (Figure 1.30 diagram A).  While the most 
lipophilic complex, D6, resided mainly on the outside of the nucleus of the fixed CHO 
cells (Figure 1.30 diagram C).  However, it must be noted that throughout their 
experiments and many other reported studies on coordination compounds, DMSO (1%) 
was used to solvate the metal complexes.   Organic solvents, such as DMSO and 
ethanol, are frequently used in cellular uptake analysis.  Alarmingly, DMSO is known 
to induce cell diffusion, cell differentiation and enhance the permeability of lipid 
membranes.  DMSO also causes the cell membrane to become less ridged, making it 
more susceptible to facilitate membrane diffusion.[79, 80]  Chapter 5 details results of the 
cytotoxic effect of DMSO and ethanol on SP2 myeloma and CHO cell lines. 
 
 
 
Figure 1.30: Confocal fluorescence microscopy images showing the distribution of 
ruthenium (II) complexes in fixed CHO cells.  D2 (A), D4 (B) and D6 (C) (10µM in 1% 
DMSO/serum free medium) were added to cells in fixed methanol for 15 minutes and 
excited at 488 nm.[77] 
  
 
 Chen et al.[81] published preliminary studies on a series of water soluble 
ruthenium (II) polypyridyl complexes which they reported induced mitochondria 
mediated apoptosis in human cancer and normal cells.  Included in this series of 
ruthenium (II) probes was the [Ru(bpy)2(picNO2)]2+ complex, which is also synthesised 
in this thesis.  One of the more interesting results found that [Ru(bpy)2(picNO2)]2+ 
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showed a greater cytotoxic effect to the human Hep G2 cell line, when compared to the 
widely used cisplatin anti-tumour drug.  However, the complex exhibited a considerably 
poorer cytotoxic effect against the other cell lines under analysis.  
 
Barton et al.[82] were one of the first research groups to investigate the cellular 
uptake of ruthenium (II) polypyridyl complexes in living cells.  The metal complexes 
were incubated with HeLa cells in tris buffer with varying final concentrations of the 
ruthenium complexes.  Figure 1.31 illustrates the chemical structures synthesised as part 
of their analysis.  Uptake of these luminophores into the cells was analysed by the mean 
luminescence intensity of the overall cell population by flow cytometry.  Results 
indicated that the complexes with the greater lipophilicity exhibited higher cellular 
uptake, with [Ru(DIP)2(dppz)]2+ (DIP = 4,7-diphenyl-1,10-phenanthroline) best of all.  
For all complexes, the greatest luminescence was evident in the cytoplasm as confirmed 
by co-localisation studies.   
   
It was thought that if a complex entered a cell by means of passive diffusion, 
one might assume that a complex with closest to neutral charge, smaller particle size 
and greater hydrophilicity should display greater cellular uptake.[82]  However, 
unexpectedly the most hydrophobic DIP ligand seemed to facilitate cellular transport 
despite its larger size.  The dye showed distribution throughout the cells cytoplasm but 
without ever entering into the nuclear envelope as shown in Figure 1.32.        
 
 
 
 
Figure 1.31: Chemical structures of the ruthenium (II) dppz derivatives synthesised by 
Barton et al. for cellular imaging.[82] 
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Figure 1.32: (top) Confocal fluorescence microscopy image of HeLa cells with 
[Ru(DIP)2(dppz)]2+.  Cells incubated with 5µM (in tris buffer) ruthenium for 2 hours at 
37 oC, excitation wavelength of 488 nm.  (bottom) Intensity profile of the ruthenium 
emission across HeLa cells following incubation for 12 hours with 10 µM (in tris buffer) 
of dye.[82] 
 
In a later report,[83] a mechanism of passive diffusion of the [Ru(DIP)2(dppz)]2+ 
complex into the cell was proposed, as uptake decreased when cells were depolarized 
with a high potassium buffer and increased when cells are hyperpolarized with 
valinomycin.  This suggested a passive diffusion mode of cellular uptake as the 
membrane potential of a cell is dependent on the potassium ion concentration.  Due to 
its lipophilicity and positive charge, [Ru(DIP)2(dppz)]2+ is likely to traverse the 
membrane in response to the membrane potential similar to other lipophilic cations such 
as rhodamine 123.[83] 
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The plasma membrane of a viable cell has a membrane potential of -50 to -70 
mV, with the inside of the cell negative with respect to the outside.[83]  As most 
transition metal complexes carry an overall positive charge, uptake of the luminophore 
may be driven by the potential difference across the cellular membrane.  The membrane 
potential in animal cells depends mainly on the potassium ion concentration in the 
cytoplasm.  Hence, in the experiments carried out by Barton et al. they use potassium-
based buffers to alter the cells potassium concentration, which drives the cellular uptake 
of the dye.[83] 
 
Tan et al.[84] also demonstrated how a similar series of ruthenium (II) 4,7-
diphenyl-1,10-phenanthroline analogues induced apoptosis in tumour cells with even 
greater potency than cisplatin.  Following optical irradiation, many photoactive 
ruthenium complexes can interact with 3O2 in a process that results in the formation of 
reactive oxygen species (ROS).  These ROS species can then cause cellular damage 
leading to cell apoptosis.  It is already known that molecules possessing reactive 
electronically excited states have found clinical use as PDT agents for the treatment of 
cancers.[85]  However, tumour cells are often hypoxic and using PDT causes further 
oxygen depletion within cells so using this type of treatment may be somewhat 
limited.[85] 
 
Due to their high phosphorescent quantum yield, long lifetimes and visible 
tunable emission, iridium (III) complexes have become the most attractive class of 
phosphorescent heavy metal complexes in biolabelling in recent years.[23]  Huang et al. 
were the first research group to investigate luminescent staining of living cells using 
iridium (III) complexes.  In a paper published in 2008,[86] they reported the synthesis 
and cellular uptake of two difluorophenyl pyridine iridium (III) complexes (Figure 1.33) 
that showed facile internalisation within HeLa cells (Figure 1.34).   
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Figure 1.33: Chemical structures of iridium (III) complexes and their corresponding 
emission profiles in dichloromethane using 365 nm excitation wavelength.[86] 
 
 
Figure 1.34: Confocal luminescence images (a and d), brightfield images (b and e) and 
overlaid images (c and f) of iridium (III) complexes 1 (top) and 2 (bottom) respectively.  
Samples are in DMSO/PBS (pH 7, 1 :49 v/v) and were incubated with HeLa cells for 10 
minutes at room temperature.[86] 
 
 
Membrane transportation was claimed to be as a result of the combination of the 
positively charged iridium (III) complexes and their increased hydrophobicity given by 
fluorination of the cyclometalating ligands.  However, presumably due to the poor 
aqueous solubility of the dye, a 2% solution of DMSO was used in their cellular uptake 
experiments.  This, once again, raises the question of whether the compounds are 
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genuinely cell permeable or are so because of DMSO.  However, the cell viability 
studies were estimated to be greater than 90% for both iridium complexes.  A later 
paper published by the same group[23] detailed the synthesis and cellular uptake of an 
additional four iridium (III) difluorophenyl pyridine complexes showing tunable 
emission from blue to red.  Their results were broadly in line to what was reported in 
their 2008 paper but again a relatively high 2% solution of DMSO was still employed 
for their cell studies and it is not clear if dyes are fully cell permeable.   
 
 A potential solution to the poor aqueous solubility of iridium (III) compounds 
was proposed by Huang et al.[87]  They suggested the synthesis of charge-separated 
zwitterionic iridium (III) complexes as shown in Figure 1.35.  These displayed good 
luminescent character with some showing good solubility (mM) in PBS buffer pH 7.0.  
Table 1.1 outlines the solubility and the cellular interactions of zwitterionic iridium (III) 
complexes 1-5.  However it is noted, that in a change from procedure by this particular 
research group, HeLa cells are no longer employed for the cell analysis and a KB cell 
line is used instead, so it is not possible to make direct comparisons. 
 
 
 
Figure 1.35: Chemical structures of zwitterionic iridium (III) complexes 1-5 for cellular 
imaging.[87] 
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complex solubility (µM) log Po/w Encapsulation efficiency (%) Release (%) 
1 2064 −1.89 49.9 39.6 
2 5096 −0.88 56.1 33.5 
3 559 −0.55 59.2 29.1 
4 174 0.69 77.9 20.7 
5 37 1.39 83.1 17.4 
 
Table 1.1: Solubility, octanol/water partitioning coefficient (log Po/w), encapsulation 
efficiency and release of zwitterionic complexes 1-5 shown in Figure 1.35.  
 
 
 Their results showed that complexes 1-4 had weak intercellular luminescence.  
However, complex 5 displayed bright luminescence inside the cell’s cytoplasm, which 
was suggestive of transmembrane transport.  Furthermore, all KB cells were still found 
to be alive after a 2 hour time period.  Additional studies indicated that the membrane 
penetrating ability of fixed cells with the iridium (III) compounds was in the order of: 1 
< 2 < 3-5.  The more hydrophilic complexes 1 and 2 had poor cell permeability, 
whereas, the hydrophobic complexes 3-5 internalised within the membrane without 
difficulty.  Once inside the cell, it was found that compounds stayed mainly in the 
cytoplasm of both living and fixed KB cells.   
 
As expected the more hydrophilic complexes showed greater aqueous solubility 
with complex 5 only slightly soluble in aqueous PBS buffer.  For the same reason, their 
amphiphilicity changed from hydrophilic to hydrophibic with log Po/w changing from     
-1.89 (complex 1) to 1.39 (complex 5).  The ability of a cellular probe to permeate 
biological membranes depends strongly on its lipophilicity, which is commonly 
estimated by the partition coefficient of the compound in octanol/water (Po/w).[30] 
 
The encapsulation efficiency of the complexes into a liposome and their 
subsequent release reflects the complexes’ permeation in and release out of the bilayer 
of a cell membrane, respectively.[87]  According to the results, the more hydrophilic 
complexes were difficult to encapsulate and were easily released from the cell 
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membrane, whereas the hydrophobic ones were more likely to stay inside the cell.  
Results suggested that for the purpose of designing iridium (III) probes for cellular 
imaging a balance must be struck where the hydrophilic part is necessary for aqueous 
solubility but the lipophilic moiety is helpful in cell permeation.   
 
Very recently, for the first time, nuclear uptake and staining within live cells by 
a series of iridium (III) dipyridoquinoxaline complexes was reported by Zhang et al.[88]  
However, it is noted that the use of these dyes with HeLa cells resulted in rapid and 
extensive cell death due to the high cytotoxicity.  The more resilient MDCK cell line 
were used in their experiments instead.  The luminophores also had to be dissolved in a 
solution of PBS containing 1% DMSO prior to analysis.   
 
Not only may metal luminophores be used as potential probes for cellular 
imaging but they also exhibit properties that could render them very useful in the 
detection of certain diseases.  Today, there are a couple of examples where iridium 
probes are already in use in medical diagnostics.  Zhang et al.[30] used the changes in the 
photophysical characteristics, namely it’s lifetime, of an iridium dye (Figure 1.36) to 
image tumour hypoxia in living animals.  Hypoxia is frequently a characteristic of 
tumour tissue and was visible after only 5 minutes following injection of the iridium 
dye.  However, the dye was fully metabolised by mice within a 24 hour time period.  
The phosphorescent lifetime of the dye was found to be 2.9 µs in the tumour tissue and 
1.9 µs in the normal tissue.  Thus, it may be concluded that the longer lifetime of the 
iridium dye in the tumour tissue was a result of the lower oxygen concentration present 
in the hypoxic tissue.  The dye was also used to detect the oxygen concentrations within 
four different cell lines, including HeLa and CHO cells.  However, the lipophilic dye 
was dissolved in a solution containing 10% DMSO prior to injection into the mice and 
cellular imaging analysis.  This is a very high concentration of organic solvent to use 
and will promote cross-tissue transport and depending on its final concentration will 
induce cell death. 
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Figure 1.36: Chemical structure of iridium luminophore used to image tumour hypoxia 
in living animals.  Its corresponding absorbance and emission profile is shown below in 
dichloroethene at room temperature.[30] 
 
 
Xiong et al.[89] demonstrated the use of an iridium (III) complex for selectively 
targeting biomarkers such as homocysteine (Hcy) and cysteine (Cys) within living KB 
cells.  The levels of Hcy are an important indicator for diseases including cardiovascular 
and Alzheimers disease, whereas, Cys deficiency is associated with slow growth, liver 
damage, lethargy, muscle loss and fat loss.  The iridium luminophore was shown to be 
membrane-permeable (with a final DMSO concentration of 0.2%), displayed low 
cytotoxicity and can readily detect the intracellular Hcy/Cys concentrations in a 
ratiometric manner by a visible change in its phosphorescent emission from yellow to 
red as shown in Figure 1.37.  The molecular design of the iridium probe is based on the 
selective reaction between the aldehyde on the ligand and the β,γ-aminothiol group on 
Hcy or Cys biomarkers to form thiazolidine and thiazine, respectively.  Complexation 
of the metal complex to these biomarkers resulted in disruption to the π bond 
conjugation within the molecule, causing a switch of the excited state from an LC 
transition to an MLCT transition and a corresponding change in the emission 
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wavelength.  However, it is noted that, high concentrations of amino acids are required 
for the successful application of such a probe.   
 
 
 
Figure 1.37: Chemical structures and resulting change in emission of the iridium (III) 
luminophore upon complexation with Cys or Hcy biomarker.[89] 
 
 
To date there are few examples in the literature of transition metal complexes 
being used directly for the purpose for cell imaging.  This is presumably due poor 
solubility issues and the low cationic charge associated with the complexes, thus 
prohibiting potential driven membrane diffusion of the dye across a cell membrane.  
Many of the luminophores reported are conjugated to polypeptides[90-92], organic 
luminophores[90], estradiol[93] and other biomolecules in an effort to alter the 
lipophilicity of the dye.   
 
We explore the conjugation of a luminescent ruthenium (II) polypyridyl 
complex to thiol functionalised polyethylene glycol linkers of varied lengths.  The 
PEGylated chromophores were then attached to 50 nm gold nanoparticles in an effort to 
improve their luminescent intensity as a result of metal enhanced luminescence.  
Furthermore, the ability of the nanoconjugate to be drawn across a lipid bilayer also 
increased significantly when compared to the free parent complex.  In Chapter 3, it is 
shown how the resulting novel supramolecular nanoconjugate displays improved 
transmembrane capabilities and emission intensity above that of the parent dye.  The 
probe is also used in the cellular imaging of live cells.   
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Chapter 5 also examines the conjugation of ruthenium (II) and iridium (III) 
polypyridyl luminophores to a cell penetrating peptide (CPP) to aid in its aqueous 
solubility and facilitate its transport across the cell membrane.  This is the first time that 
an iridium (III) luminophore has been conjugated to a polypeptide and used as a 
potential multimodal probe for cellular imaging.  This builds upon research published 
before by our group[19, 29, 33] where water soluble ruthenium (II) polypyridyl complexes 
are unable to transport efficiently across the cell membrane of mammalian cells.  
However, upon conjugation to a cell penetrating peptide, the luminophores display 
facile internalisation within the cellular structure without the need for organic solvents.   
 
 
 
1.3.1 Transition Metal Complexes and Singlet Oxygen (1O2) Generation 
 
Singlet oxygen is known to react with a number of amino acids and especially 
the DNA base guanosine and may lead to cell apoptosis. [16, 94-96]  Furthermore, singlet 
oxygen is believed to be the major cytotoxic species in PDT.[96]  Inorganic metal 
complexes are known to produce singlet oxygen typically through an energy transfer 
process from its excited triplet state to triplet oxygen (3O2).  Therefore, an efficient 
generator of 1O2 should have a high quantum yield of triplet formation, long triplet 
lifetime and a triplet state energy greater than the energy gap between singlet and triplet 
O2.  Djurovich et al.[96] showed how a series of iridium complexes they synthesised had 
quantum yields of singlet oxygen production ranging from 0.5-0.9.  The only product 
observed during quenching of the excited triplet state was 1O2, whose formation was 
promoted by contact between 3O2 and the cyclometalating ligands.  In general, however, 
little is known about how photophysical properties, such as emission energies, or 
changes in the electronic and geometric structures of metal complexes can effect the 
efficiency of 1O2 production.[96] 
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The quenching of the excited triplet state of a luminophore (Lu) by triplet 
oxygen may occur via three pathways: energy transfer to give 1O2 (Equation 1.12), 
electron transfer leading to the formation of superoxide O2·- (Equation 1.13) or simple 
deactivation (Equation 1.14).  
 
Lu* + 3O2 → Lu + 1O2……….Eq 1.12 
Lu* + 3O2 → Lu+ + O2·-……….Eq 1.13  
Lu* + 3O2 → Lu + 3O2……….Eq 1.14 
 
 It has been calculated that the quenching rates by triplet oxygen on 3MLCT of 
[Ru(bpy)3]2+ is approximately 1/9 of the diffusion rate constant and therefore it is 
considered to undergo quenching exclusively by an energy transfer process.[96]  
However, most of the iridium complexes synthesised by Djurovich et al.[96] exhibited 
quenching rates greater then this, which is an indication of electron transfer quenching.  
In general however, for most iridium complexes it is thought that singlet oxygen 
formation is formed most likely through a combination of energy and electron transfer 
processes.[96]  Both ruthenium and iridium luminescent probes synthesised in this thesis 
have previously demonstrated their triplet excited state sensitivity to dissolved oxygen 
and therefore, presumably their generation of 1O2.  This could have significant 
implications for the cell’s viability following irradiation. 
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1.4 Conjugated Gold Nanoparticles for Biomedical 
Applications 
 
Nanoparticles have emerged as promising materials for probing cellular 
processes and as such were used in this thesis in an effort to transport suitable 
luminescent probes across the cell’s membrane.  Plasmonic nanoparticles are especially 
useful for these applications due to their enhanced resonant absorption, scattering 
properties and SERS potential.[97]  AuNPs appear to have good biocompatibility and 
may be easily modified to control their surface properties, making such nanoparticles 
very attractive for applications in biomedical fields such as advanced drug delivery and 
molecular diagnostics.[97, 98]  Furthermore, there is evidence to suggest that using 
nanoparticles with a diameter of     < 80 nm sees the excretion of the nanoparticles from 
the body and as a result they may be suitable for in vivo applications.[99]  However, 
significant problems may arise due to their bio-immobilised instability and these issues 
must be addressed for their effective use in biomedicine.  These instability issues 
include the adsorption of proteins and the non-specific uptake of particles by the 
reticular-endothelial system (RES) that may decrease the lifetime of the nanoparticles in 
potential medical applications.[97] 
 
Polyethylene glycol (PEG) has proven valuable as a suitable biological linker to 
covalently attach to the metal nanoparticles in an effort to limit this non-specific 
adsorption.[97, 100]  Partially coated PEG 30 nm AuNPs have already been successfully 
used to deliver tumour necrosis factor to solid tumours in mice, by helping to inhibit the 
adsorption of the functionalised nanoparticles by the RES.[101]  Additionally, the 
attachment of PEG moieties to oligomers has also been reported to increase the 
circulation time of molecules in the blood stream and thus reducing the frequency when 
drugs must be administered.  The size, shape and attachment site of the PEG linker 
plays a significant role in the pharmacokinetics of the functionalised 
pharmaceuticals.[102] 
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Dreaden et al.[100] highlighted the potential importance of PEGylated gold 
nanoparticles in drug delivery by reporting their selective targeting of breast cancer 
cells.  Tamoxifen (TAM) has been widely used over the past 30 years for the treatment 
of breast cancer by binding to estrogen receptors and subsequently initiating 
programmed cell death.  The TAM-PEG-AuNPs (Figure 1.38) showed selective 
targeting of these cells with up to 2.7 times enhanced in vitro potency versus the free 
drug.  
 
 
Figure 1.38: Schematic illustration showing synthesis of TAM-PEG-AuNP.[100] 
 
The organisation and design of photoresponsive chromophores encapsulating 
metal nanoparticles offers exciting opportunities in the design of novel photon-based 
devices for sensing, switching and drug delivery.[47]  Gu et al.[97] used modified 
fluorescein-PEG-AuNPs (Figure 1.39) to report the enhanced aqueous stability and 
efficient intracellular transport of fluorescein into the nucleus of HeLa cells possibly 
through the nuclear pores.  The 3.7 nm monodispersed nanoparticles showed no obvious 
cytotoxicity to HeLa cells, making these particles ideal for improvement of nuclear 
targeted drug delivery.  It is believed that endocytosis is the process in which the 
nanoconjugates are up taken by the cell as its transmembrane efficiency is greatly 
affected by a decrease in temperature.  Prior to conjugation of the AuNPs, the free 
fluorescein dye did not demonstrate efficient diffusion across the cellular membrane.   
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Figure 1.39: (Top) Schematic diagram illustrating AuNP-PEG-FITC (FITC = 
Fluorescein) nanoconjugate.  (Bottom) (a) Confocal fluorescence image of isolated 
nucleus of HeLa cells and (b) concentration of the modified AuNPs (in PBS pH 7.4) in 
the nucleus and cytoplasm as measured by ICP.[97] 
  
 
  There are many examples in the literature of ruthenium polypyridyl 
functionalised gold nanoparticles.[69, 103-105]  Similar to the work carried out in this 
thesis, Pramod et al.[67] reported the synthesis of [Ru(bpy)3]2+ functionalised gold 
nanoparticles with controlled separation by PEG linkers illustrated in Figure 1.40.  
Results demonstrated a light-induced charge shift between chromophores at higher 
concentrations leading to the formation of the redox products [Ru(bpy)3]3+ and 
[Ru(bpy)3]+.  Interestingly, lowering the concentration of the ruthenium complex on the 
substrate resulted in a retention of the characteristic luminescence of [Ru(bpy)3]2+.  
Their results indicated that the local concentration of ruthenium complexes on the 
nanoparticles played a critical role in controlling the photophysics of [Ru(bpy)3]2+.   
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They also mentioned several attempts to functionalise the AuNPs with an alkane 
modified ruthenium complex without using PEG as a spacer.  However, this resulted in 
the precipitation of an unfunctionalised nanoparticle.  This was attributed to the non-
compatibility of the non-polar alkane functionalised ruthenium moiety on the gold 
surface.  The addition of polar PEG linkers to the reaction resulted in the formation of 
stable nanoparticles containing mixed monolayers on its surface.    
 
 
Figure 1.40: Schematic diagram showing gold nanoparticles (4.5 nm) containing mixed 
monolayers of an alkane functionalised ruthenium complex and PEG spacing linker for 
increased stability.[67] 
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1.5 Polypeptides as Suitable Transmembrane Transporters 
 
1.5.1 Cell Penetrating Peptides (CPPs) 
 
Another potential cargo-carrying molecule examined in this thesis to transport a 
luminophore across the cellular membrane was CPPs.  Certain naturally occurring 
molecules may enter the cell through a facilitated transport pathway mediated by 
receptors on the cell’s surface.  An example of such a molecule is the nuclear 
transcription activator protein (Tat) encoded by HIV type 1 (HIV-1).[106]  Octarginine is 
a cationic, naturally occurring derivative of the CPP Tat that has the following amino 
acid sequence RKKRRQRRR, where R = arginine, K = lysine and Q = glutamine.  The 
importance of the guanidinium groups on the peptide was demonstrated by Wender et 
al.[106] who systematically changed the cationic groups with neutral alanine residues.  
This caused a significant decrease in the cellular uptake that was directly correlated with 
the number of arginines residues.  Therefore, the large amount of arginine in the Tat 
sequence intensified research into polyarginine as a CPP.  The ability of these CPPs to 
diffuse across the cell membrane is highly dependent on the length of the arginine 
chain, with a chain length of Arg5-Arg11 necessary but octa- or nona-arginine showing 
best cargo carrying ability.[19, 107, 108]  In addition, our work involving penta- and octa-
arginine also showed an effect on uptake of a ruthenium (II) complex.[19, 107, 108] 
 
The four main routes of cellular uptake are endocytosis, active transport, 
facilitated diffusion and passive diffusion.[83]  Endocytosis is the process in which the 
cell membrane engulfs the extra-cellular molecules and they are brought into the cell by 
these tiny vesicles surrounding the substance.  The various endocytotic processes are 
illustrated in Figure 1.41.  In the process of phagocytosis the cell membrane changes 
shape to engulf the extracellular molecule with projections known as pseudopodia.  
When the plasma membrane of both projections meet membrane fusion occurs, which 
result in the formation of a vesicle capable of transporting the molecule inside the cell.  
Pinocytosis on the other hand is the process in which the cell membrane forms an 
invagination and whatever substance is found within the area of invagination is brought 
into the cell’s cytoplasm by tiny vesicles.  In general these materials will usually be 
dissolved in the extracellular fluid as pinocytosis is opposed to the ingestion of larger 
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particulate material such as bacteria.  Receptor-mediated endocytosis is an endocytotic 
mechanism in which specific molecules are brought into the cell.  Receptors on the 
cell’s surface target specific molecules outside the cell.  After binding an endocytotic 
process occurs and the molecule is ingested by the cell.   
 
 
Figure 1.41: Schematic diagram illustrating different types of endocytosis.[109] 
 
 
Electrostatic attraction is the first process in which the highly positively charged 
polypeptides are attracted to the negatively charged phosphate groups at the cell 
phospholipid membrane.  Binding then occurs between the peptides and heparan 
sulphate proteoglyans (HSPGs) located on the cell membrane leading to heparin 
sulphate mediated endocytosis.  Once the vesicle is inside the cell, the heparin sulphate 
is destroyed by heparanases releasing the peptide into the cell.  Macropinocytosis is 
reported as one of the major pathways of uptake for arginine rich peptides.[107, 110]   
 
It is widely believed that endocytosis is the most likely mechanism of cellular 
uptake of arginine rich cell penetrating peptides as results have shown the process to be 
temperature and energy dependent which is indicative of endocytosis.[19, 107, 110, 111]  
Fuchs et al.[110] reported the synthesis of a fluoroscein labelled polypeptide.  Using 
colocalisation studies with vesicular specific markers they observed that the dye-peptide 
was only present in the endocytic vesicles of live cells.  This confirmed that the 
internalisation of the dye-peptide was by entocytoic means and not by passive diffusion 
across the cell membrane.  Furthermore, their results showed the inability of the dye-
peptide to enter cells deficient in herparan sulphate, a molecule which is synonymous 
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with the endocytic process.  In addition, treatment of cells with arginine rich peptides 
has been shown to promote intracellular signalling including activation of Rac protein 
that subsequently leads to F-actin organisation and pinocytosis.[111] 
 
Although endocytosis is recognised by most as the main pathway involved in the 
cellular uptake of arginine rich peptide sequences, it has come under increased scrutiny 
as some conflicting results have been reported.  Internalisation of polypeptides has also 
been observed at 4 oC; temperatures at which endocytic pathways do not function. [111]  
This suggested an energy independent pathway, such as passive diffusion, of cellular 
uptake exists.   
 
Herce et al.[112] illustrate in Figure 1.42 an alternative mechanism called the 
translocation mechanism of polypeptides across the cell membrane via non-endocytotic 
pathways.  As illustrated in Figure 1.42 (a) the P–N dipole vector is in the plane of the 
membrane.  As the peptide approaches the surface of the membrane it attracts the 
phosphate groups and the dipole bends towards the interior of the membrane (Figure 
1.42 (b)).  Since this is not the best conformation for the system, the peptide inserts into 
the interface between the hydrophilic head groups and the carbon chains.  This allows 
the peptide to orient away from the choline groups (Figure 1.42 (c)).  As the density of 
peptides increases, the membrane gets thinner (Figure 1.42 (d)).  An arginine amino 
acid translocates with a local bending of the membrane on both sides of the bilayer 
(Figure 1.42 (e)).  This bending reduces the energetic barrier of the translocation.  A 
pore forms and the peptide translocates bound to the interior of the bilayer surface 
(Figure 1.42 (f)).  
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Figure 1.42: Schematic diagram illustrating qualitatively the steps involved in the 
translocation mechanism.  The orientation of the dipole moment vector formed by the 
phosphate group (negatively charged) and the choline group (positively charged) 
denoted by P and N, respectively is shown.[112] 
 
 
Either way, both endocytosis and translocation methods of cellular uptake have 
theoretical problems that need to be resolved: (i) the lack of cell specificity does not 
correlate well with the idea that peptides could be targeting any specific cell receptor 
and (ii) peptides are highly hydrophilic and the idea that they may directly translocate 
across the hydrophobic core of the membrane would need an excessive amount of 
energy.[112]  However in reality, neither assignment of the mechanism of cellular 
internalisation of arginine rich polypeptides has been proven conclusively and the 
mechanism of uptake remains a hotly debated topic.  Nonetheless, what has been clearly 
demonstrated is the efficiency of polyarginine as a transmembrane molecular cargo 
carrier.    
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Polypeptides have already been used to deliver a wide variety of molecular 
cargo to living cells such as quantum dots[113], drugs[46, 114], organic fluorophores[106, 
110]
, proteins[115, 116] and other smaller molecules.[117, 118]  Rothbard et al.[46] highlighted 
the potential applications of polyarginine sequences for drug delivery in Figure 1.43.  
Many drugs that prevent inflammatory skin conditions, such as cycloporin A for 
example, are ineffective topically because of their poor penetration into the skin.  They 
reported the synthesis of cycloporin A coupled to a hepta-arginine peptide via a linker 
designed to release the active drug at physiological pH within tissue cells.  Results 
showed that the conjugate was a great deal more soluble than the drug alone and that 
distribution of the drug was achieved throughout the epidermis and dermis skin layers.  
 
 
 
Figure 1.43: (a) Synthetic scheme for the chemical conjugation of cycloporin A and 
hepta-arginine peptide via a pH sensitive linker.  (b) Schematic diagram illustrating the 
mechanism of release of the drug upon contact with tissue at physiological pH.[46] 
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 The delivery of functional proteins within a cell also provides a powerful tool 
for therapeutics and the fundamental study of cell biology.  Ghosh et al.[116] reported the 
synthesis of peptide coated gold nanoparticles to promote intracellular delivery of the 
membrane-impermeable β-galactosidase protein in aqueous media as illustrated in 
Figure 1.44.  β-galactosidase is a hydrolase enzyme that catalyses the hydrolysis of β-
galactosides into monosaccharides; a source of energy for an organism.  Their initial 
efforts focused on the functionalisation of the nanoparticles with a short peptide 
sequences containing three arginine residues.  This strategy, however, yielded particles 
that were not well dispersible in water.  In an earlier study they demonstrated that 
lysine-coated particles were water-soluble and stable.[119]  As a result, they used a 
sequence containing arginine and lysine residues with the addition of a histidine (His) 
residue, as His groups are known to facilitate endosomal escape of cargo.[120] 
 
 
 
Figure 1.44: (a) Schematic representation illustrating the intracellular delivery of a 
functional protein using peptide/PEG coated gold nanoparticles.  (b) Chemical 
structure of the nanoconjugate.[116] 
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Crucially, it was found that the transported enzyme was able to escape from the 
endosomes and retained its biological activity once inside the cell.  The cellular delivery 
of the cargo was initially monitored using a fluorescent fluorescein marker.  This once 
again demonstrated the potential applications of gold nanoparticles, PEG linkers and 
polypeptides, as separate entities or in conjunction with one another, as highly suitable 
molecules to deliver materials to intracellular environments.     
 
 
 
1.5.2 Transition Metal Conjugated Polypeptides 
 
 Neugebauer et al.[19] were the first to report the synthesis of two novel 
ruthenium polypeptide conjugates for the purpose of cellular imaging, as illustrated in 
Figure 1.45.  
 
 
Figure 1.45: Structure of the first ruthenium (II) conjugated polypeptides suitable for 
cellular imaging. (where n = 5 or 8)[19] 
 
 
Results highlighted the ability of the octarginine dye-conjugate 
[Ru(bpy)2(picCOOH)Arg8]10+ to passively transport across the cell membrane of SP2  
myeloma cells without the need to use organic solvents.  In contrast, the parent dye and 
shorter pentarginine conjugate showed no evidence of distribution across the cell 
membrane.  This suggested that the length of cell penetrating peptide is all important in 
determining its transmembrane capabilities.  Diffusion of the parent ruthenium complex 
could be accomplished using the detergent Triton, DMSO or ethanol to permeabilise the 
cell.  The migration of the octarginine dye-peptide in absence of permeabilisation 
proved fast and was complete after 10-15 minutes at room temperature, in a temperature 
dependent and an irreversible process.  SP2 myeloma cells in a buffered solution were 
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exposed to 3.5 x 10-5 M of [Ru(bpy)2(picCOOH)Arg8]10+ which led to bright 
luminescence within the cells cytoplasm after only 2 minutes as shown in Figure 1.46.  
Over the next 10 minutes the dye-peptide continued to distribute throughout the cell in 
various concentrations across the cellular plasma in a non-selective manner.   
 
 
 
Figure 1.46: Luminescence images (λex = 458 nm, λem = 610 nm) of SP2 myeloma cell 
incubated with [Ru(bpy)2(picCOOH)Arg8]10+ (3.5 × 10−5 M in PBS) after (a) 3 min and 
(b) after 5 min. (c) Myeloma cell incubated with the parent complex 
[Ru(bpy)2(picCOOH)]2+ (3.5 × 10−5 M in PBS) for 26 min and (d) for 5 min after 
permeablizing the cell with Triton (1% v/v).[19] 
 
 
 In an effort to assess the distribution of the dye-peptide across SP2 myeloma cell 
organelles, Neugebauer et al.[19] counterstained the cells with a cell permeable 
localising dyes.  3,3’-Dihexyloxacarbocyanide iodide [DiOC6(3)] was chosen to 
selectively stain the mitochondria and at higher concentrations the membrane structures 
within the cell including lysozomes and endoplasmic reticulum.  Analysis of both 
[Ru(bpy)2(picCOOH)Arg8]10+ and [DiOC6(3)] in SP2 cells using confocal fluorescence 
microscopy showed that their luminescence did not coincide and therefore it may be 
concluded that the ruthenium dye-peptide does not distribute strongly within the 
mitochondria or endoplasmic reticulum of SP2 cells.   
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 SP2 cells were also counterstained with Sytox green as this dye will provide 
information on the viability of the cells.  Sytox green will only penetrate the cells with a 
disrupted cell membrane and additionally Sytox green will localise in the nucleus of the 
cells once they have been artificially permeablised.  Their results suggested that the 
Sytox green does not enter the SP2 cells stained with [Ru(bpy)2(picCOOH)Arg8]10+, 
indicating that the cells under investigation remain viable over the course of the 
experiment.  These results highlighted the ability of [Ru(bpy)2(picCOOH)Arg8]10+ to 
passively transport across the cell membrane of SP2 myeloma cells and distribute 
throughout the cell’s cytoplasm and cell membrane without causing significant SP2 cell 
apoptosis.  Such co-localisation studies were not performed using a CHO cell line. 
 
 In one of the first examples of its kind, FLIM measurements were used to 
determine the average lifetime of the dye across the various cell components.  Results in 
Figure 1.47 indicated that the dye residing towards the outer membrane displays the 
shortest lifetimes.  This is in good agreement with the higher solubility of molecular 
oxygen in the cell membrane, causing a decrease in the lifetime of the ruthenium probe.  
This demonstrated for the first time the potential value of these dye-conjugates for 
cellular oxygen sensing.   
 
 
 
Figure 1.47: (a) Fluorescence intensity image and (b) false colour FLIM image of 
[Ru(bpy)2(picCOOH)Arg8]10+ (3.5 x 10-5 M in aqueous PBS buffer) in SP2 myeloma 
cells after 15 minutes incubation.[19] 
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 In a more recent paper[29] a [Ru(dppz)2(picCOOH)Arg8]10+ complex (Figure 
1.48) is exploited for the purposes of multimodal cellular imaging.  As this dye exhibits 
a ‘molecular switching effect’ only the dye molecules protected by and associated with 
membrane structures emits phosphorescence and therefore, can not be used to assess the 
true distribution of the dye in the cell.  However, resonance Raman mapping does not 
rely on the emission of the dye and is employed here for the first time as a 
complementary technique to assess the localisation of the parent dye and dye-conjugate.  
 
 
 
Figure 1.48: Chemical structure of [Ru(dppz)2(picCOOH)Arg8]10+.[29] 
 
 
 
 
 
Figure 1.49: Resonance Raman intensity map of live myeloma cells after incubation 
with [Ru(dppz)2(picCOOH)Arg8]10+ (A1) and free parent dye (B1) after excitation at 
458 nm.  A and B represents the brightfield images of the cells in PBS.[29] 
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 Figure 1.49 illustrates the plot intensity of these ruthenium (II) vibrational 
modes and therefore the dye concentration within the cell.  It can be clearly seen that the 
parent dye remains in the outer cell membrane (Figure 1.49, image B1), whereas, the 
dye peptide diffuses across the cell membrane (Figure 1.49, image A1) and is 
distributed throughout the entire cell. 
 
Continuing with this idea of multimodal, mulitparameter cell imaging using 
polypyridyl peptide conjugates, Neugebauer et al.[33] used 
[Ru(bpy)2(picCOOH)Arg8]10+ as a suitable probe for multimodal cell analysis.  The 
conjugated ruthenium (II) dye-peptide failed to yield any significant difference the 
visible region of the absorption spectrum with a corresponding change in pH.  This was 
in contrast with its Raman spectrum that is shown in Figure 1.50 below.    
 
 
Figure 1.50: Resonance Raman spectra of [Ru(bpy)2(picCOOH)Arg8]10+at various pH 
values following irradiation at 458 nm.[33] 
 
 Here the ratio of the height/area of the pH dependent [picCOOH] ligand modes 
(at 1608 and 1550 cm-1) to the height/area of the pH independent bipyridyl ligand 
modes (at 1488 and 1318 cm-1) may be used to construct a pH plot, where any changes 
in concentrations may be corrected for.  Resonance Raman signals were collected and 
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mapped from SP2 myeloma cells containing [Ru(bpy)2(picCOOH)Arg8]10+ in PBS 
buffer.  Using the pH dependent Raman calibration curve, it was found that the cellular 
membrane had a pH of 6.7, nucleus pH 6.8 and cytoplasm pH 7.2.  These values were in 
good agreement with values previously published. 
  
 Intracellular pH is an important parameter in the natural synthesis of 
macromolecules within the cell such as DNA, RNA, protein production and in 
regulation of the cell cycle itself.[121]  Abnormal pH levels within the cell may be an 
indication of disease, as often tumour cells are found to contain higher acidity levels in 
the cytoplasm.[31, 32]   
 
 While [Ru(bpy)2(picCOOH)Arg8]10+ is highly sensitive to changes in pH, as 
seen previously it is also sensitive to changes in oxygen concentration.  As a result, one 
may take advantage of the same ruthenium dye-conjugate probe to measure both 
parameters in a single environment.  In a more detailed study, the luminescent lifetime 
of the ruthenium dye was used to calculate the oxygen concentration within the cell, as 
the lifetime is not effected by local concentrations of the dye.  Fluorescence lifetime 
imaging microscopy (FLIM) measurements were used to determine the lifetimes of the 
ruthenium luminophore within the cell as shown in Figure 1.51.  
 
Figure 1.51: (a) Fluorescence intensity map of SP2 myeloma cell incubated for 12 
minutes with [Ru(bpy)2(picCOOH)Arg8]10+ in PBS for 12 minutes and (b) false colour 
lifetime image of the same cell.[33] 
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 Three regions within the cell were identified by comparison with Raman 
spectroscopy and confocal microscopy images.  The lifetimes for the background 
medium, cell membrane, cytoplasm and nucleus are shown in Figure 1.48 above.  These 
lifetimes correspond to oxygen concentrations of 7.2 +/- 1.2 mg O2/L in the background 
solution, 9.2 +/- 1.7 mg O2/L in the cell membrane, 5.5 +/- 1.0 mg O2/L in the 
cytoplasm and 4.6 +/- 0.8 mg O2/L in the nucleus.  These results confirm that there is a 
higher concentration of molecular oxygen located in the membrane of a cell, causing a 
decrease in the lifetime of the phosphorescent dye.     
 
Barton et al.[90] are another group who have realised the potential of using a cell 
penetrating peptide to facilitate entry of a ruthenium dye peptide into HeLa cells.  
Results showed that the parent complex [Ru(phen)(bpy)(dppz))]2+ showed no transport 
across a cellular membrane prior to conjugation to the octarginine peptide.  
Interestingly, the uptake of a dye peptide containing ruthenium-Arg8-fluorescein is far 
greater at lower concentrations when compared to the ruthenium-Arg8 conjugate alone 
(Figure 1.52).  It is thought that due to the fluorescein moiety having a greater 
lipophilicity versus the ruthenium and this serves to increase the interaction of the dye 
conjugate with the cellular membrane.   
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Figure 1.52: Chemical structures and corresponding cellular distribution of complexes 
synthesised by Barton et al. in various concentrations in HeLa cells incubated at 37oC 
in complete medium (σ-MEM with 10% FBS) then rinsed with HBSS solution and 
imaged without cell fixation.[90]  
 
 
Recently Rijt et al.[122] reported the promising cancer cell cytotoxicity of an 
osmium (II) polyarginine peptide.  It has been shown to induce non-repairable damage 
to DNA by causing a large degree of DNA unwinding.  They also examined the effect 
of varying the polyarginine lengths (from Arg1 to Arg8) on the cellular uptake, toxicity 
and cell distribution of the dye-peptide in CHO cell lines.  As previously discussed their 
results also highlighted a strong correlation between increased arginine length and 
cellular uptake, nuclear uptake, DNA binding and decreased cytotoxicity.  The cellular 
uptake and increased activity of the osmium functionalised polypeptides showed 
preference in the order of Arg8>> Arg5> Arg1~unfunctionalised.  In addition, 
polyarginine peptides have been conjugated to other metal complexes including 
rhodium[91], gadolinium[92], europium[92], nickel[111], rhodamine[111], and terbium[123] for 
the purposes of cell imaging. 
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1.6 Conclusion 
 
Over the past number of year’s research into the potential applications of 
photoactive supramolecular assemblies, incorporating inorganic and organic 
chromophores, has exploded across a wide range of areas from medicine to energy 
conversion to nanoscience.  However, given their large stokes shifts, long lifetimes, 
intense luminescence, good photostability and PDT properties inorganic probes are seen 
to be the way forward in terms of challenging and improving on existing technologies.  
In addition, the ability to fine tuning their absorbance and emission characteristics for 
specific purposes only adds credence to their use as potential multimodal molecular 
probes.   
 
As part of this research two main series of luminescent metal complexes, that of 
ruthenium (II) and iridium (III), are studied to determine their suitablility as potential 
cellular probes.  A series of water soluble ruthenium (II) polypyridyl and novel water 
insoluble iridium (III) complexes were synthesised and their spectroscopic, 
photophysical, and electrochemical properties fully characterised and compared.  
Iridium has been one of the most explored metal complexes in recent years but tends to 
be poorly water soluble and non cell permeable.  This thesis addresses this issue by its 
conjugation to a CPP for applications in cellular imaging.  Most of the assemlies 
outlined in this thesis are based on the supramolecular dyad system of A-L-B, where the 
characteristics or applications of the assembly outweigh that of the individual sole 
photoactive component.  
 
To date there has been very limited research into the potential use of gold 
nanoparticles as suitable transmembrane transporter of molecular cargo, in particular 
luminescent markers.  In addition, the coupling of a luminophore to a metal nanoparticle 
is shown to enhance its emission intensity when the distance from the nanoparticle is 
appropriate.  Chapter 3 describes the functionalisation of gold nanoparticles with a 
ruthenium (II) polypyridyl complex through polyethylene glycol linkers of varied 
length.  Not only did conjugation to the gold nanoparticles provide enhanced 
luminescence and lifetimes but they also facilitated the transport of an otherwise non-
permeable ruthenium dye across the cell membrane of SP2 myeloma cells. 
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Successful conjugation of metal luminophores to polypeptides has been 
achieved previously, however, the synthesis of an iridium (III) polypeptide is yet to be 
reported.  It was hoped that the use on an iridium label would exhibit enhanced quantum 
yields and lifetimes of the molecular probe when compared to existing transition 
conjugated metal polypeptides.  In Chapter 5, conjugation of the ruthenium (II) and 
iridium (III) dyes to biomolecules builds upon previously reported work by our group 
and enables the analysis of biological samples through non-targeted localisation within 
a cell, but most importantly without destroying the cell membrane in the process.  It 
remains to be seen how further conjugation of the dye-peptides to target specific 
peptides could help with concentration of the luminophore within certain tumour cells.  
The generation of reactive oxygen species following absorption of light energy by the 
transition metal luminophores may also induce cell apoptosis and could potentially 
make these a powerful diagnostic and photo therapeutic tool.  
 
Numerous reports highlight attempts in creating light harvesting supramolecular 
assemblies capable of mimicking processes involved in plant photosynthesis.  Chapter 6 
discusses attempts to synthesise a light harvesting device for the efficient conversion of 
solar energy to electrical energy.  The attachment of an organic fluorophore to a 
supramolecular structure, namely DNA, as the backbone is attempted for the first time.  
This is in keeping with the general topic of research; in building photoactive 
supramolecular assemblies and identifying suitable luminescent probes for conjugation 
to biomolecules for applications in areas from diagnostics to solar energy conversion. 
 
One of the main aims of this thesis is to identify suitable luminophores and to 
demonstrate how their conjugation to cell membrane transporters enables their 
applications in cellular imaging.  Furthermore, the inherent properties of the dyes may 
then be exploited for multimodal cellular imaging to determine characteristics such as 
pH and oxygen levels within cellular structures.  This thesis provides an insight into the 
construction of supramolecular assemblies from its individual subunit synthesis to their 
combined functional applications.  It also gives an idea of the work currently being 
undertaken across a range of disciplines and will add to the understanding of the basic 
principles on which these luminophores may be exploited for their potential uses in 
photoactive supramolecular assemblies, diagnostics and other related photochemical 
processes.    
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2.0 Introduction to Raman spectroscopy 
 
 Raman is a vibrational spectroscopic technique which has advantages over 
others, such as infrared (IR), in that low frequency modes between 10-600 cm-1 can be 
studied.  These modes prove to be particularly important for metal ligand complexes 
and in addition resonance Raman may be used to identify optical transitions in complex 
molecules.  In Raman a laser typically in the visible region is used to irradiate the 
sample.  Once this light interacts with the sample it produces scattered light that may be 
interpreted to give bond vibrational information.  The scattered light may be divided 
into 3 types: (i) Rayleigh scatter which has the same frequency of the incident beam, 
this scatter is the most intense and contributes to more than 90% of the scattered light, 
(ii) Stokes scattering and (iii) anti-Stokes Raman scattering.  In Stokes and anti-Stokes 
scattering, energy is exchanged between the molecule and incident light beam and is 
much weaker by comparison to Rayleigh scatter.  Raman spectroscopy analysis usually 
involves Stokes scatter as anti-Stokes signals originate from molecules in vibrational 
energy levels other than the lowest.  Anti-Stokes scatter are usually poorly populated at 
room temperature leading to lower intensities.[1]  The various Raman scattering 
processes are illustrated in Figure 2.1 below.   
 
 
 
Figure 2.1: Schematic diagram showing the possible Raman and Rayleigh scattering in 
Raman spectroscopy. 
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In conventional Raman, light energy from the laser excites the molecule from 
the ground state into some virtual state.  As the molecules relaxes back to the ground 
state it scatters a photon and in doing so returns to a different vibrational or rotational 
state.  It is the difference in this energy shift from the absorbed and emitted photon that 
gives rise to Raman scattering.  If the photon returns to a higher final vibrational state 
than the initial state the emitted photon will result in Stokes scattering.  On the other 
hand, if the final state is a lower energetic state this will lead to an anti-Stokes shift.  
Rayleigh scatter is where the photon returns to the same vibrational energy level and 
there is no scattering of light following interaction between the incident beam and the 
sample.    
 
 
2.0.1 Selection rules 
 
 For a mode to be Raman active the polarisability of the molecule must change 
when placed into the laser’s electric field during the vibration.  The incident laser may 
interact with the surrounding electron density of the molecule resulting in the distortion 
of the molecule giving rise to the Raman light scattering.  Raman is a complementary 
technique to IR spectroscopy where, for a vibration to be IR active the dipole moment 
must change during the vibration.  For very symmetrical molecules bands that are IR 
inactive are usually Raman active and visa versa.  One of the main advantages of 
Raman over IR is that water is a poor Raman scatterer.  This allows for the analysis of 
biological samples with less interference.  The probability of Raman scattering 
occurring is small under most circumstances, however, two important implications of 
the Raman effect lead to strong enhancements of the Raman signal: resonance Raman 
spectroscopy and surface-enhanced Raman spectroscopy.[1] 
 
 Resonance Raman (RR) spectroscopy is more commonly exploited in this thesis.  
RR scattering occurs when the incident laser beam coincides with an optical transition 
of a compound leading to the population of an electronically excited state.  RR shows a 
large enhancement of up to six orders of magnitude of the Raman signal originating 
principally from the Franck Condon modes (i.e. those distorted by the optical transition) 
of the compound in question.[1]  Therefore, it may provide additional information on the 
chromophores being irradiated in an electronic transition.  This technique has been used 
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in the past to assign the MLCT excited states for many complexes.[2]  It is known that 
the absorbance band at around 450 nm for [Ru(bpy)2(picCOOH)]2+ corresponds to the 
MLCT transition from a ruthenium metal dπ orbital to bipyridyl ligand π* orbital.  
However, as the absorbance extends to slightly longer wavelengths, the vibrational 
modes of a MLCT from ruthenium metal centre to [picCOOH] π* orbital become 
evident.  This suggests that a ruthenium dπ to [picCOOH] π* orbital is the lowest 
energy optical transition.  Examples of this are demonstrated and explained in detail in 
Chapter 3.  Hence, resonance Raman spectroscopy may be used to assign the electronic 
transitions within a molecule.  
 
Fluorescence may prove to be a problem in gathering RR scattering information 
because when the exciting wavelength excites an emissive state or is close to its 
absorbance, the fluorescence signal may overcome the vibrational modes making 
analysis difficult.  However, for metal ligand complexes, the Stokes shifts are typically 
100 – 200 nm which is particularly amenable to RR. 
 
 
Surface enhanced Raman spectroscopy (SERS) is a surface sensitive technique 
used to intensify Raman scattering signal from molecules adsorbed on a rough/irregular 
metal surface.  Enhancement factors in the order of 1020 may be achieved and have been 
used in single molecule detection.[3]  It is normally performed on silver or gold 
substrates with roughened nanoscale surfaces.  Similar to metal enhanced fluorescence, 
surface plasmons of the metal are excited by the incident laser at a certain wavelength.  
This results in an increased electric field at the metal interface effectively enhancing the 
electric field of the incident light as Raman intensities are proportional to electric field 
strength.  Chemical enhancement also may occur where a molecule is bonded to a 
substrate leading to resonant enhancement of charge transfer transitions between metal 
and analyte.  While monolayers show superior surface enhancement there is evidence to 
suggest that SERS may operate at distances of up to tens of nanometers.  Furthermore, 
for adsorbed species, the selection rules are relaxed and vibrational modes forbidden in 
the normal Raman spectrum are frequently observed when that species is adsorbed onto 
a roughened metal surface.[1]   
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2.1 Instrumentation 
 
2.1.1 Nuclear Magnetic Spectroscopy (NMR) Spectroscopy 
 
1H-NMR was performed on a Brucker AC 400 MHz using deuterated DMSO-d6 
or CDCl3 as solvent unless otherwise specified.  Peak positions are relative to TMS (0 
ppm chemical shift).  All NMR spectra were processed and analysed using Topspin 
NMR software. 
 
2.1.2 Mass Spectrometry 
 
 Mass spectrometry experiments were carried out using a Bruker Esquire 
LC_00050 electron spray interface (ESI) with a positive ion polarity.  Samples were 
dissolved in one of HPLC grade methanol or acetonitrile or a mixture of both. 
 
2.1.3 Elemental Analysis 
 
 Elemental analysis was carried out on an Exador analytical CE440 analyser at 
the Microanalytical Laboratory in Univeristy College Dublin.  Samples were analysed 
by the technicians in UCD. 
 
2.1.4 Absorption Spectroscopy 
 
 UV-Vis spectra were recorded on a Varian Cary 50 spectrophotometer.  Samples 
were analysed in a quartz cuvette with a pathlength of 1 cm with a spectral range of 
200-600 nm unless otherwise stated.  The background was corrected for blank solvent 
absorbance prior to every measurement and was performed at room temperature.    
 
2.1.5 Fluorescence Spectroscopy 
 
 Emission spectra were recorded on a Varian Cary Eclipse fluorescence 
spectrophotometer with an excitation slit width of 5 nm and an emission slit width of 5 
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nm.  All experiments were performed using a 1 cm pathlength quartz cuvette.  The 
background was corrected for blank fluorescence before each measurement and was 
performed at room temperature. 
 
2.1.6 Lifetime Measurements 
 
 Luminescent lifetimes were obtained using a Picoquant Fluotime 100 TCSPC 
(Time Correlated Single Photon Counting) system exciting at 450 nm and using a 510 
nm narrow band pass dielectric filter for ruthenium complexes.  Excitation at 370 nm 
and the band pass dielectric filter was set for detection at 460 nm and above for iridium 
complexes.  The instrument response function was determined by using ledox AM30 
colloidal silica solution (Adrich) with an excitation source (picosecond pulse diode 
lasers) of 370 nm for iridium samples and 450 nm for ruthenium samples respectively.  
10,000 counts were collected for each lifetime measurement and all measurements were 
performed in triplicate using Nanoharp software to confirm results.  Typical pulse rates 
of the excitation source were 1x105 s-1 with typical pulse widths of 300 ps.  Degassed 
samples were degassed with nitrogen for 20 minutes prior to analysis.  It is also noted 
that solvents were used as received and as a result may contain trace water which may 
have an impact on the results.   
 
 The calculation of the luminescent lifetimes was performed by fitting an 
exponential decay function to each decay plot to extract the lifetime information using 
FluoFit software.  Due to the inherent long lifetimes of inorganic complexes all data 
was fitted to mono/bi-exponential decay functions to the baseline of the decay curve 
using tail-fit with an x2 value of between 0.9-1.1. 
 
2.1.7 Confocal Fluorescence Microscopy 
 
 Confocal fluorescence microscopy is an imaging technique that uses point 
illumination and a spatial pinhole to eliminate out of focus light in samples that are 
thicker than the focal plane as illustrated in Figure 2.2.  The incident light is focused by 
the objective lens into a cone shaped beam of light so that the maximum intensity of the 
beam strikes one spot at a specific depth within the sample.  The fluorescence from the 
sample is then focused by the dichroic mirror onto a pinhole aperture, eliminating 
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fluorescent light from outside the sample volume, yielding very high sensitivity and a 
sub-micron spatial resolution.[1] 
 
Luminescence images were recorded using with a Zeiss LSM510 Meta confocal 
microscope using a 64x oil immersion objective lens (NA 1.4).  The 458 nm argon ion 
laser excitation was used for ruthenium samples and the 375 nm laser line for iridium 
samples.  Optical density filters were reduced to 0.1% transmission in order to reduce 
any effects of photobleaching.  The luminescence from ruthenium was collected using 
490/505 nm long pass filters and iridium samples was collected using 420/490 nm long 
pass filters. 
 
Figure 2.2: Schematic diagram illustrating the components present in a confocal 
microscope.[1] 
 
 
2.1.8 Microwave Synthesis 
 
 Microwave experiments were performed in a CEM XP-500 Plus microwave 
equipped with pressure vessels, temperature control and pressure control.  Pressure 
vessels could hold up to 10 mls of samples but no more that 3 mls were ever used in any 
experiment to reduce the chances of an explosion occurring. 
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2.1.9 Thin Layer Chromatography 
 
 Thin layer chromatography (TLC) was performed on glass silica gel (Merck, 
250 µm thickness), alumina (Alumina GF, Aldrich, 250 µm thickness) or C18 (Sorbent 
Technologies, 250 µm thickness) plates.  These were then immersed in a beaker 
containing mobile phase of interest and analysed under UV light (254 and 365 nm). 
 
2.1.10 Chromatographic Techniques 
 
All silica gel chromatography was performed using an automated flash 
chromatography system (Analogix-Intelliflash 310) using 50µm silica gel particle size, 
equipped with a UV detector (200-400 nm) and auto collector.  The detection 
wavelength used was dependent on the maximum absorbance of the compound in 
between the detector limitations, with a slope sensitivity of 0.1.  Alumina 
chromatography was performed using basic alumina pre-packed chromatographic 
columns (Al2O3, 150 mesh size).   
 
High performance liquid chromatography (HPLC) used was a Varian LC 940 
series using a Varian pursuit XRs C18 250 x 4.6 mm column along with photodiode 
array detector (150-900 nm), auto sampler and auto collector.  The detection wavelength 
used was dependent on where the maximum absorbance of the compound was located.  
All mobile phases were of HPLC grade quality and were filtered and degassed prior to 
use.  The wavelength of detection was set to that of the maximum absorbance of the 
sample and usually set up to collect the peaks at a specific retention time rather than a 
threshold or slope setting.     
 
2.1.11 Electrochemistry – Cyclic Voltammetry  
 
 Cyclic voltammetry (CV) is an electrochemical technique that scans a potential 
region by varying the applied potential at a working electrode and recording the current 
produced.  It may rapidly determine information on redox systems in solution and on an 
electrode surface.  CV’s were carried out using a CH Instruments CH-600 
electrochemical workstation.  A three electrode cell was used, with a glassy carbon 
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electrode (3 mm diameter Teflon shrouded) as the working electrode, silver wire a 
reference electrode and platinum wire as auxiliary electrode.  Ferrocene was employed 
as an internal standard and calibrated for all results versus Ag/AgCl as reference.  All 
CV’s were performed in duplicate with different glassy carbon electrodes, scanning 
though the range of potentials: 1, 0.50, 0.25 and 0.05 Vs-1 respectively.   
 
 Electrochemistry was conducted using 1 mmol of sample dissolved in 5 cm3 of 
dry acetonitrile (HPLC grade, used as received) containing 0.1 M tetrabutylammonium 
tetrafluoroborate (TBA) as supporting electrolyte.  No additional care was taken to dry 
the acetonitrile solution and hence, it is noted that the presence of a protic solvent such 
as water may complicate the electrochemical results.  All samples were degassed with 
nitrogen for approximately 20 minutes prior to analysis.   
 
2.1.12 Raman Spectroscopy 
 
Micro-Raman measurements were carried out in backscattering configuration 
using an Olympus confocal microscope attached to a HORIBA Jobin-Yvon Labram HR 
1000 spectrometer coupled to Digital Instruments Bioscope II with an inverted 
microscope.  Raman scattering was detected using a Peltier cooled (−70 ◦C) charge-
coupled device (CCD) camera (255×1024 pixels), excited with vertically polarised 
excitation lines from Ar+ laser (458/488/514 nm) or 785 nm diode laser sources.  The 
spectrometer was equipped with diffraction gratings of 600 grooves / mm and the slit 
allowed the spectral resolution of 2 cm−1.  An appropriate edge filter was set in the 
spectrometer depending on the excitation source.  
 
The area of the laser spot on the samples was 1 µm in diameter. The laser power 
at the sample set from 1 to 2 mW using the inbuilt laser power control.  Data acquisition 
times used in the Raman experiments ranged from 1 to 20 s. The Raman band of a 
silicon wafer at 520 cm−1 was used to calibrate the spectrometer and the accuracy of the 
spectral measurement was estimated to be approximately 2 cm−1.  The spectral data 
were acquired and analysed using LabSpec software.   
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2.1.13 Fourier Transform Infrared Spectroscopy (FTIR) 
 
The FTIR spectrum of the iridium (III) complexes was recorded using a Varian 
610-IR microscope equipped with a nitrogen-cooled mercury cadmium telluride (MCT) 
and deuterated triglycine sulphate (DTG) detectors.  A spatula tip full of sample was 
dispersed in a KBr matrix and were recorded with a 2 cm-1 spectral resolution with KBr 
used as a beam splitter.  Raw spectra were manipulated by built in functions in Varian 
Resolution pro software, which performs corrections in atmospheric water vapour and 
CO2 absorption bands, baseline and smoothing.  
 
2.1.14 Zeta Potential Analyser 
 
 The zeta potential of the colloidal systems were analysed using a Beckmann 
Coulter Delsa Nano C Particle Analyser.  The zeta potential is a measure of the potential 
difference between the colloid material and the layer of fluid surrounding the colloid, 
also known as the electrical double layer.  The zeta potential gives an indication as to 
the stability and the degree of repulsion between adjacent colloids in the dispersion 
media.  A large zeta potential value (+/- >40 mV) suggests good colloid stability and 
repulsion between other colloids.  Whereas a smaller zeta potential value (+/- <40 mV) 
indicates less stable systems that will tend to coagulate and drop out of solution.[4] 
 
2.1.15 pH Titrations 
 
pH titrations were performed in the pH range of 0.5-12 with a VWR Symphony 
SP70P pH meter.  The instrument was calibrated using a 3 point calibration plot using 
solutions of pH 3, 7 and 9.  The pH titration experiments were performed by the 
stepwise additions of µl aliquots of concentrated perchloric acid or sodium hydroxide 
solutions into a 15 ml PBS buffered solution containing 20 µM of the complex under 
investigation.  All PBS buffer solutions throughout the thesis were made using P-5368 
PBS pH 7.4 in individual foil pouches purchased from Sigma unless otherwise stated.  
The dry powder was dissolved in 1 litre of deionised water which yielded a solution 
containing 0.01 M PBS, 0.138 M NaCl and 0.0027 M KCl at pH 7.4. 
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All pH induced spectral changes were analysed for reversibility by checking if 
their absorbance and emission spectra were fully recovered after restoring the pH to 
neutral.  The resulting spectra are not corrected for dilution as the volume added to the 
solutions were negligible compared to its total volume.  A pKa standard deviation of +/- 
0.07 pH units was experimentally calculated and a +/- 0.1 pH units was applied to each 
pKa measurement.   
 
It is noted that PBS is not supposed to be used over very large pH ranges and 
only works well over the range of approximately pH 5-9.  It would have been better to 
use discrete buffers for each pH value to eliminate this issue and should be done for any 
additional pH dependence studies.   
 
2.1.16 Cell Culture 
SP2/0-Ag 14 murine Myeloma spleen cells (ATCC no. CRL-1581) and Chinese 
hamster ovarian (CHO) (CHO-K1, ATCC no. CCL-61) were purchased from ATCC 
Cell Biology Collection (UK).  The suspension cell line SP2 were grown in Dulbecco’s 
modified Eagle’s medium (DMEM) with stable L-glutamine and CHO cells in 
DMEM/Hams F-12 both supplemented with 10% foetal calf serum (Biosera) at 37 oC 
with 5% CO2.  Cells were harvested or split when they reached 90% confluency for 
CHO cells or 1 x 106 cells per ml for the suspension SP2 cells.  
2.1.16.1 Cellular Uptake of Complexes 
In order to assess and compare the ability of the compounds to transport across 
the cell membrane, SP2 and CHO cells were cultured on 35 mm glass bottom culture 
dishes.  SP2 cells were seeded at 5 x 105 cells in 2 ml media and CHO cells were 
harvested after trypsinisation (0.25% trypsin for 5 mins at 37 oC) and seeded at 8 x 104 
cells in 2 ml media.  Both cell types were grown for 48 hours before imaging.  For 
confocal measurements the growth medium was removed by washing with PBS buffer 
(pH 7.4) and 20 µl of the parent complex (1.4 mM) or dye-peptide (1.4 mM) in PBS 
(pH 7.4, with MgCl2 and CaCl2) was added.  The luminophores and dye-peptides were 
made to a final concentration of 70 µM with PBS (pH 7.4) except for the iridium parent 
complex which made to 70 µM in 0.05% DMSO in PBS (1:20 dilution from stock with 
1% DMSO) and were imaged immediately. 
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The cell viability dye, DRAQ7 (Biostatus), was generally added after 1 hour of 
imaging as it stains the nucleus of dead cells.  DRAQ7 (4 µM final concentration) in 
PBS was carefully added to each dish and excited at 633 nm with emission collected at 
650 nm.  It is also noted that the cellular imaging results reported in this thesis take 
place at room temperature and without a 5% CO2 environmental control in place.  This 
may cause additional stresses on the cells which could account for increased cell 
apoptosis. 
 
2.1.16.2 Cytotoxicity Assay 
Cells were seeded in a 96-well plate in 100 µl of media for 24 hours at 37 oC 
with 5% CO2 before addition of compounds.  SP2 cells were seeded at 1 x 105 and CHO 
cells at 1 x 104 cells per well.  PBS solvent containing DMSO and ethanol with final 
concentrations of between 20 to 0.3% were added to the harvested cells and left for 16 
hours at 37 oC in a 5% CO2 incubator.  10 µl of either the MTT or resazurin reagents 
(PromoKine) were added and incubated for 4 hours for MTT and 7 hours for resazurin 
at 37 oC.  Formazan was solubilised with 150 µl DMSO per well for MTT assay and 
absorbance was measured at 570 nm and 630 nm (background).  The resazurin 
converted to resorufin in viable cells was detected at absorbance 570 nm with 
background subtracted at 600 nm.  Absorbance readings were performed using a Tecan 
96-well plate reader.  All cytotoxicity experiments are reported in terms of % 
cytotoxicity, e.g. 100% cytotoxicity = 100% of cells non-viable. 
 
2.1.17 Freeze Drier 
 
 The freeze drier used was a Labcono FreeZone 2.5.  Prior to placing on the 
freeze drier, all samples were dissolved or dispersed in deionised water and fully frozen 
in liquid nitrogen.  The sample was then left on the freeze drier overnight.  
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2.2 Instrumentation used for peptide synthesis 
 
2.2.1 HPLC Analysis 
 
Chromatographic purification was carried out on a Varian HPLC 
Chromatography Workstation using a Phenomenex Gemini (C-18) reverse-phase 
chromatography column.  The Gemini C-18 (250mm x 2.5 mm) was used at 1 ml per 
minute with linear gradient programs.  The UV detector was monitored for dye-peptides 
at dual wavelengths of 214 nm and 350 nm for iridium conjugate and 214 nm and 452 
nm for ruthenium conjugate respectively.  Solvent A consisted of deionised H2O 
containing 0.1% TFA and solvent B consisted of CH3CN containing 0.1% TFA.  The 
gradient ran over 30 minutes going from 5% to 65% of solvent A. 
 
2.2.2 Mass Spectrometry Analysis 
 
Mass spectrometry analysis was performed on a LaserToF by Matrix Assisted 
Laser Desorption Ionisation-Time Of Flight (MALDI-TOF).  α-Cyano-4-hydroxy 
cinnamic acid matrix was dissolved in 1:1 H2O containing 0.1% TFA and CH3CN 
containing 0.1% TFA at a concentration of 10mg/ml.  2µl of a 1:1 solution of the dye-
peptide to matrix were applied to the MALDI plate.  Measurements were kindly 
performed by Lorraine Blackmore and Graeme Kelly of the RCSI.  
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2.3 Calculating Quantum Yields 
 
In this thesis the phosphorescent quantum yield of the metal complexes are 
estimated by matching the MLCT absorbance transition of both the complex and 
standard [Ru(bpy)3]2+ [φP = 0.0642 in acetonitrile].[5]  Both solutions are excited into the 
MLCT region of maximum absorbance and the corresponding emission recorded.  The 
luminescent quantum yield may be calculated by using the following formula in 
Equation 2.1. 
 
φP(x) = (Ax/As) (Fs/Fx) (nx/ns)2 φP(s)……….(Eq 2.1) 
 
where φP is the phosphorescent quantum yield, A is the absorbance at the excitation 
wavelength, F is the area under the corrected emission spectrum and n is the refractive 
index of the solvents used.  The subscripts s and x refer to the standard and unknown 
respectively.  This procedure for quantum yield determination is a relative method and 
provides a quick way to estimate the quantum yields of a complex.  All quantum yield 
experiments were performed three times and the average quantum yield is the value 
quoted throughout this thesis for all metal complexes.   
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3.0 Introduction 
 
Inorganic luminophores offer many advantages over organic fluorophores and 
their benefits in cellular imaging,[1-3] diagnostics,[4-6] and supramolecular assemblies[7-9] 
have been known for many years.  Transition metal complexes offer significant 
synthetic flexibility where by changing the ligands one can fine tune the absorbance and 
emission characteristics of the complex.  In the cases of ruthenium, osmium, iridium 
and rhodium their relatively high phosphorescent quantum yields permits easy detection 
of luminophores at low concentrations, however, many small organic dyes such as 
fluorescein and Alexa are used at 1 nM concentrations for fluorescence measurements.  
Furthermore, the addition of ligands with environmentally sensitive functional groups, 
such as ionisable protons, offers pH sensitivity to the complex as is the case with the 
functionalised phenanthroline ligand reported throughout this chapter.   
 
Specifically, ruthenium (II) polypyridyl complexes have attracted a lot of 
attention due to their strong DNA-binding[10-13] and potential anti-cancer properties.[5, 14-
16]
  Results have shown how numerous ruthenium (II) polypyridyl complexes displayed 
excellent anti-tumour activity towards selected transfected cell lines.  More recently, 
several complexes were also shown to induce mitochondria-mediated apoptosis in 
human cancer cell lines while displaying a lower toxicity when compared to widely 
used cisplatin based drugs to treat certain cancers.[5] 
 
Much of the early bio-related research into ruthenium centred around derivatives 
of [Ru(phen)3]2+ because they were known to act like a ‘molecular switch’, as their 
luminescent output intensities were dependent on their microenvironments.  Olson et 
al.[17] reported this ‘light switching’ effect for [Ru(phen)2(dppz)]2+, where dppz = 
dipyridophenazine.  Figure 3.1 illustrates how the luminescence of the complex is 
completely quenched in aqueous media but is highly emissive in other aprotic organic 
solvents.  In this particular ruthenium species there are several excited states quite close 
in energy: (i) a MLCT state directly populated by light excitation, in which the excited 
electron resides on the LUMO centred on the ‘bpy-like’ portion of the dppz ligand, (ii) 
the excited electron is located on the LUMO centred on a phenazine bound state the of 
the dppz ligand and (iii) a ligand centred (dppz-based) excited state.[18]  In aqueous 
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solution, data showed that MLCT charge transfer is directed from the metal centre to the 
phenazine of the dppz ligand.  However, a major source of non-radiative deactivation of 
the excited state is protonation of the nitrogen atoms on the phenazine ring, here, the 
rapid radiationless decay is driven by hydrogen bonding.  Interestingly, when the 
complex is solvated by an aprotic organic solvent, the MLCT excited state involving the 
‘bpy-like’ dppz subunit becomes dominant.  Since such an energy state has better 
emissive properties the luminescence of the complex is effectively ‘switched on’.[18]  
 
 
 
Figure 3.1: (Top) Chemical structure of [Ru(phen)2(dppz)]2+ and resultant 
photophysics in both aqueous and non-aqueous media. (Bottom) Model diagram 
illustrating its solvent dependent photophysics, were MLCT’ and MLCT’’ denotes 
distinct MLCT excited states distinguished by the distribution of charge on the metal-
ligand framework.[17] 
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Furthermore, the addition of DNA to aqueous solutions containing 
[Ru(phen)2(dppz)]2+ and its derivatives also lead to a molecular ‘light switching’ effect 
as the nitrogen atoms on the dppz ligands are effectively shielded from its aqueous 
environment via intercalation with the DNA and H-bonding events.[10, 12, 19]  This allows 
for the switching of excited state from the MLCT on the ‘phenazine-like’ to the triplet 
MLCT excited state located the ‘bpy-like’ subunit of the dppz ligand and the complex 
emits brightly.  The interaction between ruthenium (II) polypyridyl complexes with 
DNA has been well documented in a series of reviews.[10, 12, 20]  The exact binding 
mechanism between a metal complex and DNA is not well understood, however, it is 
believed that electrostatic interactions and groove binding within the minor groove of 
the DNA double helix are responsible.[10]  Modification of chelating ligands can create 
interesting spatial configurations and electronic structures that have been shown to 
effect their binding interactions with DNA.[10, 12, 21]  It is noted that research into 
ruthenium complexes containing ionisable ligands has been limited in the context of 
DNA and protein binding.  The use of such pH sensitive metal complexes could 
potentially exhibit preferential selectivity towards pH-dependent damage in DNA and 
hence, show increased selectivity towards cancer cells.[13]  In addition, use of pH 
sensitive ligands may also potentially provide critical information in the identification 
of cancerous tumours as they are known to express abnormal pH levels.[4, 22, 23] 
 
[Ru(bpy)2(picCOOH)]2+ has been reported before by our research group and 
others[13] on its photophysical properties[24, 25] and its subsequent conjugation to 
biomolecules, such as polypeptides.[1, 26]  Characteristics such as long aqueous lifetimes 
(> 800 ns), large Stokes shifts, pH dependence, photostability and increased emission in 
water make this and related dyes an attractive proposition for their use as molecular 
probes.  The carboxyl functionality may be used to conjugate the luminophore to many 
naturally existing functional groups on biomolecules.  However, of particular interest is 
its conjugation to amino groups located on such biomolecules which may be achieved 
though various coupling techniques such as PyBOP/HOBt[1, 27] or EDC/NHS[28] 
coupling reactions.  
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R = COOH = [Ru(bpy)2(picCOOH)]2+ 
R = NO2 = [Ru(bpy)2(picNO2)]2+ 
R = NH2 = [Ru(bpy)2(picNH2)]2+ 
Ru
N
N
N
N
N
N N
N
R
H
 
Figure 3.2: Chemical structures of ruthenium (II) polypyridyl complexes synthesised as 
part of this thesis. 
 
 
A key aim of this chapter was to synthesise the luminophore with an amine 
reactive terminal functionality to take advantage of the many other reactive groups, in 
particular carboxyl functional groups, which are present on biomolecules.  The synthetic 
approach taken was to synthesise 2-(4-nitrophenyl)imidazo[4,5-f][1,10]phenanthroline 
followed by a reduction reaction that yielded the analogous 2-(4-
aminophenyl)imidazo[4,5-f][1,10]phenanthroline ligand.  Since the nitro ligand was 
easily synthesised it too was coordinated to the ruthenium metal centre and 
characterised by spectroscopy, photophysics and electrochemical methods to compare 
electronic behaviour between all three functionalised derivatives of the ruthenium 
luminophore to build upon the literature already available.     
 
Significant improvements on the synthesis of 2-(4-nitrophenyl)imidazo[4,5-
f][1,10]phenanthroline are reported here, where the reaction time was decreased by 86% 
compared existing published methods.[29]  Furthermore, coordination of the nitro 
functionalised ligand to the ruthenium metal centre was achieved using conditions that 
were not as harsh as previously reported[21] and did not required column 
chromatography for its purification as reported previously.[21, 30] 
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As discussed in Chapter 1, [Ru(bpy)2(picNO2)]2+ has been shown previously to 
bind to DNA[21] and has been used as a luminescent sensor for anions.  This has proven 
valuable as many biological processes involve the recognition of anionic species.[29]  
Interestingly, the free 2-(4-nitrophenyl)imidazo[4,5-f][1,10]phenanthroline ligand has 
also been used to provide colorimetric determination of anions present in samples which 
has enabled fast and easy detection of certain anions by the naked eye.[29]  In addition, it 
has been reported that the location of the nitro functionality has a significant impact on 
the photophysics of this particular complex.[21]  When the nitro group is located in the 
ortho- or para-positions, the compound’s emission is quenched completely.  Conversely, 
if located in the meta-position, the complex is found to be brightly luminescent.  This 
may be explained in terms of the differences in bond polarity and its implications are 
discussed later in this chapter.  
 
Unfortunately, whilst developing our novel synthesis of [Ru(bpy)2(picNH2)]2+, 
Liu et al.[11] published a similar procedure on its synthesis and demonstrated how this 
particular amino functionalise ruthenium polypyridyl dye has been found to (i) 
intercalate into the DNA base pairs and upon irradiation may photocleave the plasmid 
pBR 322 DNA, (ii) display anti-tumor activity against transfected cells and (iii) exhibit 
good antioxidant activity against hydroxyl radicals that may induce DNA damage in 
humans.  One of their major findings from IC50 values on selected cell lines indicated 
that coordination of the free amino ligand to the ruthenium metal centre resulted in a 
lowering of its antitumor activity.  However, the cytotoxic effect of the luminophore 
came close but did not match that of cisplatin against certain cell lines.   
 
For the first time a detailed and comparative photophysical, spectroscopic and 
electrochemical study is presented here on all three ruthenium functionalised complexes 
which extends on studies already reported for these models.  All inorganic dyes 
synthesised are fully characterised by NMR, mass spectrometry and elemental analysis.   
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3.1 Acid-Base Chemistry of Metal Complexes 
 
The excited state and ground state acid-base properties may differ significantly 
in a metal complex and any changes may be explained by differences in electron 
distribution within the complex between both states.  In most transition metal 
complexes the coordinating ligand is more acidic than that of the free ligand.  This may 
be explained by σ-donation from the ligand to the metal which reduces electron density 
around the ligand.[31]   
 
Studying the effects of protonation / deprotonation of metal-ligand complexes 
on the both absorbance and emission spectra may give valuable insight into the extent 
of electronic communication within the metal complex and provide information on the 
location of the excited state.  This is of particular interest in mixed ligand complexes 
where the nature of the lowest MLCT π* level is not necessarily known.  It is generally 
accepted that if the acidity of the excited state increases with respect to the ground state 
that the ligand involved in the acid-base process is not directly involved in the emissive 
process.  On the other hand, if the acidity decreases typically by 2 or more pH units, the 
excited state is thought to be localised on the ligand with the acid-base chemistry.  
These assumptions are based on the observation that upon excitation of ruthenium (II) 
polypyridyl complexes an electron is promoted from the metal centre d-orbital to a 
ligand π* orbital leaving a valence of +3 on the metal centre.  An increase in basicity on 
the ligand is explained by increased electron density on the ionisable ligand due to 
electron donation from the metal centre and hence, one may predict the location of the 
excited state on mixed ligand complexes.[31, 32]    
 
For example, it was found that the LUMO of the ruthenium (II) polypyridyl 
complexes synthesised in this thesis was located on the bpy ligands and not on the 
ionisable ligand involved in the acid-base chemistry.  This was confirmed by similar 
ground and excited state pKa values.  Had the excited state been located on the ionisable 
ligand, the excited state pKa* value would have been less acidic due to the increase in 
electron density on that ligand. 
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3.1.1 Background Theory: 
 
Protonation of a complex will change the electronic levels within the molecule 
leading to changes in its electronic spectroscopy, particularly if the ligand participates in 
absorbance.  The ground state pKa of a molecule may be calculated by monitoring 
absorbance of a complex at a wavelength that shows good acid-base variation plotted 
against the corresponding change in pH.  The resultant first derivative of the pH titration 
may be determined in order to extract the ground state pKa values.   
 
The excited state acidity of a complex may be evaluated using the Förster cycle.  
An acid-base equilibrium may be written for the [Ru(bpy)2(picCOOH)]2+ complex as 
follows in Equation 3.1: 
 
[Ru(bpy)2(picCOOH)]2+ [Ru(bpy)2(picCOOH)]+ + H
+
..........(Eq 3.1)
 
 
Where [Ru(bpy)2(picCOOH)]2+ and [Ru(bpy)2(picCOOH)]+ signify the acid and 
conjugate base respectively.  In the relationship between the enthalpy changes and 
electronic transitions within the molecule it is arbitrarily assumed that the protonated 
compound absorbs at a higher energy than that of the deprotonated species and this is 
confirmed by the pH titrations for this particular complex.[31]  Figure 3.3 demonstrates 
the relationship that may be used to determine the energy band gap between the ground 
and excited states of the [Ru(bpy)2(picCOOH)]2+ complex for example.  
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Figure 3.3: Relationship between enthalpy and electronic transitions for 
[Ru(bpy)2(picCOOH)]2+.   
Where, [Ru(bpy)2(picCOOH)]2+ = [Ru] and [Ru(bpy)2(picCOOH)]1+ = [Ru-L]. 
 
 
∆H* + E0-0([Ru]) = ∆H + E0-0([Ru-L])……….Eq 3.2 
∆H* + NAhv[Ru]  = ∆H + NAhv[Ru-L] ……….Eq 3.3 
∆H* - ∆H = NAh(v[Ru-L]  -  v[Ru]) ……….Eq 3.4 
 
where ∆H* and ∆H are the enthalpy changes caused by protonation in the excited and 
ground state, v[Ru] and v[Ru-L] are the frequencies of the lowest absorption or emission 
bands of [Ru] and [Ru-L], NA is Avogadro’s number and h is Plank’s constant.  If 
experiments are conducted under conditions where ∆H approximates the standard ∆Ho 
and if equal reaction entropies are assumed then; 
 
∆Ho ~ ∆Go = RT ln K = 2.303 RT pK……….Eq 3.5 
Then this gives;   
 
pKa* = pKa + (0.625/T) (v[Ru-L]  -  v[Ru]) ……….Eq 3.6 
 
where Ka and Ka* are the ground and excited state equilibrium constants, R is the gas 
constant and T is the temperature in Kelvin.  It is now possible to estimate excited state 
pKa* values from ground state values and spectroscopic parameters.   
E0-0 
([Ru(bpy)2(picCOOH)]2+) 
E0-0 
([Ru(bpy)2(picCOOH)]+) 
∆H 
∆H* 
[Ru(bpy)2(picCOOH)]2+ 
[Ru(bpy)2(picCOOH)]2+*  
[Ru(bpy)2(picCOOH)]+  
[Ru(bpy)2(picCOOH)]+* 
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 When considering whether absorption or emission data should be used in 
calculating the pKa* it is important to take into account the nature of the complex in 
question.   Many organic fluorophores emit from their lowest singlet excited state and 
for such compounds absorbance or emission data may be used as lifetimes are generally 
short.  However, for many inorganic based compounds the main absorption is in the 
visible part of the spectrum corresponding to the lowest singlet MLCT level.  Internal 
conversion then occurs to the triplet MLCT excited energy state and phosphorescent 
emission of the photon occurs and hence, lifetimes are longer.   It is then important to 
use the emission data of such species in calculating excited state pKa* values.   
 
When proton exchange is much faster than the excited-state decay of both 
protonated and deprotonated species an equilibrium may be established in the excited 
state and meaningful results can be obtained from the Förster cycle between v[Ru-L]  -  
v[Ru].  If the rate of emission decay is less then the rate of (de)protonation then the 
following Equation 3.7 holds true. 
 
pKa* = pHi + log (τHB / τB-)……….Eq 3.7 
 
Where pHi is the point of inflection on the pH titration emission curve (as 
determined using the first derivative function in Origin 6.0 software) and τHB and τB- are 
the lifetimes of the protonated and deprotonated species respectively.  As a result one 
may use the equation above to calculate the excited state pKa* of a luminophore using 
its emission data and in turn determine the location of the excited state on the molecule 
under analysis.  However to use this particular equation, it is necessary for the 
complexes to have relatively long lifetimes. 
 
 Figure 3.4 illustrates the four possible protonation states for the 
[Ru(bpy)2(picCOOH)]2+ complex and may be used to illustrate similar processes 
occurring in all the organic luminophores synthesised in this thesis with changes in pH.  
Formation of the [Ru(bpy)2(picCOOH)]3+ species was found to have a ground state pKa 
value of 1.5 +/- 0.1.  The effect of solvents on the pKa of this particular ruthenium 
polypyridyl complex is highlighted in a paper published previously.[24]  Here, it was 
determined that the formation of the protonated [Ru(bpy)2(picCOOH)]3+ species, using 
acetonitrile as solvent, had a much higher ground state pKa value of 5.  Furthermore, it 
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was also shown that the ground state pKa values for the formation of 
[Ru(bpy)2(picCOOH)]+ and [Ru(bpy)2(picCOOH)]0 was 8.9 and 9.5, respectively.   
 
However, in the aqueous based experiments carried out in this thesis only two 
ground state pKa values are evident, that of the formation of [Ru(bpy)2(picCOOH)]3+ 
and [Ru(bpy)2(picCOOH)]+ at 1.5 +/- 0.1 and 8.5 +/- 0.1, respectively.  This is further 
supported by similar experiments performed by Pellegrin et al.[25] in an earlier 
published paper.  (De)protonation of the carboxyl functionality is no longer evident in 
aqueous environments as it is involved in solvation of the complex through H-bonding.   
 
 
Figure 3.4: Schematic diagram illustrating the different protonation states for 
[Ru(bpy)2(picCOOH)]2+.[24] 
 
The likely acid-base equilibrated equations for the protonation/deprotonation of 
this complex (and other similar complexes) may be described as follows: 
 
[Ru(bpy)2(picCOOH)]2+ + H+ ↔ [Ru(bpy)2(picCOOH)]3+ (pKa = 1.5 +/- 0.1) ……….Eq 3.8 
[Ru(bpy)2(picCOOH)]2+ ↔ [Ru(bpy)2(picCOOH)]+ + H+ (pKa = 8.5 +/- 0.1) ……….Eq 3.9 
 
In the determination of pKa/pKa* values for the metal complexes, one full pH 
titration experiment was performed in triplicate to calculate the standard deviation for 
the calculated pKa values.  This standard deviation of +/- 0.07 units (or +/- 0.1 units 
[rounded to one significant figure]) was to be applied to all pKa/pKa* figures.  
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3.2 Ruthenium Conjugated Gold Nanoparticles 
 
In the second part of this chapter, the amino functionalised ruthenium complex, 
whose peptide conjugate was previously shown to be useful as a multimodal probe in 
cellular imaging,[1] was conjugated to gold nanoparticles in an effort to enhance its 
emission intensity and lifetime.  This was achieved using 50 nm gold nanoparticles as 
substrate onto which an amino functionalised ruthenium (II) dye was attached via thiol-
PEG-carboxyl bifunctionalised linkers.  This is the first time to our knowledge that a 
ruthenium complex has been directly immobilised on to a gold nanoparticle surface via 
PEG linkers.   
 
As discussed in Chapter 1, water soluble PEG linkers have been shown before to 
provide additional stability to nanoparticles[33, 34] and it was hoped that it would help in 
drawing the nanoconjugate across the cell membrane.  The length of the PEG linkers 
were varied (from PEG8 = 3.3 nm to PEG32 = 13.2 nm approximately, when in linear 
conformation) in an effort to increase the distance between chromophore and substrate 
and thus, have a direct impact on the luminescent output of the dye as a result of metal 
enhanced emission.  It has also been previously shown in Chapter 1 that a distance of 
approximately 10 nm from substrate to dye exhibited the best balance between surface 
quenching and enhancement.[35, 36] 
 
In addition, the nanoconjugate that demonstrated superior luminescence and 
lifetimes was then used in the cellular imaging of SP2 myeloma cells.  This nanoparticle 
probe has the potential to be used as a multimodal probe in determining both 
intracellular pH levels and oxygen concentrations as its photophysics are very similar to 
that of the carboxyl functionalised parent dye complex.  This parent dye has previously 
been conjugated to a cell penetrating peptide for multimodal cellular imaging 
purposes.[1, 26]  Furthermore, the ability of the luminophore to generate singlet oxygen 
means that the ruthenium nanoconjugate could prove critical in the early detection and 
subsequent apoptosis of tumour cells. 
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3.3 Experimental Procedure 
 
Chemicals 
 
All chemicals and reagents were purchased from Sigma-Aldrich (Ireland) and 
were used without any further purification unless otherwise stated.  Polyethylene glycol 
(PEG) linkers were supplied by Quanta Biodesign (except for COOH-PEG24-NH2 
[Aldrich]) and 50 nm gold nanoparticles (AuNPs) by BBInternational.  All reactions 
were performed in air unless otherwise stated. 
 
 
The preparation of ruthenium-(bis-2,2-bipyridyl)dichloride. [Ru(bpy)2Cl2] 
 
Ru
Cl
Cl
N
N
N
N
Ruthenium-(bis-2,2-bipyridyl)dichloride
N
N
RuCl3.H2O
2,2-bipyridine
LiCl / DMF anhydrous
Reflux 8 hours
Ruthenium tri
chloride hydrate
 
 The compound was prepared according to a method modified from the 
literature.[37]  RuCl3.3H2O (500 mg, 1.91 mmol) was dissolved in anhydrous DMF (7 
ml) in a three neck round bottomed flask.  Next lithium chloride (551 mg, 13.00 mmol) 
was added to the solution followed by 2,2-bipyridine (597 mg, 3.82 mmol) in three 
equal portions.  The reaction was then refluxed under a nitrogen environment at 160 0C 
for 8 hours. 
 
 The reaction mixture was then allowed to cool to room temperature and acetone 
was added to promote precipitation and left in the fridge overnight.  The precipitate was 
then collected by vacuum filtration and washed well with acetone and diethyl ether to 
leave a dark purple coloured solid. 
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 The product was then purified on an alumina (basic) chromatographic column 
using 10 % methanol ; dichloromethane as mobile phase to yield the product as a dark 
purple solid (301 mg, 62 %). 
 
1H NMR (400MHz, DMSO-d6):  δ (ppm) 9.94 (d, 2H, J = 4.8 Hz), 8.60 (d, 2H, J = 8 
Hz), 8.45 (d, 2H, J = 8.4 Hz), 8.03 (t, 2H, J = 6.4 Hz), 7.74 (t, 2H, J = 6.4 Hz), 7.64 (t, 
2H, J = 6.4 Hz), 7.47 (d, 2H, J = 5.2 Hz), 7.07 (t, 2H, J = 6.4 Hz).  
 
 
 
The preparation of 2-(4-carboxylphenyl)imidazo[4,5-f][1,10]phenanthroline). 
[(picCOOH)]  
 
N
N
O
O
Phendione
+
COOH
O H
4-carboxybenzaldehyde
N
N N
H
N
COOH
2-(4-Carboxylphenyl)imidazo
[4,5.f][1,10]phenanthroline
CH3COONH4 / CH3COOH
Reflux 3 hours
 
 
The ligand was prepared according to a method modified from the literature.[24] 
1,10-Phenanthroline 5,6-dione (210 mg, 1 mmol), 4-carboxy-benzaldehyde (180 mg, 
1.2 mmol), ammonium acetate (1540 mg, 20 mmol) and glacial acetic acid (25 ml) were 
added to a 100ml round bottomed flask and left refluxing at 130 0C for 3 hours.  The 
solution was then cooled to room temperature and excess water added to induce 
recrystallisation and was kept in the fridge overnight at 4 oC. 
 
 The precipitate was collected by vacuum filtration and washed with deionised 
water, methanol and diethyl ether to afford the ligand as a yellow solid (231 mg, 68%). 
 
1H NMR (400 MHz, DMSO-d6):  δ (ppm) 13.96 (s, 1H), 13.09 (s-broad, 1H), 9.05 (d, 
2H), 8.95 (d, 2H, J = 2.4 Hz), 8.40 (d, 2H, J = 8.4 Hz), 8.17 (d, 2H, J = 8.4 Hz), 7.87 
(m, 2H). 
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The preparation of ruthenium (II) (bis-2,2-bipyridyl)-2(4-carboxylphenyl) 
imidazo[4,5-f][1,10]phenanthroline. [Ru(bpy)2(picCOOH)]2+. (ClO4-)2 
 
Ru
N
N
N
N
N
N N
H
N COOH
Ruthenium2+ (bis-2,2-bipyridyl)-2(4-carboxylphenyl)
imidazo[4,5-f][1,10]phenanthroline. [Ru(bpy)2(picCOOH)]2+
N
N N
H
N
COOH
2-(4-Carboxylphenyl)imidazo
[4,5.f][1,10]phenanthroline
+Ru
Cl
Cl
N
N
N
N
Ruthenium-(bis-2,2-bipyridyl)dichloride
EtOH
Reflux 18 hours
 
 
The compound was prepared according to a method modified from the 
literature.[24]  [Ru(bpy)2Cl2] (50 mg, 0.103 mmol), 2-(4-carboxylphenyl)imidazo[4,5-
f][1,10]phenanthroline [(picCOOH)] (31 mg, 0.123 mmol) and ethanol (15 ml) were 
placed in a 50 ml round bottomed flask and left refluxing for 18 hours. 
 
 The solvent was evaporated under reduced pressure and the crude product was 
suspended in a saturated solution of NaClO4 and filtered.  The precipitate was then 
washed with deionised water, diethyl ether and dichloromethane to yield reddish solid.  
The product was then taken and dissolved in acetonitrile.  The precipitate was then 
removed and the solvent was evaporated to dryness to give a red coloured product (69 
mg, 87 %).   
 
 
1H NMR (400 MHz, DMSO-d6):  δ (ppm) 14.43 (s, 1H), 9.11 (d, 2H, J = 8.4 Hz), 8.85 
(d, 2H, J = 8 Hz), 8.81 (d, 2H, J = 8 Hz), 8.43 (d, 2H, J = 8.4 Hz), 8.20 (m, 4H), 8.11 (t, 
2H, J = 6.4 Hz), 8.08 (m, 2H), 7.92 (m, 2H), 7.83 (d, 2H, J = 5.2 Hz), 7.59 (m, 4H), 7.33 
(t, 2H, J = 6 Hz).  
ESI-MS (CH3OH, m/z): 952.77, ([M- 2ClO4]2+): 753.2. 
Elemental analysis calculated for C40H28N8O2Ru.(ClO4-)2.(CH2Cl2)2 : C, 44.94; H, 2.87; 
N, 9.98%.  Found: C, 43.41; H, 2.67; N, 10.00%. 
Melting point: 274 oC 
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The preparation of 2-(4-nitrophenyl)imidazo[4,5-f][1,10]phenanthroline. [(picNO2)] 
 
N
N
O
O
Phendione
+
NO2
O H
4-Nitrobenzaldehyde
N
N N
H
N
NO2
2-(4-Nitrophenyl)imidazo
[4,5.f][1,10]phenanthroline
CH3COONH4 / CH3COOH
Reflux 3 hours
 
 
 1,10-Phenanthroline 5,6-dione (500 mg, 2.38 mmol), 4-nitro-benzaldehyde (432 
mg, 2.86 mmol), ammonium acetate (3669 mg, 47.6 mmol) and glacial acetic acid (40 
ml) were added to a 100ml round bottomed flask and left refluxing at 130  0C for 5 
hours.  The solution was then cooled to room temperature and water added to induce 
recrystallisation and was left in the fridge overnight. 
 
 The precipitate was then collected by vacuum filtration and washed with water, 
diethyl ether, acetonitrile and acetone to yield the product as a yellow solid (612 mg, 75 
%).  
 
1H NMR (DMSO-d6):  δ (ppm) 14.13 (s, 1H), 9.06 (d, 2H, J = 1.6 Hz), 8.89 (dd, 2H, 
1.6 Hz, 1.6 Hz), 8.51 (q, 4H, J = 8.8 Hz, J = 7.2 Hz, J = 9.2 Hz), 7.86 (m, 2H).  
MALDI-TOF (CH3CN, m/z): 341.09, ([M-H+]): 340.57. 
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The preparation of ruthenium (II) (bis-2,2-bipyridyl)-2(4-Nitrophenyl) imidazo[4,5-
f][1,10]phenanthroline. [Ru(bpy)2(picNO2)]2+.(ClO4-)2 
 
 
Ru
N
N
N
N
N
N N
H
N NO2
Ruthenium2+ (bis-2,2-bipyridyl)-2(4-Nitrophenyl)
imidazo[4,5-f][1,10]phenanthroline. [Ru(bpy)2(picNO2)]2+
N
N N
H
N
NO2
2-(4-Nitrophenyl)imidazo
[4,5.f][1,10]phenanthroline
+Ru
Cl
Cl
N
N
N
N
Ruthenium-(bis-2,2-bipyridyl)dichloride
EtOH
Reflux 18 hours
 
 
[Ru(bpy)2Cl2] (237 mg, 0.488 mmol), 2-(4-nitrophenyl)imidazo[4,5-
f][1,10]phenanthroline [(picNO2)] (200 mg, 0.586 mmol) and ethanol (20 ml) were 
placed in a 100 ml round bottomed flask and left refluxing for 18 hours. 
 
 The reaction was cooled to room temperature and the solvent was evaporated 
under reduced pressure.  The crude product was suspended in a saturated solution of 
NaClO4 and filtered.  The precipitate was then washed with deionised water, 
dichloromethane and diethyl ether to yield bright red coloured solid (377 mg, 90 %).   
 
1H NMR (400 MHz, DMSO-d6):  δ (ppm) 14.69 (s, 1H), 9.07 (d, 2H, J = 8 Hz), 8.85 (d, 
2H, J = 8 Hz, J = 8 Hz), 8.83 (d, 2H, J = 8 Hz, J = 8 Hz), 8.53 (s, 4H), 8.21 (t, 2H, J = 8 
Hz), 8.17 (m, 4H), 7.93 (m, 2H), 7.81 (d, 2H, J = 5.2 Hz), 7.59 (m, 4H), 7.33 (t, 2H, J = 
8 Hz).  
ESI-MS (CH3OH, m/z): 854.3 ([M- ClO4]2+): 754.3. 
Elemental analysis calculated for C39H27N9O2Ru.(ClO4-)2.(CH2Cl2): C, 46.26; H, 2.81; 
N, 12.14%.  Found: C, 45.77; H, 2.70; N, 12.09%. 
Melting point: 285-287 oC 
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The preparation of 2-(4-aminophenyl)imidazo[4,5-f][1,10]phenanthroline. [(picNH2)] 
 
N
N N
H
N
NO2
2-(4-Nitrophenyl)imidazo
[4,5.f][1,10]phenanthroline
N
N N
H
N
NH2
2-(4-Aminophenyl)imidazo
[4,5.f][1,10]phenanthroline
Reflux, 4 hours
Palladium / 
Hydrozine Hydrate
 
 
 
2-(4-Nitrophenyl)imidazo[4,5-f][1,10]phenanthroline [(picNO2)]  (100 mg, 
0.293 mmol), palladium 5 % wt on activated carbon (18.8 mg) and absolute ethanol (5 
ml) were added to a 25 ml round bottomed flask.  Hydrazine hydrate (73 µl was added 
dropwise to the reaction and left refluxing at 90 oC for 4 hours.   
  
 The solution was then filtered through celite and the solvent was evaporated to 
dryness.  Diethyl ether was added and the precipitate was collected by vacuum filtration 
and washed with diethyl ether.  The solid was then purified using an alumina (basic) 
chromatographic column using 10 % methanol ; dichloromethane as mobile phase to 
yield a brown coloured product (72 mg, 79 %). 
 
1H NMR (DMSO-d6):  δ (ppm) 13.35 (s, 1H), 8.99 (d, 2H), 8.88 (d, 1H, J = 2 Hz), 8.86 
(d, 2H, J = 1.6 Hz), 7.97 (d, 2H, J = 8.8 Hz), 7.80 (m, 2H), 6.71 (d, 2H, J = 8.4 Hz), 
5.61 (s, 2H).  
ESI-MS (CH3OH, m/z): 311.34 ([M+Na+]): 334.5. 
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The preparation of ruthenium (II) (bis-2,2-bipyridyl)-2(4-aminophenyl) imidazo[4,5-
f][1,10]phenanthroline. [Ru(bpy)2(picNH2)]2+.(ClO4-)2 
 
Ru
N
N
N
N
N
N N
H
N NH2
Ruthenium2+ (bis-2,2-bipyridyl)-2(4-Aminophenyl)
imidazo[4,5-f][1,10]phenanthroline. [Ru(bpy)2(picNH2)]2+
N
N N
H
N
NH2
2-(4-Aminophenyl)imidazo
[4,5.f][1,10]phenanthroline
+Ru
Cl
Cl
N
N
N
N
Ruthenium-(bis-2,2-bipyridyl)dichloride
EtOH / H2O
Reflux 18 hours
 
 
 [Ru(bpy)2Cl2] (38.8 mg, 0.08 mmol), 2-(4-aminophenyl)imidazo[4,5-
f][1,10]phenanthroline [(picNH2)] (30 mg, 0.096 mmol), deionised water (5 ml) and 
ethanol (5 ml) were placed in a 50 ml round bottomed flask and left refluxing for 18 
hours under a nitrogen atmosphere.  After cooling, a saturated solution of NaClO4 was 
added and the red precipitate was collected. The crude product was then purified on an 
alumina (basic) chromatographic column using 10 % methanol ; dichloromethane as 
mobile phase, to leave the product as a red powder (27 mg, 46 %).   
 
 
1H NMR (400 MHz, DMSO-d6):  δ (ppm) 14.34 (s, 1H), 9.35 (d, 1H, J = 8.4 Hz), 9.06 
(d, 1H, J = 8.4 Hz), 9.02 (d, 2H, J = 8.4 Hz), 8.87 (d, 2H, J = 8.4 Hz), 8.22 (t, 2H, J = 8 
Hz), 8.12 (m, 4H), 8.03 (d, 1H, J = 4 Hz), 7.98 (d, 1H, J = 5.2 Hz), 7.91 (m, 2H), 7.84 
(d, 2H, J = 5.6 Hz), 7.58 (m, 4H), 7.34 (t, 2H, J = 6.4 Hz), 6.73 (d, 2H, J = 6 Hz), 5.78 
(d, 2H, J = 6.4 Hz).  
ESI-MS (CH3OH, m/z): 824.3 ([M- ClO4]2+): 724.2. 
Elemental analysis calculated for C39H29N9Ru.(ClO4-)2: C, 50.71; H, 3.16; N, 13.65%.  
Found: C, 51.25; H, 3.81; N, 13.58%. 
Melting point: >300 oC 
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The preparation of AuNP-PEG8-Ru.  (linear linker length approximately 3.3 nm) 
 
 Thiol-PEG8-COOH (20 mg, 0.045 mmol) and 1-ethyl-3-[3-
dimethylaminopropyl] carbodiimide hydrochloride [EDC] (42 mg, 0.218 mmol) were 
added to PBS buffer pH 7.0 (1 ml) in an eppendorf tube and left shaking for 5 minutes.  
Next N-hydroxysulfosuccinimide [NHS] sodium salt (47 mg, 0.218 mg) was added to 
the solution and left stirring for a further 20 minutes.  [Ru(bpy)2(picNH2)]2+.(ClO4-)2 (25 
mg, 0.030 mmol) was then added and the reaction mixture was left shaking gently 
overnight.  
 
Dithiothreitol [DTT] (2mg, 0.013 mmol) was added to the solution and left 
stirring for a further 10 minutes.  A concentrated solution of the 50 nm AuNPs (1 ml) 
was then added and left to shake gently overnight.  The eppendorf tube was then 
centrifuged at 9,000 rpm and the precipitate was washed with deionised water (x 8 
times), with sonication each time prior to centrifugation, to yield a reddish brown 
coloured precipitate.  The conjugated gold nanoparticles were then resuspended in a 
PBS solution (pH 7.4).   
 
 
The preparation of AuNP-PEG32-Ru.  (linear linker length approximately 13.2 nm) 
 The general procedure for the preparation of AuNP-PEG32-Ru was performed as 
outlined above for the AuNP-PEG8-Ru nanoconjugate.  The only exception was an 
additional EDC/NHS coupling reaction step between the COOH-PEG24-NH2 linker and 
thiol functionalised, SH-PEG8-COOH, linker prior to conjugation to 
[Ru(bpy)2(picNH2)]2+ complex. 
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3.4 Results and Discussion 
 
3.4.1 Synthesis 
 
 In the formation of the imidazole ligand derivatives it is the acid catalysed 
reaction of 1,10-phenanthroline 5,6-dione with the ammonium acetate which provides 
the critical 1,10-phenanthroline 5,6-di-imine intermediate (1) necessary for synthesis.  
This intermediate is then reacted with the appropriate aldehyde and undergoes an aldol-
type of condensation to form a second intermediate which is then followed by a two 
hydrogen shift and subsequent loss of a water molecule to form the desired imidazole 
complex as illustrated in Figure 3.5.[38] 
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Figure 3.5: Mechanism illustrating the formation of the imidazole ligand.[38] 
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The synthesis of [Ru(bpy)2(L-L)]2+ [where L-L = bidentate polypyridyl ligands] 
complexes from [Ru(bpy)2Cl2] is based on the propensity of this complex to replace the 
two chloride ligands with water molecules initially.  This results in a labile complex that 
may undergo further reaction with an incoming ligand to give the final product.  The 
first chloride ligand may be removed relatively easily using organic solvents and may 
be preformed at low temperatures (< 70 oC).  The replacement of the second chloride 
ligand however requires higher boiling point solvents and higher temperatures (> 70 
oC).[39]  Adding a slight excess of ligand to the reactions gave the best results for the 
synthesis of the desired complex and products were easily purified by washing or 
column chromatography.  The synthesis of the ruthenium complexes proved relatively 
straight forward and the associated high yields only lend to its use as a suitable 
multimodal molecular probe. 
 
There are a couple of approaches to the synthesis of [Ru(bpy)2(picNH2)]2+.  The 
initial preference was the reduction of [Ru(bpy)2(picNO2)]2+ to give the corresponding 
[Ru(bpy)2(picNH2)]2+, however, this did not prove successful.  Therefore, it was 
decided therefore to reduce the ligand initially before coordination of the metal centre 
and this approach proved more successful with a yield of 46%. 
 
The amino functionalised complex also proved valuable in the labelling of the 
gold nanoparticles.  The polyethylene glycol (PEG) linkers are expensive, particularly a 
thiol-PEG-amine bifunctionalised linker ($500 for 100 mg), which would have been 
necessary should the [Ru(bpy)2(picCOOH)]2+ complex have been used.  Consequently, 
a cheaper thiol-PEG-carboxyl linker ($250 for 100 mg) was purchased and used for the 
conjugation of ruthenium luminophore to the gold nanoparticles via an EDC/NHS 
coupling reaction. 
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3.4.2 1H-NMR Discussion 
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Figure 3.6: [pic-R] ligand illustrating numbering scheme for 1H-NMR analysis. 
 
 
 
Proton 
 
[picCOOH] 
ppm 
Proton 
 
[picNO2] 
ppm 
Proton 
 
[picNH2] 
Ppm 
H4 (N-H) 
 
13.96 
(s, 1H) 
H4 (N-H) 
 
14.13 
(s, 1H) 
H4 (N-H) 
 
13.35  
(s, 1H) 
Carboxyl-H 
 
13.09 
(s, 1H) 
H1, H11 
 
9.06 
(d, 2H) 
H1, H11 
 
8.99 
(d, 2H) 
H1, H11 
 
9.05  
(d, 2H) 
H3, H9 
 
8.89 
(dd, 2H) 
H3, H9 
 
8.88 
(dd, 2H) 
H3, H9 
 
8.95  
(d, 2H) 
H5, H6,  
H7, H8 
8.51 
(q, 4H) 
H5, H8 
 
7.97 
(d, 2H) 
H6, H7 
 
8.40 
(d, 2H) 
H2, H10 
 
7.86 
(m, 2H) 
H2, H10 
 
7.80 
(m, 2H) 
H5, H8 
 
8.17 
(d, 2H) 
  H6, H7 
 
6.71 
(d, 2H) 
H2, H10 
 
7.87 
(m, 2H) 
  Amino-NH2 5.61 
(s, 2H) 
 
Table 3.1: 1H-NMR resonances for [pic-R] ligand with various functional groups, 
carried out in DMSO-d6.  The integration and peak splitting are shown in brackets. 
 
 
 Mass spectrometry and elemental analysis were combined with NMR (1H-NMR 
/ COSY) to confirm the purity and structure of the complexes synthesised.  Table 3.1 
shows the full 1H-NMR data for the peak shifts for the various [pic-R] ligands.  Due to 
the electron donating and electron withdrawing constituents of the ligand’s R-group, the 
protons that show the most change in chemical shifts are located on the phenyl ring.  
Having an electron withdrawing substituent on the ligand has the effect of drawing 
 118 
electron density away from nearby protons, thus, causes a deshielding effect resulting in 
a chemical shift downfield.  On the other hand when an electron donating group is 
present, it has the opposite effect causing a shift upfield in its NMR spectrum.  This is 
most effectively demonstrated by comparison of the electron donating amino group 
versus the electron withdrawing nitro group.  The protons located at positions H6 and H7 
on the amino functionalised ligand are shifted upfield to 6.71 ppm, whereas, the 
corresponding protons on the nitro functionalised ligand have chemical shift of 8.40 
ppm.   
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Figure 3.7: [Ru(bpy)2Cl2] complex illustrating numbering scheme for 1H-NMR analysis. 
 
 
 
 Table 3.2 below shows the complete proton assignments for the 1H-NMR 
spectra of the three ruthenium (II) compounds synthesised.  As expected, due to the 
displacement of the chlorine atoms on the [Ru(bpy)2Cl2] complex, the protons in the H3 
position on the bpy ligands experience a change in their chemical environments.  This 
results in a shift of around 1 ppm upfield due to the shielding effect of the incoming 
imidazole ligand.  It must also be noted that the protons on the imidazole ring (H4) were 
not always observed, presumably because these protons are very active and may be 
easily exchanged between the two nitrogens on the imidazole ring in solution.[11] 
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[Ru(bpy)2picCOOH]2+ 
 
[Ru(bpy)2picNO2]2+ 
 
[Ru(bpy)2picNH2]2+ 
 
Bpy 
protons. 
ppm  
[picCOOH] 
protons. 
ppm 
bpy protons. 
ppm  
[picNO2] 
protons 
ppm 
bpy protons. 
ppm  
[picNH2] 
protons. 
ppm 
H3 
8.85 (d, 2H) 
H4 (N-H) 
14.43 (s, 1H) 
 
H3 
8.85 (d, 2H) 
H4 (N-H) 
14.69 (s, 1H) 
 
H3 
9.02 (d, 2H) 
H4 (N-H) 
14.34 (s, 1H) 
 
H3’  
8.81 (d, 2H) 
 
H1, H11 
9.11 (d, 2H) 
H3’  
8.81 (d, 2H) 
 
H1, H11 
9.07 (d, 2H) 
H3’  
8.87 (d, 2H) 
 
H1 
9.35 (d, 1H) 
H4 
8.20 (m, 4H) 
 
H6, H7  
8.43 (d, 2H) 
H4 
8.21 (t, 2H) 
H5, H6, H7,H8 
8.53 (m, 4H) 
 
H4 
8.22 (t, 2H) 
H11 
9.06 (d, 1H) 
H4’ 
8.11 (t, 2H) 
 
H5, H8 
8.20 (m, 4H) 
H4’ 
8.17 (m, 4H) 
 
H3, H9 
8.08 (m, 4H) 
H4’ 
8.12 (m, 4H) 
 
H5, H8 
8.12 (m, 4H) 
H6 
7.83 (d, 2H) 
 
H3, H9 
8.08 (m, 2H)
 
H6 
7.81 (d, 2H) 
 
H2, H10 
7.93 (m, 2H) 
 
H6 
7.84 (d, 2H) 
 
H3 
8.03 (d, 1H) 
H6’, H5 
7.59 (m, 4H) 
 
H2, H10 
7.92 (m, 2H) 
 
H6’, H5 
7.59 (m, 4H) 
 
 H6’, H5 
7.58 (m, 4H) 
H9 
7.98 (d, 1H) 
H5’ 
7.33 (t, 2H) 
 
 H5’ 
7.33 (t, 2H) 
 
 H5’ 
7.34 (t, 2H) 
 
H2, H10 
7.91 (m, 2H) 
 
 
 
    H6, H7  
6.73 (d, 2H) 
 
 
 
    NH2 
5.78 (d, 2H) 
 
Table 3.2: 1H-NMR resonances for the ruthenium compounds synthesised, carried out 
in DMSO-d6.  The integration and peak splitting are shown in brackets. 
 
 
Table 3.3 shows the relative shifts in ppm of the free [pic] ligand versus the 
coordinated [pic] ligand.  The protons located at H3 and H9 of the [pic-R] ligands show 
the greatest chemical shifts of 0.9 ppm following coordination to the ruthenium metal 
centre.  This may be explained by the increased electron density around the [pic-R] 
ligands due to the donation of 2 electrons from the binding ruthenium centre.  This 
causes a delocalised shielding effect which seems to be mostly concentrated on the H3 
and H9 protons and hence, results in an upfield chemical shift.  It is also considered that 
there may be possible anisotropic effects on these protons as a result of the 3-D 
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configuration of the complex and the proximity of cyclometalating ligands to one 
another. 
 
The chemical shift of the imidazole H4 proton demonstrates remarkable 
sensitivity to the identity of the carboxyl, nitro and amino substituents.  It is also noted 
that 1H-NMR analysis of [Ru(bpy)2(picNH)2]2+ shows that protons at positions H1, H11, 
and H3, H9 split into their own individual doublets with an integration of one proton.  It 
is speculated that this splitting of peaks is caused by the increased delocalisation of 
electron density over the [pic-NH2] ligand.  This may result in resonance structures 
within the phenanthroline section of the ligand as the double bond character is shifted 
from bond to bond and hence, differences in the effective magnetic field are 
experienced by the protons. 
 
 
Proton 
 
[Ru(bpy)2picCOOH]2+ 
∆ ppm 
[Ru(bpy)2picNO2]2+ 
∆ ppm 
 
[Ru(bpy)2picNH2]2+ 
∆ ppm 
H1 
 
0.06 0.01 0.36 
H2 
 
0.05 0.07 0.11 
H3 
 
-0.87 -0.81 -0.85 
H4 
 
-0.47 0.83 0.99 
H5 
 
0.03 0.02 0.15 
H6 
 
0.03 0.02 0.02 
H7 
 
0.03 0.02 0.02 
H8 
 
0.03 0.02 0.15 
H9 
 
-0.87 -0.81 -0.90 
H10 
 
0.05 0.07 0.11 
H11 
 
0.06 0.01 0.07 
 
Table 3.3: ∆ ppm of the coordinated complexes compared to the free [pic-R] ligand. 
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3.4.3 Optical and Acid-Base properties of Ruthenium (II) Complexes 
 
 
______________________________________________________________________________ 
Compound  Absorbance a  Emission a τ (ns) b        ɸ c       pKa d     pKa* d 
                         λmax    λmax            (aerated/      (+/-0.1)     (+/-0.1) 
 (ɛ, dm3mol-1cm-1)                       degassed) 
______________________________________________________________________________ 
[Ru(bpy)2(picCOOH)]2+ 457 nm (13,033) 608 nm 158/         0.068 1.5, 8.5   2.2, 8.7 
 330 nm (23,946)  502   
 285 nm (61,318)   
 
[Ru(bpy)2(picNO2)]2+   455 nm (17,220) 608 nm 55/ 0.028 3.7e, 8.0  1.5e, 8.0 
 346 nm (25,034)   66 
 282 nm (58,376)  
 
[Ru(bpy)2(picNH2)]2+ 460 nm (15,917) 611 nm 379/ 0.035 1.5, 8.8    3.2, 9.1 
 333 nm (32,737)  550 
 285 nm (71,344) 
______________________________________________________________________________  
Table 3.4: Optical and Acid-Base properties of Ruthenium (II) Complexes Synthesised. 
 
a
 Measured in acetonitrile at room temperature at concentrations of 20 x 10-6 M. 
b Monoexponential decays measured in aerated/degassed acetonitrile at room temperature 
c
 Photoluminescent quantum yield (ɸ) measured in degassed acetonitrile at room temperature, 
using [Ru(bpy)3]2+ as a standard.  
d
 Ground (pKa) and excited state (pKa*) values, measured in PBS buffer solution at room 
temperature. (standard deviation calculated +/- 0.1 units).  e has a larger associated pKa 
calculation standard deviation. 
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3.4.4 Characterisation of Ruthenium (II) Complexes 
 
3.4.4.1 Absorbance
 
  
Absorbance of ruthenium complexes -vs- wavelength
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Figure 3.8: Overlaid absorbance spectra of ruthenium (II) polypyridyl complexes 
synthesised (20 x 10-6M) in acetonitrile solution. 
 
 
Figure 3.8 above shows the overlaid absorbance spectra for the ruthenium (II) 
polypyridyl complexes synthesised.  The UV-vis spectra of all three complexes are 
distinguished by a ruthenium dπ to ligand π* MLCT transition at 457 nm (carboxyl), 
455 nm (nitro) and 460 nm (amino) respectively.  For the amino complex there is ca. 4 
nm shift to a longer wavelength in this transition when compared to the others, 
suggesting that the amino ancillary ligand is a slightly better σ-donating ligand.[30]  
There is also evidence of a further MLCT transition within the complexes at around 245 
nm. 
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The strong absorbance band at approximately 285 nm may be assigned to π-π* 
transitions within the bpy ligands, whereas the shoulder at approximately 330 nm is 
attributed to the π-π* transitions of the [pic-R] ligands containing the two ionisable 
protons on the imidazole ring as this transition exhibits a strong pH dependence, vide 
infra.  The benzimidazole spacer has little effect on the absorbance spectra of the 
complex as the energies and absorbance profile of these transitions are almost identical 
to that of [Ru(bpy)3]2+ and [Ru(bpy)2(phen)]2+, which indicates a weak interaction 
between ruthenium bis-bipyridyl and benzimidazole moieties.[25, 40] 
 
However, the absorbance peak at 346 nm for the nitro functionalised complex, 
assigned to the ILCT π-π* transitions of the [picNO2] ligand, has shifted 16 nm to a 
longer wavelength when compared to [Ru(bpy)2(picCOOH)]2+.  This confirms that this 
is a π-π* transition of the [picNO2] ligand.  It is known that the nitro substituent has a 
more pronounced effect on the HOMO-LUMO band gap of a molecule.  The dπ-π* and 
π-π* interactions permit hyperconjugation between the electronic structures and 
aromatic rings causing a decrease in the energy gap.  This is may be seen by a decrease 
in the HOMO-LUMO energy gap resulting in shift to longer wavelengths.[41, 42] 
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3.4.4.2 Emission Properties 
Emission Intensity of ruthenium (II) complexes -vs- Wavelength 
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Figure 3.9: Overlaid emission spectra of 20 x 10-6M acetonitrile solutions of 
[Ru(bpy)2(picCOOH)]2+ (excited at 457 nm), [Ru(bpy)2(picNO2)]2+ (excited at 455 nm) 
and [Ru(bpy)2(picNH2)]2+ (excited at 460 nm).  Slit widths: 5 nm.  Samples are not 
absorbance matched. 
 
The emission spectrum of [Ru(bpy)2(picCOOH)]2+, in Figure 3.9, exhibits a 
maximum emission at 608 nm when excited into the MLCT absorbance band at 457 nm 
with a quantum yield of 0.068 in aerated acetonitrile.  This complex also exhibits the 
highest quantum yield of the three ruthenium complexes synthesised.  The emission 
decays follow monoexponential kinetics with a lifetime of 158 +/- 2 ns in aerated and 
502 +/- 4 ns in degassed acetonitrile solutions.  The increase in lifetime in absence of 
oxygen is also indication of the triplet MLCT character of the emission.[1]  Unusually, 
this lifetime dramatically increases in degassed aqueous PBS buffer solutions, compared 
with acetonitrile, with luminescent lifetimes of 878 +/- 6 ns at pH 1.0, 811 +/- 4 ns at 
pH 6.9 and 526 +/- 4 ns at pH 12.0.  The longer lifetimes in aqueous media may be 
explained by stabilisation of the emissive 3MLCT of the carboxyl complex as a result of 
H-bonding between the solvent and complex.  The decrease in lifetimes of the 
deprotonated species in aqueous media may be due to the extension of the π system 
across the imidazolate or dissipation of the excited ruthenium-bpy state energy into low 
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lying less radiative ruthenium-[picCOOH] acceptor states on the imidazolate ligand, as 
determined by resonance Raman spectroscopy later in the chapter.[24]  Many other metal 
complexes exhibit a decrease in lifetimes when measured in aqueous solution and this 
demonstrates the importance of H-bonding in controlling the properties of the 
complex.[24] 
 
The emission spectrum of [Ru(bpy)2(picNO2)]2+ has a maximum emission at 608 
nm when excited at 455 nm with a quantum yield of 0.028 in aerated acetonitrile.  The 
emission decays once again follow monoexponential kinetics with a lifetime of 55 +/- 2 
ns in aerated acetonitrile and 66 +/- 3 ns in degassed acetonitrile.  The low sensitivity to 
oxygen is typical of shorter lived complexes.  In stark contrast to 
[Ru(bpy)2(picCOOH)]2+, the lifetime dramatically decreases in acetonitrile and in 
degassed aqueous PBS buffer solutions, with a lifetime of 22 +/- 0.4 ns at pH 1.0, 6 +/- 
0.2 ns at pH 6.9 and 7 +/- 0.3 ns at pH 12.0.  It is thought that the H-bonding between 
the carboxylate and water (or some constituent within the PBS) brings about a more 
stabilised excited energy state by the polar solvent giving rise to the dramatic increase in 
lifetimes.  This stabilisation of the excited state is further supported by a slight red shift 
(4 nm) in the aqueous emission spectrum of [Ru(bpy)2(picCOOH)]2+ at higher pH 
values.  Of the three ruthenium complexes synthesised [Ru(bpy)2(picNO2)]2+ displayed 
the lowest aqueous emission intensity and is also the most sensitive to solvent.  This is 
discussed in further detail in Section 3.4.4.2.1 below.  
 
The emission spectrum of [Ru(bpy)2(picNH2)]2+ exhibited a maximum at 611 
nm when excited into the MLCT band at 460 nm and a quantum yield of 0.035 in 
aerated acetonitrile.  This slight shift to a longer wavelength of emission is explained by 
the electron donating nature of the amino substituent causing a slight decrease in the 
LUMO for the [picNH2] ligand.  The emission decays, again, follow monoexponential 
kinetics with a lifetime of 379 +/- 4 ns in aerated acetonitrile and 550 +/- 4 ns in 
degassed acetonitrile.  The lifetime increases in degassed aqueous PBS buffer solutions 
with a lifetime of 905 +/- 8 ns at pH 1.0, 543 +/- 6 ns at pH 6.9 and 580 +/- 6 ns at pH 
12.0.  This once again may be attributed to the solvation of the amine functionality in 
aqueous solvent.  These values are comparable to the [Ru(bpy)2(picCOOH)]2+ complex 
and a similar decrease in lifetimes also accompanies a decrease in emission intensity at 
higher pH values. 
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3.4.4.2.1 Solvatochromism 
 
Solvatochromism may be described as the changes in the absorption and 
emission characteristics of a chromophore brought about by the solvent environment.  
Charge-transfer transitions in metal complexes are sensitive to solvents as the separation 
of charge is expected to induce dynamics in the solvent itself.  This is due to the 
changes in the local electric field associated with the solute following absorption of a 
photon.[43]  Solvent effects on electronic spectra may be complicated and can include; a 
broadening of the spectral band, a change in intensity of absorption/emission (ɛ) and the 
change in the shape of a band which is related to the various rotational and vibrational 
energy levels within the molecule.  Specific solute-solvent interactions are known to 
play an important role in the optical and thermal electron transfer process involving 
metal complexes and these may influence both the redox potentials and photophysics 
significantly.[44] 
 
As illustrated in Figures 3.10 and 3.11, [Ru(bpy)2(picNO2)]2+ shows a strong 
solvent dependence in it’s absorption and emission spectra respectively.  The polar 
protic solvent of methanol induces the most drastic change in its absorbance spectrum 
with a red shift in the π-π* [picNO2] transition from 347 nm to 378 nm.  This is 
attributed to the hydrogen bonding interactions between complex and solvent molecules 
leading to the efficient stabilisation of the polar charge transfer state.  However, this 
effect is relatively weak for other solvents and the polar compound is insoluble in non-
polar solvents.   
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Absorbance -vs- Wavelength of [Ru(bpy)2(picNO2)]2+  
(absorbance matched at 455 nm)
0
0.5
1
1.5
2
225 325 425 525
Wavelength (nm)
Ab
so
rb
an
ce
 
(a.
u
.
)
Acetonitrile
Dichloromethane
Methanol
PBS buffer pH 7.0
Not soluble in Hexane
 
Figure 3.10:  Absorbance spectra of [Ru(bpy)2(picNO2)]2+ in different solvents.  All 
spectra are absorbance matched at 455 nm.   
 
Following excitation it is known that solvent molecules may reorient and relax 
around the excited state complex which proceeds in lowering the energy of the excited 
state.[15, 45]  [Ru(bpy)2(picNO2)]2+ shows significant differences in emission intensities 
between polar protic and polar aprotic solvents (Figure 3.11).  This is attributed to an 
alternative non-radiative deactivation pathway via solvent relaxation from the triplet 
MLCT excited energy state provided by the polar protic solvent.   
 
Emission spectra are generally more sensitive to solvent effects than absorbance 
spectra.  This is because absorption occurs at a timeframe too short for motion of the 
solvent to have an effect.  In contrast, the emitting excited state complex is exposed to 
the relaxed solvent environment, whose solvent molecules may be orientated around the 
dipole moment of the excited state luminophore.[45]  Nitro functionalised systems tend 
to have higher internal conversion rates as a result of mixing of vibronic states as well 
as solvent interactions that effectively quenches luminescence.[46]   
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For Figure 3.11 all [Ru(bpy)2(picNO2)]2+ samples were absorbance matched at 
455 nm.  The strong solvent dependence on emission intensity observed would lend 
support to the use of this dye as a possible polarity sensor for future work and the nitro 
complex has already been used before as an efficient anion sensor.[29]  There are 
unexpected considerable differences in the emission intensities of the nitro 
functionalised complex in dichloromethane and acetonitrile.  As previously explained, 
all solvents were used as received and any trace elements of water, in particular in the 
acetonitrile solution, may explain its significantly lower emission intensity.     
 
Emission Intensity -vs- Wavelength of [Ru(bpy)2(picNO2)]2+  
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Figure 3.11:  Relative emission intensities of [Ru(bpy)2(picNO2)]2+ in various solvents.  
All samples were absorbance matched and excited at 455 nm. Slit widths: 5 nm.  
 
 
 This poor luminescence of [Ru(bpy)2(picNO2)]2+ in aqueous solution has been 
reported previously.[21]  In addition, merely changing the position of the nitro 
substituent on the phenyl ring plays a critical role in the emission of the complex 
itself.[21]  When the nitro group is located in the ortho-position or para-position, the 
compound’s luminescence is almost completely quenched.  However, if the nitro group 
is located in the meta-position the complex is found to be brightly luminescent.  This 
decrease in luminescence is usually explained by the capture of the photoexcited 
electron by the strong electron withdrawing nitro group.  The electron withdrawing 
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ability of the ortho- and para-nitro substituent is greater than that of the meta-substituent 
and results in a deactivation to the ground state by non-emissive pathways.  Shi et al.[21] 
proposed that this may be explained more effectively by the law of polarity alteration 
where the idea of polarity interface as well as the calculated net charge populations is 
applied.    
 
 
 
Figure 3.12: Schematic diagram of [picNO2] ligand with nitro substituent at 1) ortho- 
2) meta- and 3) para- positions of the phenyl ring.  The arrow heads show the directions 
of the moving negative charges.[21] 
 
 
 
 130 
 As illustrated in Figure 3.12 the direction interferences for the poorly emissive 
ortho (1) and para (3) functionalised ligands are the same and as a result the polarity of 
every bond is strengthened from N13-N5.  On the other hand, for the luminescent meta 
functionalised species (2) the direction interferences are opposing in nature and this 
leads to a weakening in the bond polarity from N13-N5.  As a result the electron 
withdrawing ability of the ortho- and para-substituted ligands is greater.  This provides 
a reasonable explanation for the differences in luminescent intensities between 
compounds based solely on the position of the substituent.  Neither the carboxyl nor 
amino functionalised complexes show such sensitive emission characteristics according 
to their substituent locations, presumably because their bond polarities are not altered 
significantly.    
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3.4.4.3 pH Dependence Studies 
 
3.4.4.3.1 [Ru(bpy)2(picCOOH)]2+ 
 
For the protonated species [Ru(bpy)2(picCOOH)]3+ the LC [picCOOH] π-π* 
transition at 330 nm is slightly shifted towards a shorter wavelength compared with the 
deprotonated species as shown in Figure 3.13.  This suggests that formation of the 
carboxylate leads to an increase in the HOMO-LUMO energy gap.  This transition also 
begins to overlap with the bpy π-π* transition, which itself has shifted from 284 to 280 
nm upon protonation.  The MLCT region does not change wavelength upon 
protonation, however, the relative intensities of the contributing bands do alter.  This 
decreasing relative intensity of the band at 458 nm has been described in previous 
reports as evidence of a benzo-carboxylate to phenanthroline ILCT (interligand charge 
transfer).[24]  
 
 
Figure 3.13: Absorbance spectra of 20 x 10-6 M (15 cm3) [Ru(bpy)2(picCOOH)]2+ in 
PBS buffer solution,  upon addition of µl aliquots of percholric acid solution. (inset) pH 
titration curve of [Ru(bpy)2(picCOOH)]2+ in PBS solution, monitoring the changes in 
absorbance at 340 nm upon addition of perchloric acid. 
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Formation of the imidazolate [Ru(bpy)2(picCOOH)]0 at pH > 8.7 (Figure 3.14) 
sees red shift in the MLCT to 468 nm,  LC [picCOOH] π-π* transition to 340 nm and 
bpy π-π* transition to 287 nm.  This suggests a more extended π system which is 
consistent with deprotonation of the imidazole leading to an enhanced electronic 
communication between the phenanthroline and imidazole ligand components.  These 
effects have been previously noted in imidazole and triazole ligands.[24] 
 
The spectral changes brought about by a change in pH have a relatively small 
effect on the MLCT transition and are mostly confined to the ligand, suggesting that the 
LUMO for the MLCT transition lies mainly on the bipyridine ligands.  This is found to 
be the case in calculating its pKa/pKa* values and it is also consistent with the excited 
state pKa* studies on comparable benzimidazole complexes.[25, 47]  
 
 
Figure 3.14: Absorbance spectra of 20 x 10-6 M (15 cm3) [Ru(bpy)2(picCOOH)]2+in 
PBS buffer solution,  upon addition of µl aliquots of sodium hydroxide solution. (inset) 
pH titration curve of [Ru(bpy)2(picCOOH)]2+ in PBS solution monitoring the changes 
in absorbance at 340 nm upon addition of sodium hydroxide solution. 
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The ground state pKa values of the imidazole ligand were determined by 
monitoring the spectral changes of the absorbance spectrum at 340 nm over a pH range 
of 1.0-12.0 (Figures 3.13 inset and 3.14 inset).  The data was then fitted to a plot of 
absorbance at 340 nm -vs- pH and the point of inflection was determined by 
differentiation.  This yielded pKa values of 1.5 +/- 0.1 and 8.5 +/- 0.1 respectively.  
Protonation of the imidazole, to give the imidazolium, only occurs at very low pH 
values and as a result only an estimate of this pKa value may be given.  This is thought 
to be a result of the coulombic repulsion between the positively charged imidazolium 
ring and the positive metal centre.[24]  Furthermore, as discussed in the introduction to 
Chapter 3 the pKa values are also solvent dependent.  From the pH titration curve it is 
the [Ru(bpy)2(picCOOH)]2+ complex that is the major species in solution between pH 4-
7, whereas, the [Ru(bpy)2(picCOOH)]+ complex dominates between pH 10-12.  
Interestingly, the pH dependence of the visible MLCT region is minimal under these 
changes in pH.  This is important to note because it is usually between the wavelengths 
405-488 nm that are exploited for excitation in both FLIM and confocal microscopy 
measurements.   
 
Protonation of the imidazole on the ancillary ligand has a large impact on both 
its luminescent intensity and emission wavelength.  Both [Ru(bpy)2(picCOOH)]3+ and 
[Ru(bpy)2(picCOOH)]+ exhibited red shifted emission maxima when compared to 
[Ru(bpy)2(picCOOH)]2+.  It is thought in the case of [Ru(bpy)2(picCOOH)]3+ that the 
red shift may be a result of a stabilising electrostatic interaction between the MLCT 
generated bpy anion radical and the extra positive charge of the imidazolium since the 
shift is greater than that observed in the equivalent absorbance spectra.[24] 
  
Figures 3.15 and 3.16 below illustrate the pH dependence on the emission 
spectrum of the dye in aqueous PBS buffer solution.  In acidic media the spectral 
changes are more dramatic with a red shifted emission maximum from 605 nm to 624 
nm at pH 1.0 upon the formation of the imidazolium species.  It is also proposed that the 
increase in the shoulder in the absorbance of the MLCT, assigned to ILCT of benzo-
carboxylate to phenanthroline, may cause self absorption of emitted radiation through 
energy transfer.[24]  This would account for the loss of emission intensity without a 
significant decrease in luminescent lifetimes as seen for this complex at low pH values.  
There is also a loss of luminescent intensity and red shift in emission maximum from 
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604 nm to 613 nm when the complex is deprotonated at pH 12.0 as a result of the 
extended π delocalisation across the complex.  The excitation wavelengths used for the 
pH dependence studies corresponds to (or is as close as possible to) the isosbestic point 
in the MLCT region of the absorbance spectra for all the complexes.   
 
 
Figure 3.15: Emission spectra of 20 x 10-6 M (15 cm3) [Ru(bpy)2(picCOOH)]2+in PBS 
buffer solution,  upon addition of µl aliquots of perchloric acid solution. (437 nm 
excitation wavelength, slit widths: 5 nm).  (inset) pH titration curve of 
[Ru(bpy)2(picCOOH)]2+ in PBS solution monitoring the difference in emission intensity 
(excited at 437 nm) –vs- pH upon addition of perchloric acid solution. 
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Figure 3.16: Emission profile of 20 x 10-6 M (15 cm3) [Ru(bpy)2(picCOOH)]2+in PBS 
buffer solution,  upon addition of µl aliquots of sodium hydroxide solution. (448 nm 
excitation wavelength, slit widths: 5nm).  (inset) pH titration curve of 
[Ru(bpy)2(picCOOH)]2+ in PBS solution monitoring the difference in emission intensity 
(excited at 448 nm) –vs- pH upon addition of sodium hydroxide solution. 
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intensity to plot titration curves (Figures 3.15 inset and 3.16 inset) and were fitted to an 
expression for the Förster cycle in Equation 3.10: 
 
pKa* = pHi + log(τHB / τB-)……….Eq 3.10 
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state pKa* values were calculated to be 2.2 +/- 0.1 and 8.7 +/- 0.1 respectively for the 
(de)protonation of the nitrogen moieties on the ancillary ligand.  These values are 
similar to those calculated for ground state pKa values suggesting that the excited state 
lies on the bpy ligands of the complex.  As the emissive state is one of charge transfer, 
Emission Intensity -vs- Wavelength
0
50
100
150
200
250
535 585 635 685 735 785
Wavelength (nm)
Em
is
s
io
n
 
In
te
n
si
ty
 
(a.
u
.
)
pH 4.0
pH 4.5
pH 5.0
pH 5.5
pH 6.0
pH 6.4
pH 6.8
pH 7.4
pH 7.9
pH 8.5
pH 9.0
pH 9.6
pH 10.0
pH 10.5
pH 11.0
pH 11.5
pH 12.0
pH 12.0 
pH 4.0 
 136 
one of the ligands carries the excited electron.  If the excited electron was located on the 
[picCOOH] ligand, because of the nominal charge induced by the excited state, it would 
be considered to be more basic than that of the corresponding ground state value by as 
much as 3 pH units.[31, 48]  These pKa and pKa* results are in good agreement with 
values determined previously.[25]  In this case, the ground state pKa values were 
estimated to be 1.3 and 8.4 and the excited state pKa* values were calculated to be 
equal to 1.3 and 8.5 respectively.  Any slight variation in the pKa values may be 
explained by the different PBS or ionic strength of the buffers used which will have an 
effect on pKa values.  All absorbance and emission spectral changes are fully reversible 
between pH 0.5 to pH 12.0 indicating that the compound is stable at extreme pH values 
and does not undergo chemical decomposition.   
 
 
 
3.4.4.3.2 [Ru(bpy)2(picNO2)]2+ 
 
To date, the pKa/pKa* values have not yet been reported for the nitro and amino 
functionalised ruthenium (II) complexes.  Due to the poor aqueous emission 
characteristics of [Ru(bpy)2(picNO2)]2+ the spectral changes brought about by varying 
the pH was difficult to assess when compared to the other ruthenium complexes 
synthesised.  However, changing the solvent to acetonitrile for example, made it very 
difficult to control the pH of the solution because it fluctuated significantly.  
Nevertheless, the absorbance profile changed in going from basic to acidic media in 
aqueous conditions but without evidence of an isosbestic point is shown in Figure 3.17.  
The formation of a precipitate of the nitro complex within the solution at lower pH 
values leads to changes in the absorbance baseline.  Protonation of the nitro group leads 
to a redistribution of charge and many resonance structures within the [picNO2] ligand, 
promoting hydrogen bonding between molecules and the possible formation of dimers 
in solution.  It has been noted before that nitro groups display a significant degree of 
intermolecular self-association due to π-stacking enhancement between molecules at 
lower pH.[46]  Unlike the other ruthenium complexes, all spectral changes of 
[Ru(bpy)2(picNO2)]2+ were confirmed to be irreversible and the initial absorbance and 
emission profile intensities were not re-established on restoring neutral pH [data not 
shown] due to the formation of a precipitate in solution.   
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Figure 3.17: Absorbance of 20 x 10-6 M (15 cm3) [Ru(bpy)2(picNO2)]2+in PBS buffer 
solution,  upon addition of µl aliquots of perchloric acid solution.  (inset) pH titration 
curve of [Ru(bpy)2(picNO2)]2+ in PBS solution, monitoring the changes in absorbance 
at 340 nm upon addition of perchloric acid solution. 
 
 
 Upon increasing pH from neutral (Figure 3.18), the absorbance spectra are better 
behaved but are considerably different to that seen previously for the carboxyl 
functionalised complex.  Of particular interest are the regions of the [picNO2] π-π* 
transition and the MLCT transition.   Upon formation of the imidazolate the absorbance 
maximum shifts from 357 nm to form an isobestic point at 368 nm.  An increase in the 
absorbance intensity and corresponding red shift in the MLCT peak to 463 nm is 
attributed to an increased σ-donor ability of the anionic ligand upon deprotonation.  
Once again at higher pH values it is noted that the relative intensities of the ILCT on the 
shoulder of the MLCT has increased.  Unlike for [Ru(bpy)2(picCOOH)]2+ the MLCT 
region is strongly influenced by changes in pH. 
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Figure 3.18: Absorbance of 20 x 10-6 M (15 cm3) [Ru(bpy)2(picNO2)]2+in PBS buffer 
solution,  upon addition of µl aliquots of sodium hydroxide solution.  (inset) pH titration 
curve of [Ru(bpy)2(picNO2)]2+ in PBS solution, monitoring the changes in absorbance 
at 340 nm upon addition of sodium hydroxide solution. 
 
  
The ground state pKa values of the nitrogen atoms on the benzimidazole ligand 
were estimated to be equal to 3.7 and 8.0 +/- 0.1 as illustrated in Figures 3.17 (inset) and 
3.18 (inset) respectively.  However, it is noted that the lower pKa value of 3.7 will have 
a large associated error as acidification leads to the unavoidable formation of a 
precipitate of the complex within the solution.   
 
Similar to the luminescence spectra for [Ru(bpy)2(picCOOH)]2+, there is a slight 
shift in the emission maximum of [Ru(bpy)2(picNO2)]2+ to longer wavelengths with 
protonation/deprotonation (Figures 3.19 and 3.20).  However, the spectral shifts are not 
as dramatic.  It is proposed, as in the case of [Ru(bpy)2(picCOOH)]3+, that the red shift 
may be a result of a stabilising electrostatic interaction between the MLCT generated 
bpy anion radical and the extra positive charge of the imidazolium. 
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The emission spectrum in the formation of [Ru(bpy)2(picNO2)]1+ at pH > 8.0 
(Figure 3.20) showed little change in the maximum wavelength of emission, which is 
interesting considering the equivalent absorbance spectrum of [Ru(bpy)2(picNO2)]1+ 
showed significant changes upon deprotonation.   
 
 
Figure 3.19: Emission spectra of 20 x 10-6 M (15 cm3) [Ru(bpy)2(picNO2)]2+in PBS 
buffer solution,  upon addition of µl aliquots of perchloric acid solution. (487 nm 
excitation wavelength, slit widths: 5 nm).  (inset) pH titration plot of 
[Ru(bpy)2(picNO2)]2+ in PBS solution monitoring the difference in emission intensity 
(excited at 487 nm) –vs- pH upon addition of perchloric acid solution. 
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Figure 3.20: Emission spectra of 20 x 10-6 M (15 cm3) [Ru(bpy)2(picNO2)]2+in PBS 
buffer solution,  upon addition of µl aliquots of sodium hydroxide solution.(447 nm 
excitation wavelength, slit widths: 5 nm.  (inset) pH titration plot of 
[Ru(bpy)2(picNO2)]2+ in PBS solution monitoring the difference in emission intensity 
(excited at 447 nm) –vs- pH upon addition of sodium hydroxide solution. 
 
 
The excited state pKa* values of the benzimidazole ligand were calculated to be 
equal to 1.5 and 8.0 +/- 0.1, respectively, from the graphs in Figures 3.19 (inset) and 
3.20 (inset).  The excited state pKa* value of 8.0 +/- 0.1 is identical to that of the 
ground state pKa indicating that once again the excited state lies on the bpy ligands of 
the complex.  Protonation of the second nitrogen on the imidazole gives two 
significantly different pKa and pKa* values based on the absorption and emission 
profiles respectively.  This reveals a change to the trends seen previously and may 
suggest that when it is protonated the excited state may lie on the benzimidazole ligand.  
However, due to precipitation of the protonated nitro complex at low pH, the pKa 
calculations there are large errors and it may be assumed that the excited state does 
indeed lie on the LUMO of the bpy ligands.  The pKa/pKa* values calculated here are 
similar to those calculated for the carboxyl functionalised complex, which again 
supports the assumption that the excited state lies on the bpy ligand of the complexes.  
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Density functional theory (DFT) calculations performed by Shi et al.[21] on this 
particular nitro complex indicated that the LUMO was located on the bpy ligands.  
However the pKa values were not reported.    
 
3.4.4.3.3 [Ru(bpy)2(picNH2)]2+ 
 
Changes in absorbance spectra due to variations in pH for the 
[Ru(bpy)2(picNH2)]2+ complex (Figures 3.21 and 3.22) are very similar to those of 
[Ru(bpy)2(picCOOH)]2+.  The only exception is relatively smaller changes in 
absorbance for the bpy π-π* transition following a change in pH.  Ground state pKa 
values were calculated to be 1.5 +/- 0.1 and 8.8 +/- 0.1 as illustrated in Figures 3.21 
(inset) and 3.22 (inset) respectively, which are similar to ground state pKa results for 
the [Ru(bpy)2(picCOOH)]2+ complex.  The induced spectral changes are also fully 
reversible in going from a neutral to basic pH and back again.  However interestingly, 
following acidification approximately 65 % of the emission intensity was lost 
irreversibly upon returning to a neutral pH.     
 
Figure 3.21: Absorbance spectra of 20 x 10-6 M (15 cm3) [Ru(bpy)2(picNH2)]2+in PBS 
buffer solution,  upon addition of µl aliquots of perchloric acid solution.  (inset) pH 
titration curve of [Ru(bpy)2(picNH2)]2+ in PBS solution, monitoring the changes in 
absorbance at 325 nm upon addition of perchloric acid solution. 
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Figure 3.22: Absorbance spectra of 20 x 10-6 M (15 cm3) [Ru(bpy)2(picNH2)]2+in PBS 
buffer solution,  upon addition of µl aliquots of sodium hydroxide solution.  (inset) pH 
titration curve of [Ru(bpy)2(picNH2)]2+ in PBS solution monitoring the changes in 
absorbance at 325 nm upon addition of sodium hydroxide solution. 
 
 
 The emission of [Ru(bpy)2(picNH2)]2+ is extremely pH sensitive with a 
maximum emission at a pH of 1.0 and a minimum emission at a pH of 12.0 as shown in 
Figures 3.23 and 3.24 respectively.  Unlike [Ru(bpy)2(picCOOH)]2+, acidification to 
form the imidazolium species ([Ru(bpy)2(picNH2)]3+) sees an increase in emission 
intensity.  However, as seen before for [Ru(bpy)2(picCOOH)]3+, a significant spectral 
red shift in the emission maximum from 607 nm to 620 nm of the [Ru(bpy)2(picNH2)]3+ 
complex is observed.  Once again, it is speculated that this is due to the stabilising 
electrostatic interaction between the MLCT generated bpy anion radical and the extra 
positive charge of the imidazolium.  Deprotonation of the imidazole ring to form 
[Ru(bpy)2(picNH2)]+ sees little change in the wavelength of emission maximum.  
However, in contrast to [Ru(bpy)2(picCOOH)]+ the emission intensity is almost reduced 
to zero at high pH values (Figure 3.24).  Any changes in the protonation state of the 
amino terminal functionality were not observed in the acid-base titration experiments.  
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The pKa of the NH2 group is approximately 9.9 and it is speculated that the lack of an 
observed pKa may be as a result of its involvement in the solvation of the 
[Ru(bpy)2(picNH2)]2+ complex. 
 
 
Figure 3.23: Emission spectra of 20 x 10-6 M (15 cm3) [Ru(bpy)2(picNH2)]2+in PBS 
buffer solution,  upon addition of µl aliquots of perchloric acid solution. (440 nm 
excitation wavelength, slit widths: 5 nm).  (inset) pH titration curve of 
[Ru(bpy)2(picNH2)]2+ in PBS solution monitoring the difference in emission intensity 
(excited at 440 nm) –vs- pH, upon addition of perchloric acid solution. 
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Figure 3.24: Emission spectra of 20 x 10-6 M (15 cm3) [Ru(bpy)2(picNH2)]2+in PBS 
buffer solution,  upon addition of µl aliquots of sodium hydroxide solution. (467 nm 
excitation wavelength, slit widths: 5 nm).  (inset) pH titration curve of 
[Ru(bpy)2(picNH2)]2+ in PBS solution monitoring the difference in emission intensity 
(excited at 467 nm) –vs- pH, upon addition of sodium hydroxide solution. 
 
 
The excited state pKa* values were calculated to be 3.2 +/- 0.1 and 9.1 +/- 0.1 as 
shown in Figures 3.23 (inset) and 3.24 (inset) respectively.  This is the largest difference 
calculated between pKa and pKa* values for protonation of the complex and may be 
explained by the more efficient electron donating ability of the amino functionalised 
ligand.  This causes an increase in the basicity of the ligand, thus, making it easier to 
protonate.  However, both ground state pKa and excited state pKa* values are within 3 
pH units of each other suggesting that the excited state remains on the bpy ligands.  This 
has been the trend seen for all three ruthenium (II) complexes irregardless of the 
coordinated ancillary ligand.   
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3.4.4.4 Electrochemistry – Cyclic Voltammetry 
 
The redox behaviour of the three ruthenium (II) polypyridyl complexes 
synthesised were investigated by cyclic voltametry and their redox potentials are shown 
in Table 3.5 below.  The electrochemistry of [Ru(bpy)2(picNO2)]2+ and 
[Ru(bpy)2(picNH2)]2+ has not been reported previously.   
 
 
Compound 
 
Metal-
centred 
redox 
potential (V) 
Ligand based 
redox potentials 
(V) 
[Ru(bpy)2(picCOOH)]2+ 
 
+1.32 (r) -0.72 (qr) 
-1.30 (qr)*,  
-1.61 (r)* 
-1.74 (qr). 
[Ru(bpy)2(picNO2)]2+ 
 
+1.29 (r) -0.64 (ir), 
-0.86 (r),  
-1.22 (qr), 
-1.40 (ir)*, 
-1.51 (ir), 
-1.65 (qr)*. 
[Ru(bpy)2(picNH2)]2+ 
 
+1.37 (qr) -0.67 (ir), 
-0.84 (r), 
-1.15 (qr), 
-1.40 (r)*, 
-1.57 (r)*,  
-1.97 (r). 
 
Table 3.5: Redox properties of ruthenium (II) complexes measured  in acetonitrile 
(containing 0.1M TBA as electrolyte) with a 1.5 mm glassy carbon working electrode 
and referenced against Ag/AgCl.  (r) – reversible reaction, (ir) – irreversible reaction 
and (qr) – quasi-reversible reaction.  All CV’s were performed in duplicate with 
different glassy carbon electrodes, scanning though the range of potentials (multiple 
scans): 1, 0.50, 0.25 and 0.05 Vs-1 respectively.  Electrochemistry was conducted using 
1 mmol of sample dissolved in 5 cm3 of dry acetonitrile (HPLC grade, used as received) 
containing 0.1 M tetrabutylammonium tetrafluoroborate (TBA) as supporting 
electrolyte.  All samples were degassed with nitrogen prior to analysis.  * denotes bpy 
ligand reduction potentials. 
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 Figure 3.26 below illustrates the cyclic voltammogram for the 
[Ru(bpy)2(picCOOH)]2+ complex over negative potentials and Figure 3.26 (inset) also 
shows the well behaved redox couple attributed to the reversible metal centred oxidation 
(Ru2+/Ru3+) of the compound at +1.32 V versus Ag/AgCl.[25, 42]  This is in good 
agreement with previously published results for this carboxyl complex[25] as illustrated 
in Figure  3.25. 
 
 
 
 
 
Figure 3.25: Cyclic voltammograms of [Ru(bpy)2(picCOOH)]2+ (pH 7, solid line) and 
[Ru(bpy)2(picCOOH)]+ (pH 12.0, dotted line), in phosphate buffer (0.1 M). Sweep rate: 
100 mV s−1; working electrode: glassy carbon disk (2 mm diameter); auxiliary 
electrode: platinum wire; reference electrode: aqueous Ag/AgCl. Inset: cyclic 
voltammogram of [Ru(bpy)2(picCOOH)]2+ in dry acetonitrile.[25] 
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In an ideal, fully reversible electrochemical based process the redox peak 
separations should be equal to 59 mV for a one electron process.  The metal centred 
peak separation for (Ru2+/Ru3+) is 115 mV.  As this peak separation value increases the 
redox process of a complex becomes slower and more irreversible, making regeneration 
of the original species more difficult.  The peak areas for both oxidation and reduction 
are similar in values showing a chemically reversible redox process.   
 
Two quasi-reversible bpy-centred reductions were observed at -1.30 V and -1.61 
V versus Ag/AgCl respectively as identified by previously published literature.[25, 49]  
Pellegrin et al.[25] reported of a further irreversible ligand reduction peak assigned to a 
[picCOOH] ligand-centred reduction at -1.74 V in phosphate buffer solution (0.1 M).  
However, upon addition of TBA to the phosphate buffered solution, this redox peak 
disappears but leaves both bpy reduction peaks unaffected.  Unfortunately this particular 
negatively scanned ligand reduction CV region is not published.  However, this is 
probably the case seen here as the addition of TBA to the electrolyte solution causes the 
disappearance of the peak at -1.74 V.  The redox couple at -0.72 V is also assigned to a 
further [picCOOH] ligand reduction.[50]  This suggests that the LUMO of the complex 
lies on the ancillary [picCOOH] ligand and not on the cyclometalating bpy ligands as 
determined by ground and excited state pKa* values previously.  This observation is 
consistent throughout the electrochemistry of all the ruthenium (II) complexes 
synthesised.  However it is thought that the higher lying LUMO, which determines the 
T1 state of the complexes, and therefore its emission, are dominated by the 
cyclometalating bpy ligands. 
 
It is likely that the reduction peak at -1.30 V also contains some [picCOOH] 
ligand character, or the possible adsorption of the complex onto the electrode, given the 
non-uniform areas of the peak.  Adsorption of molecules onto glassy carbon electrodes 
with oxygen containing functional groups has been observed before.[51]  During the 
potential sweep the electrode may be anodised with the complex as a result of the 
interaction between the oxygen and electrode surface.  This observation is supported by 
the cyclic voltammetry results here showing possible adsorption processes for both 
carboxyl and nitro functionalised complexes, whereas, there is little evidence of 
significant adsorption for the amino functionalised complex.  It is also considered that 
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any trace elements of water within the solution could cause a water ingress effect that 
may also affect the electrochemical results.  
 
 Bracketing experiments were performed to isolate a particular potential window 
in the scanning process.  This may provide additional information on what redox 
processes are coupled in the full CV.  For the carboxyl and nitro functionalised 
ruthenium complexes, bracketing experiments indicated when the potential is only 
applied in a positive direction (starting at 0 V), and ligand reduction potentials not 
applied, the Ru2+/Ru3+ metal redox couple is well defined and reversible as shown in 
Figure 3.26 and Figure 3.28 respectively.  However, once the ligands have been 
reduced, the metal redox couple no longer displays well defined character and other 
oxidation peaks are evident in the positive region of the potential scan as illustrated in 
Figure 3.27.  This indicates that upon ligand reduction, a chemical reaction or 
adsorption of the complex onto the electrode occurs during the negative potential 
sweep.   
 
 
Figure 3.26: Cyclic voltammogram of [Ru(bpy)2(picCOOH)]2+ in acetonitrile 
(containing 0.1M TBA as electrolyte) with 1.5 mm glassy carbon working electrode and 
referenced against Ag/AgCl.  Scans were started in a positive direction from an initial 
potential of 0 V.  (Inset) Bracketed positive region of CV. 
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Figure 3.27: Full cyclic voltammogram of [Ru(bpy)2(picCOOH)]2+ in acetonitrile 
(containing 0.1M TBA as electrolyte) with 1.5 mm glassy carbon working electrode and 
referenced against Ag/AgCl.  Scans were started in a positive direction from an initial 
potential of 0 V with a scan rate of 0.05 Vs-1. 
 
 
Figure 3.28 shows the cyclic voltammogram of [Ru(bpy)2(picNO2)]2+.  Once 
again it displayed a well defined redox couple (Ru2+/Ru3+) in Figure 3.38 (inset) at 
+1.29 V versus Ag/AgCl, when this redox couple is isolated.  The presence of the 
electron withdrawing nitro group has the effect of shifting the metal redox potential to 
slightly more negative potentials as shown in Table 3.5.  This is surprising as increasing 
the electron withdrawing nature of a ligand would be expected to make the metal 
oxidation more difficult and reduction of the ligands easier.[52]  However, the impact of 
the electron withdrawing group on the ligand is thought to be minimal due to the 
distance from the ruthenium metal centre.  Here, the metal redox peak separation is 116 
mV, which is almost identical to that observed for the carboxyl complex.   
 
Some six reduction processes were also observed when the window of analysis 
was widened to include negative potentials.  The bpy ligand reduction peaks are 
tentatively assigned to the peaks present at -1.40 V and -1.65 V respectively.[25, 53]  All 
other reduction peaks may be attributed to [picNO2] ligand reductions on the imidazole 
hetrocyclic ring, the bipyridyl ring or on the substituted phenyl ring.  It is very difficult 
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to distinguish between the ligands responsible for each of the reduction peaks as there is 
likely to be a mixture of peaks, judging by the peak areas, caused by the reduction and 
adsorption of the compound onto the electrode surface.  Furthermore, the reduction peak 
at -1.51 V is thought be as a result of adsorption of the complex as explained before. 
 
 
Figure 3.28: Cyclic voltammogram of [Ru(bpy)2(picNO2)]2+in acetonitrile (containing 
0.1M TBA as electrolyte) with 1.5 mm glassy carbon working electrode and referenced 
against Ag/AgCl.  Scans were started in a positive direction from an initial potential of 
0 V.  (Inset) Bracketed positive region of CV. 
 
 
 Finally, the cyclic voltammogram of [Ru(bpy)2(picNH2)]2+ is shown in Figures 
3.29 and 3.30.  It exhibits a quasi-reversible metal centred redox couple (Ru2+/Ru3+) 
(Figure 3.29 inset) at 1.37 V versus Ag/AgCl and even when isolated in a positive 
potential sweep this feature does not become reversible as seen for the other two 
complexes.  However, it is considered that this ruthenium oxidation peak may be 
preceeded by NH2 oxidation which may lead to polymerisation.[54] 
 
Once again this CV shows six ligand based reductions at negative potentials, 
however, they are more reversible in nature when compared to the nitro complex.  
These are tentatively assigned to; -0.67 V ([picNH2] reduction), -0.84 V ([picNH2] 
reduction), -1.15 V ([picNH2] reduction), -1.40 V ([bpy reduction), -1.57 V (bpy 
reduction) and -1.97 V ([picNH2] reduction) versus Ag/AgCl respectively.  Reduction 
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peaks at -0.84 V, -1.40 V, -1.57 V and -1.97 V seem to be fully reversible in a single 
electron or multi-electron transfer process.  Furthermore, the adsorption peaks seen 
previously at around   -1.5 V is not evident for the [Ru(bpy)2(picNH2)]2+ complex.  For 
comparison, the three bpy ligand reduction peaks for [Ru(bpy)3]2+ are reported to be 
present at -1.35 V, -1.61 V and -1.80 V and the metal centred redox couple (Ru2+/Ru3+) 
is at +1.28 V versus Ag/AgCl in acetonitrile solution.[49]  The replacement of a bpy 
ligand with the [picNH2] ligand has the largest effect on the (Ru2+/Ru3+) redox potential.  
This suggests that the amino ligand exhibits the greater electron withdrawing potential 
from the ruthenium centre and the metal centre becomes slightly more difficult to 
oxidise.  In addition, the introduction of the nitro functionalised ligand has had the 
effect of moving the reduction of the bpy ligands to more negative potentials. 
 
 
 
Figure 3.29: Cyclic voltammogram of [Ru(bpy)2(picNH2)]2+in acetonitrile (containing 
0.1M TBA as electrolyte) with 1.5 mm glassy carbon working electrode and referenced 
against Ag/AgCl.  Scans were started in a positive direction from an initial potential of 
0 V.  (Inset) Bracketed positive region of CV.  
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Figure 3.30: Full cyclic voltammogram of [Ru(bpy)2(picNH2)]2+ in acetonitrile 
(containing 0.1M TBA as electrolyte) with 1.5 mm glassy carbon working electrode and 
referenced against Ag/AgCl.  Scans were started in a positive direction from an initial 
potential of 0 V with a scan rate of 0.05 Vs-1. 
 
 
 Ventatanarayanan et al.[54] reported the production of an interfacial polymer film 
through the oxidative electropolymerisation of the amino functionality on a 
[Ru(aphen)3]2+ complex shown in Figure 3.31 below.  In acetonitrile two oxidation 
processes were observed on the first scan, that of the irreversible oxidation of the amine 
functionalised phenanthroline ligand at + 1.13 V and reversible Ru2+/3+ couple at + 1.25 
V.  For the [Ru(bpy)2(picNH2)]2+ system analysed here, there is also evidence of an 
irreversible oxidation peak of the [picNH2] ligand at + 0.91 V.  Depending on the 
mechanism of interaction, the NH· radical is thought to either dimerise with an adjacent 
NH· radical to form a diazo bond or the radical proceeds to react with an adjacent 
carbon atom on a neighbouring complex to form an imine bond.[54]  Their results 
suggested the formation of the diazo bond as the aromaticity of the ligand is preserved 
upon electropolyperisation.  It is likely that similar electropolymerisation is occurring 
here for the [Ru(bpy)2(picNH2)]2+ complex and also following the reduction of 
[Ru(bpy)2(picNO2)]2+ to the corresponding amino complex.   
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Figure 3.31: Schematic diagram illustrating the [Ru(aphen)3]2+ complex.[54] 
 
 
 
3.4.4.5 Raman Spectroscopy 
 
 Raman spectroscopy is a fundamentally weak phenomenon, but the signal may 
be considerably enhanced if the laser of excitation coincides with an intense optical 
transition within the molecule.  The resonance Raman effect can lead up to a 6 fold 
enhancement of the Raman signal of vibrations associated with the chromophores 
involved in the optical transition of a complex.[55]  Resonance with the MLCT 
transitions of ruthenium (II) polypyridyl complexes yield intense Raman spectra with 
excellent signal-to-noise ratio.  The three ruthenium (II) polypyridyl complexes were 
irradiated with 458, 514 and 785 nm laser lines.  The 458 nm laser line is coincident 
with the main visible MLCT absorption of the complexes (as shown in the UV-vis 
absorbance profiles before) and under these resonance conditions the vibrational modes 
associated only with the chromophores are enhanced.[25]  The post resonance laser line 
at 514 and non-resonant laser line at 785 nm are then used to determine the lowest 
energy state and general vibrational spectra respectively.  No pre-resonance laser lines 
of higher energies were used in the analysis of the complexes.   
 
Figure 3.32 displays the stacked resonance Raman spectra for 
[Ru(bpy)2(picCOOH)]2+ at the three wavelengths of irradiation.  Following excitation of 
[Ru(bpy)2(picCOOH)]2+ at 458 nm the signature bipyridyl vibrational modes are also 
marked in Figure 3.32 and assigned in Table 3.6.  This suggests that the optical 
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transition at 458 nm arises mainly from a ruthenium (dπ) to bipyridyl ligand (π*) MLCT 
transition.  Although, there is evidence of additional peaks suggestive of a ruthenium 
(dπ) to [picCOOH] ligand (π*) MLCT transition.  There is also evidence of a weak 
ruthenium-nitrogen stretch at 340 cm-1.  The two Raman peak at 1457 and 1427 cm-1 
throughout every Raman spectrum are not attributed to bpy ligand and are most likely 
due to post-resonance with the heteroligand based optical transition at around 330 
nm.
[56]
   
 
As the energy of excitation is decreased using the 514 and 785 nm laser lines 
more complex Raman spectra with overlapping bands were observed.  This was 
expected because in the case of the 785 nm laser line no resonance Raman is present 
and only the normal Raman spectrum of the complex is observed.  The decrease in 
Raman intensity of the bpy modes, in the 514 nm spectrum, along with the introduction 
of more intense, lower energy Raman signals (due to phenyl or pyridyl in-plane twisting 
modes) suggests that the optical transitions at shorter wavelengths consists mainly of a 
ruthenium (dπ) to [picCOOH] ligand (π*) MLCT transition.  This is consistant for all 
Raman spectra for the three ruthenium complexes.  This indicates that the lowest 
1MLCT is [picCOOH] based, even though pKa results suggest that 3MLCT seems to 
originate from the bpy ligands.  It is also considered that vibrational modes observed 
following irradiation at 514 nm originate from an ILCT and this is further supported by 
the evidence of an ILCT absorbance band on the shoulder for the MLCT transition for 
the complexes.  The intensity of the C-C and C-N stretching vibrations of the aromatic 
rings under higher irradiation energies indicates that such stretching modes are the 
dominant accepting modes for deactivation of the triplet MLCT excited state.[18]   
 
The Raman analysis was performed using solid state samples placed onto glass 
microscopy slides.  Judging by elemental analysis results of the synthesised complexes 
two perchlorate counterions are evident suggesting an overall charge of 2+ on the 
ruthenium complexes.  All peaks are tabulated and given assigned vibrational modes in 
Table 3.6 below.  All the Raman modes were assigned according to the published 
data.[25, 56-59] 
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Figure 3.32: Stacked Raman spectra of [Ru(bpy)2(picCOOH)]2+..  Solid state analysis 
of the samples was conducted using 458 nm (top), 514 nm (middle) and 785 nm 
(bottom) excitation laser lines.  All spectra were gathered with 5 acquisitions and an 
exposure time of 3 seconds with a laser power of 2 mW.  Arrows indicate signature 
bipyridyl vibrational modes. 
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[Ru(bpy)2(picR)]2+ 
458 nm  (cm-1) Assignment 
Bipyridyl vibrational modes: ~1606 
~1561 
~1488 
~1318 
~1273 
~1196 
~1026 
~666 
C=C stretch 
C=C stretch  
C=N stretch 
C=N stretch 
C-C (inter-ring bending) 
CCH (in-plane bending) 
Ring breathing 
Pyridyl in-plane twisting 
[picR] ligand vibrational modes: n/a n/a 
Ruthenium – Ligand vibrational 
modes: 
~340 Metal-Ligand stretching 
Other vibrations: ~1457 
~1427 
Post resonance vibrations 
514 nm   
Bipyridyl vibrational modes: ~1603 
~1561 
~1487 
~1318 
~1272 
~1190 
~1026 
~664 
C=C stretch 
C=C stretch 
C=N stretch 
C=N stretch 
C-C (inter-ring bending) 
CCH (in-plane bending) 
Ring breathing 
Pyridyl in-plane twisting 
[picR] ligand vibrational modes: ~1353 
~954 
~664 
C=N stretch 
Ring breathing 
Phenyl or pyridyl in-plane 
twisting 
Ruthenium – Ligand vibrational 
modes: 
~340 
~237 
Metal-Ligand stretching 
Other vibrations: ~1457 
~1427 
Post resonance vibrations 
785 nm   
Bipyridyl vibrational modes: ~1607 
~1561 
~1485 
~1317 
~1272 
~1185 
~1034 
~647 
C=C stretch 
C=C stretch 
C=N stretch 
C=N stretch 
C-C (inter-ring bending) 
CCH (in-plane bending) 
Ring breathing 
Pyridyl in-plane twisting 
[picR] ligand vibrational modes: ~1354 
~953 
~765 
~720 
~647 
C=N stretch 
Ring breathing 
Phenyl or pyridyl bending 
Phenyl or pyridyl bending 
Phenyl or pyridyl in-plane 
twisting 
Ruthenium – Ligand vibrational 
modes: 
~436 
~368 
~297 
Metal-Ligand stretching 
Other vibrations: ~1456 
~1426 
Post resonance vibrations 
 
Table 3.6: General assignment of Raman vibrational modes of the ruthenium (II) 
complexes synthesised using 458, 514 and 785 nm excitation wavelengths. 
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 The Raman spectra for [Ru(bpy)2(picNO2)]2+ are similar to the carboxyl 
functionalised equivalent.  Once again, under irradiation at 458 nm the bipyridyl 
vibrational modes mainly dominate and excitation at longer wavelengths sees the 
introduction of vibrational modes that suggest that the lowest 1MLCT is may also be 
located on the [picNO2] ligand.  One significant difference between the non-resonant 
spectra at 785 nm is the noticeable enhancement of the intensity of a pyridine ring 
stretch at 1603 cm-1 as revealed in Figure 3.33.   
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Figure 3.33: Stacked Raman spectra of [Ru(bpy)2(picNO2)]2+..  Solid state analysis of 
the samples was conducted using 458 nm (top), 514 nm (middle) and 785 nm (bottom) 
excitation laser lines.  All spectra were gathered with 5 acquisitions and an exposure 
time of 3 seconds with a laser power of 2 mW.  Arrows indicate signature bipyridyl 
vibrational modes. 
 
 
Raman results for the amino functionalised [Ru(bpy)2(picNH2)]2+ complex are 
shown in Figure 3.34.  Surprisingly, under irradiation at 458 nm, there is evidence of 
additional peaks at 1352, 1178, 1140 and 947 cm-1 that suggestive of a stronger 
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contribution of a ruthenium (dπ) to [picNH2] ligand (π*) MLCT transition at this 
wavelength of excitation.  Excitation at 514 nm yields similar spectra as seen following 
excitation at 458 nm, however, there is a slight change in the relative intensities of the 
peaks.  
 
As can be seen below, the relative intensity of the Raman bands are weaker and 
show a significantly smaller number bands under investigation at 785 nm.  However, 
this is with the exception of an intense broad peak at 545 cm-1 which was evident in 
many different spectral accumulations.  It is speculated that this might a result of the in-
plane twisting of the more delocalised phenyl ring on the [picNH2] ligand and this is 
further correlated with the experimental data previously reported by Pellegrin et al.[25] 
on a similar complex.  It is also noted that the use of glass slides in gathering the Raman 
spectra may have resulted in contamination of the sample signal by the glass Raman 
signal. 
 
 
 
Figure 3.34: Stacked Raman spectra of [Ru(bpy)2(picNH2)]2+..  Solid state analysis of 
the samples was conducted using 458 nm (top), 514 nm (middle) and 785 nm (bottom) 
excitation laser lines.  All spectra were gathered with 5 acquisitions and an exposure 
time of 3 seconds with a laser power of 2 mW.  Arrows indicate signature bipyridyl 
vibrational modes. 
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3.5 Ruthenium Conjugated Gold Nanoparticles  
 
 
3.5.1 Synthesis 
 
The amino functionalised luminophore was prepared in order to exploit this 
group for EDC/NHS coupling to a carboxyl functionalised PEG linker.  In the cross 
coupling reaction the water soluble carbodiimide crosslinker activates the carboxyl 
group for spontaneous reaction with primary amines.  Figure 3.35 shows how the EDS 
initially reacts with the carboxyl group to form an unstable amine-reactive O-
acylisourea intermediate, which is susceptible to hydrolysis, making it unstable and 
short lived in aqueous environments.  If this intermediate does not encounter an amine it 
will proceed to hydrolyse resulting in the regeneration of the carboxyl functionality.  
The efficiency of the EDC cross-coupling reaction is increased with the addition of 
NHS to form a more semi-stable amine reactive NHS-ester intermediate that may be 
coupled with an amine to produce the desired stable amide bond.  EDC couplings are 
best performed at slightly acidic pH (pH 4.5), however, the addition of NHS to the 
reaction allows for an efficient conjugation reaction to be performed at physiological 
pH.   
 
 
Figure 3.35: Schematic diagram illustrating the mechanism for EDC/NHS coupling 
reactions.[60] 
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Without isolation of the PEGylated ruthenium complex a disulphide reducing 
agent [DTT (0.3 equivalences)] was added to the solution in an effort to disrupt any 
disulphide bonds that may have formed between the thiol functionalised PEGylated 
ruthenium molecules (Figure 3.36).  Its concentration was deliberately kept low as DTT 
in solution will compete with the PEGylated ruthenium complex for conjugation to the 
gold nanoparticles.   
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Figure 3.36: Schmetic diagram illustrating the disruption of disulphide bonds by 
dithiothreitol (DTT).  
 
 
The free thiol groups located on the PEG linker covalently binds to the gold 
substrate with gentle shaking overnight.  Lateral Van der Waals interactions between 
the tails are expected to ensure a close-packed, crystalline or semi-crystalline structure 
on the surface substrate.  Simple purification of the functionalised nanoparticles was 
performed through a series of washing and centrifugation steps.  The conjugated gold 
nanoparticles were then resuspended in a PBS solution (pH 7.4) for analysis.  
Characterisation of the modified nanoparticles was performed using absorbance, 
emission, Raman, TEM and zeta potential techniques.   
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3.5.2 Characterisation 
 
UV-Vis absorption spectroscopy is the most widely used technique to 
characterise nanoparticles.  Solutions of colloid gold nanoparticles have a distinctive red 
colour that is caused by excitation of electronic plasmon absorption bands of the metal 
nanoparticles as a consequence of moving electrons on the particle’s surface.  Chemical 
modifications to nanoparticle surfaces change the dielectric at the interface leading to 
shifts in the absorption bands of the metal nanoparticle.[61] 
 
Figure 3.37 compares that the absorbance of the free parent dye, the PEGylated 
ruthenium complex, the unmodified AuNPs and ruthenium modified AuNPs.  The 
spectrum of the unmodified AuNPs exhibits an intense gold plasmon absorbance band 
at 527 nm.  Upon adsorption of the PEGylated ruthenium moieties the size and shape of 
the plasmon band changes which is attributed to changes in the surface dielectric of the 
nanoparticle.[62]  The absorbance maximum for both AuNP-PEG8-Ru and AuNP-PEG32-
Ru is shifted to 522 nm and 529 nm respectively.  The characteristic absorbance 
wavelengths of the amino functionalised ruthenium (II) polypyridyl dye are also noted 
at 285 nm (π-π* transition of the bpy ligand), 325 nm (π-π* transition of the [picNH2] 
ligand) and 455 nm (MLCT transition) respectively.  However, the electronic transitions 
of the ruthenium complex are partially obscured by the strong plasmon absorbance of 
the gold nanoparticles.  Care was taken to ensure that roughly the same amount of 
nanoparticles were present in the AuNP control to that of the functionalised AuNPs for 
all spectroscopic measurements. 
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Figure 3.37: Overlaid absorbance spectra of the unmodified 50 nm AuNPs, free 
[Ru(bpy)2(picNH2)]2+, Ru-PEG8-SH, AuNP-PEG8-Ru and AuNP-PEG32-Ru 
nanoconjugates in PBS (pH7.4) solutions.  Solutions containing the ruthenium (II) 
complex were absorbance matched at 455 nm. 
 
 
The PEGylation of the ruthenium complex did not result in significant 
alterations to the emission wavelength of the luminophore as shown in Figure 3.38.  The 
photophysical data are presented in Table 3.7.  The number of dye molecules on the 
gold colloid surface proved difficult to quantify given the small amounts of conjugated 
materials under analysis.  In an effort to ascertain the consequence of the metal 
enhanced emission on both nanoconjugates, the samples were absorbance matched at 
455 nm.  This assumes that the number of photons absorbed by ruthenium is the same 
i.e. the ruthenium surface coverage is approximately the same per nanoparticle and that 
no plasmon optical transition contributes to the absorbance at this wavelength.  
Therefore, this approach makes an underestimation of the actual emission intensity as a 
result of the conjugated ruthenium dye.  In order to separate the effects of quenching 
and dilution due to absorption/scattering by the AuNPs, the emission intensity was 
corrected for such variations using the following formula in Equation 3.11.  This 
formula has been used previously to correct for the absorption of incident light by a 
cobalt (III) complexes in quenching studies with [Ru(bpy)3]2+.[63]   
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(Io/I)corr = (Io/I)app [1-10-(Ad+Aq)/1-10-Ad] (Ad/Ad+Aq)……….Eq 3.11 
 
where (Io/I)app is the observed ratio of the emission intensity from the unquenched 
sample to that of the quenched one, and Ad and Aq are the absorbances of the donor and 
quencher, respectively, at the excitation wavelength of 455 nm. 
 
Figure 3.38 compares the corrected emission spectra of the free parent 
ruthenium (II) dye, the PEGylated ruthenium complex, the modified AuNPs and 
unmodified AuNPs following excitation into the MLCT absorbance band of 
[Ru(bpy)2(picNH2)]2+ at 455 nm of the absorbance matched solutions.  As expected the 
unmodified AuNPs showed no evidence of luminescence, whereas, the modified AuNP-
PEG8-Ru and AuNP-PEG32-Ru have an emission maxima at 605 nm and 608 nm 
respectively.  This is interesting as one of the main concerns was that the nanoparticle 
might quench the luminescence of the surface bound luminophore completely, 
particularly for the shorter linker.  However, the emission of the longer PEGylated 
nanoconjugate, AuNP-PEG32-Ru, is over 5 times that of the shorter AuNP-PEG8-Ru 
modified nanoparticle.  The close proximity of the dye to the metal surface, as a result 
of the shorter linker, leads to a greater quenching of luminescence as energy is 
transferred to the metal and the rate of non-radiative decay increases.  Furthermore, 
interestingly the emission intensity of AuNP-PEG32-Ru is greater than that of the free 
[Ru(bpy)2(picNH2)]2+ dye in PBS (pH 7.4) solution.  The emission wavelength also 
remains unaltered indicating that the nanoparticle has little impact on the wavelength of 
emission.  Any free, unbound ruthenium dye was removed from the conjugated 
nanoparticle solution by centrifugation and washing with deionised water approximately 
8 times until the supernatant showed no evidence of ruthenium emission.  Therefore, it 
can be concluded that free ruthenium contributes very little if at all to the emission 
shown in Figure 3.38. 
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Figure 3.38: Overlaid corrected emission spectra of the unmodified 50 nm AuNPs, free 
[Ru(bpy)2(picNH2)]2+, Ru-PEG8-SH, AuNP-PEG8-Ru and AuNP-PEG32-Ru 
nanoconjugates in PBS (pH 7.4) solutions.  Samples were excited at 455 nm using 10 
nm slit widths.  All ruthenium samples were absorbance matched at 455 nm.  
 
 
 The lifetimes of the nanoconjugates also vary significantly as shown in Table 
3.7 below.  The longer PEGylated nanoparticle exhibited a lifetime that is twice that of 
the shorter AuNP-PEG8-Ru complex and 1.3 times that of the free 
[Ru(bpy)2(picNH2)]2+ complex in aerated PBS (pH 7.4) buffered solution as illustrated 
in Figure 3.39.  It is thought that the increased lifetime of the AuNP-PEG32-Ru 
nanoconjugate is a result of the more protected and restricted environment provided by 
the longer PEG32 linker surrounding the luminophore.  This would result in a decrease 
in oxygen quenching of the 3MLCT state of the ruthenium complex and thus, lead to 
increased lifetimes.  This suggests that plasmonic enhancement of ruthenium emission 
is minimal.  It is also acknowledged that luminescent anisotropy experiments would be 
of particular interest in this context.  It is considered that the AuNP-PEG32-Ru 
nanoparticles might be better suited to multimodal cellular imaging given their 
enhanced luminescence and phosphorescent lifetimes.  The actual PEG linker lengths of 
3 nm and 13 nm are thought to be less than reported as they do not exist in linear 
conformation upon binding to a substrate and often form self-coiled structures.[64] 
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Figure 3.39: Overlaid TCSPC lifetime results of the free [Ru(bpy)2(picNH2)]2+, Ru-
PEG8-SH, AuNP-PEG8-Ru and AuNP-PEG32-Ru nanoconjugates in aerated PBS (pH 
7.4) solutions. (Inset) example of the monoexponential residual decay -vs- time plot for 
Ru-PEG8-SH (lifetime = 351 +/- 3 ns, x2 = 0.989). 
 
 
 
Compound Lifetime  x2 value Quantum Yields 
[Ru(bpy)2(picNH2)]2+ 357 +/- 3 ns 0.993 0.044 
Ru-PEG8-SH 351 +/- 3 ns 0.989 0.047 
AuNP-PEG8-Ru 277 +/- 9 ns 1.07 n/a 
AuNP-PEG32-Ru 448 +/- 17 ns 0.988 n/a 
Table 3.7: Lifetimes and quantum yields of the free ruthenium (II), PEGylated 
ruthenium complex and the conjugated ruthenium (II) dyes measured in aerated PBS 
(pH 7.4) solutions.  All lifetimes displayed monoexponential kinetics.   
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Figure 3.40 shows the Raman spectra of the free ruthenium (II) complex and the 
functionalised gold nanoparticles following irradiation at 514 nm.  This wavelength of 
excitation was chosen as it coincides with the surface plasmon absorbance of the gold 
nanoparticles and hence, was most likely to lead to surface enhanced Raman 
spectroscopy (SERS).  In general, all of the characteristic Raman peaks for the 
ruthenium (II) complex are present for the ruthenium modified nanoparticles at 514 nm.  
From the Raman spectra it appears that resonance Raman of the luminophore is 
dominating the signal, as PEG vibrations would be expected to be strongly enhanced 
under SERS conditions.  Furthermore, the Raman spectra for the modified AuNPs are 
not significantly different to the resonance Raman spectrum for the free ruthenium 
complex.  
 
The main differences between the Raman spectrum for the free ruthenium 
complex and the modified AuNP spectra are located at 1445 cm-1 (post resonance 
vibration), 1415 cm-1 (post resonance vibration), 1350 cm-1 (C=N stretch-bpy), 1256 
cm-1 (C-C inter ring bending-bpy), 1140 cm-1 (CCH in-plane bending-bpy), 956 cm-1 
(ring breathing-[picNH2] and 436 cm-1 (metal-ligand stretching).  Conjugation to the 
AuNP has had the effect of reducing the post resonant modes and a few bpy vibrational 
modes within the complex probably due to a shift in the ruthenium MLCT.  
Furthermore, conjugation of the ruthenium sees the elimination of a metal ligand stretch 
and ring breathing within the [picNH2] ligand possibly as a result of the more 
constrained environment of the attached luminophores.   
 
 167 
200 400 600 800 1000 1200 1400 1600
23
0
34
6 43
6
66
6
83
1 95
6
11
40
11
90
12
56
13
14
13
50
14
15
14
45
14
87
15
20
15
62
16
03
24
0 3
44
36
7
66
4
72
6
82
6 95
2 10
26
11
44
11
91
12
69
13
14
13
64
14
25
14
87
15
57
16
04
34
6
66
4
10
26
11
40 1
19
0
12
62
13
18
13
51
14
23
14
60
14
87
15
61
16
04
R
a
m
a
n
 
In
te
n
si
ty
 
(C
o
u
n
ts
)
Wavenumbers (cm-1)
[Ru(bpy)2(picNH2)]
2+
AuNP-PEG8-Ru
AuNP-PEG32-Ru
 
Figure 3.40: Stacked Raman spectra of the unmodified free [Ru(bpy)2(picNH2)]2+ 
complex (top), AuNP-PEG8-Ru (middle) and AuNP-PEG32-Ru (bottom) nanoconjugates.  
Samples were deposited onto glass slides and solvent allowed to evaporate prior to 
analysis.  Samples were irradiated using a 514 nm laser line.  All spectra were gathered 
with 5 acquisitions and an exposure time of 3 seconds with a laser power of 2 mW.   
 
 
The Zeta potential of the citrate stabilised AuNPs was also determined to be 
equal to -38.66 +/- 0.9 mV in PBS pH 7.4, indicating a good colloidal stability within 
the solution.  This zeta potential is comparable to other citrate stabilised gold 
nanoparticles.[65]  The Zeta potential of the modified AuNP-PEG8-Ru nanoparticles 
increased to + 47.97 +/- 1.3 mV in PBS (pH 7.4), indicating improved nano-stability 
and attenuation of charge around the nanoparticle surface.  This stability is also 
confirmed by the Uv-Vis spectrum in Figure 3.37 which shows no longitudinal 
absorbance modes indicative of aggregation of the nanoparticles.  In addition, the 
shifting to positive Zeta potentials is further indication of the presence of the positively 
charged [Ru(bpy)2(picNH2)]2+ complex.   
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3.5.3 Cellular Uptake of AuNP-PEG32-Ru Nanoparticles 
 
 A key objective in preparing a ruthenium conjugated nanoparticle was their 
potential use as Stokes shifted Raman and luminescent probes for cellular imaging.  In 
addition, the AuNP-PEG32-Ru nanoconjugate exhibited many favourable photophysical 
properties including longer aqueous lifetimes and greater emission intensity when 
compared to the lone parent ruthenium complex.   
 
In order to assess and compare the ability of the free [Ru(bpy)2(picNH2)]2+ 
complex (prepared as the ClO4 salt to improve aqueous solubility) and ruthenium (II) 
conjugated gold nanoparticles to transport across the cell membrane, cells were 
harvested after 2 days growth period.  The growth medium was removed by 
centrifugation at 2000 rpm for 2 minutes, washed twice and resuspended in PBS buffer 
(pH 7.4) solution.  For confocal measurements, 100 µl aliquots of the cell solution was 
used and mixed with 3 µl of the parent ruthenium complex (20 µM) or nanoconjugate 
(~0.7 µM) in PBS (pH 7.4).  Confocal measurements were performed at room 
temperature with a final [Ru(bpy)2(picNH2)]2+ complex concentration of 6 x 10-7 M or 
final nanoconjugate concentration of approximately 2 x 10-8 M. 
 
Figure 3.41 shows the confocal luminescent images of [Ru(bpy)2(picNH2)]2+, 
Ru-PEG32-SH and AuNP-PEG32-Ru which show the capacity of both parent and 
conjugates to cross the cell membrane.  The water soluble [Ru(bpy)2(picNH2)]2+ dye 
showed accumulation of the dye within the cell’s membrane but poor migration into the 
cells cytoplasm (Figure 3.41 (a)), which is consistent with similar cell experiments 
carried out with [Ru(bpy)2(picCOOH)]2+ in Chapter 5.  Following conjugation of the 
PEG linker to the metal complex (Figure 3.41 (b)), the moiety showed significant 
transmembrane transport and localisation within the cell’s cytoplasm after a period of 
10 minutes.  As was initially hoped, the water soluble PEG linker aided in drawing the 
dye into the cell’s cytoplasm.  As mentioned in Chapter 1, PEG has proven valuable 
before as a suitable biological linker to covalently attach to the molecules in an effort to 
limit non-specific adsorption by the cell and increase aqueous solubility.[28, 66]  The only 
other report on the potential benefits of PEGylation of metal complexes in cellular 
imaging is reported by Li et al.[67]  They described the synthesis of a series of PEG23 
functionalised iridium (III) polypyridine complexes.  The PEGylated complexes 
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exhibited increased water solubility when compared to the parent iridium complex and 
considerably reduced cytotoxicity in HeLa cells when compared to both cisplatin and 
the iridium control.  It is claimed thet even after 2 hours incubation with a relatively 
high concentration of PEGylated iridium complex (200 µM) the HeLa cells remained 
viable. 
 
Similarly for the nanoconjugate synthesised here, AuNP-PEG32-Ru (Figure 3.41 
(c)), the confocal luminescent images shows permeation of the probe across the 
membrane and into the cytoplasm following incubation with the SP2 myeloma cells at 
room temperature for 10 minutes.  Z-stacks of each cell confirm the dispersity of the 
luminophore throughout the cellular structure.  No further changes were detected inside 
the cells over a 60 minute timeframe.  Similarly, Gu et al.[28] described the synthesis of 
a fluorescein-PEG-AuNP probe that was reported to enhance the aqueous stability and 
efficient intracellular transport of the fluorescein dye into the nucleus of HeLa cells.  
The 3.7 nm monodispersed nanoparticles showed no obvious cytotoxicity to HeLa cells, 
making these particles ideal for improvement of nuclear targeted drug delivery.  It is 
believed that endocytosis is the process in which the nanoconjugates are up taken by the 
cell as its transmembrane efficiency is greatly affected by a decrease in temperature and 
this is discussed in detail in Chapter 1.   
 
            
                     (a)                       (b)                     (c) 
Figure 3.41: (a) Ruthenium dye only after 10 minutes [final concentration of 6 x10-5 M 
in PBS buffer (pH 7.4)], (b) ruthenium conjugated to the PEG linker after 10 minutes 
[final concentration of 6 x10-5 M in PBS buffer (pH 7.4)] and (c) AuNP-PEG32-Ru 
ruthenium after 10 minutes [final approx. concentration of 2 x10-7 M in PBS buffer (pH 
7.4)].  Images taken using SP2 myeloma cells at room temperature using 458 nm 
excitation laser line.  
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 These preliminary qualitative experiments serve to demonstrate the capacity of a 
metal complex to be transported across the cell membrane when conjugated to PEG 
linkers and AuNPs.  The linker length between luminophore and metal substrate was 
varied in an effort to increase the photophysical characteristics of the dye.  It was found 
that the larger linker length of approximately 13 nm exhibited superior emission 
intensity and aqueous lifetimes when compared to the shorter 3 nm PEGylated 
nanoparticle.  In addition, following conjugation of the novel non-membrane permeable 
ruthenium (II) complex to AuNPs, transmembrane transport was possible and 
localisation within cell organelles was achieved.  Furthermore, as discussed in Chapter 
1, a major problem up until now has been the successful internalisation of transition 
metal complexes within cells without the use of organic solvents.  It has been shown 
here that following conjugation to PEG linkers, or attachment to AuNPs, that the 
functionalised ruthenium (II) polypyridyl complexes may be easily transported across 
the cell membrane and exploited for cellular imaging without the need for organic 
solvents that are known to disrupt the cellular membrane.[68, 69]   
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3.6 Conclusion 
 
 
 The synthesis and characterisation of three ruthenium polypyridyl (II) 
complexes containing carboxyl, nitro and amino functionalised benzimidazole ancillary 
ligands is described.  The carboxyl functionalised [Ru(bpy)2(picCOOH)]2+ has been 
used for many years by our research group for the luminescent labelling of 
biomolecules.[1, 24, 25]  In the case of the [Ru(bpy)2(picNO2)]2+ complex the synthetic 
procedures are improved upon in comparison to the existing literature.  However, the 
synthesis of the novel [Ru(bpy)2(picNH2)]2+ complex was reported in the literature 
shortly after its synthesis as part of this research.   Even though the ruthenium 
complexes only differ by their substituent functionality on the benzimidazole ligand 
many contrasting results are obtained.  Not least with the [Ru(bpy)2(picNO2)]2+ complex 
that exhibited out of characteristic absorbance, emission, aqueous lifetime (~ 20 ns) , pH 
and solvent dependence.  Nevertheless, many of these abnormal results were explained 
by the para-substituted nitro substituent causing a strengthening in the bond polarity of 
the [picNO2] ligand.  As a result the electron withdrawing ability is greater, having an 
increased affect on its photophysical properties.   
 
 Both the carboxyl and amino functionalised complexes behave very similarly 
and may be characterised by long aqueous lifetimes (> 800 ns), comparable absorbance, 
emission, Raman profiles and similar pH dependence.  For all three ruthenium 
complexes the pKa/pKa* calculations suggested that the 3MLCT excited state of the 
complexes reside on the bipyridyl ligands.  The ancillary ligands are not expected to 
have a large influence on its excited state as the functionalised phenyl group lies some 
distance from the metal centre to have any influence the HOMO-LUMO energy gap.  
However, resonant Raman spectroscopy indicates that the lower energy MLCT optical 
transition is a result of a ruthenium (dπ) to bpy / [pic-R] (π*) ligands following 
irradiaton at 458 and 514 nm. 
 
Despite all three ruthenium complexes having been synthesised previously, this 
is the first time that the three have been compared and contrasted spectroscopically, 
photophysically and cyclic voltammetry with one another.  Furthermore, it is the first 
time that the [Ru(bpy)2(picNO2)]2+ and [Ru(bpy)2(picNH2)]2+ complexes have been 
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characterised by pKa titrations, Raman spectroscopy and electrochemistry.  The use of 
the pH dependant benzimidazole ligand adds extra flexibility to its potential use as a 
diagnostic tool.  The various functionalities used here will also allow for coupling of the 
ruthenium (II) polypyridyl dye to almost any biomolecule or assembly.  In Chapter 5 the 
conjugation of the [Ru(bpy)2(picCOOH)]2+ complex to a cell penetrating peptide 
octarginine is also described and its facile entry and localisation within the cell 
examined.   
 
The synthesis of a novel luminescent-nanoparticle multimodal probe is also 
achieved.  The [Ru(bpy)2(picNH2)]2+ complex was used for the luminescent labelling of 
50 nm AuNPs.  The length of the PEG linker, between dye and nanoparticle, was varied 
and it was determined that the longest linker length of 13.2 nm (in linear conformation) 
showed enhanced luminescence and increased lifetimes, more than twice, that of the 
shorter (3.3 nm) modified AuNP.  This nanoconjugate was then used for cellular 
imaging of transfected SP2 myeloma cells.  The parent dye alone remains in the outer 
membrane of the cell wall, whereas, PEGylation to gold nanoparticles helps draw the 
luminophore across the cell membrane and is shown to locate throughout cell organelles 
without the need for organic solvents such as DMSO to help with solubility.   
 
Furthermore, not only has the original parent complex [Ru(bpy)2(picCOOH)]2+,  
been shown to be useful in cell imaging but it has also served as a multimodal 
molecular probe for determining intracellular pH levels and oxygen concentrations.[1]  
Here, similar spectroscopic and photophysical results between the amino and carboxyl 
functionalised complexes were determined, lending to arguments supporting the 
potential use of AuNP-PEG32-Ru as a potential multimodal transmembrane imaging 
probe.     
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Chapter 4: Synthesis and Characterisation of 
Iridium (III) Luminophores for Bioconjugation 
 
 
 
 
 
 
 
 
 
 
 
 
 
“If we knew what we were doing, it wouldn’t be research” – Albert Einstein. 
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4.0 Introduction 
 
Iridium (III) complexes are of particular interest because of their high 
phosphorescent quantum yields and long lifetimes.  Furthermore, their spectroscopy can 
be fine tuned leading to emission from blue to red by simply adjusting the chelating 
ligands.  Such behaviour has not been observed to the same extent for ruthenium (II) 
complexes, whose emission by comparison, is rather insensitive to ligand adjustments 
and is mainly confined to the red region of the visible spectrum.[1]  However, there is a 
general lack of understanding of the correlation between triplet state energy and the 
molecular structure of ligands for iridium (III) complexes in comparison with other 
transition metal complexes.[2]   
 
The luminescent properties of iridium (III) complexes are strongly related to the 
σ-donating and π-accepting capabilities of the coordinating ligands.  Their colour 
tunability arises because emission from the excited state may be MLCT in nature, or as 
is more often the case, a mixture of MLCT and LC states.[3]  A further consequence of 
the mixing of states is that the iridium (III) complexes can have very long excited state 
lifetimes.[1]  The various advantages of iridium (III) complexes as molecular probes 
have already been outlined previously in Chapter 1. 
 
The synthetic chemistry available to iridium (III) is somewhat limited in contrast 
to ruthenium (II) complexes.  This is partly due to the more complicated synthetic 
procedures required due to the greater chemical inertness of the iridium (III) 
coordination sphere.[4]  It has also been reported that the synthesis of iridium (III) tris-
chelates are difficult due to their steric hinderences and electronic effects.[5-7]  However, 
in recent years, the use of iridium (III) chloride bridged dimers as a starting material has 
significantly simplified the synthesis of tris-chelates.  Thompson et al.[5, 6, 8] have also 
demonstrated the synthesis of many iridium (III) complexes containing mixed chelating 
ligands with relative ease using the cyclometalated iridium (III) chloride bridged dimer 
as illustrated in Figure 4.1.  
 
 179 
IrCl3 . H2O +
N
F F
2-(4,6-Difluorophenyl)pyridine
Ir
N
N
F
F
F F
Ir
N
N
F
F
FF
Cl
Cl
Iridium Trichloride
Hydrate
Iridium (III) di-u-chloro-tetrakis(2-(2, 4-difluoro
phenyl)pyridinato-N, C2'):
2-methoxyethanol : Water (3:1)
Reflux at 110 oC for 24 hours
 
Figure 4.1: The synthesis of iridium (III) chloride bridged dimers as starting material 
has led to the facile synthesis of iridium (III) tris-chelates, which may display intense 
and long lived phosphorescence in the visible region. 
 
 
Cyclometalated iridium (III) complexes have already shown significant potential 
for use as singlet oxygen sensors[8], DNA probes[7] and in biological labelling.[3, 9]  
Their use as DNA molecular probes was recently described by Lo et al.[7, 10] who 
designed a series of iridium (III) doquinoxaline and dipyridophenazine complexes as 
luminescent intercalators with DNA (Figure 4.2).  These luminophores displayed 
intense and long lived green to orange phosphorescence from triplet MLCT or triplet 
LC transitions in aprotic organic solvents.  However, in aqueous solution some 
complexes exhibited weak phosphorescence due to the effects of hydrogen bonding 
interactions between the phenazine nitrogen atoms and the aqueous solvent.  Upon 
intercalation with synthetic double stranded oligonucleotides the probe luminesced 
strongly when protected from the water.  This is not unlike observations previously for 
well known ruthenium (II) complexes containing dppz ligands.[11-13]  However, the 
emission at 591 nm of the iridium dipyrido[3,2-f:2’,3’-h]quinoxaline (dpq) complex 
(Figure 4.2 complex 1) exhibited a 33-fold emission intensity enhancement in the 
presence of double stranded calf thymus DNA.  
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Figure 4.2: Series of iridium (III) doquinoxaline and dipyridophenazine complexes 
synthesised by Lo et al.[10] to determine their intercalating ability with DNA. 
 
 
Another intensely researched application of iridium (III) polypyridyl complexes 
is their use as phosphors in organic light emitting diodes (OLEDs).  The excited state 
generated in electroluminescence is trapped in the phosphor, where spin-orbit coupling 
ensures efficient population of the triplet state at room temperature.  This leads to 
phosphorescent efficiencies of greater than 80% reported for iridium phenylpyridine 
based OLEDs.[6]  Iridium phosphors containing phenylpyridine may also be easily 
functionalised to change the energies of the excited states that may result in different 
colour emitting diodes.  The most sought after and yet most challenging 
accomplishment is the synthesis of blue emitting diodes.  This is due to their high 
energy requirements whilst trying to maintain good quantum yields and 
photostability.[1]  The ultimate aim is to achieve full colour OLED displays[2] that may 
be used in diverse applications from traffic lights to bill boards to remote controls.  
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Recently, iridium (III) complexes have been prepared using difluorophenyl 
pyridine ligands instead of bpy ligands commonly used in ruthenium complexes.  It had 
been suggested that the difluorophenyl ligands led to higher quantum yield efficiencies, 
better photostability and longer phosphorescent lifetimes in iridium complexes.[3, 9, 14]  
As emission characteristics are governed by the electron density of the cyclometalating 
ligand[15] increasing the number of electron withdrawing fluorine substituents on the 
ligand causes a decrease in the HOMO energy level.  This results in an increase of the 
HOMO-LUMO band gap and hence, a blue shift in emission maxima for the metal 
complex.[9, 14] 
 
Most of the research to date has centred on chemical modification to the 
cyclometalating ligands (e.g. bpy / [dfpp] ligands) in an effort to fine tune their optical 
characteristics.  For mixed ligand systems, little attention has thus far been dedicated to 
the ancillary ligand (e.g. [picCOOH] / [napth-R] ligands) which was thought to play an 
insignificant role in the phosphorescence of a complex as the LUMO generally lies on 
cyclometalating ligands themselves.  In addition, changing the cyclometalating ligands 
has often proven difficult due to side reactions and steric crowding.[2] 
 
However, You et al.[2] reported one of the first successful colour tuning of 
iridium (III) complexes by modification of the ancillary ligand.  They reported the 
synthesis of iridium (III) complexes containing 2-(2-hydroxyphenyl)oxazole-based 
ancillary ligands with a lower energy ancillary ligand triplet state and higher energy 
cyclometalating ligand triplet state as illustrated in Figure 4.3 case III.  They observed 
the direct optical excitation of both cyclometalating and ancillary ligands, thus 
identifying two excited species.  This double excitation allowed for favourable 
interligand energy transfer processes because phosphorescence is generated from the 
chromophoric ancillary ligand only as a result of efficient intersystem crossing to the 
lower lying ancillary ligand excited energy state.   
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Figure 4.3: Schematic representation of the potential photophysical process of 
phosphorescent iridium (III) complexes, where C^N = cyclometalating ligand, LX = 
ancillary ligand and ISC = intersystem crossing.[2] 
 
 
Their results demonstrated that the energy of LUMO on the ancillary ligand was 
lowered with increasing number of phenyl rings attached to the oxazole unit.  
Furthermore, this also occurred without any significant changes to the HOMO energy 
level.  These novel 2-(2-hydroxyphenyl)oxazole-based compounds and related 
absorbance and emission spectra are illustrated in Figure 4.4 below.  They exhibited 
broad ranging phosphorescent lifetimes (1.65-9.88 µs) and high phosphorescent 
quantum yields (0.36-0.43).   
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Figure 4.4: (Top) Schematic diagram illustrating the iridium (III) complexes containing 
2-(2-hydroxyphenyl)oxazole-based ancillary ligands (complexes 1-3).  (Bottom) 
Corresponding absorbance (left) and emission (right) spectra for the iridium (III) 
complexes 1-3.  For comparison purposes the iridium (III) bis(2-(2,4-
difluorophenyl)pyridinato-N,C2’)pinolinate) [Flrpic] complex is also illustrated. 
[dashed grey line in the photophysics corresponds to the Flrpic complex].[2]   
 
 
The iridium (III) complex containing the 2-(naphthoxazolyl)phenolate ancillary 
ligand (Figure 4.4 complex 3) displayed the longest lifetimes and largest quantum yields 
of the three compounds synthesised.  With this in mind, in an effort to create long-lived 
visible emission iridium complexes for cellular imaging, two novel derivatives of the 2-
(naphthoxazolyl)phenolate ligands containing nitro and amino substituents were 
synthesised and coordinated to the iridium (III) metal centre in this thesis.  These 
complexes were characterised and their spectroscopic, photophysical and 
electrochemical properties compared.  It was hoped that these new iridium (III) 
luminophores would display good photophysical characteristics as seen previously for 
their parent complex.  In addition, the functionalised ligands would allow for 
conjugation for other molecules.   
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Williams et al.[16] also described the synthesis of a series of benzothiazole, 
benzoxazole and benzimidazole ligand derivatives (Figure 4.5) and examined their 
photophysics as a result of changing certain substituent groups.  They demonstrated that 
the hydroxyl group located on the free ligand is essential for ligand fluorescence and 
that the oxazoles have higher quantum yield efficiency, greater UV stability and a more 
structured blue shifted fluorescence when compared to the benzothiazole or the 
benzimidazole derivatives.     
 
 
X
N
R
HO
 
 
Figure 4.5: Schematic diagram illustrating series of benzothiazole (X = S), benzoxazole 
(X = O) and benzimidazole (X = NH) ligand derivatives synthesised by Williams et 
al.[16] 
 
 
The inter-proton transfer capability of such ligands has been highlighted before 
for 2-(2’hydroxyphenyl)benzoxazole in solution phase luminescence studies and may be 
used to explain their basic mechanism of fluorescence.  The stable ground state of the 
benzoxazole has the proton predominantly on the oxygen atom, whereas, following UV 
absorbance to an excited singlet configuration the proton is transferred to the nitrogen 
atom.  It is this state which emits the visible fluorescence and decays back to the ground 
electronic state with the proton remaining on the nitrogen.  The configuration with the 
hydrogen on the oxygen atom is its most stable form and as such completes the cycle by 
thermally relaxing to this arrangement.  The importance of the proton associated with 
nitrogen to the fluorescence of the ligand is highlighted when the hydroxyl group is 
absent resulting in a non-fluorescent molecule.[16]  
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Attachment of an amino substituent to the 2-(2’hydroxyphenyl)benzoxazole 
ligand has the effect of shifting its absorbance and emission maximum to longer 
wavelengths when compared to the analogous nitro functionalised ligand as illustrated 
in Figure 4.22.  This suggests that the electron donating amino substituent has increased 
density around the ligand resulting in a decrease in the π-π* HOMO-LUMO energy gap.  
This is further supported by results in Chapter 3 for amino and nitro functionalised 
ruthenium (II) polypyridyl complexes.  Furthermore, the addition of the substituents 
does not impair the ligands ability to fluoresce in acetonitrile at room temperature.   
 
Additionally, because of its enhanced aqueous emission, the pH sensitive ligand 
2-(4-carboxylphenyl)imidazo[4,5-f][1,10]phenanthroline) [(picCOOH)] used in Chapter 
3 is also coordinated to an iridium metal centre in the synthesis of the tris-chelating 
[Ir(dfpp)2(picCOOH)]+ dye (Figure 4.6).  This novel water insoluble dye was fully 
characterised and conjugated to an octarginine peptide.  Conjugation dramatically 
increased the aqueous solubility of the iridium dye which allowed for its use in the 
cellular imaging in SP2 myeloma and CHO cells.  Direct comparisons were then made 
between the iridium dye-peptide, its parent and the analogous ruthenium (II) dye-
conjugate in terms of detection and localisation within the cellular structure and form 
the basis of discussion in Chapter 5. 
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Figure 4.6: Schematic diagram illustrating the [Ir(dfpp)2(picCOOH)]+ complex 
synthesised in this thesis. 
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4.1 Experimental Procedure 
 
Chemicals 
 
All chemicals and reagents were purchased from Sigma-Aldrich (Ireland) and 
were used without any further purification unless otherwise stated. 
 
 
The preparation of 2-(4,6-difluorophenyl)pyridine: [(dfpp)] 
 
N Br
+
F
F
B
OHHO
N
F F
2-Bromopyridine 2,4-Difluorophenyl
Boronic Acid
2-(4,6-Difluorophenyl)pyridine
PPh3 / Pd(OAc)2 / K2CO3
1, 2-dimethoxyethane
Reflux for 18 hours
 
 
 
This procedure was adapted from the literature.[2]  2-Bromopyridine (2.0 g, 12.6 
mmol), 2,4-diflorophenyl boronic acid (2.5 g, 15.2 mmol), triphenylphosphine (332 mg, 
1.2 mmol), 1,2-dimethoxyethane (15 ml) and 2 M potassium carbonate (15 ml) were 
added to a round bottomed flask and degassed with stirring under a nitrogen 
environment.  Next palladium (II) acetate (71 mg, 0.317 mmol) was added and left 
refluxing at 110 oC for 18 hours. 
 
The solution was left to cool to room temperature and the aqueous phase was 
separated and extracted with ethyl acetate (25 ml x 3 times).  The organic layers were 
combined and washed with deionised water and brine and finally dried on anhydrous 
MgSO4.  The solvent was then removed under reduced pressure to leave a transparent 
oily product. 
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The crude product was then purified on an alumina (neutral) chromatographic 
column using a mobile phase of hexane; 10% ethyl acetate to leave the product as a 
clear, oil-like substance (1.377 g, 57 %). 
 
1H NMR (400 MHz, DMSO-d6):  δ (ppm) 8.72 (d, 1H, J = 4.5 Hz), 7.98 (dd, 1H, J = 2 
Hz, J = 6.8 Hz), 7.92 (td, 1H, J = 2 Hz, J = 8 Hz), 7.78 (d, 1H, 4.8 Hz), 7.45-7.36 (m, 
2H), 7.24 (td, 1H J = 2.4 Hz, J = 8 Hz). 
Density: 1.258 g/cm3. 
 
 
 
The preparation of iridium (III) di-µ-chloro-tetrakis(2-(2, 4-
difluorophenyl)pyridinato-N, C2'): [Ir2(dfpp)4(Cl2)] 
 
IrCl3 . H2O +
N
F F
2-(4,6-Difluorophenyl)pyridine
Ir
N
N
F
F
F F
Ir
N
N
F
F
FF
Cl
Cl
Iridium Trichloride
Hydrate
Iridium (III) di-u-chloro-tetrakis(2-(2, 4-difluoro
phenyl)pyridinato-N, C2'):
2-methoxyethanol : Water (3:1)
Reflux at 110 oC for 24 hours
 
 
This procedure was modified from the literature.[5]  Iridium trichloride hydrate 
(842 mg, 2.66 mmol) was dissolved in a mixture of 2-methoxyethanol; water (60 ml, 
3:1 v/v).  2-(4, 6-difluorophenyl) pyridine (1.066 g, 5.58 mmol) was then added and was 
left stirring overnight under a nitrogen environment. 
 
Next the solution was left refluxing at 110 oC for 24 hours under a nitrogen 
environment.  The solution was allowed cool to room temperature and water was added.  
The precipitate was collected by vacuum filtration and washed with ethanol.  The solid 
was then dissolved in chloroform and washed with deionised water (10 ml x 3 times).  
The organic phase was dried on anhydrous MgSO4 and evaporated to dryness to yield a 
yellow coloured product (862 mg, 27 %). 
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1H NMR (400 MHz, CDCl3):  δ (ppm) 9.78 (d, 2H, J = 5.2 Hz), 9.56 (d, 2H, J = 4.8 
Hz), 8.32 (d, 2H, J = 8 Hz), 8.26 (d, 2H, J = 8.8 Hz), 8.21 (t, 2H, J = 8.4 Hz), 8.14 (t, 
2H, J = 8.4 Hz), 7.69 (t, 2H, J = 7.2 Hz), 7.58 (t, 2H, J = 7.2 Hz), 6.90-6.77 (m, 4H), 
5.73 (dd, 2H, J = 2.4 Hz, J = 6 Hz), 5.07 (dd, 2H, J = 2.4 Hz, J = 6 Hz).  
 
 
 
The preparation of iridium (III)  bis(2-(2,4-difluorophenyl)pyridinato-N, C2')-2(4-
carboxylphenyl)imidazo[4,5-f][1,10]phenanthroline.(ClO4-)  [Ir(dfpp)2(picCOOH)]+ 
 
 
Ir
N
N
F
F
F F
Ir
N
N
F
F
FF
Cl
Cl
Ir
N
N
N
N N
N
COOH
H
F
F
F F
N
N N
H
N
COOH
2-(4-Carboxylphenyl)imidazo
[4,5.f][1,10]phenanthroline
EtOH
Reflux 18 hours
Iridium 3+( bis(2-(2,4-difluorophenyl)pyridinato-N, C2')
-2(4-carboxylphenyl)imidazo[4,5-f][1,10]phenanthroline
+
Iridium di-u-chloro-tetrakis(2-(2, 4-
difluorophenyl)pyridinato-N, C2')
 
 
Iridium di-µ-chloro-tetrakis(2-(2, 4-difluorophenyl)pyridinato-N, C2') (220 mg, 
0.181 mmol), 2-(4-Carboxylphenyl)imidazo[4,5-f][1,10]phenanthroline [(picCOOH)] 
(130 mg, 0.380 mmol) and ethanol (30 ml) were added to a round bottomed flask and 
left refluxing at 95 oC overnight.  
 
 The reaction was allowed cool to room temperature and the solvent removed by 
warming under reduced pressure.  The solid was suspended in a saturated solution of 
sodium perchlorate and sonicated.  The precipitate was collected by vacuum filtration 
and washed with deionised water.  The precipitate was then dissolved in methanol and 
filtered once again.  The filtrate was taken and evaporated to dryness to yield a yellow 
coloured solid (285 mg, 78 %). 
 
1H NMR (400 MHz, DMSO-d6):  δ (ppm) 9.22 (d, 2H, 8 Hz), 8.41 (d, 2H, J = 8 Hz), 
8.29 (d, 2H, J = 9.2 Hz), 8.22 (d, 2H, J = 4.4 Hz), 8.17 (d, 2H, J = 8.4 Hz), 8.07 (dd, 2H, 
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J = 5.2 Hz, J = 8 Hz), 7.98 (t, 2H, J = 7.6 Hz), 7.58 (d, 2H, J = 5.6 Hz), 7.09-6.99 (m, 
4H), 5.71 (dd, 2H, J = 2 Hz, 2.4 Hz). 
ESI-MS (CH3OH, m/z): 1012.39, ([M+- ClO4]): 913.1. 
Elemental analysis calculated for C42H24F4IrN6O2.(ClO4-).(H2O)2: C, 48.12; H, 2.69; N, 
8.02%.  Found: C, 48.35; H, 2.31; N, 7.86%. 
Melting point: >300 oC 
 
 
 
The preparation of 2-(naphtho[2,3-d]oxazol-2-yl)-5-nitrophenyl: 
 
NO2
OH
COCl
2-hydroxy-4-
nitrobenzoyl chloride
NH2
OH
3-amino-2-naphthol
+
O
N
NO2
HO
2-(naphtho[2,3-d]oxazol-2-yl)
-5-nitrophenyl
dry NMP
stirr at 100 oC,
18 hours
 
 
2-Hydroxy-4-nitrobenoyl chloride (2.75 g, 15 mmol, supplied by Dr. Elena 
Lestini and used as received) was added in portions to a solution of 3-amino-2-naphthol 
(2.38 g, 15 mmol) in dry NMP (120 ml).  The mixture was stirred at 100 oC for 18 
hours.  After cooling to room temperature, the reaction was poured into deionised water 
and the pH adjusted to 8-9 by addition of aqueous ammonia.  The precipitate formed 
was collected by vacuum filtration and washed with methanol to afford the product as a 
brown solid (1.47 g, 32 %). 
 
1H NMR (400 MHz, DMSO-d6):  δ (ppm) 8.30 (d, 1H, J = 8.8 Hz), 7.83 (d, 2H, J = 8.8 
Hz), 7.76 (d, 1H, J = 7.6), 7.66 (d, 1H, J = 8 Hz), 7.35 (m, 4H). 
ESI-MS (CH3OH, m/z): 306.26, ([M+K+]): 347.5.  
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The preparation of iridium (III) bis(2-(2,4-difluorophenyl)pyridinato-N,C2’) (2-
naphthoxazoyl)4-nitrophenolate). [Ir(dfpp)2(napthNO2)]   
 
O
N
NO2
HO
2-(naphtho[2,3-d]oxazol-2-yl)
-5-nitrophenyl
Ir
N
N
F
F
F F
Ir
N
N
F
F
FF
Cl
Cl
+
Ir
N
F
F
N
F
F
O
N
O2N
O
Iridium3+ bis(2-(2,4-difluorophenyl)
pyridinato-N,C2')(2-(Naphthoxazolyl)
4-nitrohenolate
Iridium di-u-chloro-tetrakis(2-(2, 4-difluoro
phenyl)pyridinato-N, C2'):
Sodium Carbonate / 
2-methoxyethanol
Reflux at 140 oC
for 5 hours
 
 
Iridium di-µ-chloro-tetrakis(2-(2, 4-difluorophenyl)pyridinato-N, C2') (400 mg, 
0.33 mmol), 2-(naphtho[2,3-d]oxazol-2-yl)-5-nitrophenyl (260 mg, 0.850 mmol) and 
sodium carbonate (350 mg, 3.2 mmol) were dissolved in 2-methoxyethanol (30 ml) and 
left stirring bubbling under nitrogen at room temperature for 20 minutes.  The 
temperature was then raised to 140 oC and the reaction was refluxed under a nitrogen 
environment for 5 hours. 
 
 The reaction was cooled to room temperature and precipitated with a saturated 
solution of sodium perchlorate.  The crude product was then filtered and purified on a 
silica gel column using a mobile phase of hexane; 20% ethyl acetate and was 
recrystallised in methanol to yield a red solid (150 mg, 20 %). 
 
1H NMR (400 MHz, CDCl3):  δ (ppm) 8.67 (d, 1H, J = 6 Hz), 8.27 (d, 1H, J = 8.4 Hz), 
8.13 (m, 2H), 8.02 (d, 1H, J = 6.8 Hz), 7.80 (d, 2H, J = 10.8 Hz), 7.68 (m, 2H), 7.51-
7.34 (m, 4H), 7.21 (d, 1H, J = 2.4), 7.08 (t, 1H, J = 7.2 Hz), 6.86 (t, 1H, J = 7.2 Hz) 6.58 
(m, 1H), 6.51 (s, 1H), 6.39 (m, 1H), 5.92 (dd, 1H, J = 6 Hz, J = 2.4 Hz), 5.52 (dd, 1H, J 
= 6 Hz, J = 2.4 Hz). 
ESI-MS (CH3OH, m/z): 877.8, ([M- NO2ligand]): 573.2, ([M+Na+]3+): 901.0. 
Elemental analysis calculated for C39H21F4IrN4O4.(CH3OH): C, 52.80; H, 2.77; N, 
6.16%.  Found: C, 52.26; H, 2.55; N, 6.60%. 
Melting point: >300 oC 
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The preparation of 2-(naphtho[2,3-d]oxazol-2-yl)-5-aminophenyl: [(NapthNH2)] 
 
O
N
NO2
HO
2-(naphtho[2,3-d]oxazol-2-yl)-5-nitrophenyl
O
N
NH2
HO
2-(naphtho[2,3-d]oxazol-2-yl)-5-aminophenyl
Hydrosine Hydrate / 
Pd 5% wt on act. Carbon
Reflux, 4 hours
 
 
 2-(Naphtho[2,3-d]oxazol-2-yl)-5-nitrophenyl (100 mg, 0.327 mmol), 
palladium 5% weight on activated carbon (21 mg) and absolute ethanol (5 ml) were 
added to a round bottomed flask.  Next hydrazine hydrate (100 µl, 3.2 mmol) was added 
to the reaction in three equal amounts while stirring and left refluxing at 100 oC for 5 
hours. 
 
 The solution was then cooled to room temperature and filtered through celite.  
The filtrate was collected and evaporated to dryness to yield a light brown coloured 
product (85 mg, 94 %). 
 
1H NMR (400 MHz, DMSO-d6):  δ (ppm) 7.70 (d, 1H, J = 8.0 Hz), 7.67 (d, 1H, J = 8 
Hz), 7.60 (d, 1H, J = 8 Hz), 7.26 (m, 4H), 6.15 (d, 1H, J = 6.4 Hz), 6.10 (s, 1H), 5.78 (s, 
2H). 
ESI-MS (CH3OH, m/z): 276.29, ([M+K+]): 317.4. 
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The preparation of iridium (III) bis(2-(2,4-difluorophenyl)pyridinato-N,C2’) (2-
naphthoxazoyl)4-aminophenolate). [Ir(dfpp)2(napthNH2)]   
 
O
N
NH2
HO
2-(naphtho[2,3-d]oxazol-2-yl)
-5-aminophenyl
Ir
N
N
F
F
F F
Ir
N
N
F
F
FF
Cl
Cl
+
Ir
N
F
F
N
F
F
O
N
H2N
O
Iridium3+ bis(2-(2,4-difluorophenyl)
pyridinato-N,C2')(2-(Naphthoxazolyl)
4-aminophenolate
Iridium di-u-chloro-tetrakis(2-(2, 4-difluoro
phenyl)pyridinato-N, C2'):
Sodium Carbonate / 
2-methoxyethanol
Reflux at 140 oC
for 5 hours
 
 
 Iridium di-µ-chloro-tetrakis(2-(2, 4-difluorophenyl)pyridinato-N, C2') (168 mg, 
0.138 mmol), 2-(naphtho[2,3-d]oxazol-2-yl)-5-aminophenyl (80 mg, 0.290 mmol) and 
sodium carbonate (146 mg, 1.38 mmol) were dissolved in 2-methoxyethanol (15 ml) 
and left stirring under nitrogen at room temperature overnight.  The temperature was 
then raised to 140 oC and the reaction was refluxed under a nitrogen environment for 5 
hours. 
 
 The reaction was cooled to room temperature and precipitated with a saturated 
solution of sodium perchlorate.  The crude product was then filtered and purified on a 
silica gel column using a mobile phase of 10% methanol; dichloromethane to yield a 
yellow coloured solid (37 mg, 31 %). 
 
1H NMR (400 MHz, CDCl3):  δ (ppm) 8.82 (d, 1H, J = 4.8 Hz), 8.30 (d, 1H, J = 8.4 
Hz), 8.18 (m, 2H), 7.87 (d, 1H, J = 8.8 Hz), 7.80 (d, 1H, J = 8 Hz), 7.74-7.66 (m, 3H), 
7.39-7.33 (m, 4H), 7.11 (t, 1H, J = 6 Hz), 6.91 (t, 1H, J = 6.8 Hz), 6.60 (m, 1H), 6.44 
(m, 2H), 6.03 (d, 1H, J = 2.4), 5.98 (dd, 1H, J = 6.4 Hz, J = 2.4 Hz), 5.63 (dd, 1H, J = 
6.4 Hz, J = 2.4 Hz), 3.86 (s, 2H). 
MALDI-TOF (CH3CN, m/z): 848.14, ([M+H+]): 849.52, ([M- NH2ligand]): 573.42. 
Elemental analysis calculated for C39H23F4IrN4O2.(H2O): C, 54.01; H, 2.91; N, 8.78%.  
Found: C, 55.96; H, 2.80; N, 8.11%. 
Melting point: >300 oC 
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4.2 Results and Discussion 
 
4.2.1 Synthesis 
 
 The Suzuki coupling of the difluorophenyl boronic acid and bromopyridine to 
give the [dfpp] ligand as starting material proceeded with a moderate yield of 57%.  The 
full mechanism of reaction for Suzuki coupling is explained in detail in Chapter 6.  Next 
the chlorine bridged iridium dimer was synthesised by refluxing the [dfpp] ligand and 
iridium trichloride overnight to give the yellow product with a relatively low yield of 
27%.  Identical reaction conditions as used previously to synthesise the 
[Ru(bpy)2(picCOOH)]2+ complex were also used to give [Ir(dfpp)2(picCOOH)]+ in good 
yields of 78%.  This iridium (III) complex also had the added advantage of a facile 
purification procedure without a need for column chromatography when compared to 
other inorganic metal complexes. 
 
 In the synthesis of the two iridium (III) complexes containing the 2-(2-
hydroxyphenyl)oxazole-based ancillary ligands, the initial chlorination of 2-hydroxyl-4-
nitrobenzoic acid to give 2-hydroxyl-4-nitrobenzoyl chloride was performed using 
thionyl chloride in almost quantitative yields.  Next, the one-step condensation reaction 
between 2-hydroxyl-4-nitrobenzoyl chloride and 3-amino-2-naphthol yielded the 
ancillary nitro functionalised ligand with a conversion of 32%.  Reduction of the nitro 
ligand to the analogous 2-(naphtho[2,3-d]oxazol-2-yl)-5-aminophenyl ligand with 
hydrazine hydrate and palladium on activated carbon proceeded in a very efficient yield 
of 94%.  Finally, the ligand exchange reaction between the chlorine bridged iridium 
dimer and the ancillary ligands was performed by refluxing in methoxyethanol under a 
nitrogen environment to give the corresponding nitro and amino functionalised iridium 
(III) complexes in yields of 20% and 31% respectively.    
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4.2.2 1H-NMR Discussion 
 
N
F F
3'
4'
5'
6'
7'
8'
9'
 
Figure 4.7: [dfpp] ligand illustrating numbering scheme for 1H-NMR analysis. 
 
 
 
Proton 
 
[dfpp] 
ppm 
Proton 
 
[Ir2(dfpp)4(Cl2)] 
ppm 
H3’ 
 
8.72 
(d, 1H) 
H3’ 
 
9.78 
(d, 2H) 
H9’ 
 
7.98 
(dd, 1H) 
H3’ 
 
9.56 
(d, 2H) 
H5’ 
 
7.92 
(td, 1H) 
H6’ 
 
8.32 
(d, 2H) 
H6’ 
 
7.78 
(d, 1H) 
H6’ 
 
8.26 
(d, 2H) 
H4’, H8’ 
 
7.45-7.36 
(m, 2H) 
H5’ 
 
8.21 
(t, 2H) 
H7’ 
 
7.24 
(td, 1H) 
H5’ 
 
8.14 
(t, 2H) 
  H4’ 
 
7.69 
(t, 2H) 
  H4’ 
 
7.58 
(t, 2H) 
  H8’ 
 
6.90-6.77 
(m, 4H) 
  H7’ 
 
5.73 
(dd, 2H) 
  H7’ 
 
5.07 
(dd, 2H) 
 
Table 4.1: 1H-NMR resonances for [dfpp] ligand and [Ir2(dfpp)4(Cl2)] carried out in 
DMSO-d6.  The integration and peak splitting are shown in brackets. 
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 As seen previously in Chapter 3, the proton located at H3’ in Figure 4.7 showed 
the greatest shift downfield to 8.72 ppm due to the deshielding effects of the nitrogen 
atom on the cyclometalating ligand.  The H7’ proton, surrounded by the fluorine atoms 
is shifted upfield in the NMR spectrum to 7.24 ppm (Table 4.1).  The increased 
shielding effect provided by fluorine on nearby protons has been reported previously.[17]  
This was in contrast to conventional thinking, that the presence of an electron 
withdrawing halide atom would generally show a shift in the peak further downfield.  
This may be explained by the stronger electronegativity of the smaller fluorine atom 
when compared to a larger chlorine atom.  The resonance dipole is also superior for 
fluorine atoms because of the more efficient π-π overlapping with carbon.  In the case of 
fluorine, it is speculated that the two dipoles effectively cancel out giving a net dipole of 
zero and the fluorine atom does not act like an electron withdrawing substituent.[18]  
 
 The 1H-NMR spectrum of [Ir2(dfpp)4(Cl2)] (Figure 4.8) is not as easy to interpret 
as previous NMR spectra as the same protons on the four [dfpp] ligands are not always 
in the same chemical environments due to their spatial orientation around the 
coordinated metal centre.  Hence, like all complexes synthesised in this thesis, 1H-
COSY 45 spectra (see Appendix 1) were used to aid in the assignment of all protons.  
Table 4.1 also outlines the individual proton chemical shifts for the [Ir2(dfpp)4(Cl2)] 
complex. 
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Figure 4.8: [Ir2(dfpp)4(Cl2)] illustrating numbering scheme for 1H-NMR analysis. 
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 For [Ir(dfpp)2(picCOOH)]2+ (Figure 4.9), the largest change in chemical shift (∆ 
ppm) between the free [dfpp] ligand and the iridium (III) coordinated [dfpp] ligand is 
associated with the proton located at position H7’.  This proton sees a chemical shift of -
1.53 ppm upfield by comparison in Table 4.3.  This may be explained by the donation 
of electrons from the iridium (III) metal centre to the [dfpp] ligands during bonding, 
thus, causing increased delocalisation of electrons around the ligand that is concentrated 
mainly on the H7’ proton.  All of the remaining protons are assigned in Table 4.2 below.  
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Figure 4.9: [Ir(dfpp)2(picCOOH)]+ illustrating numbering scheme for 1H-NMR 
analysis. 
 
 
Proton 
 
(dfpp)2 
ppm 
Proton 
 
[picCOOH] 
ppm 
H3’ 
 
8.29 
(d, 2H) 
H1, H11 9.22 
(d, 2H) 
H4’ 
 
7.98 
(t, 2H) 
H6, H7 8.41 
(d, 2H) 
H6’ 
 
7.58 
(d, 2H) 
H3, H9 8.22 
(d, 2H) 
H5’, H8’ 
 
7.09-6.99 
(m, 4H) 
H5, H8 8.17 
(d, 2H) 
H7’ 
 
5.71 
(dd, 2H) 
H2, H10 8.07 
(dd, 2H) 
 
Table 4.2: 1H-NMR resonances for [Ir(dfpp)2(picCOOH)]+ carried out in DMSO-d6.  
The integration and peak splitting are shown in brackets. 
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Proton 
 
[dfpp]2 
∆ ppm 
Proton 
 
[picCOOH] 
∆ ppm 
H3’ 
 
-0.43 H1, H11 0.17 
H4’ 
 
0.58 H2, H10 0.20 
H5’ 
 
0.87 H3, H9 -0.73 
H6’ 
 
-0.20 H4 
 
n/a 
H7’ 
 
-1.53 H5, H8 0 
H8’ 0.35 H6, H7 0.01 
H9’ n/a   
 
Table 4.3: ∆ ppm of the free ligands compared to the coordinated complex. 
 
 
 
 Following coordination to the iridium metal centre, the protons at positions H3 
and H9 of the [picCOOH] ancillary ligand exhibited the greatest change in their 
chemical shifts (Table 4.3).  There was a slightly larger shift in ppm values for the 
[picCOOH] H1 and H11 protons for the iridium complex compared to the ruthenium 
complex.  This may be explained by the larger iridium atom, which has a greater 
electron density and greater propensity for π back donation due to the higher energy dπ 
orbital.  There is also no indication of the amine H4 or carboxyl protons in the 
[Ir(dfpp)2(picCOOH)]+ complex, presumably due to the resonance structures within the 
benzimidazole ligand or the deprotonation state in which the complex was synthesised.   
 
 
 The effects on the proton NMR of the amino and nitro substituents located on 
the ancillary ligand have been highlighted before in ruthenium (II) compounds in 
Chapter 3.  The general trend is upheld here following the analysis of the iridium 
complexes with the 2-(naphtho[2,3-d]oxazol-2-yl)phenyl ligand (Figure 4.10).  Protons 
located at the H8 and H9 positions showed an upfield chemical shift to around 6.12 ppm 
when the amino functionality was present.  However, the same protons may be found 
further downfield at 7.83 ppm when the electron withdrawing nitro group is present.  
Protons H2-H5 are at similar chemical shifts values and are evident as 
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NMR spectrum.  All other protons are assigned in Table 4.4, with the exception of the 
O-H proton which is not evident in either NMR spectra probably due to proton 
exchanging. 
 
 
O
N
R
HO12
3
4
5 6 7 8
9
 
Figure 4.10: 2-(naphtho[2,3-d]oxazol-2-yl)phenyl ligand illustrating numbering scheme 
for 1H-NMR analysis. 
 
 
Proton 
 
[NapthNO2] 
Ppm 
Proton 
 
[NapthNH2] 
Ppm 
H7 
 
8.30 
(d, 1H) 
H7 
 
7.70 
(d, 1H) 
H8, H9 
 
7.83 
(d, 2H) 
H6 
 
7.67 
(d, 1H) 
H6 
 
7.76 
(d, 1H) 
H1 
 
7.61 
(d, 1H) 
H1 
 
7.66 
(d, 1H) 
H2, H3, H4, H5 
 
7.26 
(m, 4H) 
H2, H3, H4, H5 
  
7.35 
(m, 4H) 
H8 
 
6.15 
(d, 1H) 
 
 
 H9 
 
6.10 
(s, 1H) 
  Amino-NH2 
 
5.78 
(s, 2H) 
 
Table 4.4: 1H-NMR resonances for 2-(naphtho[2,3-d]oxazol-2-yl)phenyl ligand with 
nitro and amino functional groups carried out in DMSO-d6.  The integration and peak 
splitting are shown in brackets. 
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 Due to its solubility the proton NMR for the coordinated iridium (III) complexes 
were performed in CDCl3 rather than DMSO-d6.  As a result the changes in chemical 
shifts of the ancillary ligands are affected both by coordination to the iridium metal 
centre and to the solvent.  Nevertheless, many of the trends observed before apply. 
 
 Coordination of the free 2-(naphtho[2,3-d]oxazol-2-yl)phenyl ligands to the 
iridium centre (Figure 4.11) results in the deprotonation of the ligand leading to an 
electron rich oxygen atom.  Upon coordination of the ancillary ligand the protons are 
located further upfield than protons on the free ligand.  The most affected protons are 
located at H7, H8 and H9 on the benzene ring of the napthoxazoyl ancillary ligand and 
they exhibited a chemical shift of up to 1.3 ppm upfield.  However, as expected, the 
nitro withdrawing group causes a further chemical shift downfield of protons H7, H8 and 
H9 on the phenolate ligand in comparison with the amino substituted ligand as shown in 
Table 4.5.  In general, the remaining protons are not as strongly affected as they are not 
within the three or four bonds of the electronegative oxygen site.   
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Figure 4.11: Iridium (III) bis(2-(2,4-difluorophenyl)pyridinato-N,C2’) (2-
naphthoxazoyl)4-phenolate) illustrating numbering scheme for 1H-NMR analysis. 
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[Ir(dfpp)2(napthNO2)] [Ir(dfpp)2(napthNH2)] 
[dfpp]2 protons. 
ppm  
(napthNO2) protons. 
ppm 
[dfpp]2 protons. 
ppm  
(napthNH2) protons 
Ppm 
H3’ 
8.67 (d, 1H) 
H7 
8.13 (m, 2H) 
H3’ 
8.82 (d, 1H) 
H7 
7.87 (d, 1H) 
H6’ 
8.27 (d, 1H) 
H1, H6 
7.80 (d, 2H) 
H6’ 
8.30 (d, 1H) 
H1 
7.80 (d, 1H) 
H6’ 
8.13 (m, 2H) 
H2, H3, H4, H5 
7.51-7.34 (m, 4H) 
H3’, H6’ 
8.18 (m, 2H) 
H6 
7.70 (m, 3H) 
H3’ 
8.02 (d, 1H) 
H8 
7.21 (d, 1H) 
H5’ 
7.70 (m, 3H) 
H2, H3, H4, H5 
7.33-7.39 (m, 4H) 
H5’ 
7.68 (m, 2H) 
H9 
6.51 (s, 1H) 
H4’ 
7.11 (m, 1H) 
H9 
6.44 (m, 2H) 
H4’ 
7.08 (t, 1H) 
 H4’ 
6.91 (m, 1H) 
H8 
6.03 (d, 1H) 
H4’ 
6.86 (t, 1H) 
 H8’ 
6.60 (m, 1H) 
Amino-NH2 
3.86 (s, 2H) 
H8’ 
6.58 (m, 1H) 
 H8’ 
6.44 (m, 2H) 
 
H8’ 
6.39 (m, 1H) 
 H7’ 
5.98 (m, 2H) 
 
H7’ 
5.92 (dd, 1H) 
 H7’ 
5.63 (m, 2H) 
 
H7’ 
5.52 (dd, 1H) 
   
Table 4.5: 1H-NMR resonances for the iridium (III) bis(2-(2,4-
difluorophenyl)pyridinato-N,C2’) (2-naphthoxazoyl)4-phenolate compounds 
synthesised carried out in CDCl3.  The integration and peak splitting are shown in 
brackets. 
 
 
 
 
 
 
 
 
 
 
 
 
 201 
4.2.3 Raman Spectroscopy of Iridium (III) Complexes 
 
 Figure 4.12 shows the overlaid Raman spectra of the iridium (III) complexes 
under non-resonant 785 nm excitation.  The key bands are tabulated and tentatively 
assigned in Table 4.6 below according to published data on related iridium polypyridyl 
complexes.[19]   
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Figure 4.12: Stacked Raman spectra of the three iridium (III) complexes synthesised.  
Solid state samples were irradiated with 785 nm laser line. All spectra were gathered 
with 5 acquisitions and an exposure time of 5 seconds with a laser power of 2 mW.   
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Iridium - Raman peak identification 
785 nm laser (cm-1) Assignment 
[dfpp] ligand vibrational 
modes: 
~1611 
~1555 
~1520 
~1482 
~1363 
~1250 
~1170 
~1115 
~1050 
~945 
~530 
C=C stretch 
C=C stretch  
C=C stretch  
C=N stretch 
C=N stretch 
C-C (inter-ring bending) 
CCH (in-plane bending) 
CCH (in-plane bending) 
Ring breathing 
Ring breathing 
Pyridyl in-plane twisting 
[picCOOH] ligand 
vibrational modes: 
~1300 
~990 
~772 
C=N stretch 
Ring breathing 
Phenyl or pyridyl in-plane 
twisting 
[napth-R] ligand 
vibrational modes 
~1404 
~821 
C=N  stretch 
Phenyl or pyridyl in-plane 
twisting 
Iridium – Ligand 
vibrational modes: 
< ~450 Metal-Ligand stretching 
Other vibrations: ~1450 
~1432 
Post resonance vibrations 
Table 4.6: Raman peak identification of the three iridium (III) complexes synthesised. 
 
 
 As expected, [Ir(dfpp)2(napthNO2)] and [Ir(dfpp)2(napthNH2)] display very 
similar Raman spectra with evidence of vibrational modes from both [dfpp] and [napth-
R] ligands.  In addition, vibrational modes containing contributions from both the [dfpp] 
and [picCOOH] ligands are also evident for the [Ir(dfpp)2(picCOOH)]+ complex 
following irradiation at 785 nm. 
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4.2.4 FTIR Spectroscopy of Iridium (III) Complexes 
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Figure 4.13: Stacked FTIR spectra of the three iridium (III) complexes synthesised.  
Samples were dispersed in a KBr matrix prior to analysis. 
 
 Further structural characterisation was performed using FTIR and their resulting 
spectra for the three iridium (III) complexes synthesised are shown in Figure 4.13 
above.  Common features between all three complexes include modes at ~3400 cm-1 (O-
H stretch), ~2960 cm-1 (C-H stretch), ~1604 cm-1 (C=C stretch), ~1250 cm-1 (C-N 
stretch), ~1100 cm-1 (C-F stretch) and ~820 cm-1 (C-H phenyl ring stretch).  For the 
[Ir(dfpp)2(picCOOH)]+ complex some of the more interesting features of the FTIR 
spectrum include vibrational modes at 3075 cm-1 (N-H stretch) and 1717 cm-1 (COOH 
stretch).  For the [Ir(dfpp)2(napthNO2)] complex the nitro symmetrical stretching mode 
is evident at 1262 cm-1 and the asymmetrical stretching mode at ~1500 cm-1.  Finally for 
the [Ir(dfpp)2(napthNH2)] complex the two primary amine stretching vibrations are 
observed at 3216 cm-1 and 3059 cm-1 respectively.  FTIR shows the distinctive 
functional groups of each complex quite clearly, which is unlike that seen in their 
corresponding 1H-NMR spectra.  
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4.2.5 Electrochemical Studies of Iridium (III) Complexes 
 
The voltammetric data for the three novel iridium (III) polypyridyl complexes 
are shown in Table 4.7 below.   
 
Compound 
 
Metal-
centred 
redox 
potential (V) 
Ligand based 
redox potentials 
(V) 
[Ir(dfpp)2(picCOOH)]+ 
 
 
+1.70 (qr) 
 
 
-0.85 (qr), 
-1.47 (qr)*,  
-2.09 (r)*. 
[Ir(dfpp)2(napthNO2)] 
 
+1.96 (ir) -1.47 (ir)*, 
-2.47 (ir)*, 
-2.68 (ir). 
[Ir(dfpp)2(napthNH2)] 
 
+2.36 (ir) -1.27 (ir)*, 
-2.12 (ir)*, 
-2.35 (ir), 
-2.75 (ir). 
 
Table 4.7: Redox properties of iridium (III) complexes synthesised measured in 
acetonitrile (containing 0.1M TBA as electrolyte) with 1.5 mm glassy carbon working 
electrode and referenced against Ag/AgCl.  (r) – reversible reaction, (ir) – irreversible 
reaction and (qr) – quasi-reversible reaction.  All CV’s were performed in duplicate 
with different glassy carbon electrodes, scanning though the range of potentials 
(multiple scans): 1, 0.50, 0.25 and 0.05 Vs-1 respectively.  Electrochemistry was 
conducted using 1 mmol of sample dissolved in 5 cm3 of dry acetonitrile (HPLC grade, 
used as received) containing 0.1 M tetrabutylammonium tetrafluoroborate (TBA) as 
supporting electrolyte.  All samples were degassed with nitrogen prior to analysis.  
* denotes the reduction potential of the [dfpp] ligands. 
 
 
Bracketing experiments in Figure 4.14 (inset) shows the quasi reversible Ir3+/4+ 
redox couple for the [Ir(dfpp)2(picCOOH)]+ complex which is centred at +1.70 V versus 
Ag/AgCl and has a peak separation of 142 mV.  The oxidation of iridium metal centres 
generally occurs at more positive potentials than ruthenium centres owing to less 
electron density around the metal centre.[4]  In the full cyclic voltammogram for 
[Ir(dfpp)2(picCOOH)]+,  there are two quasi-reversible ligand based redox potentials at -
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0.85 V assigned to the [picCOOH] ligand, -1.47 V attributed to the [dfpp] ligand and a 
further reversible redox peak at -2.09 V attributed to the [dfpp] ligand versus Ag/AgCl 
respectively.[20]  In contrast, the first [picCOOH] ligand reduction of the 
[Ru(bpy)2(picCOOH)]2+ complex is at a potential of -0.72 V versus Ag/AgCl, however, 
due to the sharpness and intensity of this peak it is thought to be as a result of 
adsorption or film formation on the electrode surface.  Furthermore, as previously 
mentioned in Chapter 3, the carboxyl functional group may adsorb to an anodized 
glassy carbon electrode surface.[21]   
 
There is also a peak at +1.44 V versus Ag/AgCl, which appears just before the 
metal redox couple in a full potential sweep.  During bracketing experiments, this peak 
was found to be related to a ligand reduction peak at -1.02 V as it is not present unless 
the negative reduction voltage (and thus adsorption of the complex) has been reached.  
Furthermore, this peak remains present for multiple scans at various scan rates.  There is 
no evidence of this particular oxidation peak in blank solution when the iridium 
complex is not present as shown in the control cyclic voltammogram in Appendix 1-
Figure A39.  However, it is noted that identification of redox peaks are only tentatively 
assigned based on the available literature for similar complexes. 
 
Once again, as seen for the ruthenium complexes in Chapter 3, this suggests that 
the LUMO of the complex lies on the ancillary [picCOOH] ligand and not on the 
cyclometalating [dfpp] ligands as the pKa results indicated, vide infra.  However it is 
thought that the higher lying LUMO, which determines the T1 state of the complex, is 
dominated by the cyclometalating [dfpp] ligands.  Theoretical calculations of 
cyclometalated iridium (III) complexes have also shown that reduction is generally 
considered to mainly occur on the heterocyclic portion of the cyclometalating (bpy or 
[dfpp] ligands). [14]  
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Figure 4.14: Cyclic voltammogram of [Ir(dfpp)2(picCOOH)]+ in acetonitrile 
(containing 0.1M TBA as electrolyte) with 1.5 mm glassy carbon working electrode and 
referenced against Ag/AgCl.  Scans were started in a positive direction from an initial 
potential of 0 V.  (Inset) isolated positive region of CV. 
 
 
 The metal centered oxidation of [Ir(dfpp)2(napthNO2)] at +1.96 V versus 
Ag/AgCl is irreversible with little evidence of the corresponding reduction peak for the 
Ir3+/4+ redox couple even when only scanning in the bracketed positive potential region 
window (Figure 4.15).  The ligand based redox couples are also irreversible processes.  
The ligand based reductions are tentatively assigned to -1.47 V [dfpp] ligand, -2.47 V 
[dfpp] ligand and -2.68 V [napthNO2] ligand versus Ag/AgCl, whereas, there is slight 
evidence of the corresponding ligand oxidation peaks is at -0.57 V, -2.26 V and -2.77 V 
versus Ag/AgCl respectively.   
  
It has been noted that a one electron oxidation of an iridium metal centre results 
in a lengthening of the iridium-oxygen bond length.[22]  It is likely that the Ir3+/4+ couple 
leads to disruption of the iridium ligand bond.  However, narrowing the potential 
window and changing scan rates revealed no further improvement to the CVs upto a 
scan rate of 1 Vs-1, which indicates that the bond disruption is fast.  The delicate nature 
of the iridium (III) (naphthoxazolyl) phenolate complexes was further replicated in their 
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mass spectra analysis where fragmentation of the iridium-ligand bond was evident.  
This proved unlike any other coordinated metal complex synthesised as part of this 
research where mass spectra fragmentation patterns of the ligands, under electron spray 
ionisation conditions, were not typically observed. 
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Figure 4.15: Cyclic voltammogram of  [Ir(dfpp)2(napthNO2)] in acetonitrile (containing 
0.1M TBA as electrolyte) with 1.5 mm glassy carbon working electrode and referenced 
against Ag/AgCl.  Scans were started in a positive direction from an initial potential of 
0 V. 
 
Again the cyclic voltammogram of [Ir(dfpp)2(napthNH2)] contains an 
irreversible metal oxidation.  The Ir3+/4+ occurs at +2.36 V versus Ag/AgCl in Figure 
4.16.  Additionally, there is no evidence of a reversible couple when only positive 
potentials are isolated.  Such high metal oxidation potentials are caused by low electron 
density available around the iridium (III) atom making coordinating bonds unstable.  
The ligand redox couples are also irreversible.  Ligand reduction peaks are evident at         
-1.27 V [dfpp] ligand, -2.12 V [dfpp] ligand, -2.35 V [napthNH2] ligand and -2.75 V 
[napthNH2] ligand versus Ag/AgCl respectively and irreversible oxidation peak values 
at -0.78 V, -1.45 V, -2.19 V and -2.74 V versus Ag/AgCl.  As explained previously, the 
irreversible electrochemistry is attributed to bond breakage between iridium centre and 
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ancillary ligand moiety when placed under electrochemical stress.  As seen previously 
for amino functionalised complexes,[23] it is possible that electropolymerisation is 
occurring here for the [Ir(dfpp)2(napthNH2)] complex and also following the reduction 
of [Ir(dfpp)2(napthNO2)] to the corresponding amino complex during the 
electrochemical potential sweep.  Furthermore, adsorption is not really obvious for the 
nitro or amino functionalised complexes. 
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Figure 4.16: Cyclic voltammogram of [Ir(dfpp)2(napthNH2)] in acetonitrile (containing 
0.1M TBA as electrolyte) with 1.5 mm glassy carbon working electrode and referenced 
against Ag/AgCl.  Scans were started in a positive direction from an initial potential of 
0 V. 
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4.3 Optical and Acid-Base properties of Iridium (III) Complexes 
 
______________________________________________________________________________ 
Compound  Absorbance a  Emission a ɸ b       pKa c      pKa* c 
λmax    λmax                              (+/- 0.1)   (+/- 0.1) 
 (ɛ, dm3mol-1cm-1)                        
______________________________________________________________________________ 
[Ir(dfpp)2(picCOOH)]+ 381 nm (12,390) 521 nm        0.103           3.7, 11.5     3.1, 11.1 
    324 nm (44,084)     
    283 nm (54,847)  
 
[Ir(dfpp)2(napthNO2)]   450 nm (6,271) 516 nm         0.0009       n/a           n/a 
   338 nm (21,563) 539 nm  
   243 nm (56,300)  
 
[Ir(dfpp)2(napthNH2)]   418 nm (20,800) 524 nm          0.0056        n/a              n/a 
   348 nm (19,650) 564 nm  
   245 nm (56,700) 
 
______________________________________________________________________________  
Table 4.8: Optical and Acid-Base properties of Iridium (III) Complexes Synthesised. 
 
a
 Measured in acetonitrile at room temperature using concentrations of 20 x 10-6 M. 
b
 Photoluminescent quantum yield (ɸ) measured in degassed acetonitrile at room temperature, 
using [Ru(bpy)3] 2+ as standard.   
c
 Ground (pKa) and excited state (pKa*) values, measured in PBS buffer solution at room 
temperature. 
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Complex 
 
τ (ns) a 
(percentage 
component) 
τ (ns) a 
(percentage 
component) 
x2 value 
[Ir(dfpp)2(picCOOH)]+ 
 
241 +/- 5 
(95%) 
20 +/- 3 
(5%) 
0.897 
[Ir(dfpp)2(napthNO2)]   
 
11 +/- 3 
(79%) 
3 +/- 1 
(21%) 
0.942 
[Ir(dfpp)2(napthNH2)]   
 
189 +/- 6 
(84%) 
7 +/- 2 
(16%) 
0.871 
Table 4.9: Biexponential lifetime results for the iridium (III) complexes synthesised. 
 
a Biexponential lifetimes measured in degassed acetonitrile at room temperature 
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4.3.1 Absorbance and Emission of [Ir(dfpp)2(picCOOH)]+ 
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Figure 4.17: Absorbance and normalised emission spectra (excited at 381 nm, slit 
widths: 5 nm, normalised to 1 arbitrary unit) of 20 x 10-6M [Ir(dfpp)2(picCOOH)]+ in 
acetonitrile solution. 
 
 
 Figure 4.17 shows the absorbance and emission spectra for the 
[Ir(dfpp)2(picCOOH)]+ complex.  The UV-vis spectrum of [Ir(dfpp)2(picCOOH)]+ is 
dominated by LC difluorophenyl pyridine π-π* electronic transitions giving maximum 
absorbance peaks at 245 nm and 283 nm.  This is consistent with reports of other 
iridium (III) complexes containing difluorophenyl pyridine, bipyridyl or terpyridine 
ligands.[1, 24]  The shoulder at 324 nm may be assigned to the intraligand π-π* transition 
of the [picCOOH] ligand.  A weaker, broad feature extending down into longer 
wavelengths at 381 nm is attributed to the MLCT from the iridium dπ to [dfpp] π* 
orbital.   
 
[Ir(dfpp)2(picCOOH)]+ is strongly luminescent and exhibits an emission 
maximum at 521 nm when excited into the MLCT band at 381 nm with a quantum yield 
of 0.103 in aerated acetonitrile.  This compares favourably with increased quantum 
yield when compared to the [Ru(bpy)2(picCOOH)]2+ complex (ɸ = 0.068).  
Interestingly, the emission decay follows biexponential kinetics as outlined in Table 4.9.   
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Furthermore, the lifetimes in degassed PBS buffer solutions (containing 5% 
acetonitrile) are 207 +/- 7 ns at pH 1.0, 168 +/- 6 ns at pH 6.9 and 5 +/- 1 ns at pH 12.0.  
The decrease in lifetimes of the deprotonated imidazolate species may be explained by 
the dissipation of the excited state energy into lower lying non-radiative acceptor states 
on the imidazolate ligand.[25]  Although the lifetimes are shorter, the quantum yield of 
the iridium (III) complex is 40% greater than [Ru(bpy)2(picCOOH)]2+ and its lifetime in 
degassed methanol is as long as 842 +/- 9 ns.  [Ir(dfpp)2(picCOOH)]+ is only partially 
soluble in PBS buffer and initially had to be dissolved in acetonitrile (5%) to aid 
solubility.   
 
 
 
4.3.2 pH Dependence Studies of [Ir(dfpp)2(picCOOH)]+ 
 
Protonation of the [Ir(dfpp)2(picCOOH)]+ complex had little effect on the 
wavelength of the absorbance of the iridium complex suggesting that there is no change 
in the HOMO-LUMO energy gap or in the distribution of π electrons across the system 
upon acidification (Figure 4.18).  This is in contrast to the ruthenium (II) complex as the 
formation of the protonated species leads to an increase in the HOMO-LUMO as 
indicated by a blue shift in the absorbance at 330 nm in Figure 3.13.  The formation of 
an isobestic point at 370 nm is an indication that changes its absorbance intensity is not 
just due to changes in its solubility upon protonation.  In particular, the relative 
intensities of the two LC transitions at 245 nm and 283 nm vary significantly with a 
decrease in pH.   
 213 
 
Figure 4.18: Absorbance spectra of 20 x 10-6 M (15 cm3) [Ir(dfpp)2(picCOOH)]+ in PBS 
buffer solution (containing 5% acetonitrile)  upon addition of µl aliquots of percholric 
acid solution.  (inset) pH titration curve of [Ir(dfpp)2(picCOOH)]+ in PBS solution 
(containing 5% acetonitrile) monitoring the changes in absorbance at 330 nm upon 
addition of perchloric acid. 
 
 
Upon addition of base to the iridium (III) complex the absorbance intensity 
decreases with little change to absorbance wavelengths as shown in Figure 4.19.  
However when deprotonation of the imidazole, to form [Ir(dfpp)2(picCOOH)], occurs at 
around pH 10.5 where there is a dramatic shift in absorbance wavelengths to lower 
energies.  This suggests a more extended π system which is consistent with 
deprotonation of the imidazole leading to enhanced electronic communication between 
the phenanthroline and imidazole components.[25]  The spectral changes brought about 
by a change in pH have relatively little effect on the MLCT because this transition is 
mostly concentrated on LC cyclometalating ligand transitions at higher energies.  This 
seems good confirmation that the LUMO for the MLCT lies mainly on the 
difluorophenyl pyridine ligands, which is also confirmed in calculating ground and 
excited state pKa values, vide infra.   
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Figure 4.19: Absorbance spectra of 20 x 10-6 (15 cm3) [Ir(dfpp)2(picCOOH)]+ in PBS 
buffer solution (containing 5% acetonitrile) upon addition of µl aliquots of sodium 
hydroxide solution.  (inset) pH titration curve of [Ir(dfpp)2(picCOOH)]+ in PBS solution 
(containing 5% acetonitrile) monitoring the changes in absorbance at 330 nm upon 
addition of  sodium hydroxide solution. 
 
 
The ground state pKa values of the pH sensitive imidazole ligand were 
determined by monitoring the spectral changes at 330 nm over a pH range of 1.0-12.0 
(Figures 4.18 inset and 4.19 inset).  The pKa/pKa* spectroscopy was irreversible and 
was not fully recovered on returning to the initial pH.  The ground state pKa values 
were calculated to be equal to 3.7 +/- 0.1 and 11.5 +/- 0.1 respectively.  These ground 
state values are higher than that seen before for the same benzimidazole ligand on the 
[Ru(bpy)2(picCOOH)]2+ complex.  It is considered that the calculated pKa values for 
the iridium (III) complex are higher in comparison with the ruthenium (II) complex as a 
result of the acetonitrile (5%) used to solvate the iridium complex in PBS (pH7.4) 
buffer.  Previous papers have highlighted the significant differences in pKa values for 
the [Ru(bpy)2(picCOOH)]2+ complex when performed in acetonitrile[26] and aqueous[25] 
media. 
 215 
The luminescent profile of [Ir(dfpp)2(picCOOH)]+ showed a small spectral shift 
in their emission maxima to longer wavelengths upon deprotonation from 536 nm at pH 
1.5 to 564 nm at pH 9.9 as shown in Figures 4.20 and 4.21.  This suggested an increase 
in the HOMO-LUMO energy gap at lower pH values which may be due to the 
electrostatic repulsion between the positively charged iridium 4+ metal centre and the 
extra positive charge on the imidazolium ligand.[25]   
 
 
Figure 4.20: Emission spectra of 20 x 10-6 M (15 cm3) [Ir(dfpp)2(picCOOH)]+ in PBS 
buffer solution (containing 5% acetonitrile)  upon addition of µl aliquots of perchloric 
acid solution. (370 nm excitation wavelength, slit widths: 5 nm).  (inset) pH titration 
curve of [Ir(dfpp)2(picCOOH)]+ in PBS solution (containing 5% acetonitrile) 
monitoring the differences in maximum emission intensity (excited at 370 nm) versus 
pH, upon addition of perchloric acid. 
 
 
 
However, from pH 10 to pH 12, there is a reverse in this general trend and the 
emission maximum is slightly blue shifted as shown in Figure 4.21.  This also 
corresponded with the dramatic change in the absorbance profile of the complex over 
similar pH ranges (Figure 4.19).  The excited state pKa* values of the complex were 
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calculated to be 3.1 +/- 0.1 and 11.1 +/- 0.1 respectively (Figures 4.20 inset and 4.21 
inset), which are somewhat lower than those calculated for the ground state pKa values 
(3.7 +/- 0.1 and 11.5 +/- 0.1).  This suggests that the excited state lies on the [dfpp] 
ligands because had the excited state been located on the ionisable ligand, the excited 
state pKa* value would have been more basic (by more than 3 pH units) due to the 
increase in electron density on that ligand.[27]  As seen for the pH dependence studies 
for [Ru(bpy)2(picCOOH)]2+ there is only evidence of two pKa values corresponding to 
formation of [Ir(dfpp)2(picCOOH)]2+ and [Ir(dfpp)2(picCOOH)]0 in a process very 
similar to that discussed in the introduction to Chapter 3.  However, the emission 
intensity of the iridium complex is not recovered on returning to neutral pH which is 
unlike that seen for the corresponding [Ru(bpy)2(picCOOH)]2+ complex. 
 
 
 
Figure 4.21: Emission spectra of 20 x 10-6 M (15 cm3) [Ir(dfpp)2(picCOOH)]+ in PBS 
buffer solution (containing 5% acetonitrile) upon addition of µl aliquots of sodium 
hydroxide solution. (375 nm excitation wavelength).  (inset) pH titration curve of 
[Ir(dfpp)2(picCOOH)]+ in PBS solution (containing 5% acetonitrile) monitoring the 
differences in maximum emission intensity (excited at 370 nm) versus pH, upon addition 
of sodium hydroxide solution. 
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4.4 Absorbance and Emission of Novel 2-(Naphthoxazolyl) phenolate Ancillary 
Ligands 
 
 Figure 4.22 below illustrates the absorbance and emission profiles for the novel 
uncoordinated [napthNO2] and [napthNH2] ligands in acetonitrile solutions.  The shapes 
of the vibronic absorption spectra of the free ligands strongly resemble the absorption of 
the coordinated iridium (III) complexes (Figure 4.24) suggesting a direct excitation of 
the ancillary ligands.  Therefore, it may be inferred that the ancillary ligands are related 
to the optical excitation responsible for this absorption behaviour.  This allows for the 
complexes to absorb strongly over a large spectral range making them potentially useful 
as components in solar cells or OLEDs.[2] 
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Figure 4.22: Overlaid absorbance and emission spectra of 20 x 10-6 M [napthNO2] 
(excited at 345 nm) and [napthNH2] (excited at 320 nm) free ligands in acetonitrile.  
Emission spectra are normalised to 1 arbitrary unit and slit widths of 10 nm were used 
in gathering emission data.  
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4.4.1 Absorbance of [Ir(dfpp)2(napthNO2)] and [Ir(dfpp)2(napthNH2)] 
 
 In most iridium (III) complexes containing phenylpyridine ligands the HOMO is 
spread over the iridium centre and anionic phenyl ring and the LUMO is mostly 
localised on the neutral pyridine ring of the cyclometalating ligand.[2]  As mentioned in 
the introduction the most efficient way of altering the colour tunability of heteroleptic 
iridium (III) complexes is by lowering the ancillary ligand LUMO without significantly 
effecting the HOMO energy level.  This can be achieved by controlling functionality on 
the chromophoric ancillary ligands.  Furthermore, results by You et al.[2] indicated that 
the LUMO of the ancillary ligand is lowered with increasing numbers of phenyl rings 
fused to the oxazole unit while the HOMO level showed a relatively small change in 
energy by comparison.  Results suggested that a related iridium (III) bis(2-(2,4-
difluorophenyl)pyridinato-N,C2’) (2-naphthoxazoyl)phenolate), shown in Figure 4.23,  
exhibited good photophysical characteristics including long phosphorescent lifetimes 
and quantum yields.[2]   
 
Ir
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Figure 4.23: Schematic diagram of iridium (III) bis(2-(2,4-difluorophenyl)pyridinato-
N,C2’) (2-naphthoxazoyl)phenolate). 
 
Indeed the author proposed the emission so bright that they are useful OLED 
materials.  As such, we were intended in applying them as cellular probes, however, this 
required functional groups for bioconjugation so the novel nitro and amino 
functionalised derivatives of this iridium luminophore were synthesised.  It was hoped 
that they would exhibit good photophysics as observed from their parent complex.  The 
resultant absorbance spectra of [Ir(dfpp)2(napthNO2)], [Ir(dfpp)2(napthNH2)] and the 
iridium (III) parent complex ([Ir(dfpp)2(napth)]) are shown in Figure 4.24 below.  
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Figure 4.24: Overlaid absorbance profiles of [Ir(dfpp)2(napthNO2)] and 
[Ir(dfpp)2(napthNH2)] (20 x 10-6M) in acetonitrile solution.  (inset) Absorbance profile 
of the parent [Ir(dfpp)2(napth)] complex, 1.0 x 10-5 M in toluene.[2] 
 
 
The UV-vis spectrum of [Ir(dfpp)2(napthNO2)] is dominated by LC 
cyclometalating [dfpp] π-π* ligand transitions giving maximum absorbance peaks at 
243 nm and a shoulder at 279 nm.  The lower energy peak at 338 nm is assigned to the 
π-π* [NapthNO2] ancillary ligand transition.  There is a significant degree of 
overlapping of electronic transitions and the absorbance band that extends into the 
visible region at 450 nm is believed to be a MLCT (spin-forbidden) iridium dπ to 
difluorophenyl pyridine ligand π* transition.  MLCT spin-forbidden transitions are 
known for complexes containing heavy atoms, such as iridium, due to strong spin-orbit 
coupling.[3]  The spin-orbit coupling for iridium (III) complexes is 50% larger than that 
of ruthenium (II) complexes and this leads to an enhanced triplet character for iridium 
(III) complexes.[2, 28]  
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The UV-vis spectrum of [Ir(dfpp)2(napthNH2)] is also dominated by LC π-π* 
difluorophenyl pyridine ligand electronic transitions giving maximum absorbance peak 
at 245 nm and a shoulder at 283 nm.  As seen previously for the uncoordinated ligands, 
the π-π* ancillary [NapthNH2] ligand transition is red-shifted to 348 nm in comparison 
to the [NapthNO2] ligand iridium complex.  In addition, a more defined and blue-shifted 
spin-allowed MLCT peak from the iridium (dπ) to difluorophenyl pyridine ligand (π*) 
orbital is also present at 418 nm for the amino functionalised complex which is perhaps 
due to the increase in the π acceptor state of the [napthNH2] ligand.   
 
As observed in Chapter 3, it is known that the nitro substituent has an effect on 
the HOMO-LUMO band gap of a compound.  The dπ-π* and π-π* interactions permit 
hyperconjugation between the electronic structures and aromatic rings causing a 
decrease in the energy gap.  This is may be seen by a decrease in the HOMO-LUMO 
energy gap of the [Ir(dfpp)2(napthNO2)] complex resulting in shift to longer 
wavelengths (450 nm) when compared to the amino functionalised (418 nm) and parent 
iridium (III) complexes (445 nm).  The absorbance profile of the parent 
[Ir(dfpp)2(napth)] complex is very similar to that of the [Ir(dfpp)2(napthNH2)] complex 
as shown in Figure 4.24 (inset), with the exception of the absorbance peak at 348 nm 
which is attributed to the π-π* transition as a result of the [napthNH2] ligand. 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 221 
4.4.2 Emission of [Ir(dfpp)2(napthNO2)] and [Ir(dfpp)2(napthNH2)] 
 
 
 
Figure 4.25: Overlaid emission spectra of 20 x 10-6M solutions of 
[Ir(dfpp)2(napthNO2)] (right hand side scale bar, excited at 475 nm) and 
[Ir(dfpp)2(napthNH2)] (left hand side scale bar, excited at 418 nm) in acetonitrile.  Slit 
widths: 5 nm.  (inset) Emission profile of the parent [Ir(dfpp)2(napth)] complex, 1.0 x 
10-5 M in toluene.[2] 
 
 
Figure 4.25 above shows the emission spectra for the novel iridium dyes and 
parent iridium complex inset.  The emission spectrum of [Ir(dfpp)2(napthNO2)] exhibits 
vibronic structure in its emission profile with emission maxima at 516 nm and 539 nm 
when excited into the MLCT transition band at 475 nm respectively.  The luminescence 
of the nitro functionalised complex is considerably less than that of the other iridium 
complexes synthesised.  The quantum yield was very low at 0.0009 and had a short 
biexponential lifetime as shown in Table 4.9.  The excitation spectra of all iridium (III) 
complexes containing 2-(2-hydroxyphenyl)oxazole-based ancillary ligand displayed 
strong absorbance profiles in both the π-π* difluorophenyl pyridine and π-π* [Napth-R] 
ligand regions [results not shown] when excited at into the emission maxima of the 
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complexes.  As a result it is considered that dual excitation of both ligands occurs 
simultaneously and results in the emission of the luminophores from a single emissive 
centre.  
 
On the other hand, the [Ir(dfpp)2(napthNH2)] complex exhibited a more intense 
red-shifted luminescence maximum, when compared to [Ir(dfpp)2(napthNO2)], and 
showed emission at 524 nm and 564 nm respectively.  It is thought that this is as a result 
of the slight decrease in the emissive ligand LUMO due to the electron donating amino 
substituent caused by an improved π delocalisation of electrons.  The red shift in the 
emission of the amino functionalised iridium complex, in comparison to 
[Ir(dfpp)2(napthNO2)], has also been observed in Chapter 3 when comparing both nitro 
and amino functionalised ruthenium (II) complexes.  The quantum yield of 
[Ir(dfpp)2(napthNH2)] was calculated to be equal to 0.0056 and had a biexponential 
decay kinetics (Table 4.9) which showed a significant improvement on its nitro 
functionalised counterpart, but nonetheless very weak in comparison to the [picCOOH] 
functionalised iridium (III) complex. 
 
These photophysical results proved to be far inferior to the parent 
[Ir(dfpp)2(napth)] complex, whose lifetime was determined to be 9.88 µs with quantum 
yields of 0.43.[2]  The emission profile of the parent complex is shown in Figure 4.25 
(inset) for comparative purposes.  It is proposed that the poor photophysical results in 
comparison are due to the increase in energy of the lower-lying π* ancillary ligand 
orbitals as a result of the introduction of the nitro and amino substituents on the ligand.  
As a result population of the lowest lying triplet state, which is responsible for 
phosphorescence, is prohibited and excited state energy is dissipated through lower-
lying non-luminescent molecular orbitals on the cyclometalating [dfpp] ligands.  It is 
also considered that similar to results in the previous chapter, that the poor 
photophysical characteristics of the nitro complex might be due to the para 
functionalised nitro substituent.  However, unlike the ruthenium (II) functionalised nitro 
complex, there are no significant differences in the luminescence or lifetimes of 
[Ir(dfpp)2(napthNO2)] when the solvent is changed.  
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You et al.[2] have previously shown with the parent iridium (III) complex how 
the excited state energy of the cyclometalating ligand is almost quantitatively 
transferred to the chromophoric ancillary ligand.  Furthermore, as the number of fused 
phenyl units on the ancillary ligand is increased, the phosphorescent emission displayed 
more vibronic structure in its emission profile as seen for the iridium (III) complexes 
synthesised in Figure 4.25.  The triplet transition of the [Ir(dfpp)2(napth)] complex is 
afforded by the LUMO of the ancillary ligand. However, as the phosphorescence mainly 
involves the triplet transition, ancillary-ligand-mediated phosphorescence was expected.  
This was consistent with their observed results as revealed by a single ancillary ligand 
centred phosphorescence and double excitation to both ancillary and cyclometalating 
ligands.  It was also calculated that the excited state energy of the cyclometalating 
ligand is transferred to the chromophoric ancillary ligand (through ILET – interligand 
energy transfer) where phosphorescence is generated with an efficiency of > 99%.[2]    
 
Dual emission of iridium (III) complexes with diimine ligands are unusual but 
not unprecedented as emission may occur from both MLCT and LC excited states.[29, 30]  
However, for similar difluorophenyl pyridine complexes the HOMO has been shown to 
be primarily located on the iridium centre and the phenyl ring of the difluoropyridine 
ligands.[3, 9] The HOMO-LUMO transition is MLCT with a relatively large LC 
component involving the difluoropyridine pyridine ligand.  This results in the more 
pronounced vibronic structure and smaller stokes shift of the emission spectra as seen 
for the iridium (III) complexes synthesised in this thesis.  However, due to the 
disappointing photophysics of the nitro and amino derivatives, it was decided not to 
continue efforts in using this particular series of iridium (III) dyes containing 2-(2-
hydroxyphenyl)oxazole-based ancillary ligands as luminescent markers to label 
biomolecules.  
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4.5 Conclusion 
 
 The synthesis and characterisation of three novel iridium (III) polypyridyl 
complexes is described.  Iridium complexes have been shown to display many 
favourable photophysical characteristics, above those of other transition metal 
complexes, including microsecond scale phosphorescent lifetimes, high quantum yields 
and the ability to tune its emission wavelength from blue to red by changing the 
coordinated ligands.  [Ir(dfpp)2(picCOOH)]+ exhibited improved lifetimes (842 +/- 9 ns 
in degassed organic media) and quantum yields (0.103) when compared with the 
ruthenium luminescent probes synthesised in Chapter 3.  Furthermore, like the 
ruthenium (II) complexes, [Ir(dfpp)2(picCOOH)]+ exhibited lifetime and Raman 
sensitivity with changes in oxygen concentration and pH respectively.  The location of 
the excited state was also found to be on cyclometalating [dfpp] ligands.   
 
 The [Ir(dfpp)2(napthNO2)] complex had a disappointing lifetime of 11 +/- 3 ns 
and a quantum yield of 0.0009.  Whereas, the nitro functionalised [Ir(dfpp)2(napthNH2)] 
complex had an improved lifetime of 189 +/- 6 ns and a quantum yield of 0.0056.  The 
poor photophysical properties, when compared to the parent complex, is attributed to an 
increase in energy of the lower-lying π* ancillary ligand orbitals as a result of the 
introduction of the nitro and amino substituents on the ligand.  As a result population of 
the lowest lying triplet state, which is responsible for phosphorescence, is prohibited 
and excited state energy is dissipated through lower-lying non-emissive molecular 
orbitals on the cyclometalating [dfpp] ligands.  Therefore, it was decided not to continue 
efforts in using this particular series of iridium (III) dyes as luminescent markers to 
label biomolecules. 
 
However, given the superior photophysical results observed for the 
[Ir(dfpp)2(picCOOH)]+ complex, in Chapter 5 its conjugation to a cell penetrating 
peptide was conducted in an effort to increase its aqueous solubility and potential to be 
used as a multimodal probe for cellular imaging.  
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Chapter 5: Metal Luminophore-Peptide 
Conjugates for Cellular Imaging 
 
 
 
 
 
 
 
 
 
 
 
 
 
"The reasonable man adapts himself to the world; the unreasonable man persists in 
trying to adapt the world to himself.  Therefore all progress depends on the 
unreasonable man” - George Bernard Shaw 
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5.0 Introduction 
 
A major limitation to date has been the inability of such inorganic dyes to 
passively diffuse across a cell membrane without membrane permeabilisation.  The 
relatively low cationic charge associated with many of these metal complexes means 
that they are unable to effectively use the cell’s membrane potential as a driving force 
for cellular entry.[1]  Common methods for permeabilisation include electroporation, 
organic solvents, the use of detergents and all lead to questions about the cell viability.  
Aprotic solvents, such as DMSO, have been shown before to induce water pores in lipid 
bilayers.[2, 3]  Molecular dynamic simulations indicated a number of features that were 
significant for the effects of DMSO on a cell membrane.  The solvent was shown to 
readily partition into the bilayer occupying a position beneath the lipid headgroups, 
reduce the bilayer thickness, increase headgroup area, markedly reduce both the area 
compressibility modulus and the bending ridgity of the membrane, which led to induced 
water pore formation.  The remarkable event of water pore formation was observed at a 
27 mol% concentration of DMSO after 240 ns.  Furthermore, an important application 
of DMSO is in topical drug delivery where its powerful ability to increase the skins 
permeability is exploited, however, exactly how it increases the skins permeability is 
not fully understood.[2]  
 
However, research published by our group[4, 5] demonstrated that conjugation of 
a metal complex to a CPP, like octarginine, facilitates the efficient diffusion of the 
luminescent probe across mammalian cell membranes without destroying the lipid 
bilayer.  Furthermore, once inside the cell’s membrane, the environmentally sensitive 
photophysics and spectroscopic properties of the dye-peptide may be exploited to report 
on the intracellular environment.  Cosgrave et al.[5]  have previously exploited the 
multimodal imaging capability of a related ruthenium dye-peptide synthesised here to 
give information on the intracellular pH and oxygen concentrations and this is discussed 
in detail in Chapter 1.  Chapter 1 also reviewed examples where polyarginine CPPs 
have been used for the internalisation of inorganic luminophores into cellular structures 
for live cellular imaging and the processes by which these biomolecules are uptaken by 
the cell. 
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5.1 Solid Phase Peptide Synthesis (SPPS) 
 
 Synthetic peptides are playing an increasing role in biological, medical and 
pharmaceutical research and therefore the synthesis of such polyamide molecules is of 
major interest.  The introduction of SPPS has offered many important advantages over 
conventional solution phase peptide synthesis.  Advantages include the fact that 
coupling reactions may be carried out more rapidly and to completion on a solid support 
that leads to easier purification procedures.[6]  Furthermore, the introduction of Fmoc-
protecting groups by Carpino in 1970 allowed for the process of SPPS to be conducted 
under milder conditions.[6]  Peptide coupling chemistry was then further improved with 
the use of novel side-chain protecting groups, such as Arg(Pbf) used throughout this 
chapter as shown in Figure 5.1.   
 
 
 
Figure 5.1: Chemical structure of Fmoc-Arg-Pbf used in the SPPS of octarginine. 
 
 
The first step is to couple the peptide unit to the solid support resin.  2-(1H-
Benzotriazole-1-yl)-1,1,3,3-tetramethyl uronium hexafluorophosphate (HBTU) (Figure 
5.2) is used as the coupling reagent for the automated peptide synthesis of this 
polypeptide.  It is one of the most common coupling reagents used that forms an active 
hydroxybenzotriiazole (HOBt) ester and its general mechanism of coupling is shown in 
Figure 5.3.  HBTU in the presence of a base converts carboxylic acids to the 
corresponding HOBt ester.[7]  It is the base N,N-diisopropylethylamine (DIEA) that 
initiates this coupling reaction. 
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Figure 5.2:  Schematic diagram of the HBTU coupling reagent. 
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Figure 5.3: General mechanism for the HBTU/HOBt mediated coupling reaction of 
peptides in SPPS.  (Illustrated in the above diagram is the mechanism for the 
HBTU/HOBt mediated coupling reaction of a peptide to the solid support resin). 
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Following Fmoc deprotection by piperidine in NMP the amine group on the 
resin is available for amino acid coupling.  The general mechanism of Fmoc 
deprotection using piperidine as strong base is illustrated in Figure 5.4 below.  The 
peptide is then elongated from the C-terminus (carboxylic acid functional group) to the 
N-terminus (amino functional group) via HBTU/HOBt/DIEA mediated coupling 
reactions similar to that illustrated in Figure 5.3 above.  
 
 
Figure 5.4: General mechanism for deprotection of Fmoc using piperidine (B) as the 
strong base.[8] 
 
 Following SPPS of the octarginine polypeptide, the remaining Fmoc protecting 
group on the hexanoid acid spacer is removed manually using piperidine.  The inorganic 
molecular probes were then manually conjugated to the polypeptide using 
HBTU/PyBOP/DIEA coupling reagent in a procedure described in the experimental 
section.  Finally the dye-peptides were removed from the resin and the amino acid side-
chains (Pbf) groups deprotected using a cleavage cocktail.  The reaction between the 
carboxyl group on the inorganic dyes and amino group on the peptide results in the 
formation of a stable amide bond.  The bond stability may be explained by a resonance 
contributor in which the nitrogen shares its lone pair with the carbonyl carbon.  This 
overlapping of molecular orbitals lowers the energy of the lone pair and raises the 
energy of the π* orbital of the carbonyl, making it less reactive to nucleophiles. 
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5.2 Resazurin and MTT Cell Viability Assays 
 
In order to assess and compare the viability of the cells, two cell viability assays 
were performed; the resazurin and MTT cell viability assays.  Resazurin is a 
colorimetric assay performed to determine the viability of cells and was also used in the 
cytotoxicity studies previously.  Resazurin (7-hydroxy-3H-phenoxazin-3-one-10-oxide) 
is a non-fluorescent blue coloured dye when exposed to green light.  However, upon 
reduction of the dye to form resorufin (pink in colour) the dye is brightly fluorescent 
under green light.  The dye is mainly used as an oxidation-reduction indicator in cell 
viability assays for bacteria and mammalian cells.  The resazurin assay is based on the 
ability of viable, active cells to reduce resazurin to resorufin and dihydroresorufin, and 
can be readily applied to both fixed and live cell cultures.  This redox conversion is 
intracellular and is facilitated by mitochondrial, microsomal and cytosolic 
oxidoreductases.  The rate of dye reduction is directly proportional to the amount of 
viable cells present in a given assay.[9]  An advantage of the resazurin assay over other 
cell viability assays include its low toxicity to living cells allowing for the study of cells 
over longer time periods.  Figure 5.5 illustrates the conversion of resazurin to resorufin 
following reduction by active cell enzymes. 
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Figure 5.5: Schematic diagram illustrating the conversion of resazurin to resorufin 
following reduction by active cell enzymes. 
 
 
 The MTT assay is another colorimetric assay that measures the activity of 
enzymes that cause the reduction of MTT ((3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide – yellow in colour) to formazan (purple in colour).  
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Reduction of tetrazolium salts by dehydrogenases and reductases present in living cells 
results in the production of the artificial dye formazan that may be monitored by UV-
Vis spectroscopy.  The assay detects living, but not dead cells and the signal generated 
is dependent on the degree of activation of the cells.[10]  Figure 5.6 illustrates the 
conversion of the MTT tetrazolium salt to formazan following reduction by active cell 
enzymes. 
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Figure 5.6: Schematic diagram illustrating the conversion of the MTT tetrazolium salt 
to formazan following reduction by active cell enzymes. 
 
 
 
5.3 SP2 Myeloma and CHO Cells 
 
 The two cell lines used throughout this thesis are SP2 myeloma and CHO cell 
lines.  SP2 myeloma cells are formed by fusing BALB/c spleen cells (from mice 
immunised with sheep red blood cells) with the P3X63Ag8 myeloma.  Chinese hamster 
ovary (CHO) cells are epithelial cells which grow as an adherent monolayer in culture 
in many academic research laboratories.  Furthermore, they are the most widely used 
mammalian cells for transfection, expression and protein production.  From a 
biochemical perspective, one of the main differences between both cell lines is that SP2 
cells are a suspension cell line, whereas, CHO are an adhesive cell line.  Consequently, 
there are likely to be significant differences in the surface expression proteins on the cell 
membranes, potentially leading to very different interactions between both cell lines and 
the luminophores/dye-peptides.  This is of course assuming that the surface proteins 
interact with the dyes and octarginine polypeptides.   
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 Throughout the literature cells are commonly imaged as live cells or fixed cells.  
Live cells involve taking a sample of cells directly from the cell culture and imaging 
under the microscope immediately.  In contrast, fixed cells are essentially adhered to 
and preserved on a surface so that the imaging of these cells may take place over longer 
periods of time.   
 
This chapter details the synthesis of ruthenium (II) and novel iridium (III) 
inorganic metal luminophores conjugated to polyarginine peptides.  There luminophores 
have been shown to be highly luminescent, singlet oxygen generating, have intense 
resonance Raman spectra and are oxygen / pH sensitive.  Conjugation of the dyes to the 
CPP octarginine allows for the passive and non-destructive entry of the molecular 
probes, without the need for permeabilisation, into living mammalian cells and these 
dye-peptides may then be used for cellular imaging.  As discussed to in Chapter 1, 
metallo dye-peptides hold significant potential for use as molecular probes suitable for 
multimodal cellular imaging.  Due to their large stokes shifts, photostability, long 
aqueous lifetimes and pH / oxygen sensitivity not only can these metallo dye-peptides 
image cells but they may also provide critical information on the intracellular pH levels 
and the oxygen concentrations using a single multimodal molecular probe.  
Furthermore, this is the first time that an iridium (III) luminophore has been conjugated 
to a polyarginine peptide and been used as a molecular probe for cellular imaging with 
the potential for multimodal imaging applications.    
 
In addition to the research carried out in this thesis, work is currently underway 
by our research group to conjugate target-peptides to existing cell penetrating dye-
peptides to help with targeted localisation within cell organelles.  This may prove very 
useful in the detection of certain diseases as targets may be synthesised to detect 
specific gene sequences known to be of harm.  Additionally, the intrinsic photophysical 
properties of these metal complexes, with their triplet excited states allowing for the 
generation of singlet oxygen and other reactive oxygen species may lead to induced 
apoptosis in cells,[11-13] thus, making these dye-peptides potentially valuable in the area 
of photodynamic therapy. 
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5.4 Experimental Procedure 
 
Chemicals 
 
Protected amino acids, HBTU, PyBOP and Rink-amide MBHA resin were 
purchased from Novabiochem (Merck Biosciences).  HOBt was purchased from Iris 
Biotech GmbH.  Synthesizer filters (in-line and reactor) and solvents (DCM, NMP) 
were sourced from Applied Biosystems.  All other chemicals were reagent grade 
purchased from Sigma-Aldrich and were used without further purification unless 
otherwise stated.   
 
Peptide Synthesis 
 
Automatic Peptide Synthesis 
 
  The synthesis was carried out by automated Solid Phase Peptide Synthesis 
(SPPS) performed on an Applied Biosystem ABI 433A Synthesizer.  1 mmol (10 fold 
molar excess) quantities of each protected amino acids was used.  The amine group on 
the resin is Fmoc protected initially but is available for amino acid coupling following 
piperidine (20% in NMP) deprotection.  The peptide was elongated from the C-terminus 
(carboxylic acid functional group) to the N-terminus (amino group).  The sequence was 
assembled with monitoring of the Fmoc deprotection by UV at 301 nm.  
 
 
Manual Deprotection 
 
Manual deprotection was used after automated peptide coupling to remove the 
remaining Fmoc protecting group. The manual deprotection was performed in a syringe 
fitted with a filter.  Piperidine (20%) in DMF (v/v) was then added to the syringe and 
placed on the shaker for 10-15 minutes.  The syringe was then drained and 20% 
piperidine in DMF (v/v) was added again and shaken for a further 10 minutes.  This 
process was performed twice. 
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Manual Coupling 
 
Manual peptide synthesis was used to label the peptides with the inorganic dye 
probes.  The resin was placed into a 5 ml syringe fitted with a Teflon filter and a 
stopcock.  The resin was allowed to swell for 1 hour in DMF.  Coupling reagent PyBop 
was used in 5 molar equivalents to the resin and DIEA was used in 10 molar equivalents 
to initiate the reaction.  The coupling reagents, inorganic dye and the protected amino 
acid were dissolved in 4ml of DMF and then DIEA was added.  The solution was then 
added to the syringe and placed on the shaker for overnight.  The resin was filtered and 
then washed twice with NMP and then a third time with DCM (3 x 5 ml aliquots of 
each, for 2 minutes agitation).   
 
 
Cleavage 
 
A cleavage procedure was used to remove the dye-peptide from the resin and 
deprotect the amino acid side-chains (Pbf) once assembly of the sequence was 
complete.  The resin was placed in a test tube with a magnetic stirrer and the cleavage 
cocktail was added.  The cleavage cocktail consisted of trifluoroacetic acid (6 ml, TFA 
80%) while scavenging of the cationic species formed from the protecting groups was 
achieved by using; water (450 µl, 5%), triisopropylsilane (450 µl, TIS or TIPS, 5%), 
thioanisole (450 µl, TA, 5%), ethandithiol (450 µl, EDT, 5%).  The mixture was left to 
stir for 4 hours at room temperature. 
 
After stirring, the solution was filtered into a plastic centrifuge tube using a 
teflon tube fitted with a filter.  To the centrifuge tube, diethyl ether (10 ml) was added to 
precipitate the peptide.  The centrifuge tube was then placed in the freezer for 5-10 
minutes to aid the precipitation process.  The product was centrifuged five minutes at 
2.8 × 103 rpm.  The acidic liquid supernatant was removed.  The peptide was then 
washed twice using diethyl ether (15 ml) before being air dried for 1 hour.  Finally the 
product was left on the freeze drier overnight. 
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The preparation of [Ru(bpy)2(picCOOH)Arg8]10+ bioconjugate 
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Figure 5.7: Schematic diagram of [Ru(bpy)2(picCOOH)Arg8]10+. 
 
Eight vials each containing Fmoc-Arg(Pbf)-OH (650 mg, 1 mmol) and one vial 
containing an hexanoic acid spacer Fmoc-6-Ahx-OH (354 mg, 1 mmol) were weighed 
out and placed into the SPPS.  The peptide was assembled using Rink Amide Resin 
(172 mg, 0.36 mmol) and was performed on the SPPS as described previously.  
Following the reaction, the resin was transferred into DMF (4 ml) to allow for swelling 
of the resin.   
 
Half of this solution (2 ml) was added to a vial already containing PyBOP (78 
mg, 0.15 mmol), [Ru(bpy)2(picCOOH)]2+.(ClO4-)2 (150 mg, 0.16 mmol) and DMF (2 
ml).  Finally, DIEA (40 µl, 0.23 mmol) was added and the solution was left shaking 
overnight.  The resin precipitated and was washed with NMP (5 ml x 3 times) and DMF 
(5 ml x 3 times) allowing for 2 minutes agitation before each filtering.  The remaining 
resin was then left to dry.  The peptide was cleaved by standard methods and then 
purified by RP-HPLC as described previously.  The fractions collected by semi-
preparative HPLC were analysed by mass spectrometry and it’s purity confirmed by 
HPLC analysis (conditions as outlined in Chapter 2 with a retention time of 28.41 
minutes).  The synthesis yielded an orange coloured solid (2.8 mg, 34%).  The purity of 
the dye-peptide was confirmed by mass spectrometry and HPLC analysis.  A stock 
solution (20 µM) in PBS buffer pH 7.4 was then made up and kept in the freezer.   
 
MALDI-TOF ([Ru(bpy)2(picCOOH)Arg8]10+ m/z): 2120.3, ([M]) 2120.5. 
HPLC single peak retention time of 28.41 minutes.  (HPLC conditions as described in 
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The preparation of [Ir(dfpp)2(picCOOH)Arg8]9+ bioconjugate 
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Figure 5.8: Schematic diagram of [Ir(dfpp)2(picCOOH)Arg8]9+ 
 
Eight vials each containing Fmoc-Arg(Pbf)-OH (650 mg, 1 mmol) and one vial 
containing an hexanoic acid spacer Fmoc-6-Ahx-OH (354 mg, 1 mmol) were weighed 
out and placed into the SPPS.  The peptide was assembled using Rink Amide Resin 
(172 mg, 0.36 mmol) and was performed on the SPPS as described previously.  
Following the reaction, the resin was transferred into DMF (4 ml) to allow for swelling 
of the resin.   
 
Half of this solution (2 ml) was added to a vial already containing PyBOP (78 
mg, 0.15 mmol), [Ir(dfpp)2(picCOOH)]+.(ClO4-) (200 mg, 0.20 mmol) and DMF (2 ml).  
Finally, DIEA (40 µl, 0.23 mmol) was added and the solution was left shaking 
overnight.  The resin precipitate was washed with NMP (5 ml x 3 times) and DMF (5 
ml x 3 times) allowing for 2 minutes agitation before each filtering.  The remaining 
resin is then left to dry.  The peptide was cleaved by standard methods and then purified 
by RP-HPLC as described previously only this time using 5% TFA instead of 0.1% 
TFA.  The fractions collected by semi-preparative HPLC were analysed by mass 
spectrometry.  The synthesis yielded a yellow coloured solid (3.0 mg, 34%).  The purity 
of the dye-peptide was confirmed by mass spectrometry and HPLC analysis.  A stock 
solution (20 µM) in PBS buffer pH 7.4 was then made up and kept in the freezer.   
MALDI-TOF ([Ir(dfpp)2(picCOOH)Arg8]9+ m/z): 2279.4, ([M-H5]) 2274.0. 
HPLC single peak retention time of 30.27 minutes.  (HPLC conditions as described in 
Chapter 2) 
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5.5 Results and Discussion 
 
5.5.1 Ruthenium (II) Conjugated Polypeptide 
 
This particular dye-peptide had been synthesised previously by our group[4, 14] 
and it was synthesised here again to understand the basic principles involved in SPPS, 
the bioconjugation of a luminophore to a peptide and uptake of a dye-peptide in 
mammalian cells.  Furthermore, for the first time the uptake of this ruthenium molecular 
probe in CHO cells is examined.  Coupling of [Ru(bpy)2(picCOOH)]2+ to the 
polypeptide gave a moderate yield (2.8 mg, 34%).  This is far lower than the conjugated 
percentage yield of 85% quoted by Neugebauer et al.[4] in their synthesis of this 
particular ruthenium polypeptide.  Mass spectrometry and HPLC analysis were used as 
standard to confirm the purity of both dye-conjugates.  The ruthenium (II) and iridium 
(III) polypyridyl dyes used were conjugated through a single reactive carboxyl group on 
the pH sensitive ancillary ligand with the amino functionality on the protected 
polypeptide.  As a result of the selective coupling reactivity they generally do not 
contain isomers or other competing functional groups that may in turn lower the 
synthetic yields further.[4, 15] 
 
 
 
Figure 5.9: MALDI-TOF mass spectrum of [Ru(bpy)2(picCOOH)Arg8]10+ with the 
molecular ion of interest at 2120.45 m/z. 
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MALDI-TOF mass spectrum (Figure 5.9) of the ruthenium (II) bioconjugate 
reveals the molecular ion of interest at 2120 m/z along with a stepwise fragmentation 
pattern associated with the loss of individual arginine moieties.  This sequential 
stepwise mass spectrum fragmentation for the ruthenium dye-peptide is in contrast to 
that seen for the iridium dye-peptide.  However, fragmentation of peptide bonds by 
transition metals has been observed previously.[26]  The purity of this conjugate was 
confirmed by HPLC analysis which showed a single peak with a retention time of 28.41 
minutes using HPLC conditions as set out in the Chapter 2.  Conjugation of the 
ruthenium (II) dye to the peptide did not cause any significant alterations to the 
wavelength of absorbance and emission of the conjugate when compared to the parent 
dye as shown in Figure 5.10 below.  Previous results[4] also indicated that conjugation 
of the dye did not cause any variations in the pKa of the dye-peptide when compared to 
the free parent complex. 
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Figure 5.10: Overlaid absorbance and normalised emission spectra (excited at 458 nm, 
slit widths: 5 nm, normalised to 1 arbitrary unit) of 20 x 10-6 M [Ru(bpy)2(picCOOH)]2+ 
and [Ru(bpy)2(picCOOH)Arg8]10+ in PBS buffer (pH 7.4) solutions. 
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The UV-vis spectrum of [Ru(bpy)2(picCOOH)Arg8]10+ and its parent dye 
displays a MLCT with a maximum absorbance at 457 nm as described in Chapter 3.  
However, the absorbance tail of the dye-peptide extends slightly further into longer 
wavelengths.  The absorbance band at 285 nm is assigned to π-π* transitions within the 
bpy ligands, whereas the shoulder at 330 nm is assigned to the π-π* transitions of the 
[picCOOH] ligand containing the two ionisable protons on the imidazole ring.   
 
The emission spectrum of [Ru(bpy)2(picCOOH)]2+ has a maximum at 608 nm, 
whereas, [Ru(bpy)2(picCOOH)Arg8]10+ has an emission maximum that is slightly red-
shifted to 611 nm when excited into the MLCT band at 457 nm.  Table 5.1 compares the 
photophysical results of the parent ruthenium dye and the ruthenium-peptide conjugate.  
Both the lifetimes and the quantum yields are very similar for that of the free ruthenium 
(II) dye and the conjugated complex indicating that the peptide had little effect on the 
photophysics of the luminophore.  These photophysical results correspond well with 
what has been reported in Chapter 3 and has already been published.[4] 
 
 
Compound Lifetimea x2 value  Quantum Yieldb 
[Ru(bpy)2(picCOOH)]2+  820 +/- 6 ns 0.986 0.074 
[Ru(bpy)2(picCOOH)Arg8]10+ 838 +/- 8 ns 0.107 0.071 
Table 5.1: Photophysical comparison of parent ruthenium dye versus dye-conjugate. 
  
a
 Monoexponential lifetimes measured in degassed PBS buffer solution (pH 7.4) at room 
temperature 
b
 Photoluminescent quantum yield (ɸ) in PBS buffer solution (pH 7.4) at room 
temperature, using [Ru(bpy)3]2+ as standard . 
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5.5.1.1 Cellular Uptake of [Ru(bpy)2(picCOOH)]2+ and [Ru(bpy)2(picCOOH)Arg8]10+ 
 
In order to assess and compare the ability of the compounds to transport across 
the cell membrane of two different cell lines, SP2 and CHO cells were cultured 
separately on 35 mm glass bottom culture dishes.  SP2 cells were seeded at 5 x 105 cells 
in 2 ml media and CHO cells were harvested after trypsinisation (0.25% trypsin for 5 
minutes at 37oC) and seeded at 8 x 104 cells in 2 ml media.  Both cell types were grown 
for 48 hours before imaging.  For confocal measurements the growth medium was 
removed by washing with PBS buffer (pH 7.4) and 20 µl of the ruthenium parent 
complex (1.4 mM) or ruthenium dye-peptide (1.4 mM) in PBS (pH 7.4, with MgCl2 and 
CaCl2) was added.  The luminophore and dye-peptide were made to a final 
concentration of 70 µM with PBS (pH 7.4) and were imaged immediately. Cell imaging 
throughout this chapter was performed by Dr. Roisin Moriarty, a postdoctoral 
researcher for the Prof. Tia Keyes research group. 
The cellular imaging results shown below highlight the ability of 
[Ru(bpy)2(picCOOH)Arg8]10+ to passively transport across the cell membrane of SP2  
myeloma and CHO cells, whereas, the parent dye alone showed no evidence of capacity 
to diffuse across either cell line as shown in Figure 5.11 below.  Furthermore, the parent 
ruthenium complex showed no strong luminescence within cell lines after a 40 minute 
time period.  However, diffusion of the ruthenium parent dye into SP2[4] and CHO cells 
could be accomplished using a 0.1% Triton solution, to permeabilise the membrane, as 
illustrated for CHO cells in Figure 5.12.   
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                               (a)     (b) 
Figure 5.11: Luminescencent confocal rainbow images (λex = 458 nm, λem = 610 nm) of 
(a) live SP2 myeloma cells incubated with [Ru(bpy)2(picCOOH)]2+ (70 × 10−6 M) after 
15 minutes and (b) live CHO cells incubated with [Ru(bpy)2(picCOOH)]2+ (70 × 10−6 
M)  after 15 minutes in PBS buffer (pH7.4) at room temperature.  (Images courtesy of 
Dr. Roisin Moriarty) 
 
 
 
            
 
Figure 5.12: Luminescencent confocal image (left) and rainbow image (right) (λex = 458 
nm, λem = 610 nm) of fixed CHO cells incubated with [Ru(bpy)2(picCOOH)]2+ (70 × 
10−6 M) in 0.1% triton in PBS solution (pH 7.4) after 15 minutes at room temperature.  
(Images courtesy of Dr. Roisin Moriarty) 
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As discussed in detail in Chapter 1 Neugebauer et at.[4] have previously 
demonstrated the ability of [Ru(bpy)2(picCOOH)Arg8]10+ to transport across the cell 
membrane of SP2 cells.  This material was prepared here to extend these studies and 
examine its uptake for the first time in CHO cells.  As shown previously in Chapter 1, it 
was confirmed that the migration of the ruthenium dye-peptide in SP2 cells was quick 
and was complete after 10-15 minutes at room temperature in an irreversible process.  
All SP2 myeloma cells in a buffered solution were exposed to a final concentration of 
70 µM of [Ru(bpy)2(picCOOH)Arg8]10+ which led to bright luminescence within the 
cellular membrane and cell’s cytoplasm after only 2 minutes with minimal intensity 
from the background by comparison.  Over the next 10 minutes the dye-peptide 
continues to distribute throughout the cellular plasma with little evidence for targeted 
localisation within specific cell organelles as shown in Figure 5.13.  The z-stack images 
confirming the distribution of the ruthenium dye-peptide throughout the different SP2 
cell organelles is also shown in Figure 5.14.  
 
 
         
                               (a)      (b) 
 
Figure 5.13: Luminescencent confocal images (λex = 458 nm, λem = 610 nm) of live SP2  
myeloma cells incubated with [Ru(bpy)2(picCOOH)Arg8]10+ (70 × 10−6 M) after (a) 
after 10 minutes (rainbow image) and (b) after 48 minutes (luminescent image) in PBS 
(pH 7.4) at room temperature.  (Images courtesy of Dr. Roisin Moriarty) 
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Figure 5.14: Luminescencent confocal z-stack images (λex = 458 nm, λem = 610 nm) of 
live SP2  myeloma cells incubated with [Ru(bpy)2(picCOOH)Arg8]10+ (70 × 10−6 M) 
after 30 minutes in PBS (pH 7.4) at room temperature.  (Images courtesy of Dr. Roisin 
Moriarty) 
 
 
By comparison, uptake of the ruthenium dye-peptide in CHO cells does not 
appear to be as efficient as that for SP2 cells.  Internalisation of the ruthenium dye-
peptide in SP2 cells was complete after 10-15 minutes, whereas under the same 
conditions, uptake of the ruthenium probe in CHO cells was observed to the same extent 
over time frames of upwards of 40 minutes as shown in Figure 5.15 as indicated by the 
luminescent intensity of the dye inside the cells.  Even then distribution of the dye 
within cell organelles is not the same as seen for SP2 cells.  The ruthenium probe seems 
to distribute throughout the cellular plasma with little localisation in any CHO cell 
organelles.  The longer uptake times of [Ru(bpy)2(picCOOH)Arg8]10+ may partially 
account for their decreased cytotoxicity in CHO cells when compared to other transition 
metal probes as discussed in Section 5.5.3.   
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Figure 5.15: Luminescencent confocal image (left) and rainbow image (right) (λex = 458 
nm, λem = 610 nm) of live CHO cells incubated with [Ru(bpy)2(picCOOH)Arg8]10+ (70 × 
10−6 M) after 40 minutes in PBS (pH 7.4)  at room temperature.  (Images courtesy of 
Dr. Roisin Moriarty) 
 
 
 
5.5.2 Iridium (III) Conjugated Peptide 
 
 
The synthesis of the iridium (III) conjugated peptide proved more problematic 
than the ruthenium (II) conjugated polypeptide.  This was largely due the poor aqueous 
solubility of the iridium dye, however, the isolated yield was identical to that of the 
ruthenium peptide.  Many solvent combinations were tried to dissolve the unpurified 
dye peptide including DMSO, methanol, water and DMF for HPLC purification 
purposes.  Finally, it was found that a mixture of 5% trifluoroacetic acid (TFA) in water 
was a suitable solvent mixture for the HPLC purification of the iridium peptide.  
MALDI-TOF mass spec analysis of the product is shown in Figure 5.16 below with the 
molecular dye-peptide ion of interested present at 2274 m/z.  HPLC confirmed the 
purity of the iridium dye-peptide with a single peak retention time of 30.27 minutes 
with the HPLC conditions as outlined in Chapter 2.   
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Figure 5.16: MALDI-TOF mass spectrum of [Ir(dfpp)2(picCOOH)Arg8]9+ with the 
molecular ion of interest at 2274 m/z. 
 
 
 Figure 5.17 illustrates the absorbance and emission spectra of the free iridium 
(III) polypyridyl parent dye and the corresponding iridium dye-peptide.  As seen 
previously in Chapter 4, the UV-vis spectrum of [Ir(dfpp)2(picCOOH)]+ displays a LC 
difluorophenyl pyridine π-π* electronic transitions giving maximum absorbance peaks 
at 246 nm and 282 nm.  The shoulder at 325 nm may be assigned to the intraligand π-π* 
transition of the [picCOOH] ligand and is pH dependent, as are the π-π* transitions at 
246 nm and 282 nm.  There is evidence of a MLCT transition from the iridium dπ to 
[dfpp] π* orbital at 416 nm in PBS buffered (pH7.4) solution containing 1% DMSO, 
which is red shifted when compared to the corresponding complex in acetonitrile 
solution. 
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Figure 5.17: Overlaid absorbance and normalised emission spectra (excited at 380 nm, 
slit widths: 5 nm, normalised to 0.5 arbitrary units) of 20 x 10-6M 
[Ir(dfpp)2(picCOOH)]+ in PBS buffer (pH 7.4 + 1% DMSO) solution and 
[Ir(dfpp)2(picCOOH)Arg8]9+ in PBS buffer (pH 7.4) solution. 
 
 
 The UV-vis spectra of [Ir(dfpp)2(picCOOH)Arg8]9+ is dominated by a peptide 
absorbance peak at 262 nm.  There is evidence of a shoulder at 330 nm due to the 
intraligand π-π* transition of the [picCOOH] ligand.  There is also evidence of a slight 
MLCT absorbance peak at 387 nm.  The emission spectrum of the free iridium dye has 
a maximum emission at 537 nm and the corresponding dye-peptide has a slightly red 
shift emission at 543 nm in comparison.  Table 5.2 outlines both the lifetimes and 
quantum yields of the free iridium and coupled iridium dye-peptide.  It shows that there 
are no significant differences between the lifetimes and quantum yields following 
conjugation to octarginine and the values are similar to those already determined in 
Chapter 4.   
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Compound Lifetimea  
(percentage component) 
x2 Value Quantum 
Yieldb 
[Ir(dfpp)2(picCOOH)]+ 142 +/- 5 ns 
(92%) 
13 +/- 2 ns 
(8%) 
0.897 0.115 
[Ir(dfpp)2(picCOOH)Arg8]9+ 153 +/- 7 ns 
(94%) 
10 +/- 3 ns 
(6%) 
0.921 0.109 
Table 5.2: Photophysical comparison of parent iridium dye versus dye-conjugate. 
 
a
 Biexponential lifetimes measured in degassed PBS buffer solution (pH 7.4) at room 
temperature.  
b
 Photoluminescent quantum yield (ɸ) in PBS buffer solution (pH 7.4) at room 
temperature, using [Ru(bpy)3]2+ as standard . 
*(Buffer contains 1% DMSO in the case of the free dye measurements) 
 
 
A key difficulty in the application of inorganic dyes to cellular imaging is their 
inability to penetrate the cytoplasmic membrane of the living cell.  This is greatly 
amplified by the poor aqueous solubility of the [Ir(dfpp)2(picCOOH)]+ dye.  As 
discussed in Chapter 1, iridium (III) dyes have been used before to image cells, 
however, solvents such as DMSO have been employed in the imaging process to aid 
with solubility issues.[16]  Low concentrations of DMSO (< 1%) have been reported in 
the study of SP2 myeloma cells without significant adverse effects on the cells 
themselves.[17-19]  However, it is noted that due to the toxic nature of such a solvent, it 
calls into question the viability of the cells.[2, 3]  The implications of using organic 
solvents, in particular ethanol and DMSO, on the viability of a cell during cellular 
imaging is discussed in Section 5.5.3.2.    
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5.5.2.1 Cell Uptake of [Ir(dfpp)2(picCOOH)]+ and [Ir(dfpp)2(picCOOH)Arg8]9+ 
 
As preformed previously for the ruthenium cellular uptake experiments, SP2 and 
CHO cells were cultured separately on 35 mm glass bottom culture dishes and 20 µl of 
the iridium parent complex (1.4 mM) or iridium dye-peptide (1.4 mM) in PBS (pH 7.4, 
with MgCl2 and CaCl2) was added.  The luminophore and dye-peptide were made to a 
final concentration of 70 µM with PBS (pH 7.4) except for the iridium parent complex 
which made to 70 µM in 0.05% DMSO in PBS (1:20 dilution from stock with 1% 
DMSO) and were imaged immediately. 
As Figure 5.18 shows, surprisingly, the iridium (III) parent dye transports across 
the membrane passively after less than 10 minutes.  Initially the dye is located in the 
cell’s membrane after approximately 10 minutes at room temperature in PBS (pH 7.4 
containing 0.05% DMSO) as shown in Figure 5.18 (a).  However, it is thought that the 
use of DMSO as co-solvent, to help with solubility of the dye, has permeabilised the 
cell membrane.   
 
The vesicles observed in the SP2 cell after 30 minutes (Figure 5.18 (b)) is an 
indication of cell death.  Vesicle formation also occurs in endocytosis, however as 
discussed in Section 5.5.3, the iridium (III) complex exhibits extremely high 
cytotoxicity in comparison to the ruthenium parent luminophore which does not display 
any signs of vesicle formation in SP2 cells following 30 minutes at room temperature.  
This is further confirmed when the nuclear staining dye of dead cells, DRAQ7, showed 
some penetration of SP2 cells without the iridium luminophore present after 30 minutes 
in PBS (pH 7.4 containing 0.05% DMSO).  However, under identical conditions with 
the iridium (III) complex present, the DRAQ7 dye displayed evidence of the nuclear 
staining of cells indicating cell death.  In contrast, the ruthenium luminophore showed 
little evidence of DRAQ7 nuclear staining both with and without the ruthenium 
complex present in PBS (pH 7.4) after 30 minutes.  Following incubation with the dye 
overnight at 37oC the iridium luminophore has completely permeated the cell’s 
cytoplasm.  Z-stack images of the cells confirm the distribution of the dye throughout 
the whole cell [images not shown].  
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                  (a)   (b) (c) 
Figure 5.18: Luminescencent confocal images (λex = 375 nm, λem = 520 nm) of live SP2  
myeloma cells incubated with [Ir(dfpp)2(picCOOH)]+ (70 × 10−6 M) after (a) 10 
minutes at room temperature, (b) 30 minutes at room temperature and (c) overnight at 
37 oC in PBS (pH 7.4 containing 0.05% DMSO).  (Images courtesy of Dr. Roisin 
Moriarty) 
 
 
 Longer uptake times and results are observed for the interaction of the 
[Ir(dfpp)2(picCOOH)]+ complex with CHO cells as illustrated in Figure 5.19.  Figure 
5.19 (a) shows little uptake of the iridium dye following 5 minutes incubation, however, 
after a time period of 40 minutes (Figure 5.19 (b) and (c)) at room temperature the dye 
is distributed throughout the cell’s cytoplasm but without ever entering the nucleus of 
the cell.  Once again there is evidence of cellular vesicles indicating potential cell death.  
In contrast the ruthenium parent complex did not exhibit transmembrane transport after 
40 minutes incubation time as seen here for the iridium equivalent.  Figure 5.20 
demonstrates the emission profile and luminescent image of the iridium dye in a CHO 
cell compared with the surrounding media.  Luminescence from inside the cellular 
structure corresponds to the characteristic emission of [Ir(dfpp)2(picCOOH)]+ at ~520 
nm (Figure  5.20 - region of interest 2).  Furthermore, minimal emission intensity is 
detected this wavelength as a result of the background luminescence in Figure 5.20 - 
region of interest 1. 
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      (a)                        (b)            (c) 
 
Figure 5.19: Confocal images (λex = 375 nm, λem = 520 nm) of live CHO cells incubated 
with [Ir(dfpp)2(picCOOH)]+ (70 × 10−6 M) after (a) 5 minutes at room temperature 
(rainbow image), (b) 40 minutes at room temperature (luminescent image) and (c) 40 
minutes in PBS (pH 7.4 containing 0.05% DMSO) at room temperature (rainbow 
image).  (Images courtesy of Dr. Roisin Moriarty) 
 
 
 
Figure 5.20: Emission intensity profile and luminescent confocal image (λex = 375 nm, 
λem = 520 nm) of live CHO cells incubated with [Ir(dfpp)2(picCOOH)]+ (70 × 10−6 M) 
after 30 minutes in PBS (pH 7.4 containing 0.05% DMSO) at room temperature.  
(Image courtesy of Dr. Roisin Moriarty) 
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Importantly, the distribution of the iridium dye-conjugate in both SP2 and CHO 
cells is different to that of the parent iridium dye complex.  Figure 5.21 displays the 
distribution of the iridium peptide in SP2 myeloma cells.  Figure 5.21 (a) shows that the 
dye-peptide is initially concentrated in the cell membrane after 5-10 minutes at room 
temperature.  The centre of this particular group of cells in Figure 5.21 (a) is protected 
from the iridium dye-peptide and therefore the observed uptake in these cells is less then 
that of the cells located around the edges.  After approximately 40 minutes at room 
temperature complete internalisation of the dye is observed in the cell’s cytoplasm and 
what appears to be the nuclear membrane as shown in Figure 5.21 (b).  However, Figure 
5.21 (c) suggests that the cellular walls of the SP2 cells have been disrupted following 
incubation with the parent dye for 50 minutes at room temperature.  This finding is 
supported by DRAQ7 staining of the SP2 cells after 50 minutes, which localises in the 
nucleus confirming cell death.  The high mortality rate of SP2 cells following 
incubation with the iridium-peptide is further confirmed by cytotoxicity studies of the 
dye-peptide in Section 5.5.3.  Z-stack images in Figure 5.22 shows the distribution of 
the dye-peptide in the SP2 cell membrane over a time frame of 18-24.5 minutes whilst 
imaging at room temperature.   
 
                 
      (a)                        (b)            (c) 
 
Figure 5.21: Luminescent confocal images (λex = 375 nm, λem = 520 nm) of live SP2 
myeloma cells incubated with [Ir(dfpp)2(picCOOH)Arg8]9+ (70 × 10−6 M) after (a) 5 
minutes, (b) and (c) 50 minutes in PBS (pH 7.4) at room temperature.  (Images courtesy 
of Dr. Roisin Moriarty) 
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Figure 5.22: Luminescent confocal z-stack images (λex = 375 nm, λem = 520 nm) of live 
SP2 myeloma cells incubated with [Ir(dfpp)2(picCOOH)Arg8]9+ (70 × 10−6 M) after 18-
24.5 minutes in PBS (pH 7.4) at room temperature.  (Images courtesy of Dr. Roisin 
Moriarty) 
 
 
 As expected, the transmembrane transport of the iridium dye-peptide into CHO 
cells proved to be much quicker than for the corresponding [Ir(dfpp)2(picCOOH)]+ 
complex and full penetration of the cell membrane is evident after only 10 minutes 
(Figure 5.23 (b)).  As seen previously in SP2 cells, the dye-peptide is initially 
concentrated in the cell membrane of the CHO cells.  Following a period of about 10 
minutes the dye-peptide is located throughout the CHO cell’s membrane, cytoplasm, 
nuclear membrane and inside the nucleus itself.  However, following an incubation time 
of 30 minutes at room temperature the iridium conjugate permeates the whole CHO 
cell, making identification of internal cell organelles difficult as illustrated in Figure 
5.23 (c).  Once again there is evidence of the formation of vesicles inside the cellular 
structure after only 10 minutes indicating the start of cell death.  
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      (a)                        (b)            (c) 
Figure 5.23: Luminescent confocal images (λex = 375 nm, λem = 520 nm) of live CHO 
cells incubated with [Ir(dfpp)2(picCOOH)Arg8]9+ (70 × 10−6 M) after (a) 5 minutes, (b) 
10 minutes and (c) 30 minutes in PBS (pH 7.4) at room temperature.  (Images courtesy 
of Dr. Roisin Moriarty) 
 
 
 Figure 5.24 shows the luminescent cross section of the iridium-peptide in live 
CHO cells after 25 minutes at room temperature.  A z-stack image in Figure 5.25 
confirms the distribution of the dye-peptide throughout the CHO cells.  In comparison 
the ruthenium peptide also exhibits a bright a luminescence from inside the CHO cells 
and is distributed throughout the cell’s cytoplasm, however, it is not localised as 
noticeably in specific cell organelles after a 40 minutes as shown in Figure 5.15.  
However the cytotoxicity for the iridium-peptide is far greater than the ruthenium-
peptide in CHO cells, vide infra. 
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Figure 5.24: Luminescent confocal image (λex = 375 nm, λem = 520 nm) showing 
luminescent cross section of a live CHO cell incubated with 
[Ir(dfpp)2(picCOOH)Arg8]9+ (70 × 10−6 M) after 25 minutes in PBS (pH 7.4) at room 
temperature.  (Image courtesy of Dr. Roisin Moriarty) 
 
 
Figure 5.25: Luminescent confocal z-stack images (λex = 375 nm, λem = 520 nm) of live 
CHO cells incubated with [Ir(dfpp)2(picCOOH)Arg8]9+ (70 × 10−6 M) after 18-24.5 
minutes in PBS (pH 7.4) at room temperature.  (Images courtesy of Dr. Roisin 
Moriarty) 
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5.5.3 Cytotoxicity Studies 
 
 With the evidence of vesicle formation, in particular in both SP2 and CHO cells 
following incubation with the iridium (III) complex, it is important to assess the 
potential toxic effects of the metal complexes on the cell lines.  The cytotoxic effect of 
the parent luminophores and dye-peptides was determined using the reasazurin viability 
assay which is explained in detail in the introduction.  Both cell lines were incubated 
with parent luminophores and dye-peptides in PBS (pH 7.4) overnight at 37oC in the 
dark over a range of concentrations and their cell viability results were determined the 
following day.   
 
Figures 5.26 and 5.27 below illustrate the cytotoxic effect of the parent 
luminophores and conjugated dye-peptides on SP2 myeloma and CHO cell lines 
respectively.  It is evident from both sets of results that the iridium (III) complex 
exhibits a toxic effect on the cells well above that of the ruthenium (II) complexes.  
Since the cytotoxicity experiments were performed in the dark, the cell death as a result 
of the singlet oxygen generating ability of the complex is considered to be minimal.  
Other factors that may explain the increased cytotoxicity of the iridium probe include 
the fluorination of the cyclometalating iridium (III) ligands as any potential reduction in 
the ligand in the cells may lead to the formation of fluoride, which is known to be 
highly toxic at high concentrations.[20]  In addition, the iridium metal centre is much 
larger than that of the ruthenium metal centre and as a result is not as well protected by 
the coordinated ligands from potential interactions with the surrounding cell.  This may 
result in increased cytotoxicity in cells due to the toxic iridium metal centre. 
 
The iridium polypeptide shows the greatest cytotoxicity of all the complexes 
analysed even above that of the iridium parent using DMSO as a solvent.  This is 
thought to be due to the more localised, increased and faster cellular uptake of the 
iridium peptide when compared to the iridium parent dye.  Previous results have 
indicated significant uptake of the iridium peptide occurs after only after 10 minutes, 
whereas, much longer time periods are required for similar uptake by the parent iridium 
complex, facilitated by the use of DMSO as co-solvent. 
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By comparison, the ruthenium moieties display much lower cytotoxicity in both 
SP2 and CHO cell lines when compared to the iridium equivalents.  This may be due to 
a number of things including a smaller ruthenium metal centre and no fluorination of 
cyclometalating ligands.  The ruthenium polypeptide displayed very similar cytotoxicity 
to that of the ruthenium parent dye in both cell lines.  This is very interesting 
considering that the ruthenium parent dye has been shown previously not to transport 
across the cell membrane of either cell lines without permeabilisation, whereas, the 
ruthenium dye-peptide showed internalisation inside SP2 cells after 10 minutes and 
CHO cells after approximately 50 minutes.  The relatively low cytotoxicity, up to a 
concentration of 140 µM, of the ruthenium polypeptide probe further supports its use as 
a molecular probe for multimodal imaging purposes.      
 
   
 
 
Figure 5.26: SP2 myeloma cell cytotoxicity at different concentrations of the parent 
luminophore and dye-peptide complex.  Resazurin assay (n=4) was used to determine 
the cytotoxic effects of the complexes on the cell line following incubation overnight at 
37oC.  (Data courtesy of Dr. Roisin Moriarty) 
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Figure 5.27: CHO cell cytotoxicity at different concentrations of the parent 
luminophore and dye-peptide complex.  Resazurin assay (n=4) was used to determine 
the cytotoxic effects of the complexes on the cell line following incubation overnight at 
37oC.  (Data courtesy of Dr. Roisin Moriarty) 
 
 
 The increased cytotoxicity of the iridium (III) peptide when compared to the 
ruthenium (II) peptide in CHO cell lines is highlighted again in Figure 5.28 below.  
Following incubation with the dye-peptides in the dark for approximately 35 minutes, 
DRAQ7, was added to the cells under analysis for approximately 15 minutes.  DRAQ7 
is a far red fluorescent DNA dye that only stains the nuclei of dead and permeabilised 
cells and does not enter intact live cells.  Furthermore, it is also non-toxic to cells.  
Figure 5.28 shows no luminescence from the DRAQ7 in the CHO cells and only the 
emission from [Ru(bpy)2(picCOOH)Arg8]10+ is detected.  This suggests that the CHO 
cells remain alive during the analysis of the ruthenium conjugate of up to 50 minutes.  
This observation is also seen for the ruthenium-peptide in SP2 cells [image not shown] 
and this is further supported by co-localisation studies performed by Neugebauer et 
al.[4] involving the distribution of the ruthenium (II) peptide in SP2 cells as discussed in 
Chapter 1.   
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   (a)          (b) 
Figure 5.28: Confocal images (λex = 458 nm, λem = 610 nm) of fixed CHO cells 
incubated with [Ru(bpy)2(picCOOH)Arg8]10+ (70 × 10−6 M) and DRAQ 7 (4 × 10−6 M – 
excited at 633 nm) after 50 minutes in PBS (pH7.4) at room temperature.  (a) 
Backscatter image and (b) luminescent image.  (Images courtesy of Dr. Roisin 
Moriarty) 
 
On the other hand, Figure 5.29 displays bright luminescence inside the nucleus 
of both SP2 and CHO cells following 50 minutes incubation with the 
[Ir(dfpp)2(picCOOH)Arg8]9+ conjugate at room temperature in the dark.  This signals 
the unquestionable cell death of CHO cells as a result of incubation with the iridium 
molecular probe even without scanning continuously at 375 nm.  
                 
           (a)            (b) 
Figure 5.29: Luminescent confocal image (λex = 375 nm, λem = 520 nm) of (a) SP2 and 
(b) CHO cells incubated with [Ir(dfpp)2(picCOOH)Arg8]9+ (70 × 10−6 M) and DRAQ 7 
(4 × 10−6 M – excited at 633 nm) after 50 minutes in PBS (pH7.4) at room temperature.    
(Images courtesy of Dr. Roisin Moriarty) 
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The resazurin cytotoxicity studies performed involve incubating the complexes 
with the cells overnight in the dark at 37oC and determining cell death by absorbance of 
resorufin produced at 570 nm.  Hence, one critical factor yet to be fully considered is 
the continuous wavelength of excitation used for both iridium complexes (375 nm) and 
ruthenium complexes (458 nm).  The higher energy of excitation of the iridium 
complexes, when compared to the ruthenium complexes, also accounts for its visible 
signs of increased cell death in both SP2 and CHO cells.  This is found to be the case as 
DRAQ7 staining is evident for both ruthenium and iridium luminophores in SP2 and 
CHO cells after 50 minutes following continuous irradiation at 375 nm.  Figure 5.30 
shows extensive DRAQ7 nuclear staining of SP2 cells when incubated with 
[Ru(bpy)2(picCOOH)Arg8]10+ at room temperature for 50 minutes following constant 
irradiation at 375 nm.  In general, such extensive cell death was not observed under 
identical conditions using a continuous excitation wavelength of 458 nm [image not 
shown].   
 
 
Figure 5.30: Confocal images (λex = 375 nm, λem = 610 nm) of SP2 cells incubated with 
[Ru(bpy)2(picCOOH)Arg8]10+ (70 × 10−6 M) and DRAQ 7 (4 × 10−6 M – excited at 633 
nm) after 50 minutes in PBS (pH7.4) at room temperature.  (Image courtesy of Dr. 
Roisin Moriarty) 
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Interestingly, when no dye is present under continuous excitation at 375 nm 
there is minimal evidence of cell death, as observed with the viability dye DRAQ7 
nuclear stain as shown in Figure 5.31 for CHO cells.  Therefore, it may be concluded 
that the iridium complex itself and in particular excitation of the iridium dye at 375 nm 
at shorter time frames causes a significant contribution to cell death.  Furthermore, after 
image acquisition and continuous 375 nm laser scanning for 60 minutes of the iridium 
dye-peptide, 90% of the cells were dead as observed with DRAQ7 nuclear dye.  In 
addition, when moving to a different field of view there is less evidence of staining for 
DRAQ7.  This suggests that the increased cell death is due to a light activated process, 
which most likely considered to be the generation of singlet oxygen (1O2).  This is 
further supported by preliminary experiments using ascorbic acid as a singlet oxygen 
scavenger[21] which has resulted in a reduction in cell cytotoxicity of the iridium peptide 
from 50% to 5% under similar experimental conditions outlined here. 
 
 Figure 5.31: Confocal rainbow image (λex = 375 nm, λem = 610 nm) of CHO cells with 
DRAQ 7 (4 × 10−6 M – excited at 633 nm) after 50 minutes in PBS (pH 7.4) following 
continuous irradiation at 375 nm at room temperature.  (Image courtesy of Dr. Roisin 
Moriarty) 
 
 
 263 
In general however, the ruthenium peptide (when excited at 458 nm) also 
appears to be inducing some cell death but this is not necessarily due to the laser as 
different fields of view have different cell death populations.  Similarly, the iridium 
peptide (when excited with the 375 nm laser) is inducing cell death but this is dependent 
on the laser at shorter time frames as different fields of view have different cell death as 
observed by DRAQ7 nuclear staining.  It has been shown the iridium induces cell death 
after 16 hours exposure at 37oC in the dark in the cytotoxicity studies, but one of the 
main contributing factor to cell death following 1 hour exposure time at room 
temperature seems to be the 375 nm laser excitation.  The rapidly induced cell death 
using the iridium probe at 375 nm excitation is highlighted by the fact that the DRAQ7 
mean pixel intensity goes from 1.41 to 5.94 after only 4 scans on the confocal 
microscope. 
In general, it also appears that upon increased light exposure to cells containing 
dye, the emission intensity also increases with time.  The cause of this could be two 
fold:  firstly, the effect of the 375 nm laser when the dye is present is known to damage 
cell viability and could cause membrane disruption leading to further dye leakage into 
the cells.  Or secondly, light exposure of the inorganic complexes can cause an 
increased production of singlet oxygen, and therefore a decrease in molecular oxygen in 
the cell, which could in turn induce changes in pH of the cells.  This will have an impact 
on the emission intensity of the luminophores as they have been shown previously in 
Chapters 3 & 4 to be very pH sensitive.  For example, the emission intensity of the 
iridium dye increases with decreasing pH and this could also account for the increases 
in emission intensity in the observed confocal images after 15 minutes incubation and 
peaking at 40/60 minutes [images not shown].  A further factor yet to be fully 
considered is the fact that imaging of the cells takes place at room temperature and 
without a 5% CO2 controlled environment.  This may cause additional stresses on the 
cells which could also lead to increased apoptosis. 
Overall, however, it can be concluded that phototoxicity of the luminophores is 
having a dramatic impact on the cell viability under the imaging conditions.  The 
damaged cell is either up-taking more dye than an intact one or changes in pH and 
singlet oxygen generation of these dyes is causing an increase in the overall intensity of 
the luminophore within the cells.  In light of the research reported by Djurovich et 
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al.[22], it is also considered that the increased cytotoxicity of the iridium luminophore in 
both SP2 and CHO cell lines following photoexcitation, when compared to the 
ruthenium luminophore, is potentially due to its longer triplet state lifetimes, higher 
quantum yield efficiencies and that its 1O2 generation may be a result of both energy 
and electron transfer processes.  Additional experiments in the near future intend to use 
FLIM measurements to help in determining any variations in the oxygen concentrations 
in SP2 and CHO cell lines using both ruthenium and iridium molecular probes as a 
result of experimental conditions.   
Other factors that may attribute to the overall cell death could be the decreased 
ability of endogenous enzymes, such as superoxide dismutase and catalase to combat 
the increase in free radical generation as seen with the iridium dye due to imaging 
conditions at room temperature.  In reality however, there are many different biological 
processes happening on a sub-cellular level that may have a significant effect on the 
luminophores once inside the cell and systematically examining all possibilities entails a 
great body of work that will be studied over the coming months.   
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5.5.3.1 IC50 Values 
 In order to assess and compare the effects of drugs / molecular cargo on a 
particular cell line it is important to determine their IC50 value.  The IC50 value is the 
concentration at which 50% cell death has occurred in the cell population under 
analysis.  The IC50 values for the luminophores and dye-peptides synthesised here were 
calculated using Prism statistic analysis software using the cytotoxicity results 
determined previously.  The IC50 for the ruthenium parent and conjugate could not be 
determined as there was minimal inhibition up to a concentration of 140 µM in SP2 and 
CHO cell lines.  For comparison, Liu et al.[23] reported IC50 values of 95.33 µM (in 
BEL-7402 cells), 22.77 µM (in C-6 cells), 102.01 µM (in hepG-2 cells) and 23.00 µM 
(in MCF-7 cells) for the [Ru(bpy)2(picNH2)]2+ complex in Chapter 3.  All of which 
exhibited less cytotoxicity towards the selected cell lines when compared to cisplatin 
and therefore, would not be considered as a potential anti cancer agent.  There is not 
much published on the IC50 values on either ruthenium or iridium and their conjugates, 
particularly in SP2 and CHO cell lines.  
 
IC50 Values SP2 CHO 
[Ir(dfpp)2(picCOOH)]+ 118.7 µM 102.3 µM 
[Ir(dfpp)2(picCOOH)Arg8]9+ 63.9 µM 85.5 µM 
Table 5.3: IC50 values for [Ir(dfpp)2(picCOOH)]+ and [Ir(dfpp)2(picCOOH)Arg8]9+ in 
SP2 and CHO cell lines. 
 
The IC50 values for the iridium complexes are shown in Table 5.3 above.  As 
expected, the iridium conjugate displayed lower IC50 values when compared with 
[Ir(dfpp)2(picCOOH)]+ due to more efficient and faster uptake times as a result of the 
attached peptide.  Interestingly, the cytotoxicity of the iridium peptide is greater in SP2 
cells in comparison to CHO cells.  These results also have implications for the cell 
experiments performed here as a final concentration of 70 µM is used for confocal 
measurements throughout this chapter.  This implies that approximately 50% of cell 
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death may be attributed to the iridium complex prior to any analysis being undertaken.  
Therefore, it is suggested that future cell experiments should be performed at 
concentrations lower than 70 µM.  The majority of the cell experiments performed in 
the literature use final concentrations of between 20-50 µM. 
 Zhang et al.[24] reported of the considerable cytotoxicity of a series of iridium 
complexes towards HeLa and MDCK cell lines as the majority of complexes had a IC50 
value < 10 µM..  Rijt et al.[25] also supported results here that an osmium conjugate 
exhibited more cytotoxicity when compared to the parent complex as seen for the 
iridium conjugate.  This particular osmium conjugate showed very promising activity 
with an IC50 of only 4.5 µM towards the A2780 human ovarian cancer cell line. 
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5.5.3.2 Effects of Organic Solvents on SP2 Myeloma and CHO Cell Viability   
 
 
 As DMSO was used in the media to encourage dissolution of the iridium (III) 
parent complex it was decided to examine any potential effect such an organic solvent 
might have on the viability of SP2 and CHO cell lines.  To our knowledge this is the 
first systematic study of its kind to highlight the potential implications of using 
commonly reported solvents, such as DMSO and ethanol, in cellular imaging.  In order 
to asses the cytotoxicity of organic solvents on a particular cell line, an assay for 
measuring the activity of the cell population must be performed.  The assays used here 
included the resazurin and MTT cell viability assays respectively, which are fully 
discussed in the introduction. 
PBS solvent containing DMSO and ethanol with final concentrations of between 
20 to 0.3 % were added to the harvested cells and left for 16 hours at 37oC in a 5% CO2 
incubator.  10 µl of either the MTT or resazurin reagents were added and incubated for 
4 hours for MTT and 7 hours for resazurin at 37oC.  Formazan was solubilised with 150 
µl DMSO per well for MTT assay and absorbance was measured at 570 nm and 630 nm 
(background).  The resazurin converted to resorufin in viable cells was detected at 
absorbance 570 nm with background subtracted at 600 nm.  Figures 5.32 and 5.33 
illustrate the cytotoxic effect on SP2 myeloma cell lines of ethanol and DMSO using the 
resazurin and MTT assays respectively.  The cytotoxicity of DMSO proved to be far 
greater towards SP2 cells with 100% cell cytotoxicity at a DMSO concentration of 20% 
in PBS buffer using the resazurin assay.  These results are confirmed using a MTT 
assay that yielded a comparable cell death at a DMSO concentration of 20%.  
Conversely, a solution containing 20% ethanol only exhibited a SP2 cell population 
death of approximately 60% using the resazurin assay. 
Several papers published on metal complexes used for the purpose of cellular 
imaging used a 1% DMSO solution as standard in the cellular uptake analysis.  
According to the results obtained here, a 1% DMSO solution would correspond to a cell 
population death ranging from on average from 10-20%.  This could prove significant 
as the potential toxicity of the transition metal complex and its singlet oxygen 
generating ability is not taken into account as this could lead to additional significant 
cell apoptosis.   
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Figure 5.32: SP2 myeloma cell cytotoxicity with various concentrations of ethanol and 
DMSO.  Measurements were performed using a resazurin assay (n=3).  Experiments 
were performed in PBS solution following incubation for 16 hours at 37oC.  (Data 
courtesy of Dr. Roisin Moriarty) 
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Figure 5.33: SP2 myeloma cell cytotoxicity with various concentrations of DMSO.  
Measurements were performed using a MTT assay (n=3).  Experiments were performed 
in PBS solution following incubation for 16 hours at 37oC.  (Data courtesy of Dr. Roisin 
Moriarty) 
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Similar cytotoxicity studies were performed using CHO cells.  The cytotoxicity 
of ethanol proved to be far greater towards CHO cells when compared to SP2 cell lines, 
with 100% cell death with an ethanol concentration of ~20% as illustrated in Figure 
5.34.  Additionally, at lower concentrations of DMSO (1%) there is a considerable 
increase in the cytotoxicity towards CHO cells to approximately on average 30% when 
compared to the SP2 cell line at similar DMSO concentrations as illustrated by the MTT 
assay in Figure 5.35.  
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Figure 5.34: CHO cell cytotoxicity with various concentrations of ethanol and DMSO.  
Measurements were performed using a resazurin assay (n=3).  Experiments were 
performed in PBS solution following incubation for 16 hours at 37oC.  (Data courtesy of 
Dr. Roisin Moriarty) 
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Figure 5.35: CHO cell cytotoxicity with various concentrations of DMSO.  
Measurements were performed using a MTT assay (n=3). Experiments were performed 
in PBS solution following incubation for 16 hours at 37oC.  (Data courtesy of Dr. Roisin 
Moriarty) 
The effects of using DMSO as solvent in cellular imaging is also confirmed 
using the water soluble [Ru(bpy)2(picCOOH)]2+ dye in a solution containing 1% 
DMSO.  It has been seen before how this particular ruthenium complex probe failed to 
transfer efficiently across the cellular membrane of SP2 myeloma cells in aqueous 
conditions.  However, upon addition of 1% DMSO to the solution, the dye showed signs 
of transport across the cellular membrane [results not shown].  The presence of the dye 
throughout the whole cell cytoplasm was confirmed by z-stack images of the cell.  
Unfortunately, the use of very low concentrations of organic solvent remains 
unavoidable as solubility of the parent iridium (III) dye in aqueous buffer is extremely 
poor.  Thus a key advantage, as outlined in this chapter, for the conjugation of a metal 
complex to a polypeptide is the increased water solubility, membrane penetrating ability 
and localisation of the dye-conjugate in SP2 and CHO cells.  This allows for the 
molecular probe to be exploited for cellular imaging analysis.  Further experiments are 
currently underway to determine the suitability of the iridium dye-peptide in 
determining intracellular pH (using Raman spectroscopy) and oxygen (using FLIM) 
levels as this luminophore has also been shown to be both pH and oxygen sensitive. 
Other worthwhile experiments would include studying at the photostability and 
bleaching of the luminophores inside the cells following excitation. 
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5.6 Conclusion 
  
 This chapter details the conjugation of ruthenium (II) and novel iridium (III) 
polypyridyl luminophores to the cell penetrating peptide octarginine.  The synthesis of 
the dye-peptides proceeded with relatively low yields (34%) and the purification of the 
iridium-conjugate proved to be more challenging due to its aqueous solubility issues.  
Prior to biomolecule conjugation, neither parent complex exhibited efficient transport 
across the cell membrane of SP2 myeloma and CHO cell lines.  However, 
internalisation of the [Ir(dfpp)2(picCOOH)]+ parent complex was achieved in both cell 
lines after approximately 40 minutes at room temperature when DMSO was used as co-
solvent.  This is due to the disruption of the cell membrane caused by this solvent.  
Studies to determine the effects of DMSO on a cell’s viability indicated that a 1% 
DMSO solution resulted in approximately a 10-20% cell death in SP2 cells and 
approximately a 30% cell death in CHO cells. 
 
However, once both inorganic luminophores were coupled to the CPP this 
permitted their dissolution in buffered aqueous media without the need for an organic 
solvent.  Both complex conjugates underwent diffusion across the cell membrane of 
both SP2 and CHO cells after only 10-15 minutes incubation time at room temperature.  
In general, this led to the localisation of the dyes within the cell’s membrane, cytoplasm 
and nuclear membrane of SP2 and CHO cells.  Confocal fluorescence microscopy and 
z-stack images were used to determine the distribution of the dyes throughout the cells. 
 
 Following conjugation of the luminophores to the CPPs, the ruthenium probe 
remains the more attractive proposition for use as a molecular probe when compared to 
the iridium equivalent.  The ruthenium conjugate displayed an aqueous lifetime more 
then five times greater, however, its quantum yield is only 60% that seen for the iridium 
conjugate.  For the free dye in organic solvents, this situation is generally reversed with 
the iridium (III) polypyridyl complex displaying longer lifetimes and greater quantum 
yields.  Unfortunately in aqueous media, the iridium (III) complex does not exhibit 
lifetimes that are comparable with that of the ruthenium (II) complex.   
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Furthermore, the cytotoxicity of the iridium probe is far greater when compared 
to the ruthenium conjugate.  Extensive cell death was also exhibited in both SP2 and 
CHO cells at a final iridium conjugate concentration of 70 µM in times as short as 10 
minutes under 375 nm irradiation.  This was confirmed using a DRAQ7 localising dye, 
which only stains the nucleus of dead cells.  However, the ruthenium dye-peptide also 
exhibited increased cell death as a result of 375 nm irradiation when compared with 458 
nm excitation.  Interestingly, when no dye is present under continuous excitation at 375 
nm and 458 nm there is minimal evidence of cell death, as observed with the viability 
dye DRAQ7.  This suggests that the increased cell death of the iridium complexes is a 
result of the energy of excitation and also potentially due to a light activated process, 
which most likely thought to be the generation of singlet oxygen (1O2) through an 
electron and energy transfer process.  This is further supported by preliminary 
experiments using ascorbic acid as a singlet oxygen scavenger which has resulted in a 
reduction in cell cytotoxicity of the iridium peptide from 50% to 5% under similar 
experimental conditions preformed here.  Other explanations for its increased 
cytotoxicity may include the fluorination of the cyclometalating ligands, the larger 
iridium metal centre and longer phosphorescent quantum yields and lifetimes under 
particular conditions that will also have an impact on the generation of singlet oxygen.   
 
The next step, currently being undertaken by our group, is to attach target 
specific peptides to the dye-conjugates in an effort to localise the dye within certain 
organelles of the cell.  It is proposed that the ruthenium probe synthesised in this 
chapter may be more useful for imaging cells.  However, the iridium probe may be 
useful in targeting with a nuclear probe that could potentially result in the apoptosis of 
cancer cells.  However, the wavelength of excitation of the iridium probe is not as 
amiable to biological samples when compared with the ruthenium probe.  
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Chapter 6: Model Photoantennas Based on 
Interfacial DNA Scaffolds 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Science….never solves a problem without creating ten more” – George Bernard Shaw. 
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6.0 Introduction 
 
Many of the supramolecular assemblies studied today derive their inspiration 
from or directly include biological molecules.  Deoxyribonucleic acid (DNA) contains 
all the genetic information needed for the operation of every living organism.  DNA is a 
polymer of nucleotides, consisting of a phosphodiester and sugar backbone, to which 
one of four bases is attached.  It is the sequence of these bases that determines the type 
of genetic information encoded. 
 
The base units of DNA include adenine (A), guanine (G), cytosine (C) and 
thymidine (T).  Single stranded DNA has the unique ability to recognise and hybridise 
with its complementary base sequence to form a double stranded structure.  All of 
which is possible due to the capacity of each individual base unit to recognise its 
complementary base pair, for example A binds with T and G binds with C (Figure 6.1).  
This hybridising phenomenon has been used previously to synthetically assemble 
modified DNA sequences that are capable of detecting abnormalities in complementary 
DNA sequences.[1-5] 
 
 
 
Figure 6.1: Chemical structure of DNA double helix.[6]  
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6.1 Model Photoantennas based on Interfacial DNA Scaffolds 
 
 
This chapter outlines attempts to functionalise deoxyguanosine with a 
fluorescent marker in an effort to create a supramolecular photoantenna system.  It was 
hoped to exploit the self-assembly of single stranded DNA to its complementary strand 
to control the distance and orientation of the fluorophores in relation to one another.  
For example, if every 5-7 base pairs in a sequence were tagged with a fluorescent label, 
one could ensure that the chromophores would be located every half turn within the 
DNA double helix.  Using DNA as the interfacial scaffold, which has not been 
attempted before, allows an element of control with the interspatial separation between 
fluorescent moieties and therefore directly affect their photochemical properties to 
ensure efficient energy migration through the system.   The ability of DNA to support 
single-step energy transfer using single molecule spectroscopy has already been 
demonstrated.[7]  
 
It was anticipated that the functionalised DNA oligonucleotides could then be 
self-assembled on either gold or platinum if a thiol terminated DNA strand had been 
employed.  Single strands of alkane thiols or thiol terminated polyethylene glycol may 
be used to separate these DNA strands in an effort to help to prevent a lateral approach 
taken by the functionalised dyes and reduce quenching.  Electrostatic repulsion of the 
adjacent oligonucleotides should also aid in the lateral separation of the DNA double 
helixes. 
 
The ideal situation arises where the chromophores are close enough together to 
facilitate efficient energy transfer but also far enough apart to prevent self-quenching.  
Such quenchers are formed by close contact (<1 nm) of two or more chromophores.  In 
the completed system (Figure 6.2), the energy would migrate between the dyes arriving 
at the redox centre to create an electronically excited state.  This may then act as an 
energy readout for energy migration through the system, thus, hopefully providing an 
efficient method for the conversion of light energy into electrical energy using DNA as 
the backbone for the model photoantenna.  
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Figure 6.2: Schematic illustrating the model system: A thiol terminated oligonucleotide 
and its complimentary oligonucleotide which has been functionalised with a single 
chromophore with appropriate R0 for energy transfer to self at value at set sequences, 
typically every 5 to 7 bases.  The 3’ or 5’ end of the nucleotide will be functionalised 
with an acceptor chromophore and these will be incorporated into SAMs on gold.  
Alkane thiols or thiol-terminated polyethylene glycol will be used as an inert diluent in 
the SAM. 
 
 
 
With the push to find alternative fuels, the potential of artificial light-harvesting 
systems for the conversion of solar energy has been widely discussed for many years.  It 
has also been recognised that artificial photosynthesis has potential uses in molecular 
scale optoelectronics, photonics, sensor design, and other areas of nanotechnology.[8-10] 
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6.2 Internal Fluorescent Labelling of 2’-Deoxyguanosine 
 
 There are many examples in the literature of the internal labelling of molecules 
to the C-8 position of unprotected (deoxy)guanosine[11-16], fully protected 
deoxyguanosine[17-24], and the conjugation of ruthenium (II) luminophores[2, 25, 26] and 
fluorescein[5, 27-30] to nucleobases.  These publications serve as a good starting point for 
the synthetic aim of this chapter.  However, to the best of our knowledge, nobody has 
yet managed to internally tag a fluorescein molecule to the C-8 position of a purine base 
via a short rigid linker.  Many other smaller electron withdrawing and donating groups 
have been synthesised in the C-8 position with the inference that any molecule may be 
linked to the nucleoside using such chemistry. 
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Figure 6.3: 2’-Deoxyguanosine illustrating numbering scheme for 1H-NMR analysis. 
 
 
Interestingly, Salic et al.[5] described the incorporation of fluorescent molecules 
into a double stranded sequence of DNA.  Here, 5-ethynyl-2’-deoxyuridine was initially 
integrated into a single strand of DNA as shown in Figure 6.4.  Following hybridisation 
to its complementary DNA strand, using click chemistry, the available alkyne group 
was reacted with fluorescent azides, such as azidofluorescein, to give the fluorescently 
labelled nucleoside.    
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Figure 6.4: (A) Structure of 5-ethynyl-2’-deoxyuridine, (B) schematic diagram 
illustrating click reaction chemistry for the incorporation of a fluorescent azide to the 
terminal alkyne group available in the DNA double helix and (C) chemical structures of 
the fluorescent azides conjugated to the DNA double helix.[5] 
 
 
However, most applicably to work carried out in this chapter, it is only very 
recently that a group in Japan[22, 23] have successfully managed to couple the fluorescent 
2-bromofluorene molecule to deoxyguanosine in the C-8 position via a relatively short 
linker using the Stille method of coupling.  This luminophore-bioconjugate system 
exhibited fully reversible luminescent photoswitching characteristics when light of a 
certain wavelength was applied as shown in Figure 6.5.  This was then used in the 
photoregulation of G-quadruplex formation using cis-trans photoisomerisation of the 
nucleobase at room temperature.  G-quadruplexes are formed by stacked G-quartets, a 
planar association of four guanines, by hydrogen bonding.  They are found in guanine 
rich sequences and are involved in several key biological processes.  To demonstrate the 
potential application of this technology they reported the switching of molecular 
structures between a very stable quadruplex state bound to thrombin and a non-
structured state that disrupted and suppressed binding to thrombin, in a process that is 
totally reversible as shown in Figure 6.5 below.   
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Figure 6.5: (Top) Photoinduced cis-trans isomerisation of 8-fluorenylvinyl-2’-
deoxyguanosine.  (Bottom) Photoregulation of the thrombin aptamer G-quadruplex by 
cis-trans photoisomerisation of the photochromic nucleobase.[22] 
 
 
This chapter discusses attempts to use recent advances in DNA chemistry[3, 5, 11-
13, 20, 27, 30-33]
 to create a novel internally labelled 2’-deoxyguanosine molecule with a 
common fluorophore, fluorescein, via a short rigid linker to the C-8 position of the 
nucleobase.  Another significant application of these internally labelled nucleobases is 
their potential use in biomedical fields.  Much of the research into the early detection of 
biomarkers related to illnesses, such as cancer, is based on the use of a fluorescently 
modified DNA sequence binding to its complementary base sequence and monitoring 
the output of the attached fluorescent dye.  To date many of these detection systems 
have the fluorescent markers linked to the terminal of the sequence or through long 
linkers internally.[4, 26, 32]  The ability to have the fluorophore so close to the modified 
DNA strand could lead to a reduction in the outside interferences associated with 
medical diagnostics and may lead to increased sensitivity and detection.      
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6.3 Experimental Procedure 
 
Chemicals 
 
All chemicals used were purchased from Sigma-Aldrich (Ireland) without 
further purification except for 2’- deoxyguanosine (TCI Europe), 4-bromophthalic 
anhydride (TCI Europe), tris(3-sulfonatophenyl)phosphine (ABCR), 5-aminofluorescein 
(ABCR), amyl nitrite (ABCR), diisopropyl azodicarboxylate (ABCR) and 4-
cyanophenyl boronic acid (Fisher Scientific).  All solvents were fully degassed prior to 
use.  All experiments were performed using oven-dried glassware under an N2 
environment. 
 
 
The preparation of 8-bromo-2’-deoxyguanosine 
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 8-Bromo-2’-deoxyguanosine was prepared according to a method modified from 
the literature.[20]  2’- Deoxyguanosine (2.0 g, 7.5 mmol) and N-bromosuccinimide 
[NBS] (2.0 g, 11.2 mmol) were added to a mixture of acetonitrile (80 ml) and water (20 
ml).  The NBS was added to the mixture in three equal portions, and it was then stirred 
for 30 minutes at room temperature.  The precipitate was collected by vacuum filtration 
and was then suspended in a solution of acetone (40 ml) and stirred at room temperature 
for 2 hours.  The mixture was then cooled overnight in the freezer at -20 oC. 
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The precipitate was collected by vacuum filtration, washed with cold acetone 
and dried to give a creamy white product (2.05 g, 79%).   
 
1H NMR (400 MHz, DMSO-d6):  δ (ppm) 10.81 (s, 1H, N1-H),  6.50 (s, 2H, N2-H2),  
6.15 (t, 1H, J = 7.2 Hz, C1’-H), 5.27 (d, 1H, J = 4.4 Hz, C3’-OH), 4.87 (t, 1H, J = 6 Hz, 
C5’-OH), 4.39 (m, 1H, C3’-H), 3.79 (m, 1H, C4’-H),  3.61 (m, 1H, C5’-H), 3.50 (m, 1H, 
C5’-H), 3.16 (m, 1H, C2’-H), 2.10 (m, 1H, C2’-H).  
 
 
 
The preparation of 5-bromofluorescein diacetate 
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 5-Bromofluorescein diacetate was prepared according to a method modified 
from the literature.[34]  A mixture of 4-bromophthalic anhydride (5.01 g, 22.03 mmol) 
and resorcinol (4.87 g, 44.06 mmol) were heated, as a neat reaction, at 200 oC with 
stirring for 12 hours.  The solidified shiny, rusty, green product was crushed and ground 
in a mortar to yield a mixture of 5- and 6-bromofluorescein. 
 
 Without any further purification the mixture was refluxed for 3 hours in acetic 
anhydride (35 ml).  The solution was then cooled to induce recrystallisation.  This was 
then filtered by vacuum and washed with cold acetic anhydride and ethanol, 
successively.   
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 The filtrate was collected and concentrated to half volume with warming under 
reduced pressure and was then placed in an ice bath and allowed to stand for a day to 
induce recrystallisation, which was then collected by filtration. 
 
 The first and second set of pale yellow crystals were combined and dissolved in 
hot acetic anhydride (9 ml) and cooled to allow recrystallisation.  The product was 
filtered by vacuum and washed with cold acetic anhydride and ethanol successively, to 
yield a pale yellow powder.  Further recrystallisation in acetic anhydride gave the 
regioisomerically pure 5-bromofluorescein diacetate as a yellow solid (1.80 g, 16 %). 
 
1H NMR (400 MHz, DMSO-d6):  δ (ppm) 8.25 (s, 1H, H6), 8.00 (d, 1H, J = 8.0 Hz, H4),  
7.43 (d, 1H, J = 8.0 Hz, H3), 7.29 (s, 2H, HC/C’), 6.98 (m, 4H, HA/A’, HB/B’), 2.29 (s, 6H, 
acetyl protons). 
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6.3.1 Synthetic Strategy 1: Suzuki Coupling 
 
The preparation of 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)fluorescein 
diacetate 
5-Bromofluorescein diacetate
OO O
O
O
Br
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 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)fluorescein diacetate was 
prepared according to methods modified from the literature.[35-37]  To a pressure tube 
filled with nitrogen, 5-bromofluorescein diacetate (500 mg, 1 mmol), 
dipinacholatodiboron (279 mg, 1.1 mmol), [1,1'-bis(diphenylphosphino) ferrocene] 
dichloropalladium(II) [PdCl2(dppf)] (8.2 mg, 0.01 mmol), potassium acetate (294 mg, 3 
mmol) and 1,4-dioxane (4 ml) were added.  The reaction was then heated at 85 oC for 
48 hours with stirring. 
 
 After cooling, the mixture was poured into a 0.1M NH4Cl (10 ml) solution.  The 
mixture was then extracted with benzene (2x20 ml) and the organic layer was washed 
with 0.1M NaHCO3 and 0.1M NaCl solutions successively.  The organic layer was then 
dried over anhydrous MgSO4 and the solvent evaporated under reduced pressure.  The 
product was then recrystalised from benzene/ethanol (1:1) to give the pure boronated 
fluorescein ester as a white solid (207 mg, 38 %).   
 
1H NMR (400 MHz, DMSO-d6):  δ (ppm) 8.21 (s, 1H, H6), 8.07 (d, 1H, J = 8.0 Hz, H4), 
7.43 (d, 1H, J = 8.0 Hz, H3), 7.37 (s, 1H, carboxyl-OH), 7.29 (s, 2H, HC/C’), 6.93 (m, 
4H, HA/A’, HB/B’), 2.29 (s, 6H, acetyl protons), 1.34 (s, 12H, CH3 protons x 4). 
 
 
 
 286 
The preparation of 5-fluorescein boronic acid 
O
B(OH)2
OHO
COOH
5-Fluorescein boronic acid
OO O
O
OB
O
O
5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)
 fluorescein diacetate
K2CO3
CH3CN : H20
7 hours at room
temperatureH3C CH3
O O
 
 
 5-Fluorescein boronic acid was prepared according to a method modified from 
the literature.[36]  5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)fluorescein diacetate 
(217 mg, 0.5 mmol), potassium carbonate (346 mg, 2.5 mmol) were added to a mixture 
of acetonitrile / water (1:1) (4 ml) and  left stirring at room temperature for 7 hours.   
 
The mixture was then acidified with concentrated HCl and the resulting yellow 
precipitate was filtered and washed successively with deionised water and diethyl ether.  
The solid was dried under reduced pressure to give a yellow solid product (125 mg, 
66%).   
 
[note: isolation of the pure product proved very difficult and no clean 1H-NMR 
spectrum was obtained.  Therefore, in an effort to overcome this problem, the Suzuki 
coupling was performed after in-situ hydrolysis of the boronated fluorescein ester and 
direct Suzuki coupling to 8-BrdG without isolation of the starting material.] 
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The preparation of 8-(5-fluorescein)-2’-deoxyguanosine: (Suzuki Coupling)  
 
NH
N
N
O
NH2N
O
HOH
HH
HH
HO
Br
8-Bromo 2'-
deoxyguanosine
O
B(OH)2
OHO
COOH
5-Fluorescein boronic acid
+
NH
N
N
O
NH2N
O
HOH
HH
HH
HO
O
HO
O
HOOC
8-(5-Fluorescein)-2'-deoxyguanosine
TPPTS / Pd(OAc)2 / 
Na2CO3
CH3CN : H2O
6 hours at 80 oC
 
 
 8-Bromo 2’-deoxyguanosine (87 mg, 0.25 mmol), 5-fluorescein boronic acid 
(113 mg, 0.30 mmol [not isolated-theoretical value]), tris(3-sulfonatophenyl)phosphine 
(TPPTS) (8.9 mg, 0.016 mmol), palladium acetate (1.5 mg, 0.006 mmol), and sodium 
carbonate (53 mg, 0.5 mmol) were placed in a round-bottomed flask under nitrogen.  
Degassed water : acetonitrile (2:1) (3.5 ml) was added and the mixture was heated at 80 
oC for 6 hours until reverse-phase TLC (1:1, water : methanol) showed no further 
conversion of starting materials. 
 
 
 The reaction mixture was diluted with MilliQ water (10 ml) and its pH adjusted 
to 6-7 using 10 % aqueous HCl.  The mixture was then heated to dissolve and solid 
precipitates and allowed to cool to 0 oC, and left to stand for several hours.  The product 
was then recovered by filtration as a fine yellow powder (31 mg, 20 %, impure).  
However, NMR and mass spectrometry analysis failed to show any evidence of the 
coupled product having being formed. 
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6.3.2 Synthetic Strategy 2: Sonogashira Coupling 
 
The preparation of 5-(2-trimethylsilylethynyl)fluorescein diacetate 
 
OO O
O
O
Si
CH3
H3C
H3C
5-(2-Trimethylsilylethynyl)fluorescein diacetate
OO O
O
O
Br
5-Bromofluorescein diacetate
H3C CH3
O
O
H3C
O
CH3
O
CuI / Pd(PPh3)4 / Et3N / 
trimethylsilylacetylene
THF
15 hours at 70 oC
 
 
 5-(2-trimethylsilylethynyl)fluorescein diacetate was prepared according to a 
method modified from the literature.[36, 38]  5-Bromofluorescein diacetate (500 mg, 1 
mmol), copper (I) iodide (9.5 mg 0.05 mmol), tetrakis(triphenylphosphine) palladium(0) 
(58 mg, 0.05 mmol) and anhydrous THF (1 ml) were placed in a round-bottomed flask.  
Triethylamine (1.4 ml, 10 mmol) followed by trimethylsilylacetylene (280 µl, 2 mmol) 
were added to the above reaction and stirred at 70 oC for 15 hours. 
 
 The mixture was allowed to cool to room temperature and stirring continued 
overnight.  The solution was then filtered over Celite and washed with THF.  The 
solvent was then evaporated under reduced pressure, diethyl ether (40 ml) was added, 
sonicated and extracted with 0.1M HCl (3x40 ml).  The aqueous layers were extracted 
once with diethyl ether (25 ml) and the organic layers were combined, dried over 
anhydrous MgSO4, and the solvent evaporated under reduced pressure.  The crude 
product was then recrystallised from ethanol to give 5-(2-
trimethylsilylethynyl)fluorescein diacetate as a light brown powder (361 mg, 70 %). 
 
1H NMR (400 MHz, DMSO-d6):  δ (ppm) 7.97 (s, 1H, H6), 7.78 (d, 1H, J = 8 Hz, H4), 
7.37 (d, 1H, J = 8 Hz, H3), 7.22 (s, 2H, HC/C’), 6.88 (s, 4H, HA/A’, HB/B’), 2.26 (s, 6H, 
acetyl protons), 0.21 (s, 9H, methyl protons x 3). 
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The preparation of 5-ethynylfluorescein 
 
O O
COOH
HO
5-Ethynylfluorescein
OO O
O
O
Si
CH3
H3C
H3C
5-(2-Trimethylsilylethynyl)fluorescein diacetate
H3C
O
CH3
O
K2CO3 / Methanol / THF
20 hours at 25 oC
 
 
 5-Ethynylfluorescein was prepared according to a method modified from the 
literature.[36, 38]  5-(2-Trimethylsilylethynyl)fluorescein diacetate (150 mg, 0.30 mmol), 
potassium carbonate (207 mg, 1.5 mmol) were dissolved in a mixture of methanol/THF 
(1:1) (3 ml) and stirred at 25 oC for 20 hours.  The solution was then poured into MilliQ 
water (20 ml) and acidified to pH 2 with concentrated HCl.  The precipitate was 
collected by vacuum filtration, rinsed with water and dried under vacuum to yield 5-
ethynylfluorescein as an orange solid (101 mg, 0.28 mmol, 93 % yield). 
  
1H NMR (400 MHz, DMSO-d6):  δ (ppm) 10.12 (s, 1H, carboxyl-H), 7.97 (s, 1H, H6), 
7.80 (d, 1H, J = 8 Hz, H4), 7.23 (d, 1H, J = 8 Hz, H3), 6.63 (s, 2H, HC/C’), 6.49 (m, 4H, 
HA/A’, HB/B’), 4.42 (s, 1H, ethynyl-H). 
 ESI-MS (CH3OH, m/z): 356.33, ([M+H+]): 357.4. 
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The preparation of 8-acetylene-(5-fluorescein)-2’-deoxyguanosine (Sonogashira 
Coupling)  
 
 
O O
COOH
HO
5-Ethynylfluorescein
NH
N
N
O
NH2N
O
HOH
HH
HH
HO
Br
8-Bromo 2'-
deoxyguanosine
+
NH
N
N
O
NH2N
O
HOH
HH
HH
HO
O
O
HO
HOOC
8-Acetylene-(5-fluorescein)-2'-deoxyguanosine
CuI / Pd(PPh3)4 /
Et3N
DMF
4 hours at 55 oC
 
 
 To a round-bottomed flask, 8-bromo-2’-deoxyguanosine (24 mg, 0.07 mmol), 5-
ethynylfluorescein (30 mg, 0.08 mmol), tetrakis(triphenylphosphine) palladium(0) (8 
mg, 0.007 mmol), copper (I) iodide (6.7 mg, 0.035 mmol), triethylamine (20 µl, 0.14 
mmol) and anhydrous DMF (2 ml) were added and heated at 55 oC for 4 hours.  The 
mixture was then left stirring at 25 oC overnight.  The reaction was followed by TLC 
(silica gel) using MeOH : CH2Cl2 as mobile phase until there was no further conversion 
of the starting materials.  The solution was evaporated to dryness and purified by HPLC 
chromatography using a mobile phase of methanol : water to leave a light orange 
coloured product.  However an NMR of the pure product was never isolated effectively, 
even though mass spectrometry analysis showed evidence of the final coupled product. 
 
 
ESI-MS (CH3OH, m/z): 621.55, ([M+H+]): 622.3, ([M-dG]): 356.3. 
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6.3.3 Synthetic Strategy 3: Click Reactions 
 
The preparation of 8-(4-ethynylphenyl)-2’-deoxyguanosine 
 
B
OH
HO
4-ethynylphenylboronic Acid
+
NH
N
N
O
NH2N
O
HOH
HH
HH
HO
Br
8-Bromo-2'-deoxyguanosine
NH
N
N
O
NH2N
O
HOH
HH
HH
HO
8-(4-Ethynylphenyl)-2'-deoxyguanosine
TPPTS / Pd(OAc)2 / 
K2CO3
CH3CN : H2O
3 hours at 80 oC
 
 
 8-Bromo-2’-deoxyguanosine (250 mg, 0.72 mmol), 4-ethynylphenyl boronic 
acid (168 mg, 1.152 mmol), palladium acetate (4 mg, 0.018 mmol, 2.5 mol%), tris(3-
sulfonatophenyl)phosphine (TPPTS) (25.6 mg, 0.045 mmol, 6.25 mol%), potassium 
carbonate (299 mg, 2.16 mmol) and milliQ water: acetonitrile 2:1 (3 ml) were all placed 
into a dry vial in the dry box and left stirring at 80 oC for 3 hours. 
 
 The mixture was then poured onto milliQ water (10 ml) and its pH adjusted to 
pH 6-7 with 10 % HCl.  The reaction was then left in the fridge overnight and the 
precipitate was collected by vacuum filtration.  The product was then recrystallised 
from a water/methanol mixture to yield a light brown solid product (129 mg, 35 %). 
 
1H NMR (400 MHz, DMSO-d6):  δ (ppm) 10.91 (s, 1H, H1-H),  7.89 (d, 2H, J = 8 Hz, 
Ph protons), 7.57 (d, 2H, J = 8 Hz, Ph protons), 6.62 (s, 2H, N2-H2),  6.35 (t, 1H, J = 2.4 
Hz, C1’-H), 5.33 (d, 1H, J = 1.6 Hz, C3’-OH), 4.92 (t, 1H, J = 1.6 Hz, C5’-OH), 4.44 (m, 
1H, C3’-H), 3.81 (m, 1H, C4’-H),  3.67 (m, 1H, C5’-H), 3.56 (m, 1H, C5’-H), 3.33 (s, 1H, 
ethynyl-H), 3.12 (m, 1H, C2’-H), 2.15 (m, 1H, C2’-H). 
 
 
 
 
 
 
 
 292 
The preparation of 8-(4-cyanophenyl)-2’-deoxyguanosine 
 
B
N
OH
HO
4-Cyanophenylboronic Acid
+
NH
N
N
O
NH2N
O
HOH
HH
HH
HO
Br
8-Bromo-2'-deoxyguanosine
NH
N
N
O
NH2N
O
HOH
HH
HH
HO
N
8-(4-Cyanophenyl)-2'-deoxyguanosine
TPPTS / Pd(OAc)2 / 
K2CO3
CH3CN : H2O
3 hours at 80 oC
 
 
 8-Bromo-2’-deoxyguanosine (250 mg, 0.72 mmol), 4-cyanophenyl boronic acid 
(169 mg, 1.152 mmol), palladium acetate (4 mg, 0.018 mmol, 2.5 mol%), tris(3-
sulfonatophenyl)phosphine (TPPTS) (25.6 mg, 0.045 mmol, 6.25 mol%), potassium 
carbonate (299 mg, 2.16 mmol) and milliQ water: acetonitrile 2:1 (3 ml) were all placed 
into a dry vial in the dry box and left stirring at 80 oC for 3 hours. 
 
 The mixture was then poured onto milliQ water (10 ml) and its pH adjusted to 
pH 6-7 with 10 % HCl.  The reaction was then left in the fridge overnight and the 
precipitate was collected by vacuum filtration to yield a grey/blue solid product (256 
mg, 96 %). 
 
 
1H NMR (400 MHz, DMSO-d6):  δ (ppm) 7.99 (d, 2H, J = 8 Hz, Ph protons), 7.84 (d, 
2H, J = 8 Hz, Ph protons), 6.58 (s, 2H, N2-H2),  6.09 (t, 1H, J = 6.4 Hz, C1-H), 5.91 (s, 
1H, C3’-OH), 5.17 (s, 1H, C5’-OH), 4.37 (m, 1H, C3’-H), 3.85 (m, 1H, C4’-H),  3.68 (m, 
1H, C5’-H), 3.56 (m, 1H, C5’-H), 3.18 (m, 1H, C2’-H), 2.04 (m, 1H, C2’-H). 
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The preparation of 5-azidofluorescein 
 
2) Sodium Azide
    30 mins at 4 oC
O
N3
OHO
COOH
5-Azidofluorescein
O
NH2
OHO
COOH
5-Aminofluorescein
1) Amyl nitrite
    30 mins at 4 oC
 
 
 5-Azidofluorescein was prepared according to a method modified from the 
literature[39, 40], and was performed in a dark room under red light.  5-Aminofluorescein 
(100 mg, 0.29 mmol) was dissolved in DMF anhydrous (5 ml) in a round-bottomed 
flask.  MilliQ water (5 ml) was then added to the mixture and adding more DMF 
dropwise to the reaction then dissolved any precipitate formed. 
 
The solution was acidified with concentrated H2SO4 (1 ml) and amyl nitrite (200 
µl) was added and left stirring at 4oC for 30 minutes.  Sodium azide (200 mg, 3 mmol in 
4 ml MilliQ water) was added and the reaction was continued stirring at 4 oC for a 
further 30 minutes. 
 
 After this, a solution of brine was used to make the reaction up to 20 ml and the 
solution was left in the fridge overnight.  The precipitate was collected by vacuum 
filtration and washed with a cold saturated NaCl solution to leave 5-azidofluorescein as 
a red solid (80 mg, 72  %). 
 
 
1H NMR (400 MHz, DMSO-d6):  δ (ppm) 10.12 (s, 1H, carboxyl-H), 7.98 (d, 1H, J = 8 
Hz, H4), 7.40 (d, 1H, J = 8, H3), 7.03 (d, 1H, J = 1.6, H6), 6.67 (d, 2H, J = 2, HC/C’), 6.55 
(m, 4H, HA/A’, HB/B’). 
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The preparation of 8-(4-phenyl(1,3-triazole))-5-fluorescein-2’-deoxyguanosine (Click 
reactions) 
+
NH
N
N
O
NH2N
O
HOH
HH
HH
HO
N
N N
O
O
OH
HOOC
NH
N
N
O
NH2N
O
HOH
HH
HH
HO
8-(4-Ethynylphenyl)-2'-
deoxyguanosine
O
N3
OHO
COOH
5-Azidofluorescein 8-(4-phenyl(1,3-triazole))-5-
fluorescein-2'-deoxyguanosine
THF / H2O
48 hours at room 
temperature
CuSO4 / 
Sodium ascorbate
 
 
Triazole linker formation 
  
 8-(4-Ethynylphenyl)-2’-deoxyguanosine (40 mg, 0.107 mmol) was first 
dissolved in tetrahydrofuran:water (1:1) (3 ml).  Then 5-azidofluorescein (40 mg, 0.107 
mmol), copper sulphate pentahydrate (2.7 mg, 0.0107 mmol) and sodium ascorbate (4.2 
mg, 0.0214 mmol) were added to the reaction and left stirring at room temperature for 
48 hours.  Pure product was not isolated.  
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The preparation of 8-(4-phenyl(1,5-tetrazole))-5-fluorescein-2’-deoxyguanosine  
 
+
NH
N
N
O
NH2N
O
HOH
HH
HH
HO
NN
N N
O
O
OH
HOOC
NH
N
N
O
NH2N
O
HOH
HH
HH
HO
N
8-(4-Cyanophenyl)-2'-
deoxyguanosine
O
N3
OHO
COOH
5-Azidofluorescein 8-(4-phenyl(1,5-tetrazole))-5-
fluorescein-2'-deoxyguanosine
48 hours reflux
ZnCl2 / H2O
 
 
Tetrazole linker formation 
 
 8-(4-Cyanophenyl)-2’-deoxyguanosine (40 mg, 0.109 mmol) was dissolved in 
deionised water.  5-Azidofluorescein (41 mg, 0.110 mmol) and anhydrous ZnCl2 (58 
mg, 0.424 mmol) were added and the reaction mixture was refluxed for 48 hours.  The 
solution was then cooled and acidified slightly to pH 4 and left in the fridge over night 
to promote precipitation.  The precipitate was then collected by vacuum filtration.  Pure 
product was not isolated.  
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6.3.4 Synthetic Strategy 4: Buchwald-Hartwig coupling 
 
The preparation of 8-bromo-3’,5’-O-bis(tert-butyldimethylsilyl)-2’-deoxyguanosine  
 
NH
N
N
O
NH2N
O
HO
HH
HH
O
Br
Si
Si
NH
N
N
O
NH2N
O
HOH
HH
HH
HO
Br
8-Bromo-2'-deoxyguanosine 8-Bromo-3',5'-O-bis(tert-butyldimethylsilyl)-2'-
deoxyguanosine
6 hours at room 
temperature
TBDMS / DMF
 
 
 8-bromo-3’,5’-O-bis(tert-butyldimethylsilyl)-2’-deoxyguanosine was prepared 
according to a method modified from the literature.[20]  8-Bromo 2’-deoxyguanosine 
(362 mg, 1.04 mmol) and imidazole (340 mg, 5 mmol) were suspended in anhydrous 
DMF (2.3 ml).  To this tert-butyldimethyl-chlorosilane (TBDMS) 1 M in 
dichloromethane (3 ml, 3 mmol) and was left stirring at room temperature for 6 hours. 
 
 The end of the reaction was confirmed by TLC (silica gel) analysis using 
CHCl3:MeOH (10:1) as mobile phase.  The reaction was taken and evaporated to 
dryness by warming under reduced pressure and then re-suspended in MilliQ water (12 
ml) to produce a white precipitate.  The mixture was then extracted with EtOAc (2x20 
ml).  The organic layers were combined, dried over MgSO4 anhydrous and evaporated 
to dryness to leave an off-white coloured crude compound.  The crude mixture was then 
taken and dissolved purified by silica gel chromatography using CHCl3 : 10% MeOH as 
mobile phase to give the product as a white solid (464 mg, 78 %). 
 
1H NMR (400 MHz, DMSO-d6):  δ (ppm) 10.81 (s, 1H, N1-H), 6.40 (s, 2H, N2-H2), 
6.15 (t, 1H, J = 7.4, C1’-H), 4.60 (m, 1H, C3’-H), 3.75 (m, 2H, C5’-H2), 3.63 (m, 1H, C4’-
H), 3.38 (m, 1H, C2’-H), 2.14 (m, 1H, C2’-H), 0.87 (s, 9H, tBu-H), 0.81 (s, 9H, tBu-H), 
0.09 (s, 6H, methyl group x 2), -0.04 (s, 3H, methyl group), -0.05 (s, 3H, methyl group).  
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The preparation of O6-benzyl-8-bromo-3’,5’-O-bis(tert-butyldimethylsilyl)-2’-
deoxyguanosine 
O6-benzyl-8-Bromo-3',5'-O-bis
(tert-butyldimethylsilyl)-2'-deoxyguanosine
NH
N
N
O
NH2N
O
HO
HH
HH
O
Br
Si
Si
8-Bromo-3',5'-O-bis(tert-
butyldimethylsilyl)-2'-deoxyguanosine
N
N
N
O
NH2N
O
HO
HH
HH
O
Br
Si
Si
Triphenylphosphine / 
Benzyl alcohol / 
Diisopropyl azodicarboxylate.
1,4-Dioxane
6 hours at room
temperature
 
 
 O6-benzyl-8-bromo-3’,5’-O-bis(tert-butyldimethylsilyl)-2’-deoxyguanosine was 
prepared according to a method modified from the literature.[20]  8-Bromo-3’,5’-O-
bis(tert-butyldimethylsilyl)-2’-deoxyguanosine (620 mg, 1.08 mmol) and 
triphenylphosphine (850 mg, 3.24 mmol) were added to 1,4-dioxane (12.5 ml).  To this 
suspension benzyl alcohol (559 µl, 5.4 mmol) and diisopropyl azodicarboxylate (632 µl, 
3.24 mmol) were added and sonicated to dissolve all substances. 
 
The reaction mixture was then left stirring at room temperature for 6 hours.  The 
end of the reaction was confirmed by TLC (silica gel) analysis using a mobile phase of 
Hexane : EtOAc (4:1). 
 
The solution was then concentrated and purified by silica gel chromatography 
using a mobile phase of Hexane : EtOAc (4:1) to give the product as a white solid (434 
mg, 60 %). 
 
 
1H NMR (400 MHz, DMSO-d6):  δ (ppm)  7.46-7.44 (m, 2H, Bz-H), 7.37-7.33 (m, 3H, 
Bz-H), 6.45 (s, 2H, N2-H2), 6.14 (t, 1H, J = 7.4 Hz, C1’-H), 5.44 (s, 2H, Bz-CH2), 4.64 
(m, 1H, C3’-H) 3.73 (m, 2H, C5’-H2), 3.60 (m, 1H, C4’-H), 3.48 (m, 1H, C2’-H), 2.17 (m, 
1H, C2’-H), 0.90 (s, 9H, tBu-H), 0.82 (s, 9H, tBu-H), 0.12 (s, 6H, methyl group x 2), -
0.06 (s, 3H, methyl group), -0.09 (s, 3H, methyl group).  
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The preparation of N2-Isobutyryl- O6-benzyl-8-bromo-3’,5’-O-bis(tert-
butyldimethylsilyl)-2’-deoxyguanosine 
 
N
N
N
O
N
H
N
O
HO
HH
HH
O
Br
Si
Si
N2-Isobutyryl-O6-benzyl-8-Bromo-3',5'-O-bis(tert-
butyldimethylsilyl)-2'-deoxyguanosine
O
O6-benzyl-8-Bromo-3',5'-O-bis
(tert-butyldimethylsilyl)-2'-deoxyguanosine
N
N
N
O
NH2N
O
HO
HH
HH
O
Br
Si
Si
Isobutyryl chloride / 
Pyridine
16 hours at room 
temperature
 
 
 N2-Isobutyryl- O6-benzyl-8-bromo-3’,5’-O-bis(tert-butyldimethylsilyl)-2’-
deoxyguanosine was prepared according to a method modified from the literature.[18]  
O6- Benzyl- 8-bromo 3’,5’-O- bis(tert-butyldimethylsilyl) -2’-deoxyguanosine (575 mg, 
0.87 mmol) was twice coevaporated with pyridine (2x2 ml) and then dissolved in 
anhydrous pyridine (5 ml).  Then isobutyryl chloride (228 µl, 2.18 mmol) was added 
slowly by syringe and the reaction mixture was left stirring at room temperature for 16 
hours.  Methanol (0.5 ml) was added, to dissolve any remaining precipitate, and was left 
stirring at room temperature for a few more minutes.  The solvent removed and was 
then coevaporated with toluene (5 ml). 
 
 
 The crude product was dissolved in MilliQ water (10 ml) and CH2Cl2 (10 ml) 
and the layers were separated.  The aqueous layer was extracted with CH2Cl2 (2x20 ml) 
and the combined organic layers were then washed once with MilliQ water (20 ml), 
dried over MgSO4 anhydrous and evaporated to dryness.  The residue was purified by 
silica gel chromatography using a mobile phase of Hexane:EtOAc (20:1) to give the 
product as a colourless foam (341 mg, 53 %). 
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1H NMR (400 MHz, DMSO-d6):  δ (ppm)  10.44 (s, 1H, Iso-H), 7.52 (m, 2H, Bz-H), 
7.45-7.34 (m, 3H, Bz-H), 6.25 (t, 1H, J = 6 Hz, C1’-H), 5.57 (s, 2H, Bz-CH2), 4.95 (m, 
1H, C3’-H), 3.76 (m, 2H, C5’-H2), 3.64 (m, 1H, C4’-H), 3.49 (m, 1H, C2’-H), 2.77(m, 1H, 
Iso-CH), 2.24 (m, 1H, C2’-H), 1.09 (d, 3H, J = 6.8 Hz, Iso-CH3), 1.07 (d, 3H, J = 6.8, 
Iso-CH3), 0.90 (s, 9H, tBu-H), 0.82 (s, 9H, tBu-H), 0.12 (d, 6H, J = 8.8 Hz, methyl 
group x 2), -0.13 (d, 6H, J = 8.8 Hz, methyl group x 2).  
 
 
 
The preparation of N2-isobutyryl- O6-benzyl-8N-(5-aminofluorescein)-3’,5’-O-
bis(tert-butyldimethylsilyl)-2’-deoxyguanosine (Buchwald-Hartwig coupling)  
   
N
N
N
O
N
H
N
O
HO
HH
HH
O
Br
Si
Si
N2-Isobutyryl-O6-benzyl-8-
bromo-3',5'-O-bis(tert-butyl
dimethylsilyl)-2'-deoxyguanosine
O
O
NH2
OHO
COOH
5-Aminofluorescein
N
N
N
O
N
H
N
O
HO
HH
HH
OSi
Si
O
O
O
OH
HOOC
HN
N2-isobutyryl- O6-benzyl-8N-
(5-aminofluorescein)-3',5'-O-bis
(tert-butyldimethylsilyl)-2'-deoxyguanosine
Pd2(dba)3 / 
BINAP / 
NaOtBu
Toluene
48 hours at 90 oC
 
 
 N2-Isobutyryl- O6-benzyl-8-bromo3’,5’-O-bis(tert-butyldimethylsilyl)-2’-
deoxyguanosine (100 mg, 0.136 mmol), 5-aminofluorescein (71 mg, 0.204 mmol), 
tris(dibenzylideneacetone) dipalladium(0) [Pd2(dba)3] (12 mg, 0.0136, 10 mol %), rac-
2, 2’-bis(diphenylphosphino)-1, 1’-binaphtyl (BINAP) (25 mg, 0.0408 mmol, 30 mol 
%) and fully degassed anhydrous toluene (1 ml) were added to a dry glass vial in the dry 
box and left stirring at 90oC for 40 minutes.  NaOtBu (20 mg, 0.204 mmol) was added 
and the reaction mixture was left stirring at 90 oC for another 48 hours or until the 
starting material had disappeared as indicated by TLC (silica gel) analysis using a 
mobile phase of MeOH : Chloroform (1:10). 
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 The reaction mixture was then allowed cool down to room temperature and 
diluted with diethylether (4 ml) and filtered.  Methanol was then added to the filtrate 
and the white precipitate was removed.  The filtrate was then concentrated and purified 
by HPLC using water : MeOH as mobile phase.  Pure product was never isolated. 
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6.4 Results and Discussion 
 
6.4.1 Fluorescein and Suitable FRET Pair 
 
A further important aspect of this work was to find an appropriate fluorescent 
donor-acceptor pair for the model photoantenna based on the interfacial DNA scaffold.  
If a suitable acceptor is found, the energy may be transferred from the donor to the 
acceptor, in a process known as FRET, and as a result the emission is observed at a 
longer wavelength that is characteristic of the acceptor molecule.  In addition, it would 
also be important to conduct experiments to demonstrate what quenching effects, if any, 
that the base may have on the fluorophores emission characteristics.    
 
Fluorescein is widely used as an organic fluorescent label due to its 
characteristically high quantum yields.  It may exist in several ionisation states (cation, 
neutral, anion, and dianion) each with unique spectral properties as illustrated by 
Margulies et al.[41] in Figure 6.6. 
 
 
Figure 6.6: Chemical structures and corresponding absorbance spectra of fluorescein 
in different ionic states.[41] 
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In the experiments carried out here, the fluorescein was dissolved in 0.1M 
NaOH and exists in the dianionic state, which shows an absorption maximum at 490 nm 
and an emission maximum at 515 nm.  The fluorescence lifetimes for the protonated 
and deprotonated fluorescein are approximately 3ns and 4ns respectively and the 
quantum yield is close to unity.[42]   
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Figure 6.7: Schematic diagram illustrating the assigned protons for the general 
fluorescein molecule for 1H-NMR analysis. 
 
 
5-Carboxytetramethylrhodamine (TAMRA) (Figure 6.8) has long been used as a 
suitable acceptor for FRET with a donor fluorescein molecule.  Its overlapping 
absorbance and emission are shown in Figure 6.9.  The Förster distance, at which FRET 
is 50% efficient between both donor and acceptor fluorophores, is 55 Å.[38, 43, 44]  The 
idea here was to use TAMRA as the ‘black hole’ quencher in facilitating charge transfer 
through the DNA scaffold.  Once the charge separated state has arrived at the TAMRA 
molecule, a potential may be applied to the gold substrate, and thus, achieve the 
conversion of light energy into electrical energy.    
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Figure 6.8:  Chemical structure of TAMRA. 
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Figure 6.9: Overlapping absorbance spectrum and emission spectra of fluorescein 
(excited at 490 nm in 0.1 M NaOH solution) and TAMRA (excited at 550 nm in 
deionised water).  All spectra are normalised. 
 
Figure 6.10 outlines the various synthetic procedures performed and materials 
synthesised in an effort to internally label deoxyguanosine with fluorescein.  The four 
main reactions attempted were: Suzuki couplings, Sonogashira couplings, Click 
chemistry and Buchwald-Hartwig couplings. 
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6.4.2 Synthetic Strategy Overview – internal fluorescent labelling of 2’-
deoxyguanosine. 
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Figure 6.10:  Synthetic strategy overview. 
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6.4.3 Synthetic Results 
 
The starting material of 8-bromo-2’-deoxyguanosine was synthesised with a 
good yield of 79%.  Prior to the electrophilic aromatic halogenation reaction, the 
2’deoxyguanosine exists in a mixture of both cis and trans isomers, however, following 
the bromination of the nucleoside the majority of molecules are in the cis-
configuration[14, 15] thus making the site of reaction slightly more accessible to other 
incoming molecules. [note: that all deoxyguanosine molecules are drawn in the trans 
confirmation for ease of illustration].   
 
 5-Bromofluorescein diacetate is the fluorescein precursor for many of the 
coupling strategies and was produced by the direct condensation reaction between the 
rescorcinol and 4-bromophthalic anhydride to give a mixture of the 5- and 6-
bromofluorescein isomers.  Further recrystallisation in acetic anhydride gave the 
regioisomerically pure 5-bromofluorescein diacetate as a yellow solid in a 16% yield. 
 
 
 
6.4.3.1 Synthetic Strategy 1: Suzuki Coupling 
 
Initially Suzuki coupling was used in an effort to label the nucleoside as this 
provided the shortest and most rigid linker in the final coupled product.  The borylation 
of 5-bromofluorescein proved to be challenging, resulting in low yields and poor quality 
1H-NMR spectra.  However, having experimented with many different reaction 
conditions as outlined in Table 6.1 and Table 6.2 below, a suitable method of synthesis 
was identified.  Microwave synthesis proved relatively successful with all reactions 
producing some product, however, it was the conventional heating method used in 
experiment 6 of Table 6.1 that gave the best reaction yields.   
 
 
 
 
 
 306 
Chemical 
 
Exp. 1 Exp. 2 Exp. 3 Exp. 4 Exp. 5 Exp. 6 
5-Bromo- 
fluorescein 
100 mg / 
0.02 mmol 
100 mg / 
0.02 mmol 
100 mg / 
0.02 mmol 
100 mg / 
0.02 mmol 
100 mg / 
0.02 mmol 
500 mg / 
1 mmol 
Bis(pinacol- 
ato)diboron 
56 mg / 
0.22 mmol 
56 mg / 
0.22 mmol 
56 mg / 
0.22 mmol 
78 mg / 
0.31 mmol 
76 mg / 
0.30 mmol 
280 mg / 
1.1 mmol 
NaOAc 
 
30 mg / 
0.36 mmol 
- - - - - 
[PdCl2(dppf)] 
 
1.6 mg / 
0.002 mmol 
5 mg /  
0.006 
mmol 
5 mg /  
0.006 
mmol 
5 mg / 
0.006 
mmol 
5 mg / 
0.006 mmol 
8.2 mg / 
0.01 mmol 
Toluene 
anhydrous 
5 ml - - - - - 
KOAc 
 
- 59 mg / 
0.6 mmol 
59 mg / 
0.6 mmol 
- 59 mg / 
0.6 mmol 
295 mg / 
3 mmol 
DMSO 
anhydrous 
- 5 ml - - - - 
DMF 
anhydrous 
- - 5 ml - - - 
Triethyl- 
amine 
- - - 0.08 ml / 
0.6 mmol 
- - 
1,4-Dioxane 
anhydrous 
- - - 3 ml 3 ml 4 ml 
Conditions 
 
150 oC 
16 hours 
150 oC 
16 hours 
150 oC 
24 hours 
100 oC 
16 hours 
150 oC 
48 hours 
85 oC 
48 hours 
Yields 
 
0% 0% 0% 0% 0% 207 mg /  
38 % 
Table 6.1: Summary of the experiments performed in the synthesis of 5-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)fluorescein diacetate using conventional heating 
methods.  All reactions were monitored by silica gel TLC analysis until no further 
conversion of starting material was evident (mobile phase: hexane / ethyl acetate (4:1)). 
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Chemical 
 
Exp. 1 Exp. 2 Exp. 3 Exp. 4 
5-Bromo- 
fluorescein 
500 mg / 
1 mmol 
500 mg / 
1 mmol 
500 mg / 
1 mmol 
500 mg / 
1 mmol 
Bis(pinacol- 
ato)diboron 
280 mg / 
1.1 mmol 
280 mg / 
1.1 mmol 
280 mg / 
1.1 mmol 
280 mg / 
1.1 mmol 
[PdCl2(dppf)] 
 
8.2 mg / 
0.01 mmol 
8.2 mg / 
0.01 mmol 
8.2 mg / 
0.01 mmol 
8.2 mg / 
0.01 mmol 
KOAc 
 
295 mg / 
3 mmol 
295 mg / 
3 mmol 
295 mg / 
3 mmol 
295 mg / 
3 mmol 
1,4-Dioxane 
anhydrous 
- 4 ml - 4 ml 
Toluene 
anhydrous 
4 ml - 6 ml - 
Conditions 
 
300 W  
30 minutes 
600 W 
30 minutes 
600 W 
40 minutes 
900 W 
20 minutes 
Yields 
 
37 mg / 
7 % 
106 mg / 
20 % 
86 mg 
16 % 
170 mg 
32 % 
Table 6.2: Summary of the experiments performed in the synthesis of 5-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)fluorescein diacetate using microwave heating 
methods.  All reactions were monitored by silica gel TLC analysis until no further 
conversion of starting material was evident (mobile phase: hexane / ethyl acetate (4:1)). 
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Mechanism for the borylation of 5-bromofluorescein: 
 
The Miyaura borylation reaction allows the synthesis of boronates by the cross-
coupling of bispinacolatodoboron with aryl halides[35, 37, 45, 46] and many of the processes 
are outlined in the section that follows for Suzuki coupling reactions. 
 
 
 
 
 
Figure 6.11: Schematic diagram illustrating the general mechanism of reaction in the 
borylation of compounds.[47] 
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The hydrolysis of the boronated fluorescein ester to the corresponding 5-
fluorescein boronic acid also proved less than straight forward, and no clean NMR 
spectrum of the pure product was obtained.  It is proposed that this is due to the 
cyclotrimerisation of 5-fluorescein boronic acid, which would prevent the molecule 
being involved in any further coupling reactions, and would also account for the 
inability to isolate the pure product.[27]  It is also known that pinacol esters can be 
difficult to hydrolyse and critical for the success of the reaction is the choice of base 
used, all of which may have added to the difficulties in isolating this product.  A 
summary of the experiments performed are presented in Table 6.3 below.   
 
 
Chemical 
 
Exp. 1 Exp. 2 Exp. 3 
Boronated 
fluorescein 
109 mg / 
0.20 mmol 
217 mg / 
0.50 mmol 
100 mg /  
0.18 mmol 
K2CO3 
 
55 mg /  
0.40 mmol 
346 mg /  
2.5 mmol 
- 
Na2CO3 
 
- - 127 mg /  
1.20 mmol 
Deionised  
H2O 
1.5 ml 1.5 ml 2 ml 
Acetonitrile 
 
3.5 ml 1.5 ml 1 ml 
Conditions 
 
2 hours at room 
temperature 
7 hours at room 
temperature 
3 hours at 30 oC 
Yields 
 
0% 0% 0% 
Table 6.3: Summary of the experiments performed in the synthesis of 5-fluorescein 
boronic acid.  All reactions were monitored by silica gel TLC analysis until no further 
conversion of starting material was evident (mobile phase: hexane / ethyl acetate (4:1)). 
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In an effort to overcome these issues, the hydrolysis was performed in-situ 
without isolating the product and was immediately coupled with the 8-bromo-2’-
deoxyguaonsine in a ‘one pot’ Suzuki coupling reaction.  Suzuki-Miyaura coupling 
involves a palladium cross coupling reaction between organoboronic acids and 
halides.[13, 25, 48-52]  This synthetic approach has many advantages: most noticeably the 
production of a short rigid linker as possible between base and fluorophore, the low 
toxicity and the supposed relative ease of preparation of boronic acid compounds.  
Suzuki coupling also allows for the aqueous phase modification of an unprotected 
halonucleoside,[11, 12, 49, 53] which is of interest due to the environmental benefits of such 
reactions, furthermore, no protection chemistry is required prior to the coupling.  It was 
also found that using the water-soluble catalytic mixture of Pd(OAc)2 and tris(3-
sulfonatophenyl)phosphine (TPPTS) as ligand gave the highest conversion rates for the 
arylation  of 8-bromo-2’-deoxyguanosine that was in the region of 97 % after 2 
hours.[12]  Figure 6.12 below shows the general mechanism of reaction for the Suzuki 
coupling. 
 
 
 
 
 
Figure 6.12: Schematic diagram illustrating the general mechanism of Suzuki coupling 
reactions.[54] 
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Pd(II)(OAc)2 has an oxidation state of 2+ and as a result must undergo ligand 
exchange with the TPPTS prior to entry into the Suzuki catalytic cycle to produce the 
corresponding Pd(0).  Once this has taken place the Suzuki reaction may proceed in a 
number of different steps: 
 
 
1) Oxidative addition:  The first step in the Suzuki coupling cycle is oxidative 
addition in which a neutral ligand (8-BrdG) adds to the metal centre (Pd 
catalyst) and in doing so the metal centre is oxidised, usually by 2 electrons.  In 
transferring the 2 electrons from the metal centre to the incoming 8-BrdG, this 
breaks a bond to produce two new anionic ligands (dG- and Br-), which will then 
go on to form new bonds to the metal centre and produce the organo-palladium 
compound. 
 
2) Transmetallation: this involves the exchanging of ligands between two metal 
centres.  Here the base sodium carbonate (and not NaOH as illustrated in Figure 
6.12 above) is used to exchange ligands with the metal centre having already 
undergone oxidative addition.  This results in the elimination of sodium bromide 
(NaBr) from the reaction and the production of another organo-palladium 
species. 
 
3) Boronic acid activation:  The boronic acid must first be activated by the 
presence of the base in the reaction.  The activated boron improves the 
polarisation of the organic ligand and helps with transmetallation.  This step sees 
the elimination of a boronic acid species and the formation of yet another 
organo-palladium compound. 
 
4) Reductive elimination:  The final step in the cycle regeneration Pd(0) and the 
elimination of the coupled compound of interest by a reductive elimination 
process.  This is the opposite of oxidative addition in which two anionic ligands 
from the metal centre couple together to produce a neutral molecule and 
dissociate from metal centre.  Thus, leaving the metal centre in its original 
oxidation state of 0 and the Suzuki coupled product. 
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6.4.3.1.1 Suzuki Coupling Results 
 
Chemical 
 
Exp. 1 Exp. 2 Exp. 3 Exp. 4 
8-BrdG 
 
45 mg /  
0.13 mmol 
87 mg / 
0.25 mmol 
58 mg /  
0.17 mmol 
35 mg /  
0.1 mmol 
5-fluorescein 
boronic acid* 
76 mg / 
0.20 mmol 
113 mg /  
0.30 mmol 
75 mg /  
0.20 mmol 
45 mg /  
0.12 mmol 
Pd(II)(OAc)2 
 
2.2 mg /  
0.01 mmol 
1.5 mg /  
0.006 mmol 
1 mg /  
0.004 mmol 
0.6 mg / 
0.0025 mmol  
TPPTS 
 
14 mg /  
0.025 mmol 
9 mg /  
0.016 mmol 
6 mg /  
0.011 mmol 
3.6 mg /  
0.00625 mmol 
K2CO3 
 
103 mg /  
0.75 mmol 
- - 42 mg /  
0.30 mmol 
Na2CO3 
 
- 53 mg /  
0.5 mmol 
54 mg / 
0.5 mmol  
- 
Deionised H2O 
 
1.5 ml 2.3 ml 2 ml 1 ml 
Acetonitrile 
 
3.5 ml 1.2 ml 2 ml 1 ml 
Conditions 
 
16 hour at 80 oC 6 hours at 80 oC 16 hours at 80 oC 3 hours at 80 oC,  
16 hours at R.T. 
Yields 
 
0% 0% 0% 0% 
Table 6.4: Summary of the experiments performed in the synthesis of 8-(5-fluorescein)-
2’-deoxyguanosine.  All reactions were monitored by silica gel TLC analysis until no 
further conversion of starting material was evident (mobile phase: chloroform / 
methanol (10%)).  * 5-fluorescein boronic acid was not isolated, these values represent 
a theoretical value based on published literature.   
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Table 6.4 above outlines the various experiments performed in the synthesis of 
8-(5-fluorescein)-2’-deoxyguanosine.  Analysis of the recovered product, which 
included NMR and mass spectrometry, showed that the reaction failed to produce the 
final fluorescently coupled product.  This could have been due to a number of reasons 
including; the in-situ preparation of the 5-fluorescein boronic acid had also failed to 
work efficiently, or the steric hindrance associated with the short rigid linker between 
both base and fluorophore moieties. 
 
It is known that guanine is much less reactive than the other bases when 
undergoing palladium catalysed reactions.  This has been attributed to the coordination 
of the transition metal catalyst to the guanine base under basic conditions (Figure 6.13) 
and guanine has also been shown to inhibit the coupling of both halopurine nucleosides 
and simple arly bromides.[13]   
 
 
Figure 13: Possible coordination of guanosine derivatives to palladium catalysts under 
basic reaction conditions.[13] 
 
Even though guanine is the most unreactive of the four DNA bases it was 
decided to continue with deoxyguanosine as nucleoside due to the expertise within the 
research group,[49] and the time already spent working with the compound.  In another 
effort to achieve the coupling of fluorophore to nucleoside using a relatively short linker 
another synthetic approach was examined, that of Sonogashira couplings.   
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6.4.3.2 Synthetic Strategy 2: Sonogashira Coupling 
 
 
 Sonogashira coupling, much like Suzuki coupling, would have resulted in a 
short and rigid linker between fluorophore and nucleoside moieties.  In the synthesis of 
the starting materials, Sonogashira coupling may be used to describe the alkynylation of 
5-bromofluorescein and trimethylsilylacetylene to give the corresponding 5-(2-
trimethylsilylethynyl)fluorescein diacetate in a 70 % yield, and the mechanism of 
reaction is discussed in detail below.  Desilylation of the trimethylsilyl group is 
achieved by the addition of the base potassium carbonate to the reaction to afford the 
acetylene product 5-ethynylfluorescein in a 93 % yield, however, carrying out this 
reaction again under identical conditions would yield completely inconsistent results.  
The reproducibility of this reaction is somewhat questionable as the reaction only 
worked approximately 20% of the time.  Even though NMR and mass spectrometry 
results may have suggested a clean product, HPLC analysis (shown in Figure 6.17) 
shows three separate peaks in the chromatogram.  The poor quality of the NMRs 
produced may be explained by the possible the formation of dimers of ethynyl 
fluorescein under the synthetic conditions described. 
 
 
 
Sonogashira Coupling 
 
  
Sonogashira coupling is the reaction between terminal alkynes with arly halides 
or vinyl halides and is a robust and versatile C-C reaction.[3, 15, 25, 55-59]  Not only will it 
provide the short linker necessary between base and fluorescent marker, but in 
comparison to the previous Suzuki coupling, this linker will be slightly longer and 
therefore more accessible to the site of reaction.  Protection of the sugar hydroxyl 
groups is not necessary in most cases for this reaction as doing so might effect the 
purification of such products.[24]  Firth et al.[16] also demonstrate that the ratio of 
palladium catalyst to copper additive is very important in Sonogashira cross coupling 
reactions. 
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Typically two catalysts are required for this reaction:  a zerovalent palladium 
complex (tetrakis(triphenylphosphine) palladium(0)) and a copper (I) halide additive 
(CuI).  Many of the processes in Sonogahsira couplings are very similar to that of 
Suzuki couplings already discussed in the previous section.  Conditions of both 
reactions include the presence of a base to neutralise the hydrogen halide produced as a 
byproduct that may affect the reaction and run the risk of breaking the glycosidic bond 
between the sugar and base.  In the Suzuki coupling, the base also helps to reduce the 
palladium catalyst to an oxidation state of 0, however, the palladium catalyst used here 
for the Sonogashira coupling is already a zerovalent complex and may enter directly 
into the catalytic cycle (Figure 6.14).  All solvents used were fully degassed and the 
reaction performed under a nitrogen environment as the palladium catalyst is air 
sensitive and oxygen may also promote the homocoupling of acetylenes.[24]  
 
 
 
The Palladium Cycle: 
 
The palladium catalyst proceeds in activating the aromatic halide (8-BrdG) by 
oxidative addition to form the aromatic halide palladium complex.  This may then go on 
to react with the copper acetylide produced in the copper cycle in the rate limiting 
transmetallation step and expels the copper halide.  The organic ligands are then 
orientated in the cis-conformation during the trans/cis isomerisation step.  In the last 
step the product is eliminated from the cycle by reductive elimination with the 
regeneration of the Pd(0) to the catalytic cycle. 
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The Copper Cycle: 
 
Deprotonation of the terminal alkyne occurs with the presence of a strong base 
such as triethylamine.  Although there are a few doubts as to whether or not this base is 
indeed strong enough to cause the deprotonation.  The organocopper complex formed 
after the reaction with base continues to react with the aromatic halide palladium 
complex and see the regeneration of the copper halide (CuI). 
 
 
 
Figure 6.14: Schematic diagram illustrating the general mechanism of reaction for 
Sonogashira couplings.[60] 
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6.4.3.2.1 Sonogashira Coupling Results 
 
   Mass spectrometry of the crude 8-acetylene-(5-fluorescein)-2’-deoxyguanosine 
(Figure 6.15) shows evidence of the fluorescently coupled nucleoside at 622.3 m/z 
along with some of the starting material 5-ethynyl fluorescein at 356.3 m/z.   
 
 
 
Figure 6.15: Mass spectra showing the potential presence of coupled product, 8-
acetylene-(5-fluorescein)-2’-deoxyguanosine, at 622.3 m/z and 5-ethynyl fluorescein at 
356.3 m/z. 
 
 Initially, silica gel chromatography was employed in an effort to purify the 
compound, however this proved to be unsuccessful as the strong polarity of the 
compound, and hence, its strong affinity for the polar silica gel (Si-O bonds) stationary 
phase failed to yield any elution of the compound of interest.  During this purification 
the methanol content of the mobile phase was increased to 70%, triethylamine and even 
water were also added unsuccessfully to the mobile phase in an effort to remove the 
product.  A reverse-phase HPLC method was then developed in an effort to isolate the 
product in favourable yields.   
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HPLC method development: Isolation of 8-acetylene-(5-fluorescein)-2’-
deoxyguanosine. 
 
The following HPLC conditions were found to be the best conditions for the 
analysis of the Sonogashira coupled compound. 
 
HPLC: Varian LC 940 with automatic fraction collector. 
Column used: Varian C18 Pursuit XRs 250x4.6 mm analytical column. 
Injection volume: 60 µl. (automatic injection) 
Detector Wavelengths: 254 nm and 490 nm PDA detector. 
Equilibration time: 7 mins between injections. 
 
 
Time (min) Flow Rate (ml/min) % Methanol % MilliQ Water 
0 1.0 20 80 
30 1.0 20 80 
40 1.0 50 50 
70 1.0 100 0 
90 1.0 100 0 
Table 6.5: Mobile phase composition used for the isolation of 8-acetylene-(5-
fluorescein)-2’-deoxyguanosine. 
 
 
 Firstly, the starting materials were injected in order to determine their respective 
retention times (Rt) and to ensure sufficient separation to allow for detection of other 
substances that may be present in the sample.   The splitting of the chromatographic 
peak for 8-bromo-2’-deoxyguanosine below may suggest the presence of both cis- and 
trans- isomers of the nucleoside in Figure 6.16 below. 
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Figure 6.16: HPLC chromatogram of 8-bromo-2’-deoxyguanosine using a detection 
wavelength of 254 nm.  Rt = 13.5 mins. 
 
 The chromatographic purity of the 5-ethynyl fluorescein is somewhat 
questionable (Figure 6.17), even though NMR and mass spectrometry analysis indicated 
a relatively clean product.  Such a marked difference in the purity could have been 
detected by HPLC as the ɛ of any possible impurities at certain wavelengths may vary, 
and therefore, have a more intense absorbance profile in comparison to the pure 
product.  Nevertheless, the poor chromatographic nature of 5-ethynyl fluorescein only 
served to increase difficulties in the detection and isolation of the coupled product.   
 
 
 
Figure 6.17: HPLC chromatogram of 5-ethynyl fluorescein using a detection 
wavelength of 490nm.  Rt = 63-79 mins. 
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 Injection of the crude sample onto the system yielded the chromatogram shown 
in Figure 6.18 below, and there was no evidence of elution of a nucleoside component 
at shorter retention times.  Subsequent NMR and mass spectrometry of the peaks failed 
to give any indication of the fluorescent nucleoside that was worth further investigation.   
 
 
 
Figure 6.18: HPLC chromatogram of 8-acetylene-(5-fluorescein)-2’-deoxyguanosine 
using a detection wavelength of 254nm.  Rt = 62 and 75 mins.  
 
 Chromatographic conditions and flow rates were altered in an effort to increase 
separation, and with it, the possibility of detecting any other peaks containing product, 
but none were observed.  Taking into account the poor chromatography of the 5-ethynyl 
fluorescein moiety as a starting material and the difficulties with its synthesis, it was felt 
that another method of coupling was worth investigating. 
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6.4.3.3 Synthetic Strategy 3: Click Chemistry 
 
In parallel with the Sonogashira coupling reactions, Click chemistry was also 
attempted as a possible alternative method to couple fluorophore and nucleoside to each 
other.  This involved the introduction of a phenyl group between both compounds and 
consequently a loss in some of the rigidity between the base and label but the site of 
reaction should be more accessible when compared to the previous methods of Suzuki 
and Sonogashira couplings.  The coupling of the aromatic halide (8-BrdG) to the 
boronic acid may be described by the Suzuki coupling reaction mechanism above, to 
give the starting materials of 8-(4-ethynylphenyl)-2’-deoxyguanosine and 8-(4-
cyanophenyl)-2’-deoxyguanosine in yields of 35% and 96% respectively.   
 
 
The fluorescein moiety, 5-azidofluorescein, was prepared in a 79% yield.  Here, 
5-aminofluorescein (an aromatic primary amine) quickly reacts with the amyl nitrite to 
form the corresponding diazonium salt, which then decomposes in the presence of 
sodium azide to produce the desired 5-azidofluorescein product in a nucleophilic 
aromatic substitution reaction.  
 
 
6.4.3.3.1 Click Chemistry Results 
 
1, 3-dipolar cycloaddition reaction (also known as the Huisgen reaction) is the 
reaction between an azide and alkyne to link both components via a triazole linker and 
is an adaptation on the original Sharpless ‘Click’ chemistry.[5, 32, 61-66]  The reaction is 
characterised by mild and simple reaction conditions and the ability to perform reactions 
in the presence of oxygen and aqueous conditions.[67-69]  Initially the click reaction was 
attempted with 8-(4-ethynylphenyl)-2’-deoxyguanosine and 5-azidofluorescein to give 
the linker containing a triazole 5-membered heterocyclic ring.  However, due to ease of 
synthesis and high yields of the starting material 8-(4-cyanophenyl)-2’-deoxyguanosine, 
it was also worthwhile to attempt the complementary Huisgen-Sharpless reaction 
between aromatic nitriles and organic azides that would result in a tetrazole 5-
membered hetrocyclic ring in the cross-coupling linker.[70-73]  
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The mechanism of coupling in Figure 6.19 may be used to describe the copper 
(I) catalysed cycloaddition between the azide and alkyne to form a triazole.  First step in 
the reaction is the coordination of the alkyne (8-(4-ethynylphenyl)-2’-deoxyguanosine) 
to the copper (I) catalyst, by removal of one of the copper ligands to give the copper 
acetylide.  Next the azide (5-azidofluorescein) replaces another one of the ligands and 
the copper complex binds to the nitrogen beside the carbon.  The terminal nitrogen on 
this complex proceeds to attack the second carbon of the copper acetylide to form the 
six-membered copper (III) intermediate.  Rearrangement of this ring gives the familiar 
5-membered triazole structure.  The final step sees the elimination of the compound by 
reductive elimination and regeneration the original copper (I) species.  Figure 6.20, 
shows the mechanism used to describe the formation the tetrazole heterocyclic ring. 
 
 
 
Figure 6.19: Schematic diagram illustrating the general mechanism of reaction for the 
Huisgen reaction between azides and alkynes to form a triazole linker.[74] 
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Figure 6.20: Mechanism for the formation of a 1,5-tetrazole cross-coupling linker. 
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 In the preparation of 8-(4-phenyl(1,3-triazole))-5-fluorescein-2’-deoxyguanosine 
neither NMR or mass spectrometry or TLC analysis of the product indicated that the 
Click reaction had worked.  Alternative reaction conditions used copper iodide as a 
catalyst with heating to 60 oC for 12 hours but there was no evidence of the 
fluorescently coupled product.  In another experiment tetrakis(acetonitrile) copper(I) 
hexaflurophosphate and elementary copper wire were used as catalysts in a solution of 
dichloromethane : methanol (4:1) with heating to 50 oC for 12 hours but once again 
NMR and mass spectrometry analysis proved that the reaction had also not proceeded as 
intended.  The same may be said in the experiment in the synthesis of 8-(4-phenyl(1,5-
tetrazole))-5-fluorescein-2’-deoxyguanosine as analysis of the reaction product failed to 
give any indication that the product had been synthesised.   
 
 In a final effort to achieve the fluorescent nucleoside, next to consider was a 
reaction that required the full protection of the 8-bromo-2’-deoxyguanosine before any 
coupling reactions would take place.  This has the added advantages of the ability to 
purify the nucleoside at every stage by ordinary silica gel chromatography due to the 
non-polar nature of the compound.  It may also in turn lead to increased yields due to 
more selective coupling, as the majority of the protected deoxyguanosine molecules 
should be in cis confirmation leaving the site of reaction more accessible for coupling 
reactions to take place.  Also, for incorporation of any nucleoside into a sequence of 
DNA by polymerase chain reaction (PCR), the corresponding phosphoramidite must 
first be synthesised.  In order for this to occur, certain functional groups of the 
nucleoside must be protected.  Choosing to protect the nucleoside before any coupling 
reactions take place, would eliminate many further (de)protection reactions using a 
novel compound, and hence, may lead to a decrease in yields with every synthetic step.  
The Buchwald-Hartwig reaction was the final coupling reaction to be attempted. 
. 
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6.4.3.4 Synthetic Strategy 4: Buchwald-Hartwig coupling: 
 
Buchwald-Hartwig coupling is a coupling reaction between an aryl halide and 
amine in the presence of palladium catalyst and base to form a carbon-nitrogen bond.[75-
83]
  There are many examples throughout the literature of Buchwald-Hartwig reactions 
to link molecules to the C-8 position of purine bases in high yields.[17-20, 84-86] 
 
For the successful amination of the N2-isobutyryl- O6-benzyl-8-bromo-3’,5’-O-
bis(tert-butyldimethylsilyl)-2’-deoxyguanosine and 5-aminofluorescein one must fully 
protect the deoxyguanosine nucleoside prior to Buchwald-Hartwig coupling.  The O-
silylation of the 3’ and 5’ hydroxyl on the sugar moiety was performed using conditions 
described by Ludovic et al.[20] with relatively high yields of over 70%. 
 
Next step was the protection of the O6 atom on the base.  Initially 4-
cyanophenylethyl was used as the protecting group for the O6-postion as this group may 
be removed after the oligonucleotide synthesis using 1,8-diazabicycloundec-7-ene 
(DBU) and as a result would avoid a further deprotection step before phosphoramidite 
synthesis.[19]  Hence, the O6-(4-cyanophenyl)ethyl-8-bromo-3’,5’-O-bis(tert-
butyldimethylsilyl)-2’-deoxyguanosine was synthesised and isolated in a 52% yield 
[results not shown].  However, having researched the synthesis further it is the 
benzylalcohol O6-protecting group that is more widely used throughout the literature.[17, 
18, 20, 85, 86]
  Even though yields of both O6-protection were comparable, it was decided to 
use the benzylalcohol as the protecting group and the corresponding O6-benzyl-8-
bromo-3’,5’-O-bis(tert-butyldimethylsilyl)-2’-deoxyguanosine was prepared in 60% 
yield. 
 
Finally the exocyclic amino group was protected using isobutyric anhydride, 
however, as the reaction proceeded it was only the starting material of O6-benzyl-8-
bromo-3’,5’-O-bis(tert-butyldimethylsilyl)-2’-deoxyguanosine that was returned and 
reaction failed to work satisfactorily.  The stronger isobutyic chloride was then 
employed and the fully protected N2-isobutyryl- O6-benzyl-8-bromo-3’,5’-O-bis(tert-
butyldimethylsilyl)-2’-deoxyguanosine was isolated in a 50% yield. 
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Buchwald-Hartwig Catalytic Cycle: 
 
The palladium (II) catalyst (Pd2(dba)3) is initially reduced with the BINAP 
ligand to give the active palladium (0) species.  The catalytic cycle starts when the arly 
halide coordinates to the palladium (0) species in an oxidative addition reaction.  Next, 
coordination of the amine to the palladium complex occurs to give species number 3 in 
Figure 6.21.  A strong base is then required to abstract a proton from the amine of this 
species.  Under initial reaction conditions, K3PO4 was used as base but the reaction did 
not show any signs of progress by TLC.  It was only when the stronger base of NaOtBu 
was used that the reaction showed evidence of proceeding.  This intermediate then gives 
the desired aryl amine coupled product and regeneration the Pd(0)(BINAP) species by 
reductive elimination.  At this final reductive elimination step there may be a couple of 
undesired side reactions including β-hydride elimination to the arene compound or 
elimination of the imine compound.  In either case the zerovalent palladium species is 
regenerated and the catalytic cycle continues.[77, 80] 
 
 
 
 
Figure 6.21:  Schematic diagram illustrating the general mechanism of Buchwald-
Hartwig coupling reactions.[75]  
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6.4.3.4.1 Buchwald-Hartwig Results: 
 
HPLC method development:  
 
The following HPLC conditions were found to give the best separation of 
starting materials to determine their retention times and for the analysis of the coupled 
compound. 
 
Time (min) Flow Rate (ml/min) % Methanol % MilliQ Water 
0 1.8 85 15 
10 1.8 90 10 
20 1.8 95 5 
25 1.8 100 0 
35 1.8 100 0 
Table 6.6: Mobile phase gradient for the isolation of N2-isobutyryl- O6-benzyl-8N-(5-
aminofluorescein)-3’,5’-O-bis(tert-butyldimethylsilyl)-2’-deoxyguanosine. 
 
 
Injection of starting materials: 
 
Figure 6.22: HPLC chromatogram of N2-isobutyryl- O6-benzyl-8-bromo-3’,5’-O-
bis(tert-butyldimethylsilyl)-2’-deoxyguanosine using a detector wavelength of 254 nm.  
Rt = 24.8mins. 
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Figure 6.23: HPLC chromatogram of 5-aminofluorescein using a detector wavelength 
of 254 nm.  Rt = 1.9mins. 
 
 
Figure 6.24: HPLC chromatogram of 5-aminofluorescein using a detector wavelength 
of 490 nm.  Rt = 1.9mins. 
 
 
As with many of these coupling reactions, the conditions used are often very 
sensitive to the success of the coupling reaction and no more so than with the 
Buchwald-Hartwig amination.  Meyers et al.[87] even suggest that the supplier and 
particle size of the base can have an effect on the reaction mechanism.  However, it was 
felt that the choice of solvent can have the most profound effect on the amination 
reaction,[88] and hence, 5 small scale reactions were set-up using 5 different solvents 
covering a majority of the possibilities of polar aprotic, polar protic and nonpolar 
solvents.  The reactions were only analysed by HPLC in order to determine the best 
solvent, if any, to continue with this method of synthesis.  The anhydrous solvents used 
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in the coupling reactions were toluene (nonpolar), xylene (nonpolar), 1,4-dioxane (polar 
aprotic), methylpyrrolidone (polar aprotic) and dimethoxyethane (polar aprotic).  
Results suggested that it is toluene that gives cause for most optimism and the formation 
of the coupled product, and therefore, this solvent was used for the scaled up production 
of the fluorescently labelled nucleoside.  
 
The progress of the reaction was monitored by HPLC analysis, by diluting 1 µl 
of the reaction mixture into 2 ml of mobile phase and injecting onto the HPLC system.  
The reaction was deemed to be finished when the ratio of the two starting material 
peaks did not alter anymore, which was after a period of 48 hours.  The extraction of the 
reaction mixture into diethylether and methanol prior to injection onto the HPLC 
removed large quantities of the unreacted 5-aminofluorescein and catalytic mixture.  In 
order to identify the peak containing the product of interest, the HPLC was set up to 
collect multiple injections of the crude product in 6 different fractions (Figure 6.25).  
These were then evaporated to dryness and sent for NMR analysis.  Fraction 6, with a 
retention time of 29-33 minutes (Figure 6.25) also shows absorbance at 254 nm and 490 
nm.  This might be potentially expected from a chromatographic peak containing both 
the fluorescein and nucleoside moieties. 
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Figure 6.25: HPLC chromatogram of N2-isobutyryl- O6-benzyl-8N-(5-
aminofluorescein)-3’,5’-O-bis(tert-butyldimethylsilyl)-2’-deoxyguanosine crude 
reaction mixture using a detector wavelength of 254 nm. 
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 Following proton NMR analysis, the fractions were thought to contain the 
following compounds: 
 
Fraction 1 (ret. time: 0-3 minutes): evidence of 5-aminofluorescein. 
Fraction 2 (ret. time: 3-5.5 minutes): evidence of catalytic mixture. 
Fraction 3 (ret. time: 5.5-13.5 minutes): nothing detected. 
Fraction 4 (ret. time: 13.5-23 minutes): nothing detected. 
Fraction 5 (ret. time: 23-27 minutes): N2-Isobutyryl- O6-benzyl-8-bromo-3’,5’-O-
bis(tert-butyldimethylsilyl)-2’- deoxyguanosine 
Fraction 6 (ret. time: 27-35 minutes): evidence of the product N2-isobutyryl- O6-
benzyl-8N-(5-aminofluorescein)-3’,5’-O-bis(tert-butyldimethylsilyl)-2’-
deoxyguanosine. 
 
As fraction 6 was thought the most likely to contain the product, the fraction was 
then taken and re-injected to isolate the two peaks separately and both were sent for 
further NMR and mass spectrometry analysis.  Both NMR’s still showed evidence of 
product but they were still far from pure for incorporation into a sequence of DNA.  
However, it is the second peak of fraction 6 that gives most cause for optimism as the 
mass spectrum results in Figure 6.26 and the corresponding identification of peaks in 
Table 6.7 highlight. 
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Figure 6.26: Mass spectra of HPLC fraction 6 (peak 2) with retention time of 32 
minutes in the preparation of N2-isobutyryl- O6-benzyl-8N-(5-aminofluorescein)-3’,5’-
O-bis(tert-butyldimethylsilyl)-2’-deoxyguanosine.   
 
Mass Spec Peak Comments 
1074.7 m/z N2-Isobutyryl- O6-benzyl-8N-(5-
Aminofluorescein)-3’,5’-O-bis(tert-
butyldimethylsilyl)-2’-deoxyguanosine 
plus 2 chlorine ions 
1003.3 m/z N2-Isobutyryl- O6-benzyl-8N-(5-
Aminofluorescein)-3’,5’-O-bis(tert-
butyldimethylsilyl)-2’-deoxyguanosine. 
(product of interest) 
928.9 m/z Product minus exocyclic amino 
protecting group. 
894.5 m/z Product minus O6 Benzyl protecting 
group. 
820.7 m/z Product minus exocyclic amino and  O6 
Benzyl protecting groups. 
678.6 m/z Product minus fluorescein moiety. 
590.2 m/z Fully unprotected dG with coupled 
fluorescein. 
 
Table 6.7: Analysis of fragmentation patterns found for fraction 6 (peak 2) in the 
preparation of N2-isobutyryl- O6-benzyl-8N-(5-aminofluorescein)-3’,5’-O-bis(tert-
butyldimethylsilyl)-2’-deoxyguanosine.   
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Fraction 6 (peak 2) was once again re-injected in an effort to achieve improved 
purity of the coupled product.  However, both NMR and mass spectrometry still showed 
an impure product.  It is felt that the actual amount of pure product (if any) will prove to 
have a very low conversion yield overall making this labour intensive synthetic route 
difficult to justify the time and effort required.  Furthermore, a minimum of 100 mg of 
pure fluorescently coupled product would be required for incorporation of the 
fluorescent nucleoside into a sequence of DNA by PCR. 
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6.5 Conclusion 
 
 There have been many difficulties encountered throughout the duration of this 
aspect of the thesis leading to the inability to isolate the final coupled nucleoside in 
good yields for DNA sequencing.  This is despite having tried well known techniques 
such as Suzuki, Sonogashira, Click and Buchwald-Hartwig methods of coupling.  The 
sole commercially available internally labelled fluorescein nucleoside is illustrated in 
Figure 6.27 below.  However, the length of the linker is too long for its intended 
purpose and may only lead to self quenching of the fluorophores due to their close 
proximity to one another in the model photoantenna assembly.  
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Figure 6.27: Chemical structure of a commercial fluorescein modified deoxythymidine 
phosphoramidite. 
 
 
* Contact was made and numerous discussions held with companies who specialise in 
DNA modifications worldwide about the possibility of a purchasing a commercial 
fluorescent nucleoside.  Not one had anything similar in their catalogue or were willing 
to take on the project for less than 50,000 euro to achieve what was attempted here.   
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 The shortest internally labelled fluorescent nucleoside commercially available is 
a carboxyltetramethylrhodamine (TAMRA) dye conjugated to a deoxycytosine 
phosphoramidite (Figure 6.28).  As discussed above, this could prove to be quite useful 
as TAMRA is a well known FRET energy acceptor from a fluorescein donor molecule.  
As a result this may be used as the ‘black hole quencher’ located towards the terminal of 
the complimentary strand. 
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Figure 6.28: TAMRA modified deoxycytosine. 
 
 
 The synthetic aspect of the project has proven to be far more challenging than 
first considered and may take many more years before a fluorescein coupled 
phosphoramidite ready for DNA integration, via a short rigid linker, is achieved in 
manageable yields.  It has been shown that the coupling reaction itself has been 
somewhat successful with mass spectra analysis for both Sonogashira and Buchwald-
Hartwig coupling reactions indicating formation of the fluorescently conjugated 
nucleoside.  However, the significant difficulties in purification of the fluorescent 
nucleoside and associated low yields to date have resulted in the termination of this 
project within the group.  Should the coupling of a fluorescein molecule ever be 
achieved to the C-8 position of a nucleoside it would open up an area of synthetic 
chemistry that is very under researched and could have potential applications in a broad 
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range of scientific areas from photodynamic therapy for cancer research to light 
harvesting devices 
 
 If this synthetic route is to be successful more time and resources will have to be 
spent experimenting on a small scale initially with different reaction conditions 
including changing solvents, bases, additives, catalysts and in turn varying all of their 
chemical equivalences.  Or even the possibility of altering the base to a more reactive 
nucleoside or changing the fluorescent molecule itself, all of which will entail a 
significant body of work.  Above all, it is the Buchwald-Hartwig method of coupling 
that has shown the most promise out of all the coupling reactions attempted and there is 
no reason to suggest that another method of coupling might provide superior results.  
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Chapter 7: Conclusions and Future Work 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“There are three types of people in this world: those who make things happen, those 
who watch things happen and those who wonder what happened” – Mary Kay Ash. 
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7.0 Conclusions and Future Work 
 
 This thesis focussed on the assembly of supramolecular bioconjugates of metal 
complexes and also of fluorescein for application in cellular imaging and as model solar 
antennae respectively.  Chapter 3 detailed the synthesis and a detailed comparative 
study of the spectroscopic, photophysical and redox characterisation of a series of three 
water soluble photoactive ruthenium (II) polypyridyl complexes containing bipyridyl 
ligands and only differed in their terminal functionality on the pH sensitive phenthroline 
based ancillary ligand.  These complexes had been synthesised previously but this is the 
first study to compare their electronic and photophysical properties. The carboxyl and 
amino functional derivatives displayed many similar properties including long aqueous 
lifetime, red emission characteristics, large Stokes shifts and pH/oxygen sensitivity.  In 
contrast, the nitro functionalised complex, [Ru(bpy)2(picNO2)]2+, exhibited very weak 
emission intensity and short excited state lifetime attributed to the electron withdrawing 
ability of the nitro group which lead to an increase in non-radiative decay.   
 
 The purpose of synthesising amino and carboxy functionalised luminophores 
was to aid conjugation of these complexes into extended supramolecular structures for 
cell imaging probes via amide linkages.  In the second part of Chapter 3, the amino 
functionalised ruthenium (II) complex was conjugated to polyethylene glycol linkers of 
approximately 3 nm and 13 nm chain lengths with thiol termini to permit their assembly 
to 50 nm gold nanoparticles.  This allowed for the efficient transport, of an otherwise 
non-permeable luminophore, across the cellular membrane of mammalian cells.  
Preliminary studies on the influence of chain length on the photophysics of these 
assembly showed that at a distance of 3 nm from the gold metal substrate the 
luminescence of the ruthenium dye decreased, however, emission was not completely 
quenched.  Interestingly, both emission intensity and lifetime of the probe was enhanced 
at a distance of 13 nm (in linear conformation) from nanoparticle to luminophore, 
suggesting the close-packed nature of the monolayer rather than the nanoparticles itself 
exerts the greatest influence on the photophysics of the luminophore.  The nanoparticle 
conjugates were water soluble which aided study of their interactions with mammalian 
SP2 cells without the need to permeabalise the cell’s membrane.  Results showed that 
whereas the parent dye was unable to transport across the cell’s lipid bilayer the PEG 
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conjugated complex and the functionalised gold nanoparticles, were readily uptaken by 
the cells and distrubuted throughout the cytoplasm.  
 
Chapter 4 detailed the synthesis and characterisation of a series of novel water 
insoluble iridium (III) polypyridyl complexes.  It had been reported that many iridium 
(III) complexes exhibited favourable characteristics such as longer phosphorescent 
lifetimes, larger quantum yields and tunable emission from blue to red when compared 
to ruthenium metal complexes.  This proved to be the case with [Ir(dfpp)2(picCOOH)]+ 
as it displayed lifetimes and quantum yields in organic media above that of other 
ruthenium complexes synthesised as part if this thesis.  However, in aqueous solution 
this iridium complex did not exhibit lifetimes on par with other ruthenium complexes.  
This suggests that such an iridium probe may not be as well suited for the analysis of 
biological samples and furthermore, the wavelength of excitation necessary may not be 
as amiable to tissue sample as the ruthenium dyes synthesised.  However, 
[Ir(dfpp)2(picCOOH)]+, displayed pH sensitivity in both Raman spectra and lifetimes 
and Chapter 5 detailed its conjugation to a CPP for use as a molecular imaging probe.   
 
Unfortunately, the lifetimes and quantum yields of the other iridium (III) 
complexes synthesised, [Ir(dfpp)2(napthNO2)]+ and [Ir(dfpp)2(napthNH2)]+, were not as 
great as their unfunctionalised parent complex suggested.  Furthermore, without a pH 
sensitive ligand present, the use of such a luminescent molecular probe is limited and it 
was decided not to continue in efforts to label biomolecules with these particular 
iridium dyes.  However, to date there is very little published on the characterisation, 
especially Raman and FTIR characterisation, of iridium (III) complexes.  With this in 
mind, the three iridium complexes are currently undergoing DFT calculations and along 
with the existing photophysical and vibrational spectroscopy results a paper will be 
submitted to serve as a template for similar iridium complexes.   
 
Chapter 5 discussed the conjugation of ruthenium (II) and novel iridium (III) 
polypyridyl complexes synthesised in Chapters 3 & 4 to a CPP.  The conjugation of the 
carboxyl functionalised ruthenium complex to octarginine has been reported by our 
group previously as an efficient multimodal molecular probe in determining 
intercellular pH and oxygen levels within SP2 myeloma cells.  However, this is the first 
time to our knowledge that an iridium (III) probe has been successfully conjugated to a 
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CPP for the purposes of cellular imaging.  In SP2 and CHO cells, results showed how 
the lone parent dye complexes failed to transport efficiently across the cell membrane.  
However, upon conjugation to the octarginine peptide both ruthenium and iridium 
luminophores showed internalisation within the cell without the need for 
permeabalising the cellular structure.  One concern published in the literature on metal 
complexes in cellular imaging is the use of organic solvents, such as DMSO and 
ethanol, to aid solubility issues in cellular uptake experiments.  This concern is 
confirmed by experiments performed in Chapter 5 that illustrated the cytotoxic effect of 
such solvents towards SP2 and CHO cell lines.   
 
Conjugation of the iridium (III) dye to the polypeptide dramatically increased its 
aqueous solubility and with it, its ability to diffuse across the cell membrane of the 
mammalian cells without the need for organic solvents.  However, the ruthenium probe 
remains the more attractive proposition for use as a molecular imaging probe when 
compared to the iridium equivalent.  The ruthenium conjugate displayed an aqueous 
lifetime more then five times greater, however, its quantum yield is only 60% that seen 
for the iridium conjugate.   
 
Furthermore, the cytotoxicity of the iridium probe is far greater when compared 
to the ruthenium conjugate.  Extensive cell death was also exhibited in both SP2 and 
CHO cells at a final iridium conjugate concentration of 70 µM in times as short as 10 
minutes under 375 nm irradiation.  This was confirmed using a DRAQ7 localising dye, 
which only stains the nucleus of dead cells.  However, the ruthenium dye-peptide also 
exhibited increased cell death as a result of 375 nm irradiation when compared with 458 
nm excitation.  Interestingly, when no dye is present under continuous excitation at 375 
nm and 458 nm there is minimal evidence of cell death, as observed with the viability 
dye DRAQ7.  This suggests that the increased cell death of the iridium complexes is a 
result of the energy of excitation and also potentially due to a light activated process, 
which most likely thought to be the generation of singlet oxygen (1O2) through an 
electron and energy transfer process.  This is further supported by preliminary 
experiments using ascorbic acid as a singlet oxygen scavenger which has resulted in a 
reduction in cell cytotoxicity of the iridium peptide from 50% to 5% under similar 
experimental conditions preformed here.  Other explanations for its increased 
cytotoxicity may include the fluorination of the cyclometalating ligands, the larger 
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iridium metal centre and longer phosphorescent quantum yields and lifetimes under 
particular conditions that will also have an impact on the generation of singlet oxygen.   
 
Finally, the most ambitious synthetic aspect of this thesis saw the attempt in 
creating a model photoantenna based on an interfacial DNA scaffold in Chapter 6.  It 
was hoped that the immobilisation of a fluorescently modified DNA sequence would 
yield a supramolecular assembly capable of the conversion of light energy into electrical 
energy.  Unfortunately, the conjugation of the fluorescein moiety to deoxyguanosine via 
a short and rigid linker proved problematic.  Despite attempting many coupling 
techniques such as Suzuki coupling, Sonogashira coupling, click chemistry and 
Buchwald-Hartwig coupling the fluorescent nucleoside was never isolated in sufficient 
quantities for incorporation into a sequence of DNA.   
 
Future work to emerge from this thesis will focus on extending and quantifying 
the application of the probes produced here in cellular imaging.  For the supramolecular 
ruthenium-PEG modified nanoparticles, this work demonstrated that stable 
nanoparticles assemblies incorporating the ruthenium centres can be formed by the 
approached outlined here and that depending on chain length, the metal complex retains 
its photophysical properties.  The potential for these materials in multimodal SERS 
/luminescence imaging will be the main focus of future work in these materials as well 
as detailed studies of cellular uptake, cell viability and cell localisation studies.  
 
For the ruthenium and iridium peptide conjugates further work is ongoing 
concerning the attachment of target specific peptides to existing cell penetrating dye 
peptides with the intention of selectively targeting certain cell organelles.  In addition, it 
is proposed to study the singlet oxygen generating ability of these transition metal 
complexes that may possibly result in the targeted cell death of tumour cells.  Further 
experiments would include assessment of the iridium conjugate as a multimodal 
imaging probe to determine intracellular pH and oxygen levels using Raman and FLIM 
measurements respectively.  Additional experiments could also include photostability 
and bleaching studies of the molecular imaging probe.   
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For the DNA model photoantenna work, dye to the complexity of the synthesis, 
this work was terminated within the group but any potential future work on this aspect 
of the research should involve looking at using an alternative more reactive base, such 
as thymine, as guanine is known to be the most unreactive of the four bases.  Synthetic 
conditions such as reaction times, base used, catalytic equivalences etc. will also have to 
be studied in greater detail as they are known to play a critical role in the coupling 
reactions.  However, it is the Buchwald-Hartwig method of coupling that gives rise to 
the most promise and it is recommended that this method of coupling is pursued. 
 
Many of the supramolecular synthetic strategies attempted in this thesis have 
shown potential applications in solar energy conversion, enhancing emission 
efficiencies of photoactive components, increasing aqueous solubility of metal 
complexes and using inorganic complexes as multimodal imaging probes.  Of particular 
interest, this thesis detailed the ongoing intense efforts to come up with new dyes and 
multimodal strategies to aid biochemical understanding of cellular processes and 
medical diagnostics and described potential molecular probes capable of making 
advances in these areas.     
 
From solar energy conversion to biomedical diagnostics to multimodal cellular 
imaging, both inorganic and organic photoactive supramolecular assemblies have 
provided numerous fascinating applications in every aspect of science.  With the push to 
find alternative fuels, more sensitive and selective diagnostic devices and improving on 
existing technologies the research into photoactive supramolecular assemblies will only 
continue to intensify well into the future.  
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Appendix 1: NMR and Mass Spectrometry Results 
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Figure A1: 1H-NMR of [Ru(bpy)2Cl2)]2+  in DMSO-d6. 
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Table A1: 1H-NMR resonances for [Ru(bpy)2Cl2], carried out in DMSO-d6.  The 
integration and peak splitting are shown in brackets. 
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Figure A2: 1H-NMR of [picCOOH] ligand in DMSO-d6. 
 
 
 
 
Figure A3: 1H-NMR of [Ru(bpy)2(picCOOH)]2+ in DMSO-d6. 
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GB                    0
PC                 1.40
SI                 1024
MC2                  QF
SF          400.1300000 MHz
WDW                SINE
SSB                   0
LB                 0.00 Hz
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Figure A4: COSY 45 spectrum of [Ru(bpy)2(picCOOH)]2+ in DMSO-d6. 
 
 
 
 
Figure A5: Mass spectrum of [Ru(bpy)2(picCOOH)]2+. 
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Figure A6: 1H-NMR of [picNO2] ligand in DMSO-d6. 
 
 
 
Figure A7: Mass spectrum of [picNO2] ligand. 
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Figure A8: 1H-NMR of [Ru(bpy)2(picNO2)]2+ in DMSO-d6. 
 
 
 
Figure A9: Mass spectrum of [Ru(bpy)2(picNO2)]2+. 
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Figure A10: 1H-NMR of [picNH2] ligand in DMSO-d6. 
 
 
 
Figure A11: Mass spectrum of [picNH2] ligand. 
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Figure A12: 1H-NMR of [Ru(bpy)2(picNH2)]2+ in DMSO-d6. 
 
 
Figure A13: Mass spectrum of [Ru(bpy)2(picNH2)]2+. 
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Figure A14: 1H-NMR of 2-(4,6-difluorophenyl)pyridine [dfpp] in DMSO-d6. 
 
 
 
Figure A15: 1H-NMR of [Ir2(dfpp)4(Cl2)] in DMSO-d6. 
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Figure A16: 1H-NMR of [Ir(dfpp)2(picCOOH)]+ in DMSO-d6. 
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Figure A17: COSY 45 spectrum of [Ir(dfpp)2(picCOOH)]+ in DMSO-d6. 
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Figure A18: Mass spectrum of [Ir(dfpp)2(picCOOH)]+. 
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Figure A19: 1H-NMR of [NapthNO2] ligand  in DMSO-d6. 
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Figure A20: Mass spectrum of [NapthNO2] ligand. 
 
 
 
Figure A21: 1H-NMR of [Ir(dfpp)2(napthNO2)]  in CDCl3. 
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Figure A22: Mass spectrum of [Ir(dfpp)2(napthNO2)]. 
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Figure A23: 1H-NMR of [NapthNH2] ligand in DMSO-d6. 
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Figure A24: Mass spectrum of [NapthNH2] ligand. 
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Figure A25: 1H-NMR of [Ir(dfpp)2(napthNH2)]  in CDCl3. 
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Figure A26: Mass spectrum of [Ir(dfpp)2(napthNH2)]. 
 
 
 
 
 
 
 
Figure A27: 1H-NMR of 8-bromo-2’-deoxyguanosine in DMSO-d6. 
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Figure A28: 1H-NMR of 5-bromofluorescein diacetate in DMSO-d6. 
 
 
 
 
 
 
 
Figure A29: 1H-NMR of 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)fluorescein 
diacetate in DMSO-d6. 
. 
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Figure A30: 1H-NMR of 5-(2-trimethylsilylethynyl)fluorescein diacetate in DMSO-d6. 
 
 
 
 
 
Figure A31: 1H-NMR of 5-ethynylfluorescein in DMSO-d6. 
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Figure A32: Mass spectrum of 5-ethynylfluorescein. 
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Figure A33: 1H-NMR of 8-(4-ethynylphenyl)-2’-deoxyguanosine in DMSO-d6. 
 
 XIX 
 
 
Figure A34: 1H-NMR of 8-(4-cyanophenyl)-2’-deoxyguanosine in DMSO-d6. 
 
 
 
 
 
Figure A35: 1H-NMR of 5-azidofluorescein in DMSO-d6. 
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Figure A36: 1H-NMR of 8-bromo-3’,5’-O-bis(tert-butyldimethylsilyl)-2’-
deoxyguanosine in DMSO-d6. 
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Figure A37: 1H-NMR of O6-benzyl-8-bromo-3’,5’-O-bis(tert-butyldimethylsilyl)-2’-
deoxyguanosine in DMSO-d6. 
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Figure A38: 1H-NMR of N2-isobutyryl- O6-benzyl-8-bromo-3’,5’-O-bis(tert-
butyldimethylsilyl)-2’-deoxyguanosine in DMSO-d6. 
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Figure A39: Control cyclic voltammogram of acetonitrile (containing 0.1M TBA as 
electrolyte) with 1.5 mm glassy carbon working electrode and referenced against 
Ag/AgCl.  Scans were started in a positive direction from an initial potential of 0 V.  
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